data_2kgg_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kgg _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 N--CA 1.445 -0.721 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -87.37 -175.87 5.42 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.46 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.402 ' N ' ' SG ' ' A' ' 3' ' ' CYS . . . -90.65 119.68 31.09 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 178.34 134.24 0.08 Allowed 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 125.225 1.41 . . . . 0.0 107.956 172.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -49.41 -33.92 15.12 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 123.457 0.473 . . . . 0.0 111.433 176.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -133.3 92.07 2.95 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.948 174.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.487 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 44.4 t -95.41 119.19 33.49 Favored 'General case' 0 N--CA 1.413 -2.284 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.129 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -69.09 -10.69 58.87 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.387 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.563 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 68.3 mtm180 49.38 46.03 3.38 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.563 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 3.2 Cg_exo -78.48 132.05 10.88 Favored 'Trans proline' 0 C--O 1.266 1.912 0 C-N-CA 121.521 1.48 . . . . 0.0 110.755 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.3 t -116.42 111.02 19.43 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -138.41 156.1 47.89 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -91.47 -6.62 52.37 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.078 0.466 . . . . 0.0 110.394 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -114.03 16.18 18.26 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.35 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.418 ' O ' HG12 ' A' ' 16' ' ' VAL . 8.1 p -107.83 106.13 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 121.832 0.825 . . . . 0.0 111.071 178.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -71.84 146.13 48.17 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.983 173.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -108.87 160.74 15.75 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 124.556 1.142 . . . . 0.0 110.261 -174.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.3 m -124.31 139.19 51.4 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.535 0 CA-C-O 120.651 0.263 . . . . 0.0 111.09 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -106.97 139.48 41.31 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.44 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.1 p -91.27 102.02 14.73 Favored 'General case' 0 C--O 1.256 1.407 0 C-N-CA 119.012 -1.075 . . . . 0.0 109.727 175.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -83.41 24.68 0.81 Allowed 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.386 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.32 -4.42 61.02 Favored Glycine 0 N--CA 1.432 -1.605 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.229 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.08 -20.18 1.94 Allowed Glycine 0 CA--C 1.539 1.533 0 C-N-CA 118.898 -1.62 . . . . 0.0 116.056 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.44 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 12.0 m -91.0 -34.05 15.29 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 118.806 1.303 . . . . 0.0 109.558 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 62.6 21.01 12.41 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.494 -176.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -88.08 159.41 18.26 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.257 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -108.96 130.14 55.45 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.273 0.559 . . . . 0.0 111.95 -176.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -118.47 157.46 27.19 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.975 -1.012 . . . . 0.0 109.82 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.96 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 40.3 m80 -92.11 140.32 29.76 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 173.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -62.43 -36.8 83.52 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 33' ' ' CYS . 8.7 p -75.57 -40.76 41.31 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.662 0 O-C-N 121.243 -0.911 . . . . 0.0 111.873 176.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.96 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 9.2 p -72.09 -32.91 67.46 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.706 -173.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.467 ' CG1' HG23 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -104.95 3.2 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-O 121.135 0.493 . . . . 0.0 110.884 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.65 72.86 0.61 Allowed Glycine 0 CA--C 1.557 2.689 0 N-CA-C 116.129 1.211 . . . . 0.0 116.129 -176.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.467 HG23 ' CG1' ' A' ' 34' ' ' VAL . 78.8 t -130.3 145.23 35.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 56.7 p -97.95 151.01 37.34 Favored Pre-proline 0 N--CA 1.428 -1.544 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 176.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.36 -21.8 54.94 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 122.705 2.27 . . . . 0.0 111.551 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -73.64 -35.2 65.25 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.641 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.425 ' HE2' HG11 ' A' ' 36' ' ' VAL . 36.7 ttp -72.96 -38.9 66.56 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -176.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.88 -46.21 82.03 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.782 -1.099 . . . . 0.0 112.434 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -83.13 -17.5 42.78 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -112.55 -30.12 7.23 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -173.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -123.03 168.54 12.22 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.554 0.692 . . . . 0.0 112.728 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -90.03 115.35 27.24 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.405 -1.27 . . . . 0.0 109.214 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 51.2 t80 -79.34 108.89 13.2 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -178.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.9 mm -96.02 141.73 14.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 173.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.6 p -103.3 177.05 4.95 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.057 -176.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.2 tt -56.12 -38.13 52.35 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 O-C-N 123.887 0.742 . . . . 0.0 112.346 177.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -77.88 -34.19 51.67 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 122.212 -0.305 . . . . 0.0 111.37 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 61.6 m -72.21 -29.52 64.04 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.571 0.7 . . . . 0.0 110.301 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.074 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.828 -176.017 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.4 t . . . . . 0 N--CA 1.44 -0.955 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.69 -173.96 3.32 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -177.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.65 119.98 32.61 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -177.55 144.15 0.38 Allowed 'General case' 0 CA--C 1.501 -0.912 0 C-N-CA 124.23 1.012 . . . . 0.0 108.76 172.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -47.88 -44.09 29.17 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 123.925 0.766 . . . . 0.0 110.468 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -135.53 102.29 5.07 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.328 173.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.534 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 43.3 t -95.52 118.88 33.04 Favored 'General case' 0 N--CA 1.407 -2.599 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.834 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -69.38 -9.42 53.39 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.834 178.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.564 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 79.1 ttt180 46.38 51.55 10.08 Favored Pre-proline 0 CA--C 1.574 1.897 0 C-N-CA 125.036 1.335 . . . . 0.0 112.692 -175.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 2.7 Cg_exo -81.61 134.42 8.68 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 121.839 1.693 . . . . 0.0 109.927 177.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 45.4 t -130.05 113.76 14.94 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -138.63 170.82 15.32 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -71.97 -59.46 2.73 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 171.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -74.56 87.87 2.14 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.29 177.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.2 p -172.28 100.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 122.109 0.957 . . . . 0.0 112.654 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -70.14 138.68 52.1 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.461 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 15.9 m95 -103.76 160.19 14.99 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 124.724 1.21 . . . . 0.0 108.552 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.5 m -126.02 139.63 50.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.574 0.226 . . . . 0.0 110.41 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -108.93 138.23 45.6 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.7 p -89.02 105.48 17.81 Favored 'General case' 0 C--O 1.249 1.037 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.145 177.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -85.1 22.81 1.35 Allowed 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 121.423 0.63 . . . . 0.0 110.25 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 21' ' ' CYS . . . -92.53 -13.69 56.64 Favored Glycine 0 N--CA 1.426 -1.994 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.562 -178.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.63 -27.71 0.42 Allowed Glycine 0 CA--C 1.533 1.205 0 C-N-CA 118.79 -1.672 . . . . 0.0 115.813 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.455 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 9.4 m -88.89 -30.14 19.11 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 118.533 1.167 . . . . 0.0 110.609 -176.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 60.63 19.15 9.11 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.723 0.809 . . . . 0.0 111.939 -175.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -90.0 163.48 14.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.446 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -108.66 128.94 55.29 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.504 -175.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -120.22 159.78 24.25 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.745 -176.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.96 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 44.9 m80 -95.76 138.57 33.23 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 173.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.536 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 48.9 mt-30 -54.52 -50.06 68.75 Favored 'General case' 0 C--O 1.19 -2.07 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 177.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 p -67.45 -41.95 86.64 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.305 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.96 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 6.6 p -70.67 -27.84 64.34 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.384 -175.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.482 HG22 ' HH ' ' A' ' 46' ' ' TYR . 1.4 p -106.9 11.6 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.871 0 CA-C-O 121.311 0.577 . . . . 0.0 110.574 178.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.67 38.32 95.5 Favored Glycine 0 CA--C 1.547 2.032 0 N-CA-C 117.25 1.66 . . . . 0.0 117.25 177.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.475 HG21 HG12 ' A' ' 34' ' ' VAL . 77.6 t -97.4 149.2 5.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 123.536 0.735 . . . . 0.0 109.44 176.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.4 p -99.73 152.14 37.71 Favored Pre-proline 0 N--CA 1.421 -1.907 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 24.9 Cg_endo -59.14 -22.32 63.77 Favored 'Trans proline' 0 N--CA 1.482 0.833 0 C-N-CA 122.173 1.915 . . . . 0.0 112.163 -178.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -73.8 -34.0 64.44 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.857 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.463 ' HE3' HG13 ' A' ' 36' ' ' VAL . 50.3 ttp -73.77 -39.33 64.27 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.422 -175.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.44 -48.02 77.89 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -175.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -89.0 -14.21 37.05 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -110.05 -31.26 7.43 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -173.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -128.48 165.87 19.86 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 118.289 0.495 . . . . 0.0 112.153 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -75.2 115.31 14.7 Favored 'General case' 0 C--O 1.248 0.977 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.578 -176.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.482 ' HH ' HG22 ' A' ' 34' ' ' VAL . 79.9 t80 -79.54 108.93 13.45 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.938 0.875 . . . . 0.0 112.265 175.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.0 mm -105.45 148.73 9.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 173.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.3 p -109.24 177.3 4.8 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 119.238 0.926 . . . . 0.0 108.935 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.7 tt -55.94 -41.72 68.59 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 C-N-CA 124.026 0.93 . . . . 0.0 112.491 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -75.0 -32.67 61.7 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.13 0.491 . . . . 0.0 111.003 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 66.7 m -76.27 -28.91 57.23 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.827 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.519 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.264 -176.914 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.449 -0.508 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -96.84 -172.5 2.48 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 119.394 -0.922 . . . . 0.0 108.62 -178.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.14 118.69 26.7 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -177.22 145.96 0.48 Allowed 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 171.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -48.6 -44.16 36.77 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.689 0.757 . . . . 0.0 109.118 173.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -131.55 101.52 5.54 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.159 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.501 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 50.5 t -98.34 112.23 24.3 Favored 'General case' 0 N--CA 1.406 -2.66 0 C-N-CA 118.36 -1.336 . . . . 0.0 110.262 177.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -67.12 -11.57 57.6 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.48 -1.237 . . . . 0.0 111.191 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.557 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 65.3 mtp180 52.34 44.76 2.21 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 123.834 0.854 . . . . 0.0 111.881 -173.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.557 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 23.7 Cg_exo -65.58 131.76 28.84 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 121.134 1.223 . . . . 0.0 110.341 -176.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 86.1 m -114.47 98.16 6.74 Favored 'General case' 0 N--CA 1.413 -2.292 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.885 -177.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -136.21 153.05 51.34 Favored 'General case' 0 CA--C 1.479 -1.753 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 172.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -81.13 -43.11 19.88 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 176.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -85.23 87.9 7.43 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.7 p -168.76 112.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.569 0.699 . . . . 0.0 111.427 177.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -74.22 144.79 44.56 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.685 -1.143 . . . . 0.0 112.852 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -110.31 159.94 16.98 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 125.2 1.4 . . . . 0.0 109.331 -176.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.6 m -126.62 137.09 58.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.062 0.458 . . . . 0.0 110.625 -178.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 52.0 tt0 -104.57 139.09 39.96 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 176.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.6 p -88.01 99.93 12.53 Favored 'General case' 0 C--O 1.25 1.085 0 C-N-CA 118.261 -1.376 . . . . 0.0 110.006 176.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -80.9 19.36 0.87 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.971 -176.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 21' ' ' CYS . . . -102.35 3.25 50.6 Favored Glycine 0 N--CA 1.418 -2.507 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.697 -177.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 152.6 -34.33 0.82 Allowed Glycine 0 CA--C 1.536 1.402 0 C-N-CA 118.183 -1.961 . . . . 0.0 116.551 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.478 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 5.1 m -94.51 -30.11 14.58 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 118.799 1.3 . . . . 0.0 110.033 -176.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 60.31 22.09 11.57 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.577 0.751 . . . . 0.0 112.377 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 20' ' ' GLN . 46.2 mt-10 -86.65 164.78 16.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.483 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -108.46 123.39 48.81 Favored 'General case' 0 C--O 1.245 0.836 0 O-C-N 123.575 0.547 . . . . 0.0 111.681 -174.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -117.63 160.07 21.89 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.562 -176.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.949 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 40.0 m80 -94.4 138.74 31.98 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 173.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -55.43 -48.36 74.55 Favored 'General case' 0 C--O 1.184 -2.365 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.216 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.407 HG13 ' N ' ' A' ' 33' ' ' CYS . 11.0 p -69.54 -38.27 76.42 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.272 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.287 -178.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.949 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 4.4 p -73.67 -28.97 62.04 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.811 -174.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.548 ' CG1' HG21 ' A' ' 36' ' ' VAL . 1.6 p -105.95 7.61 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.697 0 CA-C-O 121.524 0.678 . . . . 0.0 109.982 178.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.33 45.1 95.82 Favored Glycine 0 CA--C 1.546 1.984 0 N-CA-C 116.627 1.411 . . . . 0.0 116.627 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.548 HG21 ' CG1' ' A' ' 34' ' ' VAL . 84.4 t -96.2 148.17 5.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 173.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.5 p -100.86 153.03 37.97 Favored Pre-proline 0 N--CA 1.425 -1.711 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 175.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -48.48 -39.83 36.66 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 123.267 2.644 . . . . 0.0 112.813 -176.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 43.1 mt-10 -65.92 -31.0 71.67 Favored 'General case' 0 C--O 1.202 -1.428 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.457 ' HB3' HG11 ' A' ' 36' ' ' VAL . 38.2 ttp -73.54 -33.96 64.97 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 118.481 -1.288 . . . . 0.0 108.77 -176.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.84 -47.85 79.1 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.467 175.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -86.93 -27.93 23.05 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -176.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 39' ' ' GLU . 15.9 m120 -105.99 -27.41 11.18 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -171.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -127.69 173.37 9.98 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 119.821 -0.752 . . . . 0.0 112.32 -175.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -86.2 116.03 24.13 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.895 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.436 ' HH ' HG21 ' A' ' 34' ' ' VAL . 85.8 t80 -75.38 114.9 14.45 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 122.237 1.018 . . . . 0.0 113.301 178.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.8 mm -110.13 145.68 16.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 175.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.457 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 11.0 p -109.61 179.55 4.1 Favored 'General case' 0 C--O 1.217 -0.633 0 O-C-N 121.292 -0.88 . . . . 0.0 109.306 -176.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.6 tt -54.97 -40.16 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.512 0 C-N-CA 124.157 0.983 . . . . 0.0 112.626 177.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -78.06 -30.51 49.77 Favored 'General case' 0 C--O 1.212 -0.883 0 CA-C-O 120.911 0.386 . . . . 0.0 110.65 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.457 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 65.5 m -78.27 -31.09 48.88 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.054 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.669 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.582 -176.46 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 C--O 1.235 0.309 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.406 ' SG ' ' HA ' ' A' ' 29' ' ' PHE . 0.5 OUTLIER -93.74 -172.16 2.8 Favored 'General case' 0 C--O 1.255 1.361 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -178.435 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.8 119.07 30.72 Favored 'General case' 0 C--O 1.2 -1.504 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 176.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -176.68 142.85 0.43 Allowed 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 172.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -48.71 -44.67 38.34 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.613 0.765 . . . . 0.0 109.749 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -128.84 98.12 4.87 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.649 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.539 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 50.5 t -99.26 112.11 24.34 Favored 'General case' 0 N--CA 1.413 -2.307 0 C-N-CA 117.941 -1.504 . . . . 0.0 111.242 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -69.76 -7.89 43.41 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.608 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.591 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 76.7 mtp180 53.08 42.39 1.19 Allowed Pre-proline 0 CA--C 1.573 1.848 0 C-N-CA 124.348 1.059 . . . . 0.0 113.438 -175.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.591 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 11.8 Cg_exo -71.76 136.52 28.05 Favored 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 121.866 1.711 . . . . 0.0 111.951 -176.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 51.3 t -126.48 116.58 21.34 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.497 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -148.73 164.07 35.45 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 176.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -85.64 -7.66 58.7 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 176.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -128.73 88.49 2.74 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 114.691 -1.141 . . . . 0.0 108.698 -177.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.499 HG13 ' O ' ' A' ' 16' ' ' VAL . 6.9 p -178.14 96.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.657 0 CA-C-O 121.637 0.732 . . . . 0.0 110.124 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.79 144.01 57.39 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -109.16 159.52 16.84 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.242 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.8 m -129.58 135.36 61.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.036 0.446 . . . . 0.0 111.002 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -100.28 139.28 36.19 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 176.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.544 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.3 p -89.7 102.7 15.39 Favored 'General case' 0 C--O 1.258 1.55 0 C-N-CA 118.617 -1.233 . . . . 0.0 110.742 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.64 18.79 0.54 Allowed 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.841 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 21' ' ' CYS . . . -92.76 -10.26 60.35 Favored Glycine 0 N--CA 1.426 -1.988 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.886 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 147.06 -16.01 1.53 Allowed Glycine 0 C--O 1.213 -1.164 0 C-N-CA 118.459 -1.829 . . . . 0.0 116.486 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.544 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 13.6 m -92.29 -28.92 16.66 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.023 1.412 . . . . 0.0 109.332 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 58.68 18.5 5.96 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 124.289 1.036 . . . . 0.0 112.148 -174.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -84.16 162.26 20.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.291 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -108.89 126.56 53.19 Favored 'General case' 0 C--O 1.246 0.916 0 CA-C-O 121.302 0.572 . . . . 0.0 112.036 -175.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.406 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . 2.8 m-85 -118.78 161.05 20.77 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.351 -177.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.948 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 45.7 m80 -95.64 142.56 27.81 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.418 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 48.6 mt-30 -58.04 -48.44 80.07 Favored 'General case' 0 C--O 1.189 -2.124 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.7 p -70.16 -38.61 75.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.236 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.948 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 2.9 p -72.74 -31.72 65.16 Favored 'General case' 0 C--O 1.213 -0.817 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.665 -173.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.512 HG22 ' HH ' ' A' ' 46' ' ' TYR . 1.7 p -104.09 5.35 10.45 Favored 'Isoleucine or valine' 0 C--O 1.254 1.311 0 CA-C-O 121.219 0.533 . . . . 0.0 110.361 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.35 70.91 0.89 Allowed Glycine 0 CA--C 1.54 1.618 0 CA-C-N 115.079 -0.964 . . . . 0.0 115.014 -176.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.507 HG21 ' CG1' ' A' ' 34' ' ' VAL . 54.5 t -119.38 147.65 22.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 174.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.7 p -98.1 151.98 37.8 Favored Pre-proline 0 N--CA 1.426 -1.647 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -51.12 -36.8 56.45 Favored 'Trans proline' 0 N--CA 1.483 0.908 0 C-N-CA 123.052 2.501 . . . . 0.0 112.831 -176.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -73.13 -26.87 61.38 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.471 ' HE1' HG13 ' A' ' 36' ' ' VAL . 46.6 ttp -73.84 -34.19 64.44 Favored 'General case' 0 C--O 1.209 -1.071 0 C-N-CA 118.583 -1.247 . . . . 0.0 108.339 -177.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.6 -45.01 81.68 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -94.78 -32.27 13.38 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -98.05 -22.86 16.02 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -170.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -128.37 168.12 16.01 Favored 'General case' 0 C--N 1.311 -1.109 0 C-N-CA 119.92 -0.712 . . . . 0.0 112.12 -176.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -89.74 120.34 30.92 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.831 -174.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.512 ' HH ' HG22 ' A' ' 34' ' ' VAL . 89.0 t80 -81.97 108.23 15.31 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.5 mm -101.02 146.72 8.99 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 172.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.534 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 10.2 p -111.41 178.66 4.26 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 121.095 -1.003 . . . . 0.0 108.885 -177.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.9 tt -54.1 -42.36 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.358 0 C-N-CA 124.028 0.931 . . . . 0.0 112.315 177.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -76.78 -34.76 57.98 Favored 'General case' 0 C--O 1.212 -0.874 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.215 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.534 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 59.4 m -72.56 -26.03 61.58 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 121.164 0.507 . . . . 0.0 111.258 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.103 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.545 -179.023 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 57.8 t . . . . . 0 N--CA 1.446 -0.662 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -90.79 -172.16 3.28 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.17 119.48 31.85 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -176.58 146.49 0.6 Allowed 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.45 0.7 . . . . 0.0 109.237 172.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -47.65 -40.7 20.48 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 124.083 0.953 . . . . 0.0 109.834 174.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -139.46 111.55 7.45 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.244 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.548 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 46.8 t -106.15 116.06 31.28 Favored 'General case' 0 N--CA 1.416 -2.154 0 C-N-CA 117.93 -1.508 . . . . 0.0 112.355 177.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -72.89 -9.28 58.52 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 113.906 -1.497 . . . . 0.0 111.216 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.557 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 82.1 mtp180 53.21 51.85 9.51 Favored Pre-proline 0 N--CA 1.493 1.709 0 C-N-CA 124.175 0.99 . . . . 0.0 112.821 -174.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.557 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 4.2 Cg_exo -80.79 131.84 8.35 Favored 'Trans proline' 0 C--O 1.261 1.672 0 C-N-CA 122.032 1.821 . . . . 0.0 110.474 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 51.6 t -125.12 111.07 14.89 Favored 'General case' 0 N--CA 1.427 -1.613 0 O-C-N 123.661 0.601 . . . . 0.0 110.174 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.421 ' O ' HG13 ' A' ' 16' ' ' VAL . 97.1 mttt -140.35 157.53 45.41 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 175.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -87.81 2.86 50.28 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.082 0.468 . . . . 0.0 111.285 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -117.65 5.79 12.39 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.531 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.43 ' O ' HG12 ' A' ' 16' ' ' VAL . 7.9 p -97.38 105.37 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-O 121.978 0.894 . . . . 0.0 111.699 -178.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -76.17 153.31 36.27 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.629 175.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -115.23 159.55 20.83 Favored 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 124.445 1.098 . . . . 0.0 110.213 -172.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.3 m -127.44 138.91 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-O 120.738 0.304 . . . . 0.0 110.244 -177.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -106.56 139.35 41.16 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.498 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.6 p -90.0 103.51 16.17 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 118.89 -1.124 . . . . 0.0 109.113 174.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.0 26.96 0.57 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.812 0.845 . . . . 0.0 111.152 -175.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -111.21 7.25 28.81 Favored Glycine 0 N--CA 1.429 -1.774 0 CA-C-N 115.468 -0.787 . . . . 0.0 113.311 -176.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 148.45 -39.7 0.96 Allowed Glycine 0 CA--C 1.535 1.34 0 C-N-CA 118.116 -1.993 . . . . 0.0 115.375 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.498 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 7.9 m -85.88 -34.75 20.91 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 118.168 0.984 . . . . 0.0 108.457 -176.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 57.46 25.03 10.92 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.042 -177.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -87.51 168.35 13.15 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.949 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -110.87 126.42 54.66 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 122.782 0.433 . . . . 0.0 111.499 -176.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -118.83 159.27 24.05 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.689 -174.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 1.007 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 35.1 m80 -96.59 137.15 36.1 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 174.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.445 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 50.6 mt-30 -52.84 -46.43 67.8 Favored 'General case' 0 C--O 1.188 -2.156 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.3 p -72.97 -40.35 59.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 O-C-N 121.406 -0.809 . . . . 0.0 112.299 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 1.007 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 12.0 p -70.82 -27.59 63.99 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.87 -174.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.494 HG21 ' HH ' ' A' ' 46' ' ' TYR . 1.4 p -108.55 7.97 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 CA-C-O 121.394 0.616 . . . . 0.0 110.721 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.01 64.66 4.09 Favored Glycine 0 CA--C 1.559 2.828 0 N-CA-C 116.481 1.352 . . . . 0.0 116.481 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.655 HG12 ' SD ' ' A' ' 40' ' ' MET . 79.2 t -117.18 146.73 21.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 125.75 1.62 . . . . 0.0 107.193 175.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.0 p -98.31 155.42 36.91 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 177.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -55.54 -31.88 80.47 Favored 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 122.959 2.439 . . . . 0.0 113.142 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 45.6 mt-10 -71.83 -28.63 63.7 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 120.951 0.405 . . . . 0.0 110.79 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.655 ' SD ' HG12 ' A' ' 36' ' ' VAL . 28.2 ttt -69.99 -46.89 64.2 Favored 'General case' 0 C--O 1.208 -1.126 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -176.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.95 -45.25 90.93 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -86.31 -14.65 43.01 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -177.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 39' ' ' GLU . 93.0 m-20 -119.16 -34.33 3.9 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -174.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -124.6 158.55 32.79 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -172.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -72.23 114.23 10.12 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.794 -176.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.494 ' HH ' HG21 ' A' ' 34' ' ' VAL . 77.2 t80 -80.26 112.1 17.27 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 122.166 0.984 . . . . 0.0 113.438 177.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.1 mm -112.93 140.93 30.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 174.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.5 p -96.97 176.39 5.98 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -174.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.7 tt -54.06 -38.01 36.55 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 C-N-CA 123.965 0.906 . . . . 0.0 112.721 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -80.61 -30.82 36.79 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.0 0.429 . . . . 0.0 111.136 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 84.5 m -78.35 -27.83 47.09 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.323 0.582 . . . . 0.0 111.129 176.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.867 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.748 -177.758 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 49.0 t . . . . . 0 N--CA 1.442 -0.857 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.02 -176.3 4.85 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.04 -175.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.3 119.67 33.41 Favored 'General case' 0 C--O 1.198 -1.634 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -175.37 148.79 0.97 Allowed 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 173.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -47.4 -42.82 22.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 123.958 0.786 . . . . 0.0 110.533 174.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -141.56 105.32 4.72 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.635 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.537 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 53.2 t -97.43 110.17 22.78 Favored 'General case' 0 N--CA 1.419 -2.02 0 C-N-CA 118.771 -1.172 . . . . 0.0 111.47 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.4 ' NE2' HG21 ' A' ' 32' ' ' VAL . 72.5 mt-30 -67.56 -8.34 33.32 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.6 1.16 . . . . 0.0 111.016 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.594 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 88.7 mtm180 51.0 44.54 2.23 Favored Pre-proline 0 CA--C 1.563 1.457 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -178.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.594 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 8.4 Cg_exo -76.36 137.4 18.75 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 122.205 1.937 . . . . 0.0 111.248 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 45.6 t -130.89 114.54 15.39 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.313 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -148.24 166.84 26.74 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -71.07 -61.69 1.67 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.728 0.775 . . . . 0.0 108.958 173.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -65.55 30.07 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 126.197 1.799 . . . . 0.0 115.53 -175.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.0 p -123.55 109.0 22.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 119.444 1.02 . . . . 0.0 112.983 178.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -73.94 146.62 43.79 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.231 -1.35 . . . . 0.0 111.928 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.0 m95 -113.13 159.21 19.47 Favored 'General case' 0 C--O 1.216 -0.699 0 C-N-CA 124.365 1.066 . . . . 0.0 109.047 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.3 m -125.05 138.02 55.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 O-C-N 121.945 -0.472 . . . . 0.0 110.535 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -105.76 138.94 41.1 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.4 p -91.92 107.28 19.09 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 119.329 -0.948 . . . . 0.0 110.742 178.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -87.86 27.02 1.22 Allowed 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.517 0.675 . . . . 0.0 110.312 -176.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.4 -7.9 57.84 Favored Glycine 0 N--CA 1.425 -2.086 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.377 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 151.16 -20.82 0.96 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 118.899 -1.62 . . . . 0.0 115.65 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.481 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 8.4 m -94.32 -32.19 13.73 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 118.771 1.286 . . . . 0.0 111.478 -176.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 60.42 19.54 9.2 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 123.856 0.862 . . . . 0.0 111.905 -174.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -86.68 161.11 18.62 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.236 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 80.0 m95 -105.97 127.16 52.97 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.235 -176.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -120.12 157.71 28.42 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.112 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.921 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 51.9 m80 -93.09 138.72 31.28 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 174.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.474 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 48.1 mt-30 -52.88 -55.19 25.01 Favored 'General case' 0 C--O 1.198 -1.632 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 177.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.4 HG21 ' NE2' ' A' ' 9' ' ' GLN . 7.3 p -65.65 -36.96 78.85 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.489 0 CA-C-O 121.736 0.779 . . . . 0.0 111.755 -177.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.921 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 1.7 p -73.95 -24.65 59.67 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.045 -175.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.514 HG23 ' HH ' ' A' ' 46' ' ' TYR . 1.7 p -111.31 12.51 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.834 0 CA-C-O 121.484 0.659 . . . . 0.0 110.875 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.12 36.19 91.55 Favored Glycine 0 CA--C 1.555 2.577 0 N-CA-C 117.598 1.799 . . . . 0.0 117.598 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.677 HG12 ' SD ' ' A' ' 40' ' ' MET . 94.3 t -97.03 144.05 11.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 174.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.3 p -98.93 152.14 37.68 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 176.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.474 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 17.8 Cg_endo -57.32 -26.8 72.37 Favored 'Trans proline' 0 N--CA 1.486 1.032 0 C-N-CA 122.409 2.072 . . . . 0.0 112.629 -177.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -74.97 -25.87 59.17 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 121.549 0.69 . . . . 0.0 109.94 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.677 ' SD ' HG12 ' A' ' 36' ' ' VAL . 28.0 ttt -73.71 -46.23 47.46 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 124.313 1.045 . . . . 0.0 110.114 -178.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.92 -47.15 81.28 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.243 -0.889 . . . . 0.0 112.021 -176.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -78.55 -13.39 59.85 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -116.11 -39.88 3.37 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 116.755 2.131 . . . . 0.0 116.755 -173.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -124.16 165.32 17.76 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.007 0.821 . . . . 0.0 112.641 -174.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -74.11 115.32 13.45 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.178 -177.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.514 ' HH ' HG23 ' A' ' 34' ' ' VAL . 81.1 t80 -72.28 111.52 7.56 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-O 121.946 0.879 . . . . 0.0 112.272 172.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.5 mm -108.44 138.54 34.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 174.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 11.1 p -98.21 176.23 5.8 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -174.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.6 tt -57.91 -35.87 53.56 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.644 0 C-N-CA 123.586 0.755 . . . . 0.0 112.276 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -79.66 -34.34 40.47 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 120.824 0.345 . . . . 0.0 110.774 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 59.4 m -72.18 -26.0 61.9 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 121.326 0.584 . . . . 0.0 110.539 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.804 -177.602 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 CA--C 1.518 -0.283 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' A' ' 4' ' ' ALA . 0.4 OUTLIER -87.88 -177.79 5.87 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.792 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.419 ' N ' ' SG ' ' A' ' 3' ' ' CYS . . . -90.54 120.04 31.3 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 178.73 135.34 0.09 Allowed 'General case' 0 C--O 1.214 -0.768 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 171.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -49.93 -42.64 48.79 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 120.983 0.421 . . . . 0.0 111.086 177.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -121.54 90.62 3.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.906 173.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.504 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 44.2 t -93.94 117.03 29.54 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.529 177.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -69.32 -8.0 42.28 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.019 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.571 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 29.7 mtm180 47.82 46.21 3.4 Favored Pre-proline 0 CA--C 1.563 1.461 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -175.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.571 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 4.2 Cg_exo -76.35 131.86 13.15 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 121.942 1.761 . . . . 0.0 111.87 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 53.4 t -121.4 114.89 21.93 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -146.01 157.54 43.87 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -76.99 -10.04 59.1 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.434 0.635 . . . . 0.0 110.827 177.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -124.51 84.73 2.31 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.159 177.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 16' ' ' VAL . 7.1 p -172.31 97.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 122.149 0.976 . . . . 0.0 111.239 176.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -71.06 146.66 49.17 Favored 'General case' 0 C--N 1.279 -2.464 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.242 174.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -107.01 159.51 16.23 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.482 -174.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.9 m -125.48 132.82 70.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 120.69 0.281 . . . . 0.0 110.573 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -99.34 137.87 37.23 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.0 p -86.98 104.45 16.31 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 118.681 -1.208 . . . . 0.0 110.077 176.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -82.46 16.99 1.87 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.849 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.96 -7.31 74.35 Favored Glycine 0 N--CA 1.431 -1.644 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.973 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.19 -13.24 1.86 Allowed Glycine 0 CA--C 1.54 1.63 0 C-N-CA 119.063 -1.541 . . . . 0.0 116.907 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.485 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 17.3 m -95.23 -27.65 15.41 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 119.669 1.734 . . . . 0.0 110.444 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 63.94 16.4 9.86 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.655 0.782 . . . . 0.0 111.53 -176.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -91.36 159.4 16.01 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -176.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -106.33 126.35 52.12 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.638 -175.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -118.05 159.06 23.85 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.629 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.95 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 36.5 m80 -93.51 139.2 31.01 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 174.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.469 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 50.5 mt-30 -57.63 -42.91 84.3 Favored 'General case' 0 C--O 1.192 -1.959 0 O-C-N 123.579 0.55 . . . . 0.0 112.077 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.413 HG11 ' N ' ' A' ' 33' ' ' CYS . 10.0 p -73.59 -41.02 55.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.603 -0.685 . . . . 0.0 112.197 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.95 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 11.3 p -71.55 -31.33 66.89 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.407 -173.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.52 HG21 ' HH ' ' A' ' 46' ' ' TYR . 1.2 p -104.23 6.51 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.715 0 CA-C-O 121.312 0.577 . . . . 0.0 111.066 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.29 67.75 1.96 Allowed Glycine 0 CA--C 1.547 2.093 0 N-CA-C 115.95 1.14 . . . . 0.0 115.95 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.488 HG23 ' CG1' ' A' ' 34' ' ' VAL . 70.6 t -124.22 149.51 28.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 174.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.1 p -103.81 151.61 38.86 Favored Pre-proline 0 N--CA 1.421 -1.884 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 175.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.469 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 73.3 Cg_exo -52.52 -22.97 17.93 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.771 2.314 . . . . 0.0 112.231 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.504 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 34.1 tt0 -74.1 -36.62 64.25 Favored 'General case' 0 C--O 1.187 -2.215 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.091 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.413 ' HB3' HG11 ' A' ' 36' ' ' VAL . 39.4 ttp -73.83 -37.64 64.79 Favored 'General case' 0 CA--C 1.503 -0.859 0 O-C-N 121.097 -1.002 . . . . 0.0 110.092 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.96 -48.59 78.01 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.154 -0.93 . . . . 0.0 113.242 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -94.6 -16.05 23.54 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 119.82 -0.752 . . . . 0.0 112.833 -176.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.504 ' HB2' ' O ' ' A' ' 39' ' ' GLU . 16.3 m120 -105.39 -19.09 13.9 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -173.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -138.3 177.02 8.19 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.174 0.512 . . . . 0.0 111.706 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -92.11 121.6 33.81 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.791 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.52 ' HH ' HG21 ' A' ' 34' ' ' VAL . 80.4 t80 -75.72 104.86 6.46 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.017 1.118 . . . . 0.0 114.017 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.9 mm -94.6 139.05 19.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 170.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.431 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 13.2 p -101.19 173.66 6.36 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 119.061 -1.056 . . . . 0.0 108.751 -177.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.4 tt -57.53 -37.51 58.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 123.057 0.543 . . . . 0.0 112.042 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -75.44 -29.79 59.8 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-O 120.981 0.419 . . . . 0.0 110.535 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.431 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 52.4 m -77.76 -27.38 50.34 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.296 0.57 . . . . 0.0 110.61 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.082 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.531 -176.481 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.4 t . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -88.75 -172.25 3.64 Favored 'General case' 0 C--O 1.248 1.023 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -177.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.59 119.79 33.06 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -179.98 132.02 0.1 Allowed 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 171.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -50.04 -42.82 50.33 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 121.411 0.624 . . . . 0.0 110.99 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -123.9 97.62 5.44 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 173.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.493 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 46.6 t -99.25 121.06 40.54 Favored 'General case' 0 N--CA 1.423 -1.821 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.238 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -70.41 -8.02 47.62 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 124.122 0.969 . . . . 0.0 110.29 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.536 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 32.8 ttp180 42.88 56.22 11.17 Favored Pre-proline 0 CA--C 1.568 1.663 0 C-N-CA 126.084 1.754 . . . . 0.0 114.592 -177.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.536 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 6.3 Cg_exo -87.87 144.96 6.45 Favored 'Trans proline' 0 C--O 1.26 1.577 0 C-N-CA 122.896 2.397 . . . . 0.0 112.307 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 59.0 m -127.44 125.73 41.08 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -144.15 162.13 37.08 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 176.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -84.55 -9.26 58.48 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 174.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -129.11 84.99 2.27 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.031 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.466 ' O ' HG12 ' A' ' 16' ' ' VAL . 8.1 p -172.02 104.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.738 0.78 . . . . 0.0 111.312 177.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -73.11 145.89 46.12 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.471 176.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -107.48 159.82 16.12 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 124.568 1.147 . . . . 0.0 109.206 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.9 m -123.06 141.95 41.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 120.607 0.242 . . . . 0.0 110.413 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 64.2 tt0 -112.28 139.32 47.93 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.446 ' C ' ' H ' ' A' ' 23' ' ' GLY . 29.1 p -89.6 105.58 17.89 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.806 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -77.58 29.1 0.16 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.869 0.868 . . . . 0.0 111.391 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.516 ' HA3' ' SG ' ' A' ' 51' ' ' CYS . . . -95.08 -22.78 21.94 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 141.51 1.82 1.38 Allowed Glycine 0 CA--C 1.542 1.745 0 C-N-CA 119.875 -1.155 . . . . 0.0 115.581 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.437 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 24.7 m -94.66 -29.69 14.7 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 118.74 1.27 . . . . 0.0 109.208 177.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 64.68 16.46 10.37 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.107 0.963 . . . . 0.0 112.117 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 20' ' ' GLN . 46.6 mt-10 -82.24 161.95 22.51 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.045 0.45 . . . . 0.0 111.638 -177.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -114.9 124.31 51.37 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.63 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -115.56 156.51 25.63 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -175.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.978 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 40.9 m80 -89.98 138.75 31.24 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -56.88 -49.93 74.04 Favored 'General case' 0 C--O 1.194 -1.835 0 O-C-N 123.537 0.523 . . . . 0.0 112.276 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.403 HG13 ' N ' ' A' ' 33' ' ' CYS . 12.9 p -67.55 -37.39 78.71 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.628 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.978 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 6.6 p -76.11 -25.58 55.55 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -175.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.503 HG23 ' HH ' ' A' ' 46' ' ' TYR . 0.8 OUTLIER -108.68 10.05 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.976 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.72 177.783 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.93 39.55 93.33 Favored Glycine 0 CA--C 1.549 2.214 0 N-CA-C 117.032 1.573 . . . . 0.0 117.032 178.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.474 HG22 ' CG1' ' A' ' 34' ' ' VAL . 85.1 t -96.25 145.44 8.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 117.742 0.771 . . . . 0.0 108.983 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.6 p -97.88 147.66 33.36 Favored Pre-proline 0 N--CA 1.414 -2.269 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.21 -25.08 62.65 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 C-N-CA 123.008 2.472 . . . . 0.0 112.497 -176.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -74.56 -29.49 61.37 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.441 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 37.3 ttp -74.6 -39.22 62.31 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-O 121.107 0.479 . . . . 0.0 110.509 -176.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.44 -45.29 80.87 Favored 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -87.62 -13.36 42.97 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -117.31 -20.93 8.96 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -172.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -135.07 164.02 28.59 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.22 -176.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -83.19 119.79 24.99 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.212 -175.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.503 ' HH ' HG23 ' A' ' 34' ' ' VAL . 77.6 t80 -76.64 114.13 15.05 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 122.124 0.964 . . . . 0.0 112.379 174.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.6 mm -109.97 143.75 19.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 173.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.405 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 11.5 p -104.72 172.54 6.73 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 118.671 -1.211 . . . . 0.0 109.379 -176.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.5 tt -52.44 -37.38 23.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 C-N-CA 124.052 0.941 . . . . 0.0 112.73 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -79.93 -29.67 39.81 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-O 121.099 0.476 . . . . 0.0 110.918 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.516 ' SG ' ' HA3' ' A' ' 23' ' ' GLY . 54.5 m -77.29 -31.44 54.79 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.339 178.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.865 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.567 -176.749 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.9 t . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.31 -173.0 2.23 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.239 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.93 120.54 35.33 Favored 'General case' 0 C--O 1.2 -1.548 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -173.81 145.52 1.15 Allowed 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 173.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -48.29 -39.12 20.67 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 123.515 0.509 . . . . 0.0 110.725 174.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -138.48 100.19 4.03 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.855 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.545 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 48.1 t -99.65 113.57 26.1 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 118.359 -1.336 . . . . 0.0 111.557 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -69.29 -10.77 59.39 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 124.889 1.276 . . . . 0.0 111.402 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.49 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 71.4 mtp180 47.32 54.77 15.96 Favored Pre-proline 0 N--CA 1.484 1.23 0 C-N-CA 123.692 0.797 . . . . 0.0 112.649 -172.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.49 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 14.1 Cg_exo -72.95 131.29 16.68 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 121.257 1.305 . . . . 0.0 110.559 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 81.1 m -111.67 105.48 14.01 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.442 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -143.66 143.09 31.29 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -68.67 -54.4 16.52 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 176.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -85.12 96.66 9.51 Favored 'General case' 0 N--CA 1.424 -1.73 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.633 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.5 p -168.66 116.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 123.482 0.713 . . . . 0.0 110.326 174.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -78.86 140.78 38.08 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.234 -0.894 . . . . 0.0 113.279 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -107.75 160.41 15.74 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 125.557 1.543 . . . . 0.0 108.429 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.7 m -124.43 138.46 53.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 117.962 0.346 . . . . 0.0 110.513 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.408 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 53.4 tt0 -106.44 138.82 41.92 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.456 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 30.6 p -90.23 113.86 25.75 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.979 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -85.67 27.6 0.84 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.813 0.845 . . . . 0.0 110.631 -177.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.437 ' HA3' ' SG ' ' A' ' 51' ' ' CYS . . . -96.63 -19.71 26.53 Favored Glycine 0 N--CA 1.432 -1.605 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.333 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.76 -14.81 0.91 Allowed Glycine 0 CA--C 1.539 1.556 0 C-N-CA 119.711 -1.233 . . . . 0.0 115.371 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.456 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 7.9 m -89.82 -29.62 18.5 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 118.709 1.254 . . . . 0.0 110.544 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 59.54 19.77 8.26 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.54 -177.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 20' ' ' GLN . 42.7 mt-10 -89.7 165.37 14.24 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.918 -178.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -106.25 127.29 53.13 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.276 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -118.76 155.64 30.76 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.47 -176.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.929 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 57.5 m80 -92.3 139.07 30.98 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 174.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.502 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 50.1 mt-30 -55.17 -51.87 65.11 Favored 'General case' 0 C--O 1.2 -1.533 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.9 p -66.38 -37.72 80.25 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.621 0 CA-C-O 121.587 0.708 . . . . 0.0 112.188 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.929 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 2.7 p -74.06 -25.16 59.68 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.029 -174.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.537 HG22 ' HH ' ' A' ' 46' ' ' TYR . 1.6 p -112.86 13.24 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 CA-C-O 121.494 0.664 . . . . 0.0 110.882 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.11 38.51 96.07 Favored Glycine 0 CA--C 1.556 2.633 0 N-CA-C 117.014 1.566 . . . . 0.0 117.014 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.595 HG11 ' SD ' ' A' ' 40' ' ' MET . 95.2 t -95.93 147.13 6.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 174.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 52.3 p -98.22 151.46 37.53 Favored Pre-proline 0 C--N 1.298 -1.673 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 174.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.502 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 14.6 Cg_endo -54.41 -31.43 68.24 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.801 2.334 . . . . 0.0 113.416 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -69.43 -32.45 71.41 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 123.932 0.893 . . . . 0.0 110.153 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.595 ' SD ' HG11 ' A' ' 36' ' ' VAL . 28.2 ttt -69.1 -42.85 75.59 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.033 0.933 . . . . 0.0 110.191 -176.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.52 -38.78 69.67 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -177.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -92.1 -47.0 7.48 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 119.053 -1.059 . . . . 0.0 113.712 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -71.15 -37.55 72.25 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -174.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -126.7 160.76 29.84 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.071 -1.052 . . . . 0.0 112.111 -171.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -78.02 115.53 17.83 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 121.294 0.569 . . . . 0.0 110.868 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.537 ' HH ' HG22 ' A' ' 34' ' ' VAL . 82.3 t80 -72.72 118.4 15.6 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.886 0.851 . . . . 0.0 112.796 175.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.2 mm -113.35 139.16 40.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 173.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.1 p -97.85 178.67 5.06 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.508 -174.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.1 tt -57.0 -37.63 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.622 0 C-N-CA 124.076 0.95 . . . . 0.0 112.805 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -83.36 -28.1 29.22 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 121.255 0.55 . . . . 0.0 110.849 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.437 ' SG ' ' HA3' ' A' ' 23' ' ' GLY . 60.2 m -77.11 -24.99 51.7 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.339 0.59 . . . . 0.0 110.693 177.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.58 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.873 -178.347 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 C--O 1.245 0.821 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.32 -174.41 4.38 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 119.676 -0.81 . . . . 0.0 109.027 -177.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.96 119.22 30.97 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -175.6 142.03 0.54 Allowed 'General case' 0 CA--C 1.496 -1.105 0 C-N-CA 123.432 0.693 . . . . 0.0 109.303 174.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -47.61 -44.27 26.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 124.264 0.978 . . . . 0.0 110.239 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -135.38 95.77 3.34 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.373 176.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.518 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 49.5 t -92.81 115.65 28.31 Favored 'General case' 0 N--CA 1.419 -1.992 0 C-N-CA 119.15 -1.02 . . . . 0.0 110.678 178.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -72.07 -8.74 56.34 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.415 177.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.502 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 58.9 ttt180 47.89 52.64 12.81 Favored Pre-proline 0 CA--C 1.565 1.548 0 C-N-CA 125.345 1.458 . . . . 0.0 112.073 -177.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.502 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 14.9 Cg_exo -70.97 132.76 22.0 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 121.503 1.469 . . . . 0.0 110.398 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 46.3 t -119.39 106.27 12.11 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.45 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -149.57 163.35 38.1 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -83.9 -55.91 3.98 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 173.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -68.19 82.95 0.23 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 121.333 -0.147 . . . . 0.0 111.206 172.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.453 HG13 ' O ' ' A' ' 16' ' ' VAL . 7.7 p -173.1 104.52 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 122.052 0.929 . . . . 0.0 110.752 175.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -74.56 149.68 40.07 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 114.947 -1.024 . . . . 0.0 113.334 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -113.59 160.69 18.29 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 125.262 1.425 . . . . 0.0 109.793 -175.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.5 m -123.63 136.96 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-O 120.715 0.293 . . . . 0.0 110.274 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.454 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 54.1 tt0 -103.79 138.68 40.06 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 175.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 29.4 p -90.73 103.56 16.25 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 118.976 -1.09 . . . . 0.0 110.688 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -82.82 21.03 1.06 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.052 -0.977 . . . . 0.0 111.18 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.49 -8.08 61.33 Favored Glycine 0 N--CA 1.434 -1.464 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.694 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 151.72 -23.7 0.93 Allowed Glycine 0 CA--C 1.54 1.627 0 C-N-CA 118.646 -1.74 . . . . 0.0 115.412 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.487 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 8.5 m -91.99 -29.59 16.53 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 118.839 1.319 . . . . 0.0 109.462 -176.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 58.07 26.47 13.64 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.921 -176.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.454 ' O ' ' HA ' ' A' ' 20' ' ' GLN . 37.7 mt-10 -94.43 167.19 11.67 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.4 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -108.39 129.31 55.25 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.374 -175.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -122.9 156.94 33.64 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.844 -177.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.934 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 56.1 m80 -94.0 141.19 28.81 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.573 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 51.0 mt-30 -58.38 -44.08 88.75 Favored 'General case' 0 C--O 1.187 -2.213 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.416 HG12 ' N ' ' A' ' 33' ' ' CYS . 9.6 p -76.02 -37.8 34.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 118.862 -1.135 . . . . 0.0 111.273 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.934 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 1.8 p -70.76 -33.16 70.5 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.793 -174.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.433 ' CG1' HG21 ' A' ' 36' ' ' VAL . 1.5 p -106.16 12.25 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.803 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.42 66.12 3.07 Favored Glycine 0 CA--C 1.55 2.219 0 N-CA-C 116.586 1.394 . . . . 0.0 116.586 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.433 HG21 ' CG1' ' A' ' 34' ' ' VAL . 78.7 t -116.98 149.15 19.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 175.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.4 p -95.97 147.99 33.84 Favored Pre-proline 0 N--CA 1.418 -2.044 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.573 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 18.2 Cg_endo -56.3 -27.19 65.67 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 C-N-CA 122.725 2.283 . . . . 0.0 112.231 -176.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -74.54 -28.81 61.12 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.82 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 34.6 ttp -72.33 -39.0 68.51 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -176.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.73 -30.61 65.69 Favored 'General case' 0 CA--C 1.564 1.5 0 CA-C-N 114.633 -1.167 . . . . 0.0 113.431 -176.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -95.26 -13.18 25.09 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -118.03 -35.85 3.76 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 -172.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -131.17 153.48 49.38 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.584 0.629 . . . . 0.0 110.974 -173.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -71.72 126.9 30.9 Favored 'General case' 0 C--O 1.251 1.154 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.495 -176.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.478 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 54.1 t80 -76.36 110.93 11.29 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-O 122.028 0.918 . . . . 0.0 113.454 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.4 mm -95.21 134.93 30.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 173.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.455 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 13.4 p -101.57 -179.79 4.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 119.326 0.966 . . . . 0.0 109.095 -175.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.5 tt -54.43 -42.79 60.42 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 C-N-CA 123.862 0.865 . . . . 0.0 112.131 177.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -77.5 -28.5 52.17 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-O 120.656 0.265 . . . . 0.0 111.121 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.455 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 56.5 m -77.01 -26.25 53.58 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-O 121.06 0.457 . . . . 0.0 110.916 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.738 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.0 -178.145 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 44.1 t . . . . . 0 C--O 1.244 0.784 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.434 ' SG ' ' N ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -86.31 -172.89 4.27 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.575 -178.559 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.434 ' N ' ' SG ' ' A' ' 3' ' ' CYS . . . -97.4 123.07 41.11 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 176.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -172.32 141.66 1.24 Allowed 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 172.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -48.2 -28.22 2.87 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.967 0.907 . . . . 0.0 110.8 173.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -153.43 104.45 2.75 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.927 174.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.556 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 52.2 t -101.35 123.69 45.85 Favored 'General case' 0 N--CA 1.412 -2.341 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.566 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -75.64 -7.35 54.05 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.176 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.581 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 36.5 ttt180 47.93 48.78 6.32 Favored Pre-proline 0 CA--C 1.573 1.861 0 C-N-CA 125.751 1.62 . . . . 0.0 112.197 -176.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.581 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 6.1 Cg_exo -77.42 141.6 20.28 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.252 1.968 . . . . 0.0 111.818 -177.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.5 t -134.38 116.59 15.36 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.968 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -139.11 158.36 44.31 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 174.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -81.42 -3.0 51.59 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 122.056 0.932 . . . . 0.0 108.772 175.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -128.91 85.47 2.33 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.128 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.3 p -175.79 111.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 122.015 0.912 . . . . 0.0 111.003 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -73.01 159.26 33.94 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 114.116 -1.402 . . . . 0.0 111.953 176.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 17.8 m95 -125.51 159.35 32.21 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.068 0.947 . . . . 0.0 109.905 -174.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.1 m -129.19 136.42 59.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 120.79 0.329 . . . . 0.0 110.249 -178.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -101.48 139.74 36.72 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.484 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 29.9 p -88.06 103.14 15.44 Favored 'General case' 0 C--O 1.248 1.006 0 C-N-CA 118.698 -1.201 . . . . 0.0 110.124 176.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -81.66 21.51 0.81 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.066 -175.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 21' ' ' CYS . . . -94.22 -12.94 55.66 Favored Glycine 0 N--CA 1.423 -2.217 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.87 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 149.78 -16.14 1.07 Allowed Glycine 0 CA--C 1.537 1.408 0 C-N-CA 118.509 -1.805 . . . . 0.0 116.143 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.484 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 13.5 m -90.63 -30.33 17.23 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 119.014 1.407 . . . . 0.0 109.454 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 60.83 22.55 12.6 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.52 -175.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -88.66 161.42 16.87 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.953 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -108.93 127.87 54.44 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.438 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -118.63 160.18 22.28 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.376 -176.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.983 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 48.9 m80 -94.77 134.71 37.09 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 174.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -54.27 -38.26 65.64 Favored 'General case' 0 C--O 1.203 -1.389 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 178.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.41 HG11 ' N ' ' A' ' 33' ' ' CYS . 10.5 p -77.14 -42.16 31.3 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.315 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.696 178.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.983 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 10.0 p -71.71 -30.98 66.24 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.805 -172.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.535 HG22 ' HH ' ' A' ' 46' ' ' TYR . 1.4 p -103.99 10.85 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.073 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.636 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.34 60.33 9.14 Favored Glycine 0 CA--C 1.543 1.793 0 N-CA-C 116.187 1.235 . . . . 0.0 116.187 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.491 HG21 ' CG1' ' A' ' 34' ' ' VAL . 77.4 t -107.93 146.63 13.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 174.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.7 p -99.38 156.33 35.53 Favored Pre-proline 0 N--CA 1.413 -2.276 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -58.49 -25.88 75.84 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.458 2.105 . . . . 0.0 111.307 177.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -71.33 -34.41 70.52 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.015 -178.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 35.1 ttp -75.1 -47.42 28.79 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.696 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.7 -45.18 90.07 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -175.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -79.23 -18.69 52.36 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -177.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -116.43 -30.99 5.73 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 -173.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -131.42 166.34 21.51 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 119.638 1.108 . . . . 0.0 113.806 -172.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.82 117.64 17.77 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.463 -177.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.535 ' HH ' HG22 ' A' ' 34' ' ' VAL . 82.6 t80 -73.91 117.11 15.31 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-O 122.184 0.992 . . . . 0.0 113.598 178.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.5 mm -107.03 148.06 11.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 106.16 -1.792 . . . . 0.0 106.16 174.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.473 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 11.8 p -111.55 177.32 4.69 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 119.123 0.874 . . . . 0.0 108.756 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.2 tt -55.2 -41.17 59.23 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.339 0 C-N-CA 124.047 0.939 . . . . 0.0 112.358 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -76.15 -32.79 59.26 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.048 0.451 . . . . 0.0 110.808 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.473 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 64.2 m -74.46 -25.38 59.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.219 0.533 . . . . 0.0 110.448 176.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.49 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.401 -178.525 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.4 t . . . . . 0 N--CA 1.442 -0.864 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.412 ' SG ' ' N ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -96.01 -172.48 2.58 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.776 -176.147 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.412 ' N ' ' SG ' ' A' ' 3' ' ' CYS . . . -91.77 120.53 32.58 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -177.08 146.38 0.51 Allowed 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 172.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -47.9 -43.01 28.4 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 124.019 0.824 . . . . 0.0 110.802 174.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -140.12 99.96 3.8 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.91 173.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.534 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 47.3 t -91.5 120.42 32.31 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.892 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -71.06 -8.17 51.55 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.791 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.505 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 68.7 ttt180 48.99 53.99 15.47 Favored Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 125.51 1.524 . . . . 0.0 112.012 -175.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.505 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 10.8 Cg_exo -73.91 131.93 16.31 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 121.825 1.683 . . . . 0.0 111.037 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.3 t -125.36 110.21 13.7 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.003 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -137.44 156.59 47.99 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 174.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -68.52 -50.48 51.77 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.6 0.714 . . . . 0.0 110.236 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -103.11 92.73 4.65 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.227 0.537 . . . . 0.0 110.499 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.4 p -156.42 123.89 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.939 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.503 ' HB2' ' NE2' ' A' ' 31' ' ' GLN . 6.9 m-20 -69.62 157.63 36.84 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.747 -1.115 . . . . 0.0 113.204 177.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -133.29 159.67 39.56 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 125.524 1.53 . . . . 0.0 107.798 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.5 m -131.06 130.93 64.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 120.987 0.422 . . . . 0.0 110.577 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 50.4 tt0 -98.7 138.58 35.66 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 175.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.48 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 32.0 p -87.7 108.27 19.03 Favored 'General case' 0 C--O 1.25 1.121 0 C-N-CA 118.404 -1.318 . . . . 0.0 110.155 177.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -82.99 23.73 0.82 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.385 -177.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 21' ' ' CYS . . . -92.32 -9.8 61.45 Favored Glycine 0 N--CA 1.417 -2.595 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.3 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 139.9 -14.35 3.1 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 119.12 -1.514 . . . . 0.0 115.567 177.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.48 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 19.1 m -87.41 -28.12 22.33 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 119.14 1.47 . . . . 0.0 108.709 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 59.5 21.59 10.08 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.961 -177.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 20' ' ' GLN . 42.9 mt-10 -88.99 163.96 15.31 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 120.951 0.405 . . . . 0.0 111.653 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 44.9 m95 -108.14 128.69 54.91 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.239 -175.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -121.89 158.54 28.77 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.913 -178.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.981 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 49.0 m80 -97.56 140.19 32.34 Favored 'General case' 0 CA--C 1.488 -1.413 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 174.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.503 ' NE2' ' HB2' ' A' ' 17' ' ' ASP . 50.8 mt-30 -56.95 -45.62 82.71 Favored 'General case' 0 C--O 1.191 -2.023 0 O-C-N 123.771 0.67 . . . . 0.0 112.75 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.478 HG13 ' N ' ' A' ' 33' ' ' CYS . 9.8 p -71.07 -40.17 75.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 O-C-N 121.575 -0.703 . . . . 0.0 112.086 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.981 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 9.4 p -70.85 -33.95 71.16 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.837 -174.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.474 HG13 HG23 ' A' ' 36' ' ' VAL . 1.7 p -104.13 10.23 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 CA-C-O 121.291 0.567 . . . . 0.0 110.497 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.08 60.52 8.49 Favored Glycine 0 CA--C 1.551 2.339 0 N-CA-C 116.501 1.36 . . . . 0.0 116.501 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.474 HG23 HG13 ' A' ' 34' ' ' VAL . 74.6 t -115.87 148.3 18.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 175.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.1 p -100.13 149.83 36.36 Favored Pre-proline 0 N--CA 1.421 -1.912 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.452 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 72.9 Cg_exo -53.94 -30.23 57.68 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 122.961 2.441 . . . . 0.0 112.507 -178.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -69.3 -31.88 70.66 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.062 -178.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 35.2 ttp -74.84 -42.3 58.23 Favored 'General case' 0 C--O 1.208 -1.112 0 CA-C-O 121.269 0.557 . . . . 0.0 110.185 -177.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.42 -41.24 79.99 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -176.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -86.21 -14.02 45.19 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -113.37 -34.18 5.69 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -174.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -130.02 144.21 51.21 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 118.654 0.661 . . . . 0.0 111.105 -174.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -70.45 115.61 9.83 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.293 -178.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -69.74 120.2 15.13 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -176.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.8 mm -102.41 139.87 22.3 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.904 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 173.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.2 p -102.19 178.57 4.56 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.875 0.761 . . . . 0.0 109.88 -176.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.7 tt -55.98 -39.45 57.7 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.476 0 C-N-CA 123.769 0.828 . . . . 0.0 112.247 177.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -74.55 -38.47 62.72 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 121.159 0.504 . . . . 0.0 110.848 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 63.7 m -69.33 -27.18 65.14 Favored 'General case' 0 C--O 1.213 -0.819 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.89 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.109 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.67 -177.362 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.8 t . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.42 ' SG ' ' N ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -90.45 -175.21 4.39 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.502 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.42 ' N ' ' SG ' ' A' ' 3' ' ' CYS . . . -95.67 123.17 39.1 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -176.11 151.31 1.04 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 172.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -47.13 -42.91 20.17 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.259 0.624 . . . . 0.0 110.928 173.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -141.58 107.57 5.18 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.801 176.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.547 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 47.0 t -101.19 116.85 33.77 Favored 'General case' 0 N--CA 1.42 -1.938 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.976 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -74.38 -11.38 60.23 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.156 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.523 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 31.5 mtm180 49.11 53.51 14.67 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 125.511 1.524 . . . . 0.0 114.388 -174.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.523 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 8.5 Cg_exo -78.05 139.7 17.36 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 121.826 1.684 . . . . 0.0 111.265 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.4 t -132.86 115.81 15.73 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -149.68 156.83 42.54 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.39 -15.38 63.53 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.194 0.598 . . . . 0.0 111.667 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -116.75 18.98 14.71 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -170.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.8 p -114.76 106.18 20.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.945 0.878 . . . . 0.0 112.465 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -72.75 148.37 44.69 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.355 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -113.18 158.97 19.77 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.511 1.125 . . . . 0.0 110.182 -174.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.2 m -125.98 132.16 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-O 120.678 0.275 . . . . 0.0 110.77 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -99.23 138.88 35.69 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.5 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 28.8 p -83.88 108.77 17.08 Favored 'General case' 0 C--O 1.255 1.345 0 C-N-CA 118.708 -1.197 . . . . 0.0 111.667 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -76.39 18.87 0.28 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.315 1.046 . . . . 0.0 112.17 -176.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.595 ' HA3' ' SG ' ' A' ' 51' ' ' CYS . . . -92.93 -18.67 39.36 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.117 -179.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 141.41 -6.83 2.5 Favored Glycine 0 CA--C 1.545 1.93 0 C-N-CA 119.185 -1.483 . . . . 0.0 115.978 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.5 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 16.9 m -88.89 -25.1 22.31 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 119.133 1.467 . . . . 0.0 109.315 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 59.92 18.48 7.53 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.299 1.04 . . . . 0.0 113.051 -176.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -85.91 159.36 19.68 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.212 0.529 . . . . 0.0 111.181 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -106.39 126.24 52.0 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.06 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.405 ' CD1' ' HE2' ' A' ' 46' ' ' TYR . 3.0 m-85 -118.64 159.31 23.83 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.706 -177.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.97 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 41.6 m80 -96.28 135.86 37.54 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.472 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 50.8 mt-30 -55.02 -40.05 69.76 Favored 'General case' 0 C--O 1.188 -2.148 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 177.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.417 HG11 ' N ' ' A' ' 33' ' ' CYS . 11.7 p -76.43 -38.86 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.454 0 C-N-CA 119.692 -0.803 . . . . 0.0 112.092 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.97 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 7.7 p -75.08 -29.5 60.68 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -174.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.562 HG22 ' OH ' ' A' ' 46' ' ' TYR . 2.1 p -104.7 1.95 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 CA-C-O 121.678 0.751 . . . . 0.0 110.117 178.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.7 75.03 0.35 Allowed Glycine 0 CA--C 1.55 2.233 0 N-CA-C 115.813 1.085 . . . . 0.0 115.813 -176.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.507 HG23 ' CG1' ' A' ' 34' ' ' VAL . 64.3 t -127.97 147.94 32.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 175.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 52.2 p -99.54 150.97 37.27 Favored Pre-proline 0 N--CA 1.421 -1.886 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.472 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 18.2 Cg_endo -56.09 -23.75 45.86 Favored 'Trans proline' 0 N--CA 1.485 0.988 0 C-N-CA 122.925 2.417 . . . . 0.0 112.32 -177.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -74.2 -32.97 63.25 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.186 -178.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 35.4 ttp -73.91 -41.32 62.29 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -176.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.26 -43.06 87.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.214 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -83.58 -21.35 32.66 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -177.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -110.38 -27.68 8.93 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 -174.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -132.7 166.08 23.02 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.461 1.028 . . . . 0.0 111.927 -174.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -81.91 115.64 21.19 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.562 ' OH ' HG22 ' A' ' 34' ' ' VAL . 49.7 t80 -68.72 113.37 6.13 Favored 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.4 mm -101.28 140.5 19.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.478 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 8.3 p -107.9 178.53 4.49 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.171 -177.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.2 tt -55.36 -41.83 63.98 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 C-N-CA 124.131 0.972 . . . . 0.0 112.245 177.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -77.64 -25.31 49.58 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 121.25 0.548 . . . . 0.0 110.393 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.595 ' SG ' ' HA3' ' A' ' 23' ' ' GLY . 55.5 m -78.03 -26.93 48.68 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.191 177.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.779 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.023 -176.638 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.0 t . . . . . 0 N--CA 1.441 -0.914 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.16 -173.56 3.29 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.43 119.73 33.6 Favored 'General case' 0 C--O 1.207 -1.162 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -177.64 142.26 0.31 Allowed 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 173.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -47.87 -45.1 29.94 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 124.046 0.841 . . . . 0.0 110.895 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -130.67 94.91 3.73 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.69 176.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.504 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 51.8 t -93.63 123.21 36.8 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 118.995 -1.082 . . . . 0.0 111.181 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -81.45 -11.68 59.15 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.831 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.564 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 62.4 mtm180 52.9 43.57 1.61 Allowed Pre-proline 0 CA--C 1.566 1.584 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -176.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 10.4 Cg_exo -76.86 143.63 23.57 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 121.619 1.546 . . . . 0.0 110.608 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 53.2 t -137.7 113.32 9.56 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.412 ' O ' HG12 ' A' ' 16' ' ' VAL . 97.7 mttt -142.69 151.38 41.3 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 177.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.24 -4.85 15.52 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 178.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -121.25 8.92 10.33 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -176.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 13' ' ' LYS . 7.2 p -102.86 107.18 21.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-O 121.756 0.789 . . . . 0.0 112.044 -178.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -74.07 146.8 43.38 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.592 176.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -111.95 159.16 18.67 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 124.638 1.175 . . . . 0.0 109.676 -174.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 23.1 m -123.86 132.65 71.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 O-C-N 121.949 -0.469 . . . . 0.0 110.763 -177.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -101.15 138.82 37.67 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.492 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.1 p -90.66 107.81 19.41 Favored 'General case' 0 C--O 1.255 1.35 0 C-N-CA 119.161 -1.016 . . . . 0.0 110.741 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -86.79 23.83 1.62 Allowed 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.926 -176.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.72 -14.09 60.14 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.11 -9.11 1.74 Allowed Glycine 0 CA--C 1.542 1.755 0 C-N-CA 119.032 -1.556 . . . . 0.0 116.234 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.492 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 13.9 m -92.58 -28.71 16.57 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 119.641 1.72 . . . . 0.0 110.209 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 61.91 17.69 9.15 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.831 1.253 . . . . 0.0 111.69 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -87.8 161.48 17.53 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.134 0.493 . . . . 0.0 111.598 -178.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -107.33 127.9 53.97 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.004 -176.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.409 ' HE1' ' SG ' ' A' ' 21' ' ' CYS . 3.5 m-85 -119.48 155.32 32.31 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -178.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.953 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 42.5 m80 -91.18 139.85 30.36 Favored 'General case' 0 CA--C 1.476 -1.867 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 174.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.458 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 48.4 mt-30 -54.45 -51.32 65.35 Favored 'General case' 0 C--O 1.192 -1.947 0 O-C-N 123.666 0.604 . . . . 0.0 111.806 177.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.403 HG12 ' N ' ' A' ' 33' ' ' CYS . 10.8 p -68.2 -39.51 81.32 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 CA-C-O 121.125 0.488 . . . . 0.0 112.136 -178.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.953 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 3.4 p -72.76 -25.05 61.05 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.336 -174.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.529 HG22 ' HH ' ' A' ' 46' ' ' TYR . 0.9 OUTLIER -110.81 11.72 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.821 177.259 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.54 39.98 95.85 Favored Glycine 0 CA--C 1.546 2.021 0 N-CA-C 117.34 1.696 . . . . 0.0 117.34 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.464 HG21 ' CG1' ' A' ' 34' ' ' VAL . 69.4 t -93.92 147.95 5.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 118.153 0.976 . . . . 0.0 109.378 175.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.9 p -99.37 147.35 33.2 Favored Pre-proline 0 N--CA 1.414 -2.249 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 175.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.458 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 74.9 Cg_exo -51.41 -32.27 41.83 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.312 2.675 . . . . 0.0 114.062 -175.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.57 -26.02 60.63 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 35.9 ttp -73.38 -38.17 65.74 Favored 'General case' 0 C--O 1.213 -0.822 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.42 -43.98 79.9 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.659 -177.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -90.46 -12.28 37.82 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -113.59 -27.0 8.02 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -128.77 151.19 49.84 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.06 0.457 . . . . 0.0 110.324 -175.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -79.15 115.71 18.98 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.659 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.529 ' HH ' HG22 ' A' ' 34' ' ' VAL . 90.5 t80 -67.01 114.86 6.13 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-O 122.812 1.292 . . . . 0.0 114.428 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.0 mm -103.64 141.65 18.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 172.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.439 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 9.3 p -106.83 179.21 4.33 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.361 -176.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.5 tt -56.04 -43.28 74.94 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 C-N-CA 123.684 0.794 . . . . 0.0 112.269 177.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -76.04 -28.23 57.61 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.095 0.474 . . . . 0.0 110.943 -178.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.439 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 58.0 m -76.59 -25.56 54.07 Favored 'General case' 0 C--O 1.213 -0.83 0 CA-C-O 121.524 0.678 . . . . 0.0 110.901 176.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.293 -1.877 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.753 -176.809 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.5 t . . . . . 0 N--CA 1.449 -0.511 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.62 ' SG ' ' HA ' ' A' ' 29' ' ' PHE . 0.5 OUTLIER -100.77 -172.43 2.18 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 119.108 -1.037 . . . . 0.0 109.767 -176.204 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.99 121.94 31.85 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -173.78 145.3 1.14 Allowed 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 172.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -47.99 -42.0 26.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 123.771 0.669 . . . . 0.0 109.439 173.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -136.06 97.93 3.74 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.337 174.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.561 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 53.4 t -94.19 156.92 16.31 Favored 'General case' 0 N--CA 1.422 -1.843 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.24 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.649 ' C ' ' HD3' ' A' ' 11' ' ' PRO . 76.6 mt-30 -119.2 173.27 7.03 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.772 -177.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.434 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 19.2 mmm180 -116.69 62.88 2.77 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 123.416 0.686 . . . . 0.0 111.085 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.649 ' HD3' ' C ' ' A' ' 9' ' ' GLN . 5.0 Cg_exo -88.6 145.43 5.76 Favored 'Trans proline' 0 C--N 1.359 1.099 0 C-N-CA 123.389 2.726 . . . . 0.0 112.077 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.6 t -130.16 107.44 9.31 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.801 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -152.97 156.57 39.12 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 124.862 1.265 . . . . 0.0 108.581 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -87.77 -51.1 6.05 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 172.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -72.32 79.55 1.01 Allowed 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.992 175.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 16' ' ' VAL . 7.6 p -165.61 102.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 122.125 0.964 . . . . 0.0 110.604 176.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -67.88 137.89 55.61 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 114.191 -1.368 . . . . 0.0 112.283 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 21.4 m95 -106.53 160.3 15.53 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.015 1.326 . . . . 0.0 108.945 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.5 m -127.83 132.72 68.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.115 0.483 . . . . 0.0 110.851 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -100.45 138.99 36.76 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 30.6 p -87.69 102.67 14.87 Favored 'General case' 0 C--O 1.256 1.416 0 C-N-CA 118.997 -1.081 . . . . 0.0 110.595 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.52 24.44 0.57 Allowed 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.122 -175.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 21' ' ' CYS . . . -92.64 -18.27 41.91 Favored Glycine 0 N--CA 1.437 -1.253 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 177.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 147.61 -10.65 1.27 Allowed Glycine 0 C--N 1.351 1.41 0 N-CA-C 116.951 1.54 . . . . 0.0 116.951 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.465 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 15.9 m -88.9 -26.8 21.4 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 119.754 1.777 . . . . 0.0 109.724 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 61.1 20.53 11.0 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.859 0.863 . . . . 0.0 112.417 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -91.77 158.08 16.55 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.744 -178.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -107.77 132.78 53.02 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.896 -177.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.62 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . 3.5 m-85 -120.72 159.72 24.79 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.152 -177.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.898 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 42.4 m80 -93.35 134.49 35.52 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -56.87 -33.04 66.46 Favored 'General case' 0 C--O 1.197 -1.7 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 176.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.6 p -77.2 -41.6 30.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-O 121.336 0.589 . . . . 0.0 111.968 177.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.898 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 4.2 p -75.52 -29.17 59.37 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.992 -173.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.473 ' CG1' HG23 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -106.66 2.79 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.764 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.485 179.66 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.31 72.49 0.62 Allowed Glycine 0 CA--C 1.555 2.586 0 N-CA-C 116.316 1.286 . . . . 0.0 116.316 -176.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.473 HG23 ' CG1' ' A' ' 34' ' ' VAL . 59.3 t -121.2 148.77 24.34 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 C-N-CA 124.547 1.139 . . . . 0.0 108.176 175.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.6 p -99.99 150.83 37.22 Favored Pre-proline 0 N--CA 1.42 -1.946 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -49.95 -42.71 44.3 Favored 'Trans proline' 0 C--N 1.358 1.066 0 C-N-CA 123.051 2.501 . . . . 0.0 112.115 -177.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -60.07 -35.04 74.29 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.416 ' HE1' HG13 ' A' ' 36' ' ' VAL . 42.2 ttp -69.25 -43.33 74.19 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.617 -176.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.13 -48.24 80.84 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 123.792 0.683 . . . . 0.0 112.072 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -77.91 -13.78 59.77 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -176.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -122.19 -43.03 2.34 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 117.021 2.23 . . . . 0.0 117.021 -172.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -126.89 171.31 11.38 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -168.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -68.35 115.14 7.44 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.48 0.712 . . . . 0.0 112.184 -173.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.458 ' OH ' HG22 ' A' ' 34' ' ' VAL . 79.3 t80 -82.81 105.66 14.01 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 122.239 1.019 . . . . 0.0 111.757 172.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.0 mm -98.92 145.14 10.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 175.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.419 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 13.5 p -105.32 178.28 4.61 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 119.306 -0.958 . . . . 0.0 108.872 -178.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.0 tt -55.83 -41.31 65.94 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 124.071 0.948 . . . . 0.0 111.928 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -75.62 -39.89 57.15 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.912 0.485 . . . . 0.0 111.433 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.419 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 52.1 m -63.21 -29.81 71.08 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.023 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.696 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.587 -175.399 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.7 t . . . . . 0 N--CA 1.45 -0.438 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -87.68 -173.68 4.43 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -178.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.59 119.98 34.1 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 174.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -173.25 140.91 0.89 Allowed 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 171.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -48.99 -43.61 40.38 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.931 0.769 . . . . 0.0 109.474 176.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -127.96 104.88 8.04 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.797 177.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.54 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 42.1 t -105.9 125.23 50.75 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 117.738 -1.585 . . . . 0.0 112.614 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -81.23 -6.06 58.45 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.161 -1.381 . . . . 0.0 110.571 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.593 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 73.3 mtp180 53.11 39.9 0.69 Allowed Pre-proline 0 CA--C 1.57 1.712 0 C-N-CA 124.465 1.106 . . . . 0.0 113.787 -176.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.593 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 7.2 Cg_exo -74.67 134.0 17.85 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 121.687 1.591 . . . . 0.0 112.076 -175.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 51.2 t -127.69 125.1 39.44 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -149.04 164.23 35.23 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -77.35 -14.63 59.69 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.498 0.666 . . . . 0.0 109.253 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -131.45 91.44 3.01 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.929 -177.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.431 HG13 ' O ' ' A' ' 16' ' ' VAL . 7.2 p -171.56 103.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 122.164 0.983 . . . . 0.0 111.143 179.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.667 ' HB2' ' NE2' ' A' ' 31' ' ' GLN . 4.1 m-20 -68.85 140.56 55.22 Favored 'General case' 0 C--N 1.275 -2.665 0 CA-C-N 114.433 -1.258 . . . . 0.0 111.722 177.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -107.55 159.82 16.14 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 124.198 0.999 . . . . 0.0 108.825 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.4 m -127.26 134.08 66.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 120.905 0.383 . . . . 0.0 110.397 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -101.0 139.07 37.2 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 30.1 p -91.63 99.68 12.54 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 118.875 -1.13 . . . . 0.0 109.951 176.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -85.07 22.45 1.42 Allowed 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.698 -175.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' A' ' 21' ' ' CYS . . . -95.21 -2.75 62.02 Favored Glycine 0 N--CA 1.426 -2.022 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.562 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.15 -23.74 1.12 Allowed Glycine 0 CA--C 1.541 1.675 0 C-N-CA 118.878 -1.629 . . . . 0.0 116.203 178.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.475 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 5.6 m -95.09 -31.84 13.38 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 119.089 1.444 . . . . 0.0 110.015 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 61.59 19.39 10.36 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 124.019 0.825 . . . . 0.0 111.908 -176.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -85.73 158.95 19.9 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.716 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -104.67 127.63 52.49 Favored 'General case' 0 C--O 1.242 0.669 0 O-C-N 123.619 0.574 . . . . 0.0 112.342 -176.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.405 ' HE1' ' SG ' ' A' ' 21' ' ' CYS . 8.9 m-85 -118.12 156.38 28.77 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.889 -1.051 . . . . 0.0 108.786 -177.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.983 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 47.2 m80 -93.56 139.11 31.13 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 174.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.667 ' NE2' ' HB2' ' A' ' 17' ' ' ASP . 50.6 mt-30 -56.12 -46.24 79.23 Favored 'General case' 0 C--O 1.188 -2.137 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 33' ' ' CYS . 9.0 p -72.66 -37.85 57.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.738 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.983 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 5.4 p -72.24 -31.75 66.09 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.832 -175.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.532 HG22 ' HH ' ' A' ' 46' ' ' TYR . 1.4 p -104.47 5.69 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.659 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.36 72.12 0.73 Allowed Glycine 0 CA--C 1.548 2.142 0 N-CA-C 115.408 0.923 . . . . 0.0 115.408 -176.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.491 HG23 ' CG1' ' A' ' 34' ' ' VAL . 74.5 t -127.61 147.3 32.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 173.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.4 p -100.25 150.56 37.02 Favored Pre-proline 0 N--CA 1.422 -1.832 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 176.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.58 -25.2 32.0 Favored 'Trans proline' 0 N--CA 1.488 1.148 0 C-N-CA 123.513 2.809 . . . . 0.0 112.735 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -73.53 -34.27 65.14 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.364 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 39.8 ttp -74.43 -38.16 63.12 Favored 'General case' 0 C--O 1.21 -0.986 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.206 -176.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.88 -44.11 77.84 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -176.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -85.82 -46.14 10.92 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 176.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -75.1 -35.48 61.76 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 -173.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -128.08 164.07 23.22 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -171.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -82.93 115.67 21.89 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.877 0.871 . . . . 0.0 111.512 -174.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.532 ' HH ' HG22 ' A' ' 34' ' ' VAL . 77.8 t80 -78.49 110.77 13.86 Favored 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.2 mm -102.29 146.22 10.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 172.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.481 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 7.9 p -111.0 179.83 3.94 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 119.226 -0.99 . . . . 0.0 109.737 -175.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.6 tt -55.02 -40.05 52.43 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.538 0 C-N-CA 124.448 1.099 . . . . 0.0 112.636 177.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -82.93 -29.13 29.38 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.481 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 56.7 m -73.98 -27.98 61.25 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-O 120.887 0.375 . . . . 0.0 111.198 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.423 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.578 -176.043 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.4 p -87.72 -172.16 3.75 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -176.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.61 118.87 32.38 Favored 'General case' 0 C--O 1.206 -1.206 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 172.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -177.03 135.56 0.2 Allowed 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 171.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -51.36 -43.31 61.79 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.287 0.565 . . . . 0.0 110.483 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -121.91 103.11 8.61 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.886 175.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.55 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 42.2 t -107.49 122.16 46.08 Favored 'General case' 0 N--CA 1.417 -2.083 0 C-N-CA 118.024 -1.47 . . . . 0.0 111.993 177.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -79.49 -8.46 59.15 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.33 178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.496 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 38.1 ttp180 46.1 61.81 12.22 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 126.763 2.025 . . . . 0.0 111.997 -175.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.496 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 17.0 Cg_exo -76.23 132.98 14.32 Favored 'Trans proline' 0 C--O 1.252 1.184 0 C-N-CA 123.048 2.499 . . . . 0.0 111.752 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.4 t -123.82 102.66 7.92 Favored 'General case' 0 N--CA 1.44 -0.971 0 O-C-N 123.894 0.746 . . . . 0.0 110.479 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -141.03 159.6 41.87 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 175.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -81.74 -50.1 9.66 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.826 -0.75 . . . . 0.0 112.031 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -73.39 18.83 0.11 Allowed 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.5 p -102.74 111.21 31.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 119.287 0.949 . . . . 0.0 111.928 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -71.39 146.93 48.43 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.047 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -113.69 159.2 19.95 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.262 1.025 . . . . 0.0 109.822 -175.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.7 137.59 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-O 120.71 0.29 . . . . 0.0 110.546 -177.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -110.52 138.3 47.09 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.572 178.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.407 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.4 p -93.22 102.42 14.71 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.497 176.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -86.68 25.26 1.29 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.808 0.813 . . . . 0.0 109.881 -176.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.11 1.68 57.71 Favored Glycine 0 N--CA 1.431 -1.643 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.699 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 151.75 -35.28 0.86 Allowed Glycine 0 CA--C 1.534 1.256 0 C-N-CA 118.726 -1.702 . . . . 0.0 115.608 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.407 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 7.4 m -89.27 -32.75 17.23 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 118.548 1.174 . . . . 0.0 109.488 -176.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 59.95 21.39 10.43 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.748 1.219 . . . . 0.0 111.634 -177.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -88.15 163.7 16.06 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.731 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -105.29 127.52 52.99 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.115 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -117.12 155.15 29.8 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.684 -178.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.983 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 44.2 m80 -92.54 137.73 32.11 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 174.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -52.46 -51.74 57.76 Favored 'General case' 0 C--O 1.198 -1.62 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.3 p -68.63 -37.02 77.04 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 CA-C-N 118.533 0.606 . . . . 0.0 112.246 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.983 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 8.1 p -72.51 -27.29 62.17 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.23 -175.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.492 HG23 ' HH ' ' A' ' 46' ' ' TYR . 0.8 OUTLIER -109.68 12.92 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.944 0 CA-C-O 121.753 0.787 . . . . 0.0 110.727 177.779 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.18 35.98 92.65 Favored Glycine 0 CA--C 1.553 2.433 0 N-CA-C 117.257 1.663 . . . . 0.0 117.257 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.489 HG22 ' CG1' ' A' ' 34' ' ' VAL . 86.5 t -93.97 147.48 5.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 117.775 0.788 . . . . 0.0 109.74 176.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.3 p -104.36 150.69 38.72 Favored Pre-proline 0 N--CA 1.415 -2.198 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 175.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -47.59 -39.63 29.74 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 123.475 2.783 . . . . 0.0 112.987 -177.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -58.15 -38.86 77.41 Favored 'General case' 0 C--O 1.214 -0.809 0 C-N-CA 124.475 1.11 . . . . 0.0 111.609 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.407 ' HB3' HG12 ' A' ' 36' ' ' VAL . 33.3 ttp -72.36 -39.54 67.99 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.813 -175.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.83 -49.05 77.96 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 123.741 0.651 . . . . 0.0 112.71 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -90.13 -24.01 21.2 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -177.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -98.53 -28.03 13.77 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.177 -1.009 . . . . 0.0 113.684 -172.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -139.05 -179.83 6.07 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -176.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -83.92 118.26 23.88 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 113.586 -1.643 . . . . 0.0 112.477 -174.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.492 ' HH ' HG23 ' A' ' 34' ' ' VAL . 64.4 t80 -88.18 110.37 20.64 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 122.272 1.035 . . . . 0.0 113.551 175.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.2 mm -107.89 141.15 23.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 172.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.9 p -97.9 176.56 5.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.276 -175.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.8 tt -54.15 -36.25 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.343 0 C-N-CA 124.255 1.022 . . . . 0.0 112.596 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -81.71 -35.67 29.51 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-O 120.881 0.372 . . . . 0.0 110.095 -178.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 64.6 m -74.39 -25.05 59.25 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-O 121.422 0.63 . . . . 0.0 111.482 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.1 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -178.812 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 99.6 t . . . . . 0 N--CA 1.446 -0.657 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' ' 29' ' ' PHE . 0.5 OUTLIER -94.28 -174.83 3.48 Favored 'General case' 0 N--CA 1.433 -1.313 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.35 -176.08 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.07 120.06 31.72 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -175.25 147.19 0.88 Allowed 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 123.166 0.586 . . . . 0.0 109.454 171.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -48.04 -41.52 25.97 Favored 'General case' 0 CA--C 1.558 1.267 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.825 173.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -137.69 98.27 3.64 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.488 173.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.501 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 43.8 t -94.33 117.82 30.69 Favored 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.284 -178.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -85.67 164.34 17.73 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.47 83.64 11.07 Favored Pre-proline 0 C--N 1.311 -1.073 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -70.4 157.43 59.16 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.759 2.973 . . . . 0.0 111.49 172.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.9 p -135.72 27.73 3.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.127 0.489 . . . . 0.0 111.28 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -94.54 146.48 24.08 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 120.475 -0.49 . . . . 0.0 112.022 -177.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -68.33 -53.93 20.87 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 174.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -76.05 91.49 3.1 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.366 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.8 p -170.43 98.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 122.409 1.099 . . . . 0.0 110.961 173.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -66.52 142.71 57.43 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 114.252 -1.34 . . . . 0.0 113.589 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 15.7 m95 -109.12 160.3 16.18 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.763 1.225 . . . . 0.0 109.899 -177.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.3 m -130.35 143.61 40.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 121.291 0.567 . . . . 0.0 111.898 -178.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -112.62 138.73 48.99 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.527 ' HB3' ' O ' ' A' ' 25' ' ' CYS . 43.4 t -77.67 101.31 6.55 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.424 0.631 . . . . 0.0 111.401 -178.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -88.74 10.57 20.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 122.524 1.154 . . . . 0.0 108.435 -178.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.9 -2.14 78.75 Favored Glycine 0 N--CA 1.419 -2.436 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.338 177.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 144.74 -26.25 1.94 Allowed Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 119.919 -1.134 . . . . 0.0 114.929 176.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.527 ' O ' ' HB3' ' A' ' 21' ' ' CYS . 17.2 p -114.87 90.09 3.25 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 117.151 -1.82 . . . . 0.0 111.955 -177.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -39.73 13.96 0.0 OUTLIER 'General case' 0 N--CA 1.532 3.631 0 N-CA-C 117.806 2.521 . . . . 0.0 117.806 173.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.475 ' H ' ' C ' ' A' ' 25' ' ' CYS . 40.4 mt-10 -81.73 160.91 23.52 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-N 118.769 0.713 . . . . 0.0 109.725 176.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -105.73 130.21 53.78 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.472 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . 17.6 m-85 -118.95 151.62 37.84 Favored 'General case' 0 CA--C 1.562 1.407 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.646 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.909 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 35.2 m80 -88.5 141.87 28.18 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 173.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.433 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 49.8 mt-30 -56.94 -52.11 66.5 Favored 'General case' 0 C--O 1.192 -1.932 0 C-N-CA 120.3 -0.56 . . . . 0.0 112.015 176.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.5 p -67.12 -40.52 85.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.909 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 2.1 p -71.1 -27.31 63.51 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.215 -174.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.474 HG23 ' HH ' ' A' ' 46' ' ' TYR . 0.5 OUTLIER -109.96 9.15 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.123 0 CA-C-O 121.255 0.55 . . . . 0.0 111.448 178.781 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.38 40.54 96.47 Favored Glycine 0 CA--C 1.557 2.675 0 N-CA-C 117.392 1.717 . . . . 0.0 117.392 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.476 HG11 ' HE3' ' A' ' 40' ' ' MET . 78.5 t -92.13 149.18 4.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.9 p -100.7 150.42 36.98 Favored Pre-proline 0 N--CA 1.426 -1.666 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 176.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.71 -34.58 54.49 Favored 'Trans proline' 0 N--CA 1.483 0.855 0 C-N-CA 123.031 2.488 . . . . 0.0 112.733 -176.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -72.98 -27.86 62.05 Favored 'General case' 0 N--CA 1.414 -2.235 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.287 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.476 ' HE3' HG11 ' A' ' 36' ' ' VAL . 49.9 ttp -73.12 -37.3 66.73 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -177.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.02 -32.11 70.58 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.823 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -95.7 -21.31 18.26 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -113.32 -33.81 5.83 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 115.729 1.752 . . . . 0.0 115.729 -171.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -123.33 163.52 20.59 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 118.809 -1.156 . . . . 0.0 113.045 -173.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -82.63 115.13 21.45 Favored 'General case' 0 C--O 1.253 1.266 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.153 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.474 ' HH ' HG23 ' A' ' 34' ' ' VAL . 63.5 t80 -71.59 108.97 5.23 Favored 'General case' 0 C--O 1.249 1.079 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.6 mm -98.61 146.21 8.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 170.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 18.2 p -107.04 178.68 4.49 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.509 -0.877 . . . . 0.0 110.6 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.3 tt -50.5 -34.79 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.368 0 C-N-CA 125.399 1.48 . . . . 0.0 113.126 177.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -89.79 -37.92 14.16 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 80.1 m -78.04 -23.5 48.12 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.889 0.376 . . . . 0.0 111.155 -177.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.685 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.357 179.553 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.8 t . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.427 ' SG ' ' HA ' ' A' ' 29' ' ' PHE . 0.5 OUTLIER -100.08 -172.38 2.21 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 119.544 -0.862 . . . . 0.0 108.731 -178.506 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.54 119.45 29.0 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -177.88 143.8 0.33 Allowed 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 172.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -47.58 -40.91 20.38 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 123.63 0.582 . . . . 0.0 110.956 175.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -136.8 102.03 4.77 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.118 174.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.557 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 50.3 t -96.48 117.49 31.01 Favored 'General case' 0 N--CA 1.412 -2.345 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.846 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -76.16 -5.35 46.3 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.379 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.558 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 80.7 mtp180 54.92 38.25 0.46 Allowed Pre-proline 0 CA--C 1.573 1.856 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.558 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 14.0 Cg_exo -69.99 139.16 38.74 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 121.213 1.275 . . . . 0.0 112.24 -176.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 53.3 t -139.67 118.72 12.62 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.223 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -145.06 174.08 11.35 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -70.29 -66.16 0.63 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.239 0.542 . . . . 0.0 110.794 175.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -87.35 94.0 9.56 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -178.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.409 ' O ' HG12 ' A' ' 16' ' ' VAL . 8.3 p -165.07 103.85 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.981 0.896 . . . . 0.0 111.305 176.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -69.16 146.3 52.57 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 114.233 -1.349 . . . . 0.0 113.238 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -115.71 160.4 20.12 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 125.779 1.631 . . . . 0.0 109.201 -177.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.3 m -126.64 136.93 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 120.772 0.32 . . . . 0.0 110.772 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -104.55 138.05 41.48 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 174.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.402 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 28.8 p -87.81 106.58 18.17 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 118.728 -1.189 . . . . 0.0 108.973 176.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -83.82 17.24 2.4 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.685 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.63 -1.27 66.12 Favored Glycine 0 N--CA 1.435 -1.397 0 C-N-CA 121.049 -0.596 . . . . 0.0 113.159 -176.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.23 -31.17 1.07 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 118.581 -1.771 . . . . 0.0 115.793 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.4 m -86.74 -28.66 22.91 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 118.934 1.367 . . . . 0.0 110.167 -175.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 60.02 22.28 11.42 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.763 1.225 . . . . 0.0 112.11 -176.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -93.87 165.79 12.5 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -108.93 130.87 55.45 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.427 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . 6.3 m-85 -122.83 153.62 39.33 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.493 -177.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.939 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 49.5 m80 -91.18 137.61 32.23 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 173.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.561 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 50.6 mt-30 -55.38 -45.67 76.55 Favored 'General case' 0 C--O 1.189 -2.104 0 O-C-N 123.892 0.745 . . . . 0.0 112.623 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.43 HG11 ' N ' ' A' ' 33' ' ' CYS . 10.4 p -72.01 -40.42 67.52 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.39 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.751 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.939 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 2.8 p -72.8 -32.36 65.5 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.476 -173.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.482 HG11 HG22 ' A' ' 36' ' ' VAL . 2.5 p -103.61 6.9 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-O 121.256 0.55 . . . . 0.0 110.136 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.87 73.85 0.43 Allowed Glycine 0 CA--C 1.543 1.825 0 N-CA-C 115.452 0.941 . . . . 0.0 115.452 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.482 HG22 HG11 ' A' ' 34' ' ' VAL . 56.5 t -127.15 145.15 35.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.7 p -92.22 147.57 34.88 Favored Pre-proline 0 N--CA 1.425 -1.69 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 175.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.561 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 10.7 Cg_endo -51.22 -39.39 62.0 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.424 2.749 . . . . 0.0 113.457 -174.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -74.03 -25.38 59.84 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -178.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.446 ' CE ' HG11 ' A' ' 36' ' ' VAL . 37.5 ttp -68.48 -36.73 79.36 Favored 'General case' 0 C--O 1.211 -0.951 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.77 -39.76 81.97 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.286 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -88.4 -21.97 24.0 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 -177.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -115.64 -31.71 5.76 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -172.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -117.96 157.11 27.35 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.975 -171.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -83.36 116.25 22.38 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.139 -176.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -82.82 103.81 12.58 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.2 mm -94.32 137.87 21.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 113.581 -1.645 . . . . 0.0 106.692 172.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.8 p -99.0 178.34 4.97 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 119.406 -0.917 . . . . 0.0 109.3 -174.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.8 tt -55.76 -41.45 65.83 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.287 0 C-N-CA 123.969 0.908 . . . . 0.0 112.383 178.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -76.61 -33.14 58.42 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 121.395 0.617 . . . . 0.0 110.88 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 61.4 m -72.75 -26.67 61.64 Favored 'General case' 0 C--O 1.211 -0.944 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.156 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.296 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -177.243 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.8 t . . . . . 0 C--O 1.218 -0.595 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -92.17 -172.24 3.07 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.61 118.78 28.51 Favored 'General case' 0 C--O 1.213 -0.859 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -176.65 145.7 0.55 Allowed 'General case' 0 CA--C 1.492 -1.251 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 171.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -48.09 -43.58 30.9 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 123.732 0.645 . . . . 0.0 110.324 175.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -137.39 105.75 5.77 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.228 175.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.56 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 53.4 t -97.71 117.12 31.29 Favored 'General case' 0 N--CA 1.402 -2.83 0 C-N-CA 119.734 -0.787 . . . . 0.0 111.512 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -69.48 -8.6 48.35 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.936 177.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.562 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 46.3 ttt180 52.64 43.21 1.46 Allowed Pre-proline 0 CA--C 1.604 3.057 0 C-N-CA 124.727 1.211 . . . . 0.0 113.768 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.562 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 2.8 Cg_exo -78.84 145.54 20.08 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.072 1.848 . . . . 0.0 112.622 -178.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.9 t -133.47 115.96 15.41 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.122 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -146.84 154.02 40.85 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 174.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.15 -12.55 61.77 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.225 0.536 . . . . 0.0 110.509 176.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -125.36 51.27 1.71 Allowed 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.21 -173.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.417 HG11 ' O ' ' A' ' 16' ' ' VAL . 7.5 p -141.51 99.57 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 121.809 0.814 . . . . 0.0 110.718 175.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -68.72 145.0 54.22 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 114.817 -1.083 . . . . 0.0 112.07 176.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -106.93 159.73 16.05 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 124.577 1.151 . . . . 0.0 109.34 -176.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.0 m -125.76 141.37 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.602 -178.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 61.4 tt0 -111.29 137.85 48.5 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.6 p -94.81 104.48 16.38 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.882 178.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -88.22 23.97 2.0 Allowed 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.264 0.554 . . . . 0.0 110.322 -177.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.4 -4.98 73.01 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 148.6 -17.48 1.27 Allowed Glycine 0 CA--C 1.539 1.586 0 C-N-CA 119.68 -1.247 . . . . 0.0 115.64 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.491 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 9.6 m -97.8 -33.37 11.29 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.505 1.152 . . . . 0.0 110.495 -178.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 62.24 19.03 10.67 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 123.767 0.827 . . . . 0.0 111.877 -176.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.425 ' O ' ' HA ' ' A' ' 20' ' ' GLN . 47.8 mt-10 -85.05 168.14 15.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.831 -176.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -114.49 125.9 54.33 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-O 121.283 0.563 . . . . 0.0 111.915 -176.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -119.32 159.03 24.91 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.505 -176.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.971 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 38.1 m80 -94.37 136.17 34.97 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 173.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.428 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 50.3 mt-30 -55.34 -41.06 71.97 Favored 'General case' 0 C--O 1.191 -2.017 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 177.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.462 HG13 ' N ' ' A' ' 33' ' ' CYS . 9.8 p -74.77 -41.74 47.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.914 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.971 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 9.2 p -72.0 -29.27 64.05 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.574 -174.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.51 HG23 ' HH ' ' A' ' 46' ' ' TYR . 1.4 p -105.0 5.48 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.958 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.87 73.64 0.46 Allowed Glycine 0 CA--C 1.553 2.443 0 N-CA-C 115.452 0.941 . . . . 0.0 115.452 -176.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.503 HG11 ' HE2' ' A' ' 40' ' ' MET . 54.9 t -125.58 149.46 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 174.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.7 p -101.25 147.97 34.51 Favored Pre-proline 0 N--CA 1.418 -2.056 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 176.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.428 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 19.4 Cg_endo -55.84 -27.47 62.76 Favored 'Trans proline' 0 N--CA 1.487 1.132 0 C-N-CA 123.11 2.54 . . . . 0.0 112.283 -176.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -73.7 -28.36 61.69 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.719 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.503 ' HE2' HG11 ' A' ' 36' ' ' VAL . 44.2 ttp -74.13 -39.67 63.16 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -178.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.07 -43.91 82.58 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -176.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -88.12 -13.62 40.86 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -111.39 -39.24 4.74 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -175.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -126.07 166.32 17.21 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -170.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -74.98 118.58 18.1 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.907 0.883 . . . . 0.0 112.473 -178.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.51 ' HH ' HG23 ' A' ' 34' ' ' VAL . 78.9 t80 -83.11 103.8 12.81 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 122.383 1.087 . . . . 0.0 111.979 175.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.6 mm -100.21 143.57 13.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 173.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.422 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 12.4 p -103.93 176.97 4.98 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -176.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.2 tt -54.0 -38.23 36.75 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.343 0 C-N-CA 123.979 0.912 . . . . 0.0 112.89 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -87.04 -26.5 23.7 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.982 -0.448 . . . . 0.0 111.683 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.422 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 52.1 m -72.41 -25.63 61.55 Favored 'General case' 0 C--O 1.213 -0.828 0 CA-C-O 121.101 0.476 . . . . 0.0 110.796 176.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -1.001 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -177.766 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.4 m . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.792 0.806 . . . . 0.0 111.948 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.3 t -107.95 135.54 46.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -87.37 -175.87 5.42 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.46 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.402 ' N ' ' SG ' ' A' ' 3' ' ' CYS . . . -90.65 119.68 31.09 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 178.34 134.24 0.08 Allowed 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 125.225 1.41 . . . . 0.0 107.956 172.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -49.41 -33.92 15.12 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 123.457 0.473 . . . . 0.0 111.433 176.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -133.3 92.07 2.95 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.948 174.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.487 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 44.4 t -95.41 119.19 33.49 Favored 'General case' 0 N--CA 1.413 -2.284 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.129 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -69.09 -10.69 58.87 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.387 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.563 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 68.3 mtm180 49.38 46.03 3.38 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.563 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 3.2 Cg_exo -78.48 132.05 10.88 Favored 'Trans proline' 0 C--O 1.266 1.912 0 C-N-CA 121.521 1.48 . . . . 0.0 110.755 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.3 t -116.42 111.02 19.43 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -138.41 156.1 47.89 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -91.47 -6.62 52.37 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.078 0.466 . . . . 0.0 110.394 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -114.03 16.18 18.26 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.35 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.418 ' O ' HG12 ' A' ' 16' ' ' VAL . 8.1 p -107.83 106.13 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 121.832 0.825 . . . . 0.0 111.071 178.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -71.84 146.13 48.17 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.983 173.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -108.87 160.74 15.75 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 124.556 1.142 . . . . 0.0 110.261 -174.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.3 m -124.31 139.19 51.4 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.535 0 CA-C-O 120.651 0.263 . . . . 0.0 111.09 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -106.97 139.48 41.31 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.44 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.1 p -91.27 102.02 14.73 Favored 'General case' 0 C--O 1.256 1.407 0 C-N-CA 119.012 -1.075 . . . . 0.0 109.727 175.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -83.41 24.68 0.81 Allowed 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.386 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.32 -4.42 61.02 Favored Glycine 0 N--CA 1.432 -1.605 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.229 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.08 -20.18 1.94 Allowed Glycine 0 CA--C 1.539 1.533 0 C-N-CA 118.898 -1.62 . . . . 0.0 116.056 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.44 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 12.0 m -91.0 -34.05 15.29 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 118.806 1.303 . . . . 0.0 109.558 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 62.6 21.01 12.41 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.494 -176.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -88.08 159.41 18.26 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.257 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -108.96 130.14 55.45 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.273 0.559 . . . . 0.0 111.95 -176.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -118.47 157.46 27.19 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.975 -1.012 . . . . 0.0 109.82 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.96 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 40.3 m80 -92.11 140.32 29.76 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 173.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -62.43 -36.8 83.52 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 33' ' ' CYS . 8.7 p -75.57 -40.76 41.31 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.662 0 O-C-N 121.243 -0.911 . . . . 0.0 111.873 176.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.96 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 9.2 p -72.09 -32.91 67.46 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.706 -173.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.467 ' CG1' HG23 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -104.95 3.2 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-O 121.135 0.493 . . . . 0.0 110.884 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.65 72.86 0.61 Allowed Glycine 0 CA--C 1.557 2.689 0 N-CA-C 116.129 1.211 . . . . 0.0 116.129 -176.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.467 HG23 ' CG1' ' A' ' 34' ' ' VAL . 78.8 t -130.3 145.23 35.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 56.7 p -97.95 151.01 37.34 Favored Pre-proline 0 N--CA 1.428 -1.544 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 176.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.36 -21.8 54.94 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 122.705 2.27 . . . . 0.0 111.551 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -73.64 -35.2 65.25 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.641 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.425 ' HE2' HG11 ' A' ' 36' ' ' VAL . 36.7 ttp -72.96 -38.9 66.56 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -176.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.88 -46.21 82.03 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.782 -1.099 . . . . 0.0 112.434 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -83.13 -17.5 42.78 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -112.55 -30.12 7.23 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -173.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -123.03 168.54 12.22 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.554 0.692 . . . . 0.0 112.728 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -90.03 115.35 27.24 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.405 -1.27 . . . . 0.0 109.214 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 51.2 t80 -79.34 108.89 13.2 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -178.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.9 mm -96.02 141.73 14.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 173.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.6 p -103.3 177.05 4.95 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.057 -176.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.2 tt -56.12 -38.13 52.35 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 O-C-N 123.887 0.742 . . . . 0.0 112.346 177.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -77.88 -34.19 51.67 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 122.212 -0.305 . . . . 0.0 111.37 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 61.6 m -72.21 -29.52 64.04 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.571 0.7 . . . . 0.0 110.301 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.074 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.828 -176.017 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.7 m . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 121.432 0.634 . . . . 0.0 111.285 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.4 t -104.28 135.26 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.69 -173.96 3.32 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -177.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.65 119.98 32.61 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -177.55 144.15 0.38 Allowed 'General case' 0 CA--C 1.501 -0.912 0 C-N-CA 124.23 1.012 . . . . 0.0 108.76 172.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -47.88 -44.09 29.17 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 123.925 0.766 . . . . 0.0 110.468 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -135.53 102.29 5.07 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.328 173.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.534 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 43.3 t -95.52 118.88 33.04 Favored 'General case' 0 N--CA 1.407 -2.599 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.834 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -69.38 -9.42 53.39 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.834 178.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.564 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 79.1 ttt180 46.38 51.55 10.08 Favored Pre-proline 0 CA--C 1.574 1.897 0 C-N-CA 125.036 1.335 . . . . 0.0 112.692 -175.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 2.7 Cg_exo -81.61 134.42 8.68 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 121.839 1.693 . . . . 0.0 109.927 177.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 45.4 t -130.05 113.76 14.94 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -138.63 170.82 15.32 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -71.97 -59.46 2.73 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 171.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -74.56 87.87 2.14 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.29 177.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.2 p -172.28 100.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 122.109 0.957 . . . . 0.0 112.654 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -70.14 138.68 52.1 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.461 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 15.9 m95 -103.76 160.19 14.99 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 124.724 1.21 . . . . 0.0 108.552 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.5 m -126.02 139.63 50.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.574 0.226 . . . . 0.0 110.41 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -108.93 138.23 45.6 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.7 p -89.02 105.48 17.81 Favored 'General case' 0 C--O 1.249 1.037 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.145 177.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -85.1 22.81 1.35 Allowed 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 121.423 0.63 . . . . 0.0 110.25 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 21' ' ' CYS . . . -92.53 -13.69 56.64 Favored Glycine 0 N--CA 1.426 -1.994 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.562 -178.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.63 -27.71 0.42 Allowed Glycine 0 CA--C 1.533 1.205 0 C-N-CA 118.79 -1.672 . . . . 0.0 115.813 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.455 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 9.4 m -88.89 -30.14 19.11 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 118.533 1.167 . . . . 0.0 110.609 -176.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 60.63 19.15 9.11 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.723 0.809 . . . . 0.0 111.939 -175.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -90.0 163.48 14.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.446 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -108.66 128.94 55.29 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.504 -175.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -120.22 159.78 24.25 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.745 -176.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.96 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 44.9 m80 -95.76 138.57 33.23 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 173.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.536 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 48.9 mt-30 -54.52 -50.06 68.75 Favored 'General case' 0 C--O 1.19 -2.07 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 177.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 p -67.45 -41.95 86.64 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.305 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.96 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 6.6 p -70.67 -27.84 64.34 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.384 -175.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.482 HG22 ' HH ' ' A' ' 46' ' ' TYR . 1.4 p -106.9 11.6 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.871 0 CA-C-O 121.311 0.577 . . . . 0.0 110.574 178.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.67 38.32 95.5 Favored Glycine 0 CA--C 1.547 2.032 0 N-CA-C 117.25 1.66 . . . . 0.0 117.25 177.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.475 HG21 HG12 ' A' ' 34' ' ' VAL . 77.6 t -97.4 149.2 5.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 123.536 0.735 . . . . 0.0 109.44 176.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.4 p -99.73 152.14 37.71 Favored Pre-proline 0 N--CA 1.421 -1.907 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 24.9 Cg_endo -59.14 -22.32 63.77 Favored 'Trans proline' 0 N--CA 1.482 0.833 0 C-N-CA 122.173 1.915 . . . . 0.0 112.163 -178.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -73.8 -34.0 64.44 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.857 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.463 ' HE3' HG13 ' A' ' 36' ' ' VAL . 50.3 ttp -73.77 -39.33 64.27 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.422 -175.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.44 -48.02 77.89 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -175.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -89.0 -14.21 37.05 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -110.05 -31.26 7.43 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -173.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -128.48 165.87 19.86 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 118.289 0.495 . . . . 0.0 112.153 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -75.2 115.31 14.7 Favored 'General case' 0 C--O 1.248 0.977 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.578 -176.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.482 ' HH ' HG22 ' A' ' 34' ' ' VAL . 79.9 t80 -79.54 108.93 13.45 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.938 0.875 . . . . 0.0 112.265 175.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.0 mm -105.45 148.73 9.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 173.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.3 p -109.24 177.3 4.8 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 119.238 0.926 . . . . 0.0 108.935 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.7 tt -55.94 -41.72 68.59 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 C-N-CA 124.026 0.93 . . . . 0.0 112.491 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -75.0 -32.67 61.7 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.13 0.491 . . . . 0.0 111.003 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 66.7 m -76.27 -28.91 57.23 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.827 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.519 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.264 -176.914 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 28.7 t . . . . . 0 CA--C 1.558 1.271 0 CA-C-O 122.523 1.154 . . . . 0.0 109.202 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.9 t -122.97 136.34 60.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -96.84 -172.5 2.48 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 119.394 -0.922 . . . . 0.0 108.62 -178.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.14 118.69 26.7 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -177.22 145.96 0.48 Allowed 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 171.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -48.6 -44.16 36.77 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.689 0.757 . . . . 0.0 109.118 173.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -131.55 101.52 5.54 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.159 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.501 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 50.5 t -98.34 112.23 24.3 Favored 'General case' 0 N--CA 1.406 -2.66 0 C-N-CA 118.36 -1.336 . . . . 0.0 110.262 177.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -67.12 -11.57 57.6 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.48 -1.237 . . . . 0.0 111.191 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.557 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 65.3 mtp180 52.34 44.76 2.21 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 123.834 0.854 . . . . 0.0 111.881 -173.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.557 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 23.7 Cg_exo -65.58 131.76 28.84 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 121.134 1.223 . . . . 0.0 110.341 -176.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 86.1 m -114.47 98.16 6.74 Favored 'General case' 0 N--CA 1.413 -2.292 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.885 -177.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -136.21 153.05 51.34 Favored 'General case' 0 CA--C 1.479 -1.753 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 172.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -81.13 -43.11 19.88 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 176.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -85.23 87.9 7.43 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.7 p -168.76 112.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.569 0.699 . . . . 0.0 111.427 177.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -74.22 144.79 44.56 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.685 -1.143 . . . . 0.0 112.852 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -110.31 159.94 16.98 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 125.2 1.4 . . . . 0.0 109.331 -176.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.6 m -126.62 137.09 58.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.062 0.458 . . . . 0.0 110.625 -178.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 52.0 tt0 -104.57 139.09 39.96 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 176.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.6 p -88.01 99.93 12.53 Favored 'General case' 0 C--O 1.25 1.085 0 C-N-CA 118.261 -1.376 . . . . 0.0 110.006 176.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -80.9 19.36 0.87 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.971 -176.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 21' ' ' CYS . . . -102.35 3.25 50.6 Favored Glycine 0 N--CA 1.418 -2.507 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.697 -177.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 152.6 -34.33 0.82 Allowed Glycine 0 CA--C 1.536 1.402 0 C-N-CA 118.183 -1.961 . . . . 0.0 116.551 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.478 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 5.1 m -94.51 -30.11 14.58 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 118.799 1.3 . . . . 0.0 110.033 -176.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 60.31 22.09 11.57 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.577 0.751 . . . . 0.0 112.377 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 20' ' ' GLN . 46.2 mt-10 -86.65 164.78 16.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.483 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -108.46 123.39 48.81 Favored 'General case' 0 C--O 1.245 0.836 0 O-C-N 123.575 0.547 . . . . 0.0 111.681 -174.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -117.63 160.07 21.89 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.562 -176.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.949 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 40.0 m80 -94.4 138.74 31.98 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 173.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -55.43 -48.36 74.55 Favored 'General case' 0 C--O 1.184 -2.365 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.216 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.407 HG13 ' N ' ' A' ' 33' ' ' CYS . 11.0 p -69.54 -38.27 76.42 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.272 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.287 -178.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.949 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 4.4 p -73.67 -28.97 62.04 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.811 -174.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.548 ' CG1' HG21 ' A' ' 36' ' ' VAL . 1.6 p -105.95 7.61 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.697 0 CA-C-O 121.524 0.678 . . . . 0.0 109.982 178.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.33 45.1 95.82 Favored Glycine 0 CA--C 1.546 1.984 0 N-CA-C 116.627 1.411 . . . . 0.0 116.627 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.548 HG21 ' CG1' ' A' ' 34' ' ' VAL . 84.4 t -96.2 148.17 5.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 173.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.5 p -100.86 153.03 37.97 Favored Pre-proline 0 N--CA 1.425 -1.711 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 175.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -48.48 -39.83 36.66 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 123.267 2.644 . . . . 0.0 112.813 -176.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 43.1 mt-10 -65.92 -31.0 71.67 Favored 'General case' 0 C--O 1.202 -1.428 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.457 ' HB3' HG11 ' A' ' 36' ' ' VAL . 38.2 ttp -73.54 -33.96 64.97 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 118.481 -1.288 . . . . 0.0 108.77 -176.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.84 -47.85 79.1 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.467 175.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -86.93 -27.93 23.05 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -176.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 39' ' ' GLU . 15.9 m120 -105.99 -27.41 11.18 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -171.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -127.69 173.37 9.98 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 119.821 -0.752 . . . . 0.0 112.32 -175.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -86.2 116.03 24.13 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.895 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.436 ' HH ' HG21 ' A' ' 34' ' ' VAL . 85.8 t80 -75.38 114.9 14.45 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 122.237 1.018 . . . . 0.0 113.301 178.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.8 mm -110.13 145.68 16.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 175.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.457 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 11.0 p -109.61 179.55 4.1 Favored 'General case' 0 C--O 1.217 -0.633 0 O-C-N 121.292 -0.88 . . . . 0.0 109.306 -176.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.6 tt -54.97 -40.16 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.512 0 C-N-CA 124.157 0.983 . . . . 0.0 112.626 177.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -78.06 -30.51 49.77 Favored 'General case' 0 C--O 1.212 -0.883 0 CA-C-O 120.911 0.386 . . . . 0.0 110.65 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.457 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 65.5 m -78.27 -31.09 48.88 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.054 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.669 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.582 -176.46 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.3 p . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.642 0.734 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.5 t -131.27 135.53 59.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.406 ' SG ' ' HA ' ' A' ' 29' ' ' PHE . 0.5 OUTLIER -93.74 -172.16 2.8 Favored 'General case' 0 C--O 1.255 1.361 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -178.435 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.8 119.07 30.72 Favored 'General case' 0 C--O 1.2 -1.504 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 176.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -176.68 142.85 0.43 Allowed 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 172.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -48.71 -44.67 38.34 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.613 0.765 . . . . 0.0 109.749 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -128.84 98.12 4.87 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.649 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.539 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 50.5 t -99.26 112.11 24.34 Favored 'General case' 0 N--CA 1.413 -2.307 0 C-N-CA 117.941 -1.504 . . . . 0.0 111.242 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -69.76 -7.89 43.41 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.608 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.591 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 76.7 mtp180 53.08 42.39 1.19 Allowed Pre-proline 0 CA--C 1.573 1.848 0 C-N-CA 124.348 1.059 . . . . 0.0 113.438 -175.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.591 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 11.8 Cg_exo -71.76 136.52 28.05 Favored 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 121.866 1.711 . . . . 0.0 111.951 -176.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 51.3 t -126.48 116.58 21.34 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.497 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -148.73 164.07 35.45 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 176.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -85.64 -7.66 58.7 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 176.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -128.73 88.49 2.74 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 114.691 -1.141 . . . . 0.0 108.698 -177.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.499 HG13 ' O ' ' A' ' 16' ' ' VAL . 6.9 p -178.14 96.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.657 0 CA-C-O 121.637 0.732 . . . . 0.0 110.124 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.79 144.01 57.39 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -109.16 159.52 16.84 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.242 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.8 m -129.58 135.36 61.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.036 0.446 . . . . 0.0 111.002 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -100.28 139.28 36.19 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 176.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.544 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.3 p -89.7 102.7 15.39 Favored 'General case' 0 C--O 1.258 1.55 0 C-N-CA 118.617 -1.233 . . . . 0.0 110.742 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.64 18.79 0.54 Allowed 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.841 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 21' ' ' CYS . . . -92.76 -10.26 60.35 Favored Glycine 0 N--CA 1.426 -1.988 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.886 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 147.06 -16.01 1.53 Allowed Glycine 0 C--O 1.213 -1.164 0 C-N-CA 118.459 -1.829 . . . . 0.0 116.486 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.544 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 13.6 m -92.29 -28.92 16.66 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.023 1.412 . . . . 0.0 109.332 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 58.68 18.5 5.96 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 124.289 1.036 . . . . 0.0 112.148 -174.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -84.16 162.26 20.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.291 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -108.89 126.56 53.19 Favored 'General case' 0 C--O 1.246 0.916 0 CA-C-O 121.302 0.572 . . . . 0.0 112.036 -175.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.406 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . 2.8 m-85 -118.78 161.05 20.77 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.351 -177.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.948 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 45.7 m80 -95.64 142.56 27.81 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.418 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 48.6 mt-30 -58.04 -48.44 80.07 Favored 'General case' 0 C--O 1.189 -2.124 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.7 p -70.16 -38.61 75.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.236 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.948 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 2.9 p -72.74 -31.72 65.16 Favored 'General case' 0 C--O 1.213 -0.817 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.665 -173.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.512 HG22 ' HH ' ' A' ' 46' ' ' TYR . 1.7 p -104.09 5.35 10.45 Favored 'Isoleucine or valine' 0 C--O 1.254 1.311 0 CA-C-O 121.219 0.533 . . . . 0.0 110.361 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.35 70.91 0.89 Allowed Glycine 0 CA--C 1.54 1.618 0 CA-C-N 115.079 -0.964 . . . . 0.0 115.014 -176.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.507 HG21 ' CG1' ' A' ' 34' ' ' VAL . 54.5 t -119.38 147.65 22.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 174.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.7 p -98.1 151.98 37.8 Favored Pre-proline 0 N--CA 1.426 -1.647 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -51.12 -36.8 56.45 Favored 'Trans proline' 0 N--CA 1.483 0.908 0 C-N-CA 123.052 2.501 . . . . 0.0 112.831 -176.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -73.13 -26.87 61.38 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.471 ' HE1' HG13 ' A' ' 36' ' ' VAL . 46.6 ttp -73.84 -34.19 64.44 Favored 'General case' 0 C--O 1.209 -1.071 0 C-N-CA 118.583 -1.247 . . . . 0.0 108.339 -177.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.6 -45.01 81.68 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -94.78 -32.27 13.38 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -98.05 -22.86 16.02 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -170.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -128.37 168.12 16.01 Favored 'General case' 0 C--N 1.311 -1.109 0 C-N-CA 119.92 -0.712 . . . . 0.0 112.12 -176.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -89.74 120.34 30.92 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.831 -174.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.512 ' HH ' HG22 ' A' ' 34' ' ' VAL . 89.0 t80 -81.97 108.23 15.31 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.5 mm -101.02 146.72 8.99 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 172.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.534 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 10.2 p -111.41 178.66 4.26 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 121.095 -1.003 . . . . 0.0 108.885 -177.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.9 tt -54.1 -42.36 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.358 0 C-N-CA 124.028 0.931 . . . . 0.0 112.315 177.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -76.78 -34.76 57.98 Favored 'General case' 0 C--O 1.212 -0.874 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.215 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.534 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 59.4 m -72.56 -26.03 61.58 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 121.164 0.507 . . . . 0.0 111.258 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.103 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.545 -179.023 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 121.136 0.494 . . . . 0.0 111.616 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 57.8 t -118.8 140.46 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -178.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -90.79 -172.16 3.28 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.17 119.48 31.85 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -176.58 146.49 0.6 Allowed 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.45 0.7 . . . . 0.0 109.237 172.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -47.65 -40.7 20.48 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 124.083 0.953 . . . . 0.0 109.834 174.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -139.46 111.55 7.45 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.244 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.548 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 46.8 t -106.15 116.06 31.28 Favored 'General case' 0 N--CA 1.416 -2.154 0 C-N-CA 117.93 -1.508 . . . . 0.0 112.355 177.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -72.89 -9.28 58.52 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 113.906 -1.497 . . . . 0.0 111.216 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.557 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 82.1 mtp180 53.21 51.85 9.51 Favored Pre-proline 0 N--CA 1.493 1.709 0 C-N-CA 124.175 0.99 . . . . 0.0 112.821 -174.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.557 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 4.2 Cg_exo -80.79 131.84 8.35 Favored 'Trans proline' 0 C--O 1.261 1.672 0 C-N-CA 122.032 1.821 . . . . 0.0 110.474 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 51.6 t -125.12 111.07 14.89 Favored 'General case' 0 N--CA 1.427 -1.613 0 O-C-N 123.661 0.601 . . . . 0.0 110.174 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.421 ' O ' HG13 ' A' ' 16' ' ' VAL . 97.1 mttt -140.35 157.53 45.41 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 175.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -87.81 2.86 50.28 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.082 0.468 . . . . 0.0 111.285 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -117.65 5.79 12.39 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.531 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.43 ' O ' HG12 ' A' ' 16' ' ' VAL . 7.9 p -97.38 105.37 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-O 121.978 0.894 . . . . 0.0 111.699 -178.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -76.17 153.31 36.27 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.629 175.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -115.23 159.55 20.83 Favored 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 124.445 1.098 . . . . 0.0 110.213 -172.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.3 m -127.44 138.91 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-O 120.738 0.304 . . . . 0.0 110.244 -177.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -106.56 139.35 41.16 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.498 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.6 p -90.0 103.51 16.17 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 118.89 -1.124 . . . . 0.0 109.113 174.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.0 26.96 0.57 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.812 0.845 . . . . 0.0 111.152 -175.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -111.21 7.25 28.81 Favored Glycine 0 N--CA 1.429 -1.774 0 CA-C-N 115.468 -0.787 . . . . 0.0 113.311 -176.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 148.45 -39.7 0.96 Allowed Glycine 0 CA--C 1.535 1.34 0 C-N-CA 118.116 -1.993 . . . . 0.0 115.375 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.498 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 7.9 m -85.88 -34.75 20.91 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 118.168 0.984 . . . . 0.0 108.457 -176.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 57.46 25.03 10.92 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.042 -177.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -87.51 168.35 13.15 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.949 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -110.87 126.42 54.66 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 122.782 0.433 . . . . 0.0 111.499 -176.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -118.83 159.27 24.05 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.689 -174.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 1.007 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 35.1 m80 -96.59 137.15 36.1 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 174.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.445 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 50.6 mt-30 -52.84 -46.43 67.8 Favored 'General case' 0 C--O 1.188 -2.156 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.3 p -72.97 -40.35 59.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 O-C-N 121.406 -0.809 . . . . 0.0 112.299 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 1.007 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 12.0 p -70.82 -27.59 63.99 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.87 -174.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.494 HG21 ' HH ' ' A' ' 46' ' ' TYR . 1.4 p -108.55 7.97 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 CA-C-O 121.394 0.616 . . . . 0.0 110.721 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.01 64.66 4.09 Favored Glycine 0 CA--C 1.559 2.828 0 N-CA-C 116.481 1.352 . . . . 0.0 116.481 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.655 HG12 ' SD ' ' A' ' 40' ' ' MET . 79.2 t -117.18 146.73 21.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 125.75 1.62 . . . . 0.0 107.193 175.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.0 p -98.31 155.42 36.91 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 177.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -55.54 -31.88 80.47 Favored 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 122.959 2.439 . . . . 0.0 113.142 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 45.6 mt-10 -71.83 -28.63 63.7 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 120.951 0.405 . . . . 0.0 110.79 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.655 ' SD ' HG12 ' A' ' 36' ' ' VAL . 28.2 ttt -69.99 -46.89 64.2 Favored 'General case' 0 C--O 1.208 -1.126 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -176.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.95 -45.25 90.93 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -86.31 -14.65 43.01 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -177.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 39' ' ' GLU . 93.0 m-20 -119.16 -34.33 3.9 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -174.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -124.6 158.55 32.79 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -172.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -72.23 114.23 10.12 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.794 -176.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.494 ' HH ' HG21 ' A' ' 34' ' ' VAL . 77.2 t80 -80.26 112.1 17.27 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 122.166 0.984 . . . . 0.0 113.438 177.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.1 mm -112.93 140.93 30.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 174.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.5 p -96.97 176.39 5.98 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -174.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.7 tt -54.06 -38.01 36.55 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 C-N-CA 123.965 0.906 . . . . 0.0 112.721 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -80.61 -30.82 36.79 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.0 0.429 . . . . 0.0 111.136 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 84.5 m -78.35 -27.83 47.09 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.323 0.582 . . . . 0.0 111.129 176.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.867 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.748 -177.758 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.1 t . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 121.332 0.587 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 49.0 t -98.95 132.84 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.02 -176.3 4.85 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.04 -175.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.3 119.67 33.41 Favored 'General case' 0 C--O 1.198 -1.634 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -175.37 148.79 0.97 Allowed 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 173.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -47.4 -42.82 22.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 123.958 0.786 . . . . 0.0 110.533 174.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -141.56 105.32 4.72 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.635 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.537 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 53.2 t -97.43 110.17 22.78 Favored 'General case' 0 N--CA 1.419 -2.02 0 C-N-CA 118.771 -1.172 . . . . 0.0 111.47 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.4 ' NE2' HG21 ' A' ' 32' ' ' VAL . 72.5 mt-30 -67.56 -8.34 33.32 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.6 1.16 . . . . 0.0 111.016 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.594 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 88.7 mtm180 51.0 44.54 2.23 Favored Pre-proline 0 CA--C 1.563 1.457 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -178.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.594 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 8.4 Cg_exo -76.36 137.4 18.75 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 122.205 1.937 . . . . 0.0 111.248 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 45.6 t -130.89 114.54 15.39 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.313 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -148.24 166.84 26.74 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -71.07 -61.69 1.67 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.728 0.775 . . . . 0.0 108.958 173.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -65.55 30.07 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 126.197 1.799 . . . . 0.0 115.53 -175.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.0 p -123.55 109.0 22.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 119.444 1.02 . . . . 0.0 112.983 178.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -73.94 146.62 43.79 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.231 -1.35 . . . . 0.0 111.928 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.0 m95 -113.13 159.21 19.47 Favored 'General case' 0 C--O 1.216 -0.699 0 C-N-CA 124.365 1.066 . . . . 0.0 109.047 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.3 m -125.05 138.02 55.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 O-C-N 121.945 -0.472 . . . . 0.0 110.535 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -105.76 138.94 41.1 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.4 p -91.92 107.28 19.09 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 119.329 -0.948 . . . . 0.0 110.742 178.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -87.86 27.02 1.22 Allowed 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.517 0.675 . . . . 0.0 110.312 -176.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.4 -7.9 57.84 Favored Glycine 0 N--CA 1.425 -2.086 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.377 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 151.16 -20.82 0.96 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 118.899 -1.62 . . . . 0.0 115.65 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.481 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 8.4 m -94.32 -32.19 13.73 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 118.771 1.286 . . . . 0.0 111.478 -176.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 60.42 19.54 9.2 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 123.856 0.862 . . . . 0.0 111.905 -174.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -86.68 161.11 18.62 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.236 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 80.0 m95 -105.97 127.16 52.97 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.235 -176.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -120.12 157.71 28.42 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.112 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.921 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 51.9 m80 -93.09 138.72 31.28 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 174.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.474 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 48.1 mt-30 -52.88 -55.19 25.01 Favored 'General case' 0 C--O 1.198 -1.632 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 177.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.4 HG21 ' NE2' ' A' ' 9' ' ' GLN . 7.3 p -65.65 -36.96 78.85 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.489 0 CA-C-O 121.736 0.779 . . . . 0.0 111.755 -177.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.921 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 1.7 p -73.95 -24.65 59.67 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.045 -175.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.514 HG23 ' HH ' ' A' ' 46' ' ' TYR . 1.7 p -111.31 12.51 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.834 0 CA-C-O 121.484 0.659 . . . . 0.0 110.875 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.12 36.19 91.55 Favored Glycine 0 CA--C 1.555 2.577 0 N-CA-C 117.598 1.799 . . . . 0.0 117.598 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.677 HG12 ' SD ' ' A' ' 40' ' ' MET . 94.3 t -97.03 144.05 11.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 174.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.3 p -98.93 152.14 37.68 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 176.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.474 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 17.8 Cg_endo -57.32 -26.8 72.37 Favored 'Trans proline' 0 N--CA 1.486 1.032 0 C-N-CA 122.409 2.072 . . . . 0.0 112.629 -177.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -74.97 -25.87 59.17 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 121.549 0.69 . . . . 0.0 109.94 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.677 ' SD ' HG12 ' A' ' 36' ' ' VAL . 28.0 ttt -73.71 -46.23 47.46 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 124.313 1.045 . . . . 0.0 110.114 -178.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.92 -47.15 81.28 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.243 -0.889 . . . . 0.0 112.021 -176.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -78.55 -13.39 59.85 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -116.11 -39.88 3.37 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 116.755 2.131 . . . . 0.0 116.755 -173.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -124.16 165.32 17.76 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.007 0.821 . . . . 0.0 112.641 -174.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -74.11 115.32 13.45 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.178 -177.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.514 ' HH ' HG23 ' A' ' 34' ' ' VAL . 81.1 t80 -72.28 111.52 7.56 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-O 121.946 0.879 . . . . 0.0 112.272 172.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.5 mm -108.44 138.54 34.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 174.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 11.1 p -98.21 176.23 5.8 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -174.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.6 tt -57.91 -35.87 53.56 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.644 0 C-N-CA 123.586 0.755 . . . . 0.0 112.276 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -79.66 -34.34 40.47 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 120.824 0.345 . . . . 0.0 110.774 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 59.4 m -72.18 -26.0 61.9 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 121.326 0.584 . . . . 0.0 110.539 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.804 -177.602 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.483 1.214 0 CA-C-O 121.295 0.569 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.2 t -113.59 135.56 52.79 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' A' ' 4' ' ' ALA . 0.4 OUTLIER -87.88 -177.79 5.87 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.792 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.419 ' N ' ' SG ' ' A' ' 3' ' ' CYS . . . -90.54 120.04 31.3 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 178.73 135.34 0.09 Allowed 'General case' 0 C--O 1.214 -0.768 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 171.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -49.93 -42.64 48.79 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 120.983 0.421 . . . . 0.0 111.086 177.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -121.54 90.62 3.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.906 173.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.504 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 44.2 t -93.94 117.03 29.54 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.529 177.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -69.32 -8.0 42.28 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.019 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.571 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 29.7 mtm180 47.82 46.21 3.4 Favored Pre-proline 0 CA--C 1.563 1.461 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -175.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.571 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 4.2 Cg_exo -76.35 131.86 13.15 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 121.942 1.761 . . . . 0.0 111.87 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 53.4 t -121.4 114.89 21.93 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -146.01 157.54 43.87 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -76.99 -10.04 59.1 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.434 0.635 . . . . 0.0 110.827 177.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -124.51 84.73 2.31 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.159 177.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 16' ' ' VAL . 7.1 p -172.31 97.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 122.149 0.976 . . . . 0.0 111.239 176.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -71.06 146.66 49.17 Favored 'General case' 0 C--N 1.279 -2.464 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.242 174.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -107.01 159.51 16.23 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.482 -174.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.9 m -125.48 132.82 70.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 120.69 0.281 . . . . 0.0 110.573 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -99.34 137.87 37.23 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.0 p -86.98 104.45 16.31 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 118.681 -1.208 . . . . 0.0 110.077 176.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -82.46 16.99 1.87 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.849 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.96 -7.31 74.35 Favored Glycine 0 N--CA 1.431 -1.644 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.973 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.19 -13.24 1.86 Allowed Glycine 0 CA--C 1.54 1.63 0 C-N-CA 119.063 -1.541 . . . . 0.0 116.907 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.485 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 17.3 m -95.23 -27.65 15.41 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 119.669 1.734 . . . . 0.0 110.444 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 63.94 16.4 9.86 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.655 0.782 . . . . 0.0 111.53 -176.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -91.36 159.4 16.01 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -176.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -106.33 126.35 52.12 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.638 -175.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -118.05 159.06 23.85 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.629 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.95 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 36.5 m80 -93.51 139.2 31.01 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 174.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.469 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 50.5 mt-30 -57.63 -42.91 84.3 Favored 'General case' 0 C--O 1.192 -1.959 0 O-C-N 123.579 0.55 . . . . 0.0 112.077 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.413 HG11 ' N ' ' A' ' 33' ' ' CYS . 10.0 p -73.59 -41.02 55.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.603 -0.685 . . . . 0.0 112.197 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.95 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 11.3 p -71.55 -31.33 66.89 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.407 -173.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.52 HG21 ' HH ' ' A' ' 46' ' ' TYR . 1.2 p -104.23 6.51 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.715 0 CA-C-O 121.312 0.577 . . . . 0.0 111.066 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.29 67.75 1.96 Allowed Glycine 0 CA--C 1.547 2.093 0 N-CA-C 115.95 1.14 . . . . 0.0 115.95 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.488 HG23 ' CG1' ' A' ' 34' ' ' VAL . 70.6 t -124.22 149.51 28.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 174.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.1 p -103.81 151.61 38.86 Favored Pre-proline 0 N--CA 1.421 -1.884 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 175.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.469 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 73.3 Cg_exo -52.52 -22.97 17.93 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.771 2.314 . . . . 0.0 112.231 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.504 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 34.1 tt0 -74.1 -36.62 64.25 Favored 'General case' 0 C--O 1.187 -2.215 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.091 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.413 ' HB3' HG11 ' A' ' 36' ' ' VAL . 39.4 ttp -73.83 -37.64 64.79 Favored 'General case' 0 CA--C 1.503 -0.859 0 O-C-N 121.097 -1.002 . . . . 0.0 110.092 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.96 -48.59 78.01 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.154 -0.93 . . . . 0.0 113.242 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -94.6 -16.05 23.54 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 119.82 -0.752 . . . . 0.0 112.833 -176.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.504 ' HB2' ' O ' ' A' ' 39' ' ' GLU . 16.3 m120 -105.39 -19.09 13.9 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -173.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -138.3 177.02 8.19 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.174 0.512 . . . . 0.0 111.706 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -92.11 121.6 33.81 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.791 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.52 ' HH ' HG21 ' A' ' 34' ' ' VAL . 80.4 t80 -75.72 104.86 6.46 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.017 1.118 . . . . 0.0 114.017 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.9 mm -94.6 139.05 19.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 170.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.431 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 13.2 p -101.19 173.66 6.36 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 119.061 -1.056 . . . . 0.0 108.751 -177.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.4 tt -57.53 -37.51 58.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 123.057 0.543 . . . . 0.0 112.042 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -75.44 -29.79 59.8 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-O 120.981 0.419 . . . . 0.0 110.535 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.431 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 52.4 m -77.76 -27.38 50.34 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.296 0.57 . . . . 0.0 110.61 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.082 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.531 -176.481 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 31.9 m . . . . . 0 CA--C 1.555 1.144 0 CA-C-O 121.696 0.76 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.4 t -131.23 129.74 62.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -88.75 -172.25 3.64 Favored 'General case' 0 C--O 1.248 1.023 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -177.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.59 119.79 33.06 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -179.98 132.02 0.1 Allowed 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 171.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -50.04 -42.82 50.33 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 121.411 0.624 . . . . 0.0 110.99 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -123.9 97.62 5.44 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 173.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.493 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 46.6 t -99.25 121.06 40.54 Favored 'General case' 0 N--CA 1.423 -1.821 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.238 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -70.41 -8.02 47.62 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 124.122 0.969 . . . . 0.0 110.29 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.536 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 32.8 ttp180 42.88 56.22 11.17 Favored Pre-proline 0 CA--C 1.568 1.663 0 C-N-CA 126.084 1.754 . . . . 0.0 114.592 -177.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.536 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 6.3 Cg_exo -87.87 144.96 6.45 Favored 'Trans proline' 0 C--O 1.26 1.577 0 C-N-CA 122.896 2.397 . . . . 0.0 112.307 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 59.0 m -127.44 125.73 41.08 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -144.15 162.13 37.08 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 176.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -84.55 -9.26 58.48 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 174.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -129.11 84.99 2.27 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.031 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.466 ' O ' HG12 ' A' ' 16' ' ' VAL . 8.1 p -172.02 104.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.738 0.78 . . . . 0.0 111.312 177.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -73.11 145.89 46.12 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.471 176.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -107.48 159.82 16.12 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 124.568 1.147 . . . . 0.0 109.206 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.9 m -123.06 141.95 41.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 120.607 0.242 . . . . 0.0 110.413 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 64.2 tt0 -112.28 139.32 47.93 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.446 ' C ' ' H ' ' A' ' 23' ' ' GLY . 29.1 p -89.6 105.58 17.89 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.806 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -77.58 29.1 0.16 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.869 0.868 . . . . 0.0 111.391 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.516 ' HA3' ' SG ' ' A' ' 51' ' ' CYS . . . -95.08 -22.78 21.94 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 141.51 1.82 1.38 Allowed Glycine 0 CA--C 1.542 1.745 0 C-N-CA 119.875 -1.155 . . . . 0.0 115.581 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.437 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 24.7 m -94.66 -29.69 14.7 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 118.74 1.27 . . . . 0.0 109.208 177.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 64.68 16.46 10.37 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.107 0.963 . . . . 0.0 112.117 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 20' ' ' GLN . 46.6 mt-10 -82.24 161.95 22.51 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.045 0.45 . . . . 0.0 111.638 -177.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -114.9 124.31 51.37 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.63 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -115.56 156.51 25.63 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -175.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.978 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 40.9 m80 -89.98 138.75 31.24 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -56.88 -49.93 74.04 Favored 'General case' 0 C--O 1.194 -1.835 0 O-C-N 123.537 0.523 . . . . 0.0 112.276 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.403 HG13 ' N ' ' A' ' 33' ' ' CYS . 12.9 p -67.55 -37.39 78.71 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.628 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.978 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 6.6 p -76.11 -25.58 55.55 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -175.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.503 HG23 ' HH ' ' A' ' 46' ' ' TYR . 0.8 OUTLIER -108.68 10.05 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.976 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.72 177.783 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.93 39.55 93.33 Favored Glycine 0 CA--C 1.549 2.214 0 N-CA-C 117.032 1.573 . . . . 0.0 117.032 178.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.474 HG22 ' CG1' ' A' ' 34' ' ' VAL . 85.1 t -96.25 145.44 8.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 117.742 0.771 . . . . 0.0 108.983 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.6 p -97.88 147.66 33.36 Favored Pre-proline 0 N--CA 1.414 -2.269 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.21 -25.08 62.65 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 C-N-CA 123.008 2.472 . . . . 0.0 112.497 -176.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -74.56 -29.49 61.37 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.441 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 37.3 ttp -74.6 -39.22 62.31 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-O 121.107 0.479 . . . . 0.0 110.509 -176.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.44 -45.29 80.87 Favored 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -87.62 -13.36 42.97 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -117.31 -20.93 8.96 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -172.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -135.07 164.02 28.59 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.22 -176.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -83.19 119.79 24.99 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.212 -175.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.503 ' HH ' HG23 ' A' ' 34' ' ' VAL . 77.6 t80 -76.64 114.13 15.05 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 122.124 0.964 . . . . 0.0 112.379 174.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.6 mm -109.97 143.75 19.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 173.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.405 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 11.5 p -104.72 172.54 6.73 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 118.671 -1.211 . . . . 0.0 109.379 -176.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.5 tt -52.44 -37.38 23.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 C-N-CA 124.052 0.941 . . . . 0.0 112.73 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -79.93 -29.67 39.81 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-O 121.099 0.476 . . . . 0.0 110.918 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.516 ' SG ' ' HA3' ' A' ' 23' ' ' GLY . 54.5 m -77.29 -31.44 54.79 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.339 178.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.865 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.567 -176.749 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.1 p . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 120.872 0.367 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.9 t -120.38 139.54 47.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.31 -173.0 2.23 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.239 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.93 120.54 35.33 Favored 'General case' 0 C--O 1.2 -1.548 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -173.81 145.52 1.15 Allowed 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 173.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -48.29 -39.12 20.67 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 123.515 0.509 . . . . 0.0 110.725 174.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -138.48 100.19 4.03 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.855 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.545 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 48.1 t -99.65 113.57 26.1 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 118.359 -1.336 . . . . 0.0 111.557 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -69.29 -10.77 59.39 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 124.889 1.276 . . . . 0.0 111.402 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.49 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 71.4 mtp180 47.32 54.77 15.96 Favored Pre-proline 0 N--CA 1.484 1.23 0 C-N-CA 123.692 0.797 . . . . 0.0 112.649 -172.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.49 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 14.1 Cg_exo -72.95 131.29 16.68 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 121.257 1.305 . . . . 0.0 110.559 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 81.1 m -111.67 105.48 14.01 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.442 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -143.66 143.09 31.29 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -68.67 -54.4 16.52 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 176.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -85.12 96.66 9.51 Favored 'General case' 0 N--CA 1.424 -1.73 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.633 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.5 p -168.66 116.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 123.482 0.713 . . . . 0.0 110.326 174.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -78.86 140.78 38.08 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.234 -0.894 . . . . 0.0 113.279 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -107.75 160.41 15.74 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 125.557 1.543 . . . . 0.0 108.429 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.7 m -124.43 138.46 53.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 117.962 0.346 . . . . 0.0 110.513 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.408 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 53.4 tt0 -106.44 138.82 41.92 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.45 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 30.6 p -90.23 113.86 25.75 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.979 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -85.67 27.6 0.84 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.813 0.845 . . . . 0.0 110.631 -177.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.437 ' HA3' ' SG ' ' A' ' 51' ' ' CYS . . . -96.63 -19.71 26.53 Favored Glycine 0 N--CA 1.432 -1.605 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.333 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.76 -14.81 0.91 Allowed Glycine 0 CA--C 1.539 1.556 0 C-N-CA 119.711 -1.233 . . . . 0.0 115.371 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.45 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 7.9 m -89.82 -29.62 18.5 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 118.709 1.254 . . . . 0.0 110.544 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 59.54 19.77 8.26 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.54 -177.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 20' ' ' GLN . 42.7 mt-10 -89.7 165.37 14.24 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.918 -178.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -106.25 127.29 53.13 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.276 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -118.76 155.64 30.76 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.47 -176.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.929 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 57.5 m80 -92.3 139.07 30.98 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 174.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.502 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 50.1 mt-30 -55.17 -51.87 65.11 Favored 'General case' 0 C--O 1.2 -1.533 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.9 p -66.38 -37.72 80.25 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.621 0 CA-C-O 121.587 0.708 . . . . 0.0 112.188 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.929 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 2.7 p -74.06 -25.16 59.68 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.029 -174.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.537 HG22 ' HH ' ' A' ' 46' ' ' TYR . 1.6 p -112.86 13.24 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 CA-C-O 121.494 0.664 . . . . 0.0 110.882 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.11 38.51 96.07 Favored Glycine 0 CA--C 1.556 2.633 0 N-CA-C 117.014 1.566 . . . . 0.0 117.014 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.595 HG11 ' SD ' ' A' ' 40' ' ' MET . 95.2 t -95.93 147.13 6.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 174.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 52.3 p -98.22 151.46 37.53 Favored Pre-proline 0 C--N 1.298 -1.673 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 174.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.502 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 14.6 Cg_endo -54.41 -31.43 68.24 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.801 2.334 . . . . 0.0 113.416 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -69.43 -32.45 71.41 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 123.932 0.893 . . . . 0.0 110.153 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.595 ' SD ' HG11 ' A' ' 36' ' ' VAL . 28.2 ttt -69.1 -42.85 75.59 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.033 0.933 . . . . 0.0 110.191 -176.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.52 -38.78 69.67 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -177.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -92.1 -47.0 7.48 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 119.053 -1.059 . . . . 0.0 113.712 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -71.15 -37.55 72.25 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -174.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -126.7 160.76 29.84 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.071 -1.052 . . . . 0.0 112.111 -171.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -78.02 115.53 17.83 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 121.294 0.569 . . . . 0.0 110.868 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.537 ' HH ' HG22 ' A' ' 34' ' ' VAL . 82.3 t80 -72.72 118.4 15.6 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.886 0.851 . . . . 0.0 112.796 175.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.2 mm -113.35 139.16 40.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 173.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.1 p -97.85 178.67 5.06 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.508 -174.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.1 tt -57.0 -37.63 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.622 0 C-N-CA 124.076 0.95 . . . . 0.0 112.805 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -83.36 -28.1 29.22 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 121.255 0.55 . . . . 0.0 110.849 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.437 ' SG ' ' HA3' ' A' ' 23' ' ' GLY . 60.2 m -77.11 -24.99 51.7 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.339 0.59 . . . . 0.0 110.693 177.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.58 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.873 -178.347 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.497 ' N ' HH21 ' A' ' 10' ' ' ARG . 48.7 m . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 121.362 0.601 . . . . 0.0 111.302 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.7 t -112.58 136.3 49.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 177.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.32 -174.41 4.38 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 119.676 -0.81 . . . . 0.0 109.027 -177.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.96 119.22 30.97 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -175.6 142.03 0.54 Allowed 'General case' 0 CA--C 1.496 -1.105 0 C-N-CA 123.432 0.693 . . . . 0.0 109.303 174.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -47.61 -44.27 26.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 124.264 0.978 . . . . 0.0 110.239 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -135.38 95.77 3.34 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.373 176.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.518 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 49.5 t -92.81 115.65 28.31 Favored 'General case' 0 N--CA 1.419 -1.992 0 C-N-CA 119.15 -1.02 . . . . 0.0 110.678 178.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -72.07 -8.74 56.34 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.415 177.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.502 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 58.9 ttt180 47.89 52.64 12.81 Favored Pre-proline 0 CA--C 1.565 1.548 0 C-N-CA 125.345 1.458 . . . . 0.0 112.073 -177.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.502 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 14.9 Cg_exo -70.97 132.76 22.0 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 121.503 1.469 . . . . 0.0 110.398 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 46.3 t -119.39 106.27 12.11 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.45 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -149.57 163.35 38.1 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -83.9 -55.91 3.98 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 173.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -68.19 82.95 0.23 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 121.333 -0.147 . . . . 0.0 111.206 172.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.453 HG13 ' O ' ' A' ' 16' ' ' VAL . 7.7 p -173.1 104.52 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 122.052 0.929 . . . . 0.0 110.752 175.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -74.56 149.68 40.07 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 114.947 -1.024 . . . . 0.0 113.334 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -113.59 160.69 18.29 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 125.262 1.425 . . . . 0.0 109.793 -175.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.5 m -123.63 136.96 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-O 120.715 0.293 . . . . 0.0 110.274 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.454 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 54.1 tt0 -103.79 138.68 40.06 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 175.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 29.4 p -90.73 103.56 16.25 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 118.976 -1.09 . . . . 0.0 110.688 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -82.82 21.03 1.06 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.052 -0.977 . . . . 0.0 111.18 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.49 -8.08 61.33 Favored Glycine 0 N--CA 1.434 -1.464 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.694 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 151.72 -23.7 0.93 Allowed Glycine 0 CA--C 1.54 1.627 0 C-N-CA 118.646 -1.74 . . . . 0.0 115.412 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.487 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 8.5 m -91.99 -29.59 16.53 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 118.839 1.319 . . . . 0.0 109.462 -176.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 58.07 26.47 13.64 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.921 -176.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.454 ' O ' ' HA ' ' A' ' 20' ' ' GLN . 37.7 mt-10 -94.43 167.19 11.67 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.4 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -108.39 129.31 55.25 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.374 -175.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -122.9 156.94 33.64 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.844 -177.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.934 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 56.1 m80 -94.0 141.19 28.81 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.573 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 51.0 mt-30 -58.38 -44.08 88.75 Favored 'General case' 0 C--O 1.187 -2.213 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.416 HG12 ' N ' ' A' ' 33' ' ' CYS . 9.6 p -76.02 -37.8 34.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 118.862 -1.135 . . . . 0.0 111.273 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.934 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 1.8 p -70.76 -33.16 70.5 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.793 -174.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.433 ' CG1' HG21 ' A' ' 36' ' ' VAL . 1.5 p -106.16 12.25 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.803 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.42 66.12 3.07 Favored Glycine 0 CA--C 1.55 2.219 0 N-CA-C 116.586 1.394 . . . . 0.0 116.586 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.433 HG21 ' CG1' ' A' ' 34' ' ' VAL . 78.7 t -116.98 149.15 19.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 175.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.4 p -95.97 147.99 33.84 Favored Pre-proline 0 N--CA 1.418 -2.044 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.573 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 18.2 Cg_endo -56.3 -27.19 65.67 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 C-N-CA 122.725 2.283 . . . . 0.0 112.231 -176.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -74.54 -28.81 61.12 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.82 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 34.6 ttp -72.33 -39.0 68.51 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -176.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.73 -30.61 65.69 Favored 'General case' 0 CA--C 1.564 1.5 0 CA-C-N 114.633 -1.167 . . . . 0.0 113.431 -176.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -95.26 -13.18 25.09 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -118.03 -35.85 3.76 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 -172.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -131.17 153.48 49.38 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.584 0.629 . . . . 0.0 110.974 -173.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -71.72 126.9 30.9 Favored 'General case' 0 C--O 1.251 1.154 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.495 -176.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.478 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 54.1 t80 -76.36 110.93 11.29 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-O 122.028 0.918 . . . . 0.0 113.454 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.4 mm -95.21 134.93 30.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 173.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.455 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 13.4 p -101.57 -179.79 4.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 119.326 0.966 . . . . 0.0 109.095 -175.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.5 tt -54.43 -42.79 60.42 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 C-N-CA 123.862 0.865 . . . . 0.0 112.131 177.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -77.5 -28.5 52.17 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-O 120.656 0.265 . . . . 0.0 111.121 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.455 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 56.5 m -77.01 -26.25 53.58 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-O 121.06 0.457 . . . . 0.0 110.916 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.738 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.0 -178.145 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.7 t . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 122.317 1.056 . . . . 0.0 108.21 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 44.1 t -131.45 140.4 48.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.434 ' SG ' ' N ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -86.31 -172.89 4.27 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.575 -178.559 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.434 ' N ' ' SG ' ' A' ' 3' ' ' CYS . . . -97.4 123.07 41.11 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 176.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -172.32 141.66 1.24 Allowed 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 172.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -48.2 -28.22 2.87 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.967 0.907 . . . . 0.0 110.8 173.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -153.43 104.45 2.75 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.927 174.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.556 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 52.2 t -101.35 123.69 45.85 Favored 'General case' 0 N--CA 1.412 -2.341 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.566 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -75.64 -7.35 54.05 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.176 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.581 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 36.5 ttt180 47.93 48.78 6.32 Favored Pre-proline 0 CA--C 1.573 1.861 0 C-N-CA 125.751 1.62 . . . . 0.0 112.197 -176.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.581 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 6.1 Cg_exo -77.42 141.6 20.28 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.252 1.968 . . . . 0.0 111.818 -177.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.5 t -134.38 116.59 15.36 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.968 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -139.11 158.36 44.31 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 174.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -81.42 -3.0 51.59 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 122.056 0.932 . . . . 0.0 108.772 175.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -128.91 85.47 2.33 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.128 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.3 p -175.79 111.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 122.015 0.912 . . . . 0.0 111.003 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -73.01 159.26 33.94 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 114.116 -1.402 . . . . 0.0 111.953 176.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 17.8 m95 -125.51 159.35 32.21 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.068 0.947 . . . . 0.0 109.905 -174.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.1 m -129.19 136.42 59.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 120.79 0.329 . . . . 0.0 110.249 -178.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -101.48 139.74 36.72 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.484 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 29.9 p -88.06 103.14 15.44 Favored 'General case' 0 C--O 1.248 1.006 0 C-N-CA 118.698 -1.201 . . . . 0.0 110.124 176.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -81.66 21.51 0.81 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.066 -175.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 21' ' ' CYS . . . -94.22 -12.94 55.66 Favored Glycine 0 N--CA 1.423 -2.217 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.87 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 149.78 -16.14 1.07 Allowed Glycine 0 CA--C 1.537 1.408 0 C-N-CA 118.509 -1.805 . . . . 0.0 116.143 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.484 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 13.5 m -90.63 -30.33 17.23 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 119.014 1.407 . . . . 0.0 109.454 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 60.83 22.55 12.6 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.52 -175.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -88.66 161.42 16.87 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.953 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -108.93 127.87 54.44 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.438 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -118.63 160.18 22.28 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.376 -176.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.983 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 48.9 m80 -94.77 134.71 37.09 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 174.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -54.27 -38.26 65.64 Favored 'General case' 0 C--O 1.203 -1.389 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 178.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.41 HG11 ' N ' ' A' ' 33' ' ' CYS . 10.5 p -77.14 -42.16 31.3 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.315 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.696 178.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.983 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 10.0 p -71.71 -30.98 66.24 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.805 -172.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.535 HG22 ' HH ' ' A' ' 46' ' ' TYR . 1.4 p -103.99 10.85 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.073 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.636 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.34 60.33 9.14 Favored Glycine 0 CA--C 1.543 1.793 0 N-CA-C 116.187 1.235 . . . . 0.0 116.187 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.491 HG21 ' CG1' ' A' ' 34' ' ' VAL . 77.4 t -107.93 146.63 13.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 174.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.7 p -99.38 156.33 35.53 Favored Pre-proline 0 N--CA 1.413 -2.276 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -58.49 -25.88 75.84 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.458 2.105 . . . . 0.0 111.307 177.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -71.33 -34.41 70.52 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.015 -178.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 35.1 ttp -75.1 -47.42 28.79 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.696 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.7 -45.18 90.07 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -175.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -79.23 -18.69 52.36 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -177.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -116.43 -30.99 5.73 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 -173.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -131.42 166.34 21.51 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 119.638 1.108 . . . . 0.0 113.806 -172.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.82 117.64 17.77 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.463 -177.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.535 ' HH ' HG22 ' A' ' 34' ' ' VAL . 82.6 t80 -73.91 117.11 15.31 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-O 122.184 0.992 . . . . 0.0 113.598 178.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.5 mm -107.03 148.06 11.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 106.16 -1.792 . . . . 0.0 106.16 174.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.473 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 11.8 p -111.55 177.32 4.69 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 119.123 0.874 . . . . 0.0 108.756 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.2 tt -55.2 -41.17 59.23 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.339 0 C-N-CA 124.047 0.939 . . . . 0.0 112.358 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -76.15 -32.79 59.26 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.048 0.451 . . . . 0.0 110.808 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.473 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 64.2 m -74.46 -25.38 59.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.219 0.533 . . . . 0.0 110.448 176.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.49 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.401 -178.525 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 C--O 1.249 1.072 0 CA-C-O 121.617 0.722 . . . . 0.0 110.563 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.4 t -119.02 139.57 45.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.412 ' SG ' ' N ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -96.01 -172.48 2.58 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.776 -176.147 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.412 ' N ' ' SG ' ' A' ' 3' ' ' CYS . . . -91.77 120.53 32.58 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -177.08 146.38 0.51 Allowed 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 172.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -47.9 -43.01 28.4 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 124.019 0.824 . . . . 0.0 110.802 174.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -140.12 99.96 3.8 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.91 173.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.534 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 47.3 t -91.5 120.42 32.31 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.892 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -71.06 -8.17 51.55 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.791 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.505 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 68.7 ttt180 48.99 53.99 15.47 Favored Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 125.51 1.524 . . . . 0.0 112.012 -175.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.505 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 10.8 Cg_exo -73.91 131.93 16.31 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 121.825 1.683 . . . . 0.0 111.037 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.3 t -125.36 110.21 13.7 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.003 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -137.44 156.59 47.99 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 174.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -68.52 -50.48 51.77 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.6 0.714 . . . . 0.0 110.236 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -103.11 92.73 4.65 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.227 0.537 . . . . 0.0 110.499 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.4 p -156.42 123.89 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.939 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.503 ' HB2' ' NE2' ' A' ' 31' ' ' GLN . 6.9 m-20 -69.62 157.63 36.84 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.747 -1.115 . . . . 0.0 113.204 177.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -133.29 159.67 39.56 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 125.524 1.53 . . . . 0.0 107.798 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.5 m -131.06 130.93 64.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 120.987 0.422 . . . . 0.0 110.577 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 50.4 tt0 -98.7 138.58 35.66 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 175.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.48 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 32.0 p -87.7 108.27 19.03 Favored 'General case' 0 C--O 1.25 1.121 0 C-N-CA 118.404 -1.318 . . . . 0.0 110.155 177.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -82.99 23.73 0.82 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.385 -177.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 21' ' ' CYS . . . -92.32 -9.8 61.45 Favored Glycine 0 N--CA 1.417 -2.595 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.3 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 139.9 -14.35 3.1 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 119.12 -1.514 . . . . 0.0 115.567 177.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.48 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 19.1 m -87.41 -28.12 22.33 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 119.14 1.47 . . . . 0.0 108.709 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 59.5 21.59 10.08 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.961 -177.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 20' ' ' GLN . 42.9 mt-10 -88.99 163.96 15.31 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 120.951 0.405 . . . . 0.0 111.653 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 44.9 m95 -108.14 128.69 54.91 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.239 -175.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -121.89 158.54 28.77 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.913 -178.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.981 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 49.0 m80 -97.56 140.19 32.34 Favored 'General case' 0 CA--C 1.488 -1.413 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 174.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.503 ' NE2' ' HB2' ' A' ' 17' ' ' ASP . 50.8 mt-30 -56.95 -45.62 82.71 Favored 'General case' 0 C--O 1.191 -2.023 0 O-C-N 123.771 0.67 . . . . 0.0 112.75 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.478 HG13 ' N ' ' A' ' 33' ' ' CYS . 9.8 p -71.07 -40.17 75.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 O-C-N 121.575 -0.703 . . . . 0.0 112.086 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.981 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 9.4 p -70.85 -33.95 71.16 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.837 -174.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.474 HG13 HG23 ' A' ' 36' ' ' VAL . 1.7 p -104.13 10.23 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 CA-C-O 121.291 0.567 . . . . 0.0 110.497 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.08 60.52 8.49 Favored Glycine 0 CA--C 1.551 2.339 0 N-CA-C 116.501 1.36 . . . . 0.0 116.501 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.474 HG23 HG13 ' A' ' 34' ' ' VAL . 74.6 t -115.87 148.3 18.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 175.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.1 p -100.13 149.83 36.36 Favored Pre-proline 0 N--CA 1.421 -1.912 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.452 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 72.9 Cg_exo -53.94 -30.23 57.68 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 122.961 2.441 . . . . 0.0 112.507 -178.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -69.3 -31.88 70.66 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.062 -178.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 35.2 ttp -74.84 -42.3 58.23 Favored 'General case' 0 C--O 1.208 -1.112 0 CA-C-O 121.269 0.557 . . . . 0.0 110.185 -177.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.42 -41.24 79.99 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -176.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -86.21 -14.02 45.19 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -113.37 -34.18 5.69 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -174.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -130.02 144.21 51.21 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 118.654 0.661 . . . . 0.0 111.105 -174.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -70.45 115.61 9.83 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.293 -178.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -69.74 120.2 15.13 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -176.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.8 mm -102.41 139.87 22.3 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.904 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 173.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.2 p -102.19 178.57 4.56 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.875 0.761 . . . . 0.0 109.88 -176.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.7 tt -55.98 -39.45 57.7 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.476 0 C-N-CA 123.769 0.828 . . . . 0.0 112.247 177.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -74.55 -38.47 62.72 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 121.159 0.504 . . . . 0.0 110.848 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 63.7 m -69.33 -27.18 65.14 Favored 'General case' 0 C--O 1.213 -0.819 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.89 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.109 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.67 -177.362 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 36.0 t . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 120.761 0.315 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.8 t -123.81 130.69 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -178.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.42 ' SG ' ' N ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -90.45 -175.21 4.39 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.502 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.42 ' N ' ' SG ' ' A' ' 3' ' ' CYS . . . -95.67 123.17 39.1 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -176.11 151.31 1.04 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 172.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -47.13 -42.91 20.17 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.259 0.624 . . . . 0.0 110.928 173.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -141.58 107.57 5.18 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.801 176.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.547 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 47.0 t -101.19 116.85 33.77 Favored 'General case' 0 N--CA 1.42 -1.938 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.976 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -74.38 -11.38 60.23 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.156 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.523 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 31.5 mtm180 49.11 53.51 14.67 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 125.511 1.524 . . . . 0.0 114.388 -174.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.523 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 8.5 Cg_exo -78.05 139.7 17.36 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 121.826 1.684 . . . . 0.0 111.265 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.4 t -132.86 115.81 15.73 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -149.68 156.83 42.54 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.39 -15.38 63.53 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.194 0.598 . . . . 0.0 111.667 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -116.75 18.98 14.71 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -170.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.8 p -114.76 106.18 20.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.945 0.878 . . . . 0.0 112.465 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -72.75 148.37 44.69 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.355 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -113.18 158.97 19.77 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.511 1.125 . . . . 0.0 110.182 -174.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.2 m -125.98 132.16 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-O 120.678 0.275 . . . . 0.0 110.77 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -99.23 138.88 35.69 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.5 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 28.8 p -83.88 108.77 17.08 Favored 'General case' 0 C--O 1.255 1.345 0 C-N-CA 118.708 -1.197 . . . . 0.0 111.667 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -76.39 18.87 0.28 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.315 1.046 . . . . 0.0 112.17 -176.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.595 ' HA3' ' SG ' ' A' ' 51' ' ' CYS . . . -92.93 -18.67 39.36 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.117 -179.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 141.41 -6.83 2.5 Favored Glycine 0 CA--C 1.545 1.93 0 C-N-CA 119.185 -1.483 . . . . 0.0 115.978 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.5 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 16.9 m -88.89 -25.1 22.31 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 119.133 1.467 . . . . 0.0 109.315 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 59.92 18.48 7.53 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.299 1.04 . . . . 0.0 113.051 -176.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -85.91 159.36 19.68 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.212 0.529 . . . . 0.0 111.181 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -106.39 126.24 52.0 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.06 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.405 ' CD1' ' HE2' ' A' ' 46' ' ' TYR . 3.0 m-85 -118.64 159.31 23.83 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.706 -177.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.97 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 41.6 m80 -96.28 135.86 37.54 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.472 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 50.8 mt-30 -55.02 -40.05 69.76 Favored 'General case' 0 C--O 1.188 -2.148 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 177.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.417 HG11 ' N ' ' A' ' 33' ' ' CYS . 11.7 p -76.43 -38.86 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.454 0 C-N-CA 119.692 -0.803 . . . . 0.0 112.092 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.97 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 7.7 p -75.08 -29.5 60.68 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -174.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.562 HG22 ' OH ' ' A' ' 46' ' ' TYR . 2.1 p -104.7 1.95 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 CA-C-O 121.678 0.751 . . . . 0.0 110.117 178.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.7 75.03 0.35 Allowed Glycine 0 CA--C 1.55 2.233 0 N-CA-C 115.813 1.085 . . . . 0.0 115.813 -176.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.507 HG23 ' CG1' ' A' ' 34' ' ' VAL . 64.3 t -127.97 147.94 32.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 175.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 52.2 p -99.54 150.97 37.27 Favored Pre-proline 0 N--CA 1.421 -1.886 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.472 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 18.2 Cg_endo -56.09 -23.75 45.86 Favored 'Trans proline' 0 N--CA 1.485 0.988 0 C-N-CA 122.925 2.417 . . . . 0.0 112.32 -177.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -74.2 -32.97 63.25 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.186 -178.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 35.4 ttp -73.91 -41.32 62.29 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -176.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.26 -43.06 87.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.214 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -83.58 -21.35 32.66 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -177.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -110.38 -27.68 8.93 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 -174.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -132.7 166.08 23.02 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.461 1.028 . . . . 0.0 111.927 -174.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -81.91 115.64 21.19 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.562 ' OH ' HG22 ' A' ' 34' ' ' VAL . 49.7 t80 -68.72 113.37 6.13 Favored 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.4 mm -101.28 140.5 19.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.478 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 8.3 p -107.9 178.53 4.49 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.171 -177.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.2 tt -55.36 -41.83 63.98 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 C-N-CA 124.131 0.972 . . . . 0.0 112.245 177.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -77.64 -25.31 49.58 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 121.25 0.548 . . . . 0.0 110.393 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.595 ' SG ' ' HA3' ' A' ' 23' ' ' GLY . 55.5 m -78.03 -26.93 48.68 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.191 177.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.779 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.023 -176.638 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.5 p . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.516 0.674 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.0 t -124.0 134.67 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.16 -173.56 3.29 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.43 119.73 33.6 Favored 'General case' 0 C--O 1.207 -1.162 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -177.64 142.26 0.31 Allowed 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 173.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -47.87 -45.1 29.94 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 124.046 0.841 . . . . 0.0 110.895 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -130.67 94.91 3.73 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.69 176.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.504 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 51.8 t -93.63 123.21 36.8 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 118.995 -1.082 . . . . 0.0 111.181 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -81.45 -11.68 59.15 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.831 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.564 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 62.4 mtm180 52.9 43.57 1.61 Allowed Pre-proline 0 CA--C 1.566 1.584 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -176.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 10.4 Cg_exo -76.86 143.63 23.57 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 121.619 1.546 . . . . 0.0 110.608 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 53.2 t -137.7 113.32 9.56 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.412 ' O ' HG12 ' A' ' 16' ' ' VAL . 97.7 mttt -142.69 151.38 41.3 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 177.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.24 -4.85 15.52 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 178.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -121.25 8.92 10.33 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -176.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 13' ' ' LYS . 7.2 p -102.86 107.18 21.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-O 121.756 0.789 . . . . 0.0 112.044 -178.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -74.07 146.8 43.38 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.592 176.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -111.95 159.16 18.67 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 124.638 1.175 . . . . 0.0 109.676 -174.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 23.1 m -123.86 132.65 71.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 O-C-N 121.949 -0.469 . . . . 0.0 110.763 -177.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -101.15 138.82 37.67 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.492 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.1 p -90.66 107.81 19.41 Favored 'General case' 0 C--O 1.255 1.35 0 C-N-CA 119.161 -1.016 . . . . 0.0 110.741 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -86.79 23.83 1.62 Allowed 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.926 -176.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.72 -14.09 60.14 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.11 -9.11 1.74 Allowed Glycine 0 CA--C 1.542 1.755 0 C-N-CA 119.032 -1.556 . . . . 0.0 116.234 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.492 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 13.9 m -92.58 -28.71 16.57 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 119.641 1.72 . . . . 0.0 110.209 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 61.91 17.69 9.15 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.831 1.253 . . . . 0.0 111.69 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -87.8 161.48 17.53 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.134 0.493 . . . . 0.0 111.598 -178.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -107.33 127.9 53.97 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.004 -176.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.409 ' HE1' ' SG ' ' A' ' 21' ' ' CYS . 3.5 m-85 -119.48 155.32 32.31 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -178.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.953 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 42.5 m80 -91.18 139.85 30.36 Favored 'General case' 0 CA--C 1.476 -1.867 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 174.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.458 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 48.4 mt-30 -54.45 -51.32 65.35 Favored 'General case' 0 C--O 1.192 -1.947 0 O-C-N 123.666 0.604 . . . . 0.0 111.806 177.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.403 HG12 ' N ' ' A' ' 33' ' ' CYS . 10.8 p -68.2 -39.51 81.32 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 CA-C-O 121.125 0.488 . . . . 0.0 112.136 -178.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.953 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 3.4 p -72.76 -25.05 61.05 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.336 -174.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.529 HG22 ' HH ' ' A' ' 46' ' ' TYR . 0.9 OUTLIER -110.81 11.72 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.821 177.259 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.54 39.98 95.85 Favored Glycine 0 CA--C 1.546 2.021 0 N-CA-C 117.34 1.696 . . . . 0.0 117.34 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.464 HG21 ' CG1' ' A' ' 34' ' ' VAL . 69.4 t -93.92 147.95 5.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 118.153 0.976 . . . . 0.0 109.378 175.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.9 p -99.37 147.35 33.2 Favored Pre-proline 0 N--CA 1.414 -2.249 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 175.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.458 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 74.9 Cg_exo -51.41 -32.27 41.83 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.312 2.675 . . . . 0.0 114.062 -175.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.57 -26.02 60.63 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 35.9 ttp -73.38 -38.17 65.74 Favored 'General case' 0 C--O 1.213 -0.822 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.42 -43.98 79.9 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.659 -177.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -90.46 -12.28 37.82 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -113.59 -27.0 8.02 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -128.77 151.19 49.84 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.06 0.457 . . . . 0.0 110.324 -175.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -79.15 115.71 18.98 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.659 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.529 ' HH ' HG22 ' A' ' 34' ' ' VAL . 90.5 t80 -67.01 114.86 6.13 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-O 122.812 1.292 . . . . 0.0 114.428 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.0 mm -103.64 141.65 18.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 172.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.439 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 9.3 p -106.83 179.21 4.33 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.361 -176.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.5 tt -56.04 -43.28 74.94 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 C-N-CA 123.684 0.794 . . . . 0.0 112.269 177.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -76.04 -28.23 57.61 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.095 0.474 . . . . 0.0 110.943 -178.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.439 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 58.0 m -76.59 -25.56 54.07 Favored 'General case' 0 C--O 1.213 -0.83 0 CA-C-O 121.524 0.678 . . . . 0.0 110.901 176.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.293 -1.877 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.753 -176.809 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 121.644 0.735 . . . . 0.0 110.372 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.5 t -129.43 137.71 56.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.62 ' SG ' ' HA ' ' A' ' 29' ' ' PHE . 0.5 OUTLIER -100.77 -172.43 2.18 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 119.108 -1.037 . . . . 0.0 109.767 -176.204 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.99 121.94 31.85 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -173.78 145.3 1.14 Allowed 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 172.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -47.99 -42.0 26.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 123.771 0.669 . . . . 0.0 109.439 173.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -136.06 97.93 3.74 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.337 174.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.561 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 53.4 t -94.19 156.92 16.31 Favored 'General case' 0 N--CA 1.422 -1.843 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.24 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.649 ' C ' ' HD3' ' A' ' 11' ' ' PRO . 76.6 mt-30 -119.2 173.27 7.03 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.772 -177.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.434 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 19.2 mmm180 -116.69 62.88 2.77 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 123.416 0.686 . . . . 0.0 111.085 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.649 ' HD3' ' C ' ' A' ' 9' ' ' GLN . 5.0 Cg_exo -88.6 145.43 5.76 Favored 'Trans proline' 0 C--N 1.359 1.099 0 C-N-CA 123.389 2.726 . . . . 0.0 112.077 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.6 t -130.16 107.44 9.31 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.801 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -152.97 156.57 39.12 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 124.862 1.265 . . . . 0.0 108.581 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -87.77 -51.1 6.05 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 172.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -72.32 79.55 1.01 Allowed 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.992 175.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 16' ' ' VAL . 7.6 p -165.61 102.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 122.125 0.964 . . . . 0.0 110.604 176.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -67.88 137.89 55.61 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 114.191 -1.368 . . . . 0.0 112.283 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 21.4 m95 -106.53 160.3 15.53 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.015 1.326 . . . . 0.0 108.945 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.5 m -127.83 132.72 68.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.115 0.483 . . . . 0.0 110.851 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -100.45 138.99 36.76 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 30.6 p -87.69 102.67 14.87 Favored 'General case' 0 C--O 1.256 1.416 0 C-N-CA 118.997 -1.081 . . . . 0.0 110.595 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.52 24.44 0.57 Allowed 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.122 -175.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 21' ' ' CYS . . . -92.64 -18.27 41.91 Favored Glycine 0 N--CA 1.437 -1.253 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 177.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 147.61 -10.65 1.27 Allowed Glycine 0 C--N 1.351 1.41 0 N-CA-C 116.951 1.54 . . . . 0.0 116.951 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.465 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 15.9 m -88.9 -26.8 21.4 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 119.754 1.777 . . . . 0.0 109.724 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 61.1 20.53 11.0 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.859 0.863 . . . . 0.0 112.417 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -91.77 158.08 16.55 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.744 -178.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -107.77 132.78 53.02 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.896 -177.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.62 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . 3.5 m-85 -120.72 159.72 24.79 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.152 -177.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.898 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 42.4 m80 -93.35 134.49 35.52 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -56.87 -33.04 66.46 Favored 'General case' 0 C--O 1.197 -1.7 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 176.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.6 p -77.2 -41.6 30.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-O 121.336 0.589 . . . . 0.0 111.968 177.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.898 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 4.2 p -75.52 -29.17 59.37 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.992 -173.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.473 ' CG1' HG23 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -106.66 2.79 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.764 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.485 179.66 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.31 72.49 0.62 Allowed Glycine 0 CA--C 1.555 2.586 0 N-CA-C 116.316 1.286 . . . . 0.0 116.316 -176.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.473 HG23 ' CG1' ' A' ' 34' ' ' VAL . 59.3 t -121.2 148.77 24.34 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 C-N-CA 124.547 1.139 . . . . 0.0 108.176 175.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.6 p -99.99 150.83 37.22 Favored Pre-proline 0 N--CA 1.42 -1.946 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -49.95 -42.71 44.3 Favored 'Trans proline' 0 C--N 1.358 1.066 0 C-N-CA 123.051 2.501 . . . . 0.0 112.115 -177.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -60.07 -35.04 74.29 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.416 ' HE1' HG13 ' A' ' 36' ' ' VAL . 42.2 ttp -69.25 -43.33 74.19 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.617 -176.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.13 -48.24 80.84 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 123.792 0.683 . . . . 0.0 112.072 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -77.91 -13.78 59.77 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -176.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -122.19 -43.03 2.34 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 117.021 2.23 . . . . 0.0 117.021 -172.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -126.89 171.31 11.38 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -168.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -68.35 115.14 7.44 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.48 0.712 . . . . 0.0 112.184 -173.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.458 ' OH ' HG22 ' A' ' 34' ' ' VAL . 79.3 t80 -82.81 105.66 14.01 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 122.239 1.019 . . . . 0.0 111.757 172.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.0 mm -98.92 145.14 10.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 175.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.419 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 13.5 p -105.32 178.28 4.61 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 119.306 -0.958 . . . . 0.0 108.872 -178.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.0 tt -55.83 -41.31 65.94 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 124.071 0.948 . . . . 0.0 111.928 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -75.62 -39.89 57.15 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.912 0.485 . . . . 0.0 111.433 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.419 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 52.1 m -63.21 -29.81 71.08 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.023 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.696 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.587 -175.399 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.9 m . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 121.174 0.511 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.7 t -132.08 139.93 49.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -87.68 -173.68 4.43 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -178.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.59 119.98 34.1 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 174.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -173.25 140.91 0.89 Allowed 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 171.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -48.99 -43.61 40.38 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.931 0.769 . . . . 0.0 109.474 176.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -127.96 104.88 8.04 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.797 177.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.54 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 42.1 t -105.9 125.23 50.75 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 117.738 -1.585 . . . . 0.0 112.614 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -81.23 -6.06 58.45 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.161 -1.381 . . . . 0.0 110.571 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.593 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 73.3 mtp180 53.11 39.9 0.69 Allowed Pre-proline 0 CA--C 1.57 1.712 0 C-N-CA 124.465 1.106 . . . . 0.0 113.787 -176.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.593 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 7.2 Cg_exo -74.67 134.0 17.85 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 121.687 1.591 . . . . 0.0 112.076 -175.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 51.2 t -127.69 125.1 39.44 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -149.04 164.23 35.23 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -77.35 -14.63 59.69 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.498 0.666 . . . . 0.0 109.253 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -131.45 91.44 3.01 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.929 -177.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.431 HG13 ' O ' ' A' ' 16' ' ' VAL . 7.2 p -171.56 103.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 122.164 0.983 . . . . 0.0 111.143 179.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.667 ' HB2' ' NE2' ' A' ' 31' ' ' GLN . 4.1 m-20 -68.85 140.56 55.22 Favored 'General case' 0 C--N 1.275 -2.665 0 CA-C-N 114.433 -1.258 . . . . 0.0 111.722 177.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -107.55 159.82 16.14 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 124.198 0.999 . . . . 0.0 108.825 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.4 m -127.26 134.08 66.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 120.905 0.383 . . . . 0.0 110.397 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -101.0 139.07 37.2 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 30.1 p -91.63 99.68 12.54 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 118.875 -1.13 . . . . 0.0 109.951 176.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -85.07 22.45 1.42 Allowed 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.698 -175.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' A' ' 21' ' ' CYS . . . -95.21 -2.75 62.02 Favored Glycine 0 N--CA 1.426 -2.022 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.562 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.15 -23.74 1.12 Allowed Glycine 0 CA--C 1.541 1.675 0 C-N-CA 118.878 -1.629 . . . . 0.0 116.203 178.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.475 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 5.6 m -95.09 -31.84 13.38 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 119.089 1.444 . . . . 0.0 110.015 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 61.59 19.39 10.36 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 124.019 0.825 . . . . 0.0 111.908 -176.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -85.73 158.95 19.9 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.716 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -104.67 127.63 52.49 Favored 'General case' 0 C--O 1.242 0.669 0 O-C-N 123.619 0.574 . . . . 0.0 112.342 -176.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.405 ' HE1' ' SG ' ' A' ' 21' ' ' CYS . 8.9 m-85 -118.12 156.38 28.77 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.889 -1.051 . . . . 0.0 108.786 -177.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.983 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 47.2 m80 -93.56 139.11 31.13 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 174.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.667 ' NE2' ' HB2' ' A' ' 17' ' ' ASP . 50.6 mt-30 -56.12 -46.24 79.23 Favored 'General case' 0 C--O 1.188 -2.137 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 33' ' ' CYS . 9.0 p -72.66 -37.85 57.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.738 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.983 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 5.4 p -72.24 -31.75 66.09 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.832 -175.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.532 HG22 ' HH ' ' A' ' 46' ' ' TYR . 1.4 p -104.47 5.69 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.659 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.36 72.12 0.73 Allowed Glycine 0 CA--C 1.548 2.142 0 N-CA-C 115.408 0.923 . . . . 0.0 115.408 -176.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.491 HG23 ' CG1' ' A' ' 34' ' ' VAL . 74.5 t -127.61 147.3 32.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 173.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.4 p -100.25 150.56 37.02 Favored Pre-proline 0 N--CA 1.422 -1.832 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 176.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.58 -25.2 32.0 Favored 'Trans proline' 0 N--CA 1.488 1.148 0 C-N-CA 123.513 2.809 . . . . 0.0 112.735 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -73.53 -34.27 65.14 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.364 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 39.8 ttp -74.43 -38.16 63.12 Favored 'General case' 0 C--O 1.21 -0.986 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.206 -176.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.88 -44.11 77.84 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -176.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -85.82 -46.14 10.92 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 176.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -75.1 -35.48 61.76 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 -173.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -128.08 164.07 23.22 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -171.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -82.93 115.67 21.89 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.877 0.871 . . . . 0.0 111.512 -174.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.532 ' HH ' HG22 ' A' ' 34' ' ' VAL . 77.8 t80 -78.49 110.77 13.86 Favored 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.2 mm -102.29 146.22 10.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 172.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.481 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 7.9 p -111.0 179.83 3.94 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 119.226 -0.99 . . . . 0.0 109.737 -175.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.6 tt -55.02 -40.05 52.43 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.538 0 C-N-CA 124.448 1.099 . . . . 0.0 112.636 177.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -82.93 -29.13 29.38 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.481 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 56.7 m -73.98 -27.98 61.25 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-O 120.887 0.375 . . . . 0.0 111.198 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.423 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.578 -176.043 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 40.6 m . . . . . 0 N--CA 1.495 1.825 0 CA-C-O 121.951 0.881 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.2 t -123.53 139.84 48.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -178.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.4 p -87.72 -172.16 3.75 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -176.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.61 118.87 32.38 Favored 'General case' 0 C--O 1.206 -1.206 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 172.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -177.03 135.56 0.2 Allowed 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 171.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -51.36 -43.31 61.79 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.287 0.565 . . . . 0.0 110.483 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -121.91 103.11 8.61 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.886 175.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.55 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 42.2 t -107.49 122.16 46.08 Favored 'General case' 0 N--CA 1.417 -2.083 0 C-N-CA 118.024 -1.47 . . . . 0.0 111.993 177.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -79.49 -8.46 59.15 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.33 178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.496 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 38.1 ttp180 46.1 61.81 12.22 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 126.763 2.025 . . . . 0.0 111.997 -175.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.496 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 17.0 Cg_exo -76.23 132.98 14.32 Favored 'Trans proline' 0 C--O 1.252 1.184 0 C-N-CA 123.048 2.499 . . . . 0.0 111.752 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.4 t -123.82 102.66 7.92 Favored 'General case' 0 N--CA 1.44 -0.971 0 O-C-N 123.894 0.746 . . . . 0.0 110.479 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -141.03 159.6 41.87 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 175.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -81.74 -50.1 9.66 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.826 -0.75 . . . . 0.0 112.031 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -73.39 18.83 0.11 Allowed 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.5 p -102.74 111.21 31.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 119.287 0.949 . . . . 0.0 111.928 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -71.39 146.93 48.43 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.047 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -113.69 159.2 19.95 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.262 1.025 . . . . 0.0 109.822 -175.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.7 137.59 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-O 120.71 0.29 . . . . 0.0 110.546 -177.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -110.52 138.3 47.09 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.572 178.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 31.4 p -93.22 102.42 14.71 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.497 176.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -86.68 25.26 1.29 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.808 0.813 . . . . 0.0 109.881 -176.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.11 1.68 57.71 Favored Glycine 0 N--CA 1.431 -1.643 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.699 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 151.75 -35.28 0.86 Allowed Glycine 0 CA--C 1.534 1.256 0 C-N-CA 118.726 -1.702 . . . . 0.0 115.608 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.4 m -89.27 -32.75 17.23 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 118.548 1.174 . . . . 0.0 109.488 -176.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 59.95 21.39 10.43 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.748 1.219 . . . . 0.0 111.634 -177.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -88.15 163.7 16.06 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.731 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -105.29 127.52 52.99 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.115 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -117.12 155.15 29.8 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.684 -178.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.983 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 44.2 m80 -92.54 137.73 32.11 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 174.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -52.46 -51.74 57.76 Favored 'General case' 0 C--O 1.198 -1.62 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.3 p -68.63 -37.02 77.04 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 CA-C-N 118.533 0.606 . . . . 0.0 112.246 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.983 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 8.1 p -72.51 -27.29 62.17 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.23 -175.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.492 HG23 ' HH ' ' A' ' 46' ' ' TYR . 0.8 OUTLIER -109.68 12.92 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.944 0 CA-C-O 121.753 0.787 . . . . 0.0 110.727 177.779 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.18 35.98 92.65 Favored Glycine 0 CA--C 1.553 2.433 0 N-CA-C 117.257 1.663 . . . . 0.0 117.257 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.489 HG22 ' CG1' ' A' ' 34' ' ' VAL . 86.5 t -93.97 147.48 5.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 117.775 0.788 . . . . 0.0 109.74 176.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.3 p -104.36 150.69 38.72 Favored Pre-proline 0 N--CA 1.415 -2.198 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 175.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -47.59 -39.63 29.74 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 123.475 2.783 . . . . 0.0 112.987 -177.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -58.15 -38.86 77.41 Favored 'General case' 0 C--O 1.214 -0.809 0 C-N-CA 124.475 1.11 . . . . 0.0 111.609 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.407 ' HB3' HG12 ' A' ' 36' ' ' VAL . 33.3 ttp -72.36 -39.54 67.99 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.813 -175.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.83 -49.05 77.96 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 123.741 0.651 . . . . 0.0 112.71 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -90.13 -24.01 21.2 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -177.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -98.53 -28.03 13.77 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.177 -1.009 . . . . 0.0 113.684 -172.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -139.05 -179.83 6.07 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -176.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -83.92 118.26 23.88 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 113.586 -1.643 . . . . 0.0 112.477 -174.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.492 ' HH ' HG23 ' A' ' 34' ' ' VAL . 64.4 t80 -88.18 110.37 20.64 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 122.272 1.035 . . . . 0.0 113.551 175.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.2 mm -107.89 141.15 23.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 172.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.9 p -97.9 176.56 5.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.276 -175.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.8 tt -54.15 -36.25 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.343 0 C-N-CA 124.255 1.022 . . . . 0.0 112.596 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -81.71 -35.67 29.51 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-O 120.881 0.372 . . . . 0.0 110.095 -178.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 64.6 m -74.39 -25.05 59.25 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-O 121.422 0.63 . . . . 0.0 111.482 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.1 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -178.812 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 37.4 t . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 120.934 0.397 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 99.6 t -99.12 127.72 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -178.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' ' 29' ' ' PHE . 0.5 OUTLIER -94.28 -174.83 3.48 Favored 'General case' 0 N--CA 1.433 -1.313 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.35 -176.08 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.07 120.06 31.72 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -175.25 147.19 0.88 Allowed 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 123.166 0.586 . . . . 0.0 109.454 171.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -48.04 -41.52 25.97 Favored 'General case' 0 CA--C 1.558 1.267 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.825 173.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -137.69 98.27 3.64 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.488 173.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.501 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 43.8 t -94.33 117.82 30.69 Favored 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.284 -178.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -85.67 164.34 17.73 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.47 83.64 11.07 Favored Pre-proline 0 C--N 1.311 -1.073 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -70.4 157.43 59.16 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.759 2.973 . . . . 0.0 111.49 172.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.9 p -135.72 27.73 3.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.127 0.489 . . . . 0.0 111.28 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -94.54 146.48 24.08 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 120.475 -0.49 . . . . 0.0 112.022 -177.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -68.33 -53.93 20.87 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 174.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -76.05 91.49 3.1 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.366 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.8 p -170.43 98.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 122.409 1.099 . . . . 0.0 110.961 173.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -66.52 142.71 57.43 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 114.252 -1.34 . . . . 0.0 113.589 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 15.7 m95 -109.12 160.3 16.18 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.763 1.225 . . . . 0.0 109.899 -177.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.3 m -130.35 143.61 40.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 121.291 0.567 . . . . 0.0 111.898 -178.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -112.62 138.73 48.99 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.527 ' HB3' ' O ' ' A' ' 25' ' ' CYS . 43.4 t -77.67 101.31 6.55 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.424 0.631 . . . . 0.0 111.401 -178.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -88.74 10.57 20.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 122.524 1.154 . . . . 0.0 108.435 -178.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.9 -2.14 78.75 Favored Glycine 0 N--CA 1.419 -2.436 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.338 177.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 144.74 -26.25 1.94 Allowed Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 119.919 -1.134 . . . . 0.0 114.929 176.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.527 ' O ' ' HB3' ' A' ' 21' ' ' CYS . 17.2 p -114.87 90.09 3.25 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 117.151 -1.82 . . . . 0.0 111.955 -177.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -39.73 13.96 0.0 OUTLIER 'General case' 0 N--CA 1.532 3.631 0 N-CA-C 117.806 2.521 . . . . 0.0 117.806 173.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.475 ' H ' ' C ' ' A' ' 25' ' ' CYS . 40.4 mt-10 -81.73 160.91 23.52 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-N 118.769 0.713 . . . . 0.0 109.725 176.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -105.73 130.21 53.78 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.472 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . 17.6 m-85 -118.95 151.62 37.84 Favored 'General case' 0 CA--C 1.562 1.407 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.646 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.909 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 35.2 m80 -88.5 141.87 28.18 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 173.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.433 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 49.8 mt-30 -56.94 -52.11 66.5 Favored 'General case' 0 C--O 1.192 -1.932 0 C-N-CA 120.3 -0.56 . . . . 0.0 112.015 176.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.5 p -67.12 -40.52 85.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.909 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 2.1 p -71.1 -27.31 63.51 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.215 -174.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.474 HG23 ' HH ' ' A' ' 46' ' ' TYR . 0.5 OUTLIER -109.96 9.15 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.123 0 CA-C-O 121.255 0.55 . . . . 0.0 111.448 178.781 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.38 40.54 96.47 Favored Glycine 0 CA--C 1.557 2.675 0 N-CA-C 117.392 1.717 . . . . 0.0 117.392 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.476 HG11 ' HE3' ' A' ' 40' ' ' MET . 78.5 t -92.13 149.18 4.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.9 p -100.7 150.42 36.98 Favored Pre-proline 0 N--CA 1.426 -1.666 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 176.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.71 -34.58 54.49 Favored 'Trans proline' 0 N--CA 1.483 0.855 0 C-N-CA 123.031 2.488 . . . . 0.0 112.733 -176.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -72.98 -27.86 62.05 Favored 'General case' 0 N--CA 1.414 -2.235 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.287 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.476 ' HE3' HG11 ' A' ' 36' ' ' VAL . 49.9 ttp -73.12 -37.3 66.73 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -177.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.02 -32.11 70.58 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.823 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -95.7 -21.31 18.26 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -113.32 -33.81 5.83 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 115.729 1.752 . . . . 0.0 115.729 -171.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -123.33 163.52 20.59 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 118.809 -1.156 . . . . 0.0 113.045 -173.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -82.63 115.13 21.45 Favored 'General case' 0 C--O 1.253 1.266 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.153 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.474 ' HH ' HG23 ' A' ' 34' ' ' VAL . 63.5 t80 -71.59 108.97 5.23 Favored 'General case' 0 C--O 1.249 1.079 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.6 mm -98.61 146.21 8.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 170.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 18.2 p -107.04 178.68 4.49 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.509 -0.877 . . . . 0.0 110.6 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.3 tt -50.5 -34.79 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.368 0 C-N-CA 125.399 1.48 . . . . 0.0 113.126 177.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -89.79 -37.92 14.16 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 80.1 m -78.04 -23.5 48.12 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.889 0.376 . . . . 0.0 111.155 -177.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.685 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.357 179.553 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.411 ' N ' HH21 ' A' ' 10' ' ' ARG . 51.0 m . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 120.923 0.392 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.8 t -129.46 137.35 57.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.427 ' SG ' ' HA ' ' A' ' 29' ' ' PHE . 0.5 OUTLIER -100.08 -172.38 2.21 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 119.544 -0.862 . . . . 0.0 108.731 -178.506 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.54 119.45 29.0 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -177.88 143.8 0.33 Allowed 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 172.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -47.58 -40.91 20.38 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 123.63 0.582 . . . . 0.0 110.956 175.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -136.8 102.03 4.77 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.118 174.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.557 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 50.3 t -96.48 117.49 31.01 Favored 'General case' 0 N--CA 1.412 -2.345 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.846 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -76.16 -5.35 46.3 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.379 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.558 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 80.7 mtp180 54.92 38.25 0.46 Allowed Pre-proline 0 CA--C 1.573 1.856 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.558 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 14.0 Cg_exo -69.99 139.16 38.74 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 121.213 1.275 . . . . 0.0 112.24 -176.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 53.3 t -139.67 118.72 12.62 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.223 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -145.06 174.08 11.35 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -70.29 -66.16 0.63 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.239 0.542 . . . . 0.0 110.794 175.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -87.35 94.0 9.56 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -178.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.409 ' O ' HG12 ' A' ' 16' ' ' VAL . 8.3 p -165.07 103.85 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.981 0.896 . . . . 0.0 111.305 176.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -69.16 146.3 52.57 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 114.233 -1.349 . . . . 0.0 113.238 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -115.71 160.4 20.12 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 125.779 1.631 . . . . 0.0 109.201 -177.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.3 m -126.64 136.93 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 120.772 0.32 . . . . 0.0 110.772 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -104.55 138.05 41.48 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 174.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.402 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 28.8 p -87.81 106.58 18.17 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 118.728 -1.189 . . . . 0.0 108.973 176.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -83.82 17.24 2.4 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.685 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.63 -1.27 66.12 Favored Glycine 0 N--CA 1.435 -1.397 0 C-N-CA 121.049 -0.596 . . . . 0.0 113.159 -176.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.23 -31.17 1.07 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 118.581 -1.771 . . . . 0.0 115.793 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.4 m -86.74 -28.66 22.91 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 118.934 1.367 . . . . 0.0 110.167 -175.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 60.02 22.28 11.42 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.763 1.225 . . . . 0.0 112.11 -176.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -93.87 165.79 12.5 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -108.93 130.87 55.45 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.427 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . 6.3 m-85 -122.83 153.62 39.33 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.493 -177.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.939 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 49.5 m80 -91.18 137.61 32.23 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 173.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.561 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 50.6 mt-30 -55.38 -45.67 76.55 Favored 'General case' 0 C--O 1.189 -2.104 0 O-C-N 123.892 0.745 . . . . 0.0 112.623 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.43 HG11 ' N ' ' A' ' 33' ' ' CYS . 10.4 p -72.01 -40.42 67.52 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.39 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.751 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.939 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 2.8 p -72.8 -32.36 65.5 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.476 -173.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.482 HG11 HG22 ' A' ' 36' ' ' VAL . 2.5 p -103.61 6.9 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-O 121.256 0.55 . . . . 0.0 110.136 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.87 73.85 0.43 Allowed Glycine 0 CA--C 1.543 1.825 0 N-CA-C 115.452 0.941 . . . . 0.0 115.452 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.482 HG22 HG11 ' A' ' 34' ' ' VAL . 56.5 t -127.15 145.15 35.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.7 p -92.22 147.57 34.88 Favored Pre-proline 0 N--CA 1.425 -1.69 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 175.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.561 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 10.7 Cg_endo -51.22 -39.39 62.0 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.424 2.749 . . . . 0.0 113.457 -174.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -74.03 -25.38 59.84 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -178.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.446 ' CE ' HG11 ' A' ' 36' ' ' VAL . 37.5 ttp -68.48 -36.73 79.36 Favored 'General case' 0 C--O 1.211 -0.951 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.77 -39.76 81.97 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.286 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -88.4 -21.97 24.0 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 -177.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -115.64 -31.71 5.76 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -172.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -117.96 157.11 27.35 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.975 -171.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -83.36 116.25 22.38 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.139 -176.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -82.82 103.81 12.58 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.2 mm -94.32 137.87 21.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 113.581 -1.645 . . . . 0.0 106.692 172.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.8 p -99.0 178.34 4.97 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 119.406 -0.917 . . . . 0.0 109.3 -174.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.8 tt -55.76 -41.45 65.83 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.287 0 C-N-CA 123.969 0.908 . . . . 0.0 112.383 178.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -76.61 -33.14 58.42 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 121.395 0.617 . . . . 0.0 110.88 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 61.4 m -72.75 -26.67 61.64 Favored 'General case' 0 C--O 1.211 -0.944 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.156 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.296 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -177.243 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.409 ' N ' HH21 ' A' ' 10' ' ' ARG . 22.5 m . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.737 0.303 . . . . 0.0 110.604 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.8 t -125.75 140.68 47.76 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -178.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -92.17 -172.24 3.07 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.61 118.78 28.51 Favored 'General case' 0 C--O 1.213 -0.859 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -176.65 145.7 0.55 Allowed 'General case' 0 CA--C 1.492 -1.251 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 171.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -48.09 -43.58 30.9 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 123.732 0.645 . . . . 0.0 110.324 175.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -137.39 105.75 5.77 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.228 175.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.56 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 53.4 t -97.71 117.12 31.29 Favored 'General case' 0 N--CA 1.402 -2.83 0 C-N-CA 119.734 -0.787 . . . . 0.0 111.512 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -69.48 -8.6 48.35 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.936 177.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.562 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 46.3 ttt180 52.64 43.21 1.46 Allowed Pre-proline 0 CA--C 1.604 3.057 0 C-N-CA 124.727 1.211 . . . . 0.0 113.768 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.562 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 2.8 Cg_exo -78.84 145.54 20.08 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.072 1.848 . . . . 0.0 112.622 -178.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.9 t -133.47 115.96 15.41 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.122 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -146.84 154.02 40.85 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 174.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.15 -12.55 61.77 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.225 0.536 . . . . 0.0 110.509 176.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -125.36 51.27 1.71 Allowed 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.21 -173.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.417 HG11 ' O ' ' A' ' 16' ' ' VAL . 7.5 p -141.51 99.57 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 121.809 0.814 . . . . 0.0 110.718 175.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -68.72 145.0 54.22 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 114.817 -1.083 . . . . 0.0 112.07 176.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -106.93 159.73 16.05 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 124.577 1.151 . . . . 0.0 109.34 -176.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.0 m -125.76 141.37 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.602 -178.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 61.4 tt0 -111.29 137.85 48.5 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.6 p -94.81 104.48 16.38 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.882 178.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -88.22 23.97 2.0 Allowed 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.264 0.554 . . . . 0.0 110.322 -177.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.4 -4.98 73.01 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 148.6 -17.48 1.27 Allowed Glycine 0 CA--C 1.539 1.586 0 C-N-CA 119.68 -1.247 . . . . 0.0 115.64 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.491 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 9.6 m -97.8 -33.37 11.29 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.505 1.152 . . . . 0.0 110.495 -178.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 62.24 19.03 10.67 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 123.767 0.827 . . . . 0.0 111.877 -176.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.425 ' O ' ' HA ' ' A' ' 20' ' ' GLN . 47.8 mt-10 -85.05 168.14 15.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.831 -176.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -114.49 125.9 54.33 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-O 121.283 0.563 . . . . 0.0 111.915 -176.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -119.32 159.03 24.91 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.505 -176.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.971 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 38.1 m80 -94.37 136.17 34.97 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 173.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.428 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 50.3 mt-30 -55.34 -41.06 71.97 Favored 'General case' 0 C--O 1.191 -2.017 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 177.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.462 HG13 ' N ' ' A' ' 33' ' ' CYS . 9.8 p -74.77 -41.74 47.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.914 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.971 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 9.2 p -72.0 -29.27 64.05 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.574 -174.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.51 HG23 ' HH ' ' A' ' 46' ' ' TYR . 1.4 p -105.0 5.48 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.958 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.87 73.64 0.46 Allowed Glycine 0 CA--C 1.553 2.443 0 N-CA-C 115.452 0.941 . . . . 0.0 115.452 -176.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.503 HG11 ' HE2' ' A' ' 40' ' ' MET . 54.9 t -125.58 149.46 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 174.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.7 p -101.25 147.97 34.51 Favored Pre-proline 0 N--CA 1.418 -2.056 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 176.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.428 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 19.4 Cg_endo -55.84 -27.47 62.76 Favored 'Trans proline' 0 N--CA 1.487 1.132 0 C-N-CA 123.11 2.54 . . . . 0.0 112.283 -176.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -73.7 -28.36 61.69 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.719 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.503 ' HE2' HG11 ' A' ' 36' ' ' VAL . 44.2 ttp -74.13 -39.67 63.16 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -178.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.07 -43.91 82.58 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -176.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -88.12 -13.62 40.86 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -111.39 -39.24 4.74 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -175.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -126.07 166.32 17.21 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -170.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -74.98 118.58 18.1 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.907 0.883 . . . . 0.0 112.473 -178.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.51 ' HH ' HG23 ' A' ' 34' ' ' VAL . 78.9 t80 -83.11 103.8 12.81 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 122.383 1.087 . . . . 0.0 111.979 175.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.6 mm -100.21 143.57 13.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 173.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.422 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 12.4 p -103.93 176.97 4.98 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -176.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.2 tt -54.0 -38.23 36.75 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.343 0 C-N-CA 123.979 0.912 . . . . 0.0 112.89 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -87.04 -26.5 23.7 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.982 -0.448 . . . . 0.0 111.683 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.422 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 52.1 m -72.41 -25.63 61.55 Favored 'General case' 0 C--O 1.213 -0.828 0 CA-C-O 121.101 0.476 . . . . 0.0 110.796 176.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -1.001 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -177.766 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 N--CA 1.445 -0.721 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -87.37 -175.87 5.42 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.46 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.402 ' N ' ' SG ' ' A' ' 3' ' ' CYS . . . -90.65 119.68 31.09 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 178.34 134.24 0.08 Allowed 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 125.225 1.41 . . . . 0.0 107.956 172.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -49.41 -33.92 15.12 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 123.457 0.473 . . . . 0.0 111.433 176.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -133.3 92.07 2.95 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.948 174.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.487 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 44.4 t -95.41 119.19 33.49 Favored 'General case' 0 N--CA 1.413 -2.284 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.129 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -69.09 -10.69 58.87 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.387 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.567 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 68.3 mtm180 49.38 46.03 3.38 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.567 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 3.2 Cg_exo -78.48 132.05 10.88 Favored 'Trans proline' 0 C--O 1.266 1.912 0 C-N-CA 121.521 1.48 . . . . 0.0 110.755 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.3 t -116.42 111.02 19.43 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -138.41 156.1 47.89 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -91.47 -6.62 52.37 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.078 0.466 . . . . 0.0 110.394 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -114.03 16.18 18.26 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.35 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.1 p -107.83 106.13 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 121.832 0.825 . . . . 0.0 111.071 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -71.84 146.13 48.17 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.983 173.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -108.87 160.74 15.75 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 124.556 1.142 . . . . 0.0 110.261 -174.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.3 m -124.31 139.19 51.4 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.535 0 CA-C-O 120.651 0.263 . . . . 0.0 111.09 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -106.97 139.48 41.31 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 46' ' ' TYR . 31.1 p -91.27 102.02 14.73 Favored 'General case' 0 C--O 1.256 1.407 0 C-N-CA 119.012 -1.075 . . . . 0.0 109.727 175.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -83.41 24.68 0.81 Allowed 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.386 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.32 -4.42 61.02 Favored Glycine 0 N--CA 1.432 -1.605 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.229 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.08 -20.18 1.94 Allowed Glycine 0 CA--C 1.539 1.533 0 C-N-CA 118.898 -1.62 . . . . 0.0 116.056 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.429 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 12.0 m -91.0 -34.05 15.29 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 118.806 1.303 . . . . 0.0 109.558 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 62.6 21.01 12.41 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.494 -176.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -88.08 159.41 18.26 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.257 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -108.96 130.14 55.45 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.273 0.559 . . . . 0.0 111.95 -176.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -118.47 157.46 27.19 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.975 -1.012 . . . . 0.0 109.82 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.916 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 40.3 m80 -92.11 140.32 29.76 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 173.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.423 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 51.0 mt-30 -62.43 -36.8 83.52 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.7 p -75.57 -40.76 41.31 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.662 0 O-C-N 121.243 -0.911 . . . . 0.0 111.873 176.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.916 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 9.2 p -72.09 -32.91 67.46 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.706 -173.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.442 HG13 HG23 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -104.95 3.2 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-O 121.135 0.493 . . . . 0.0 110.884 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.65 72.86 0.61 Allowed Glycine 0 CA--C 1.557 2.689 0 N-CA-C 116.129 1.211 . . . . 0.0 116.129 -176.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.442 HG23 HG13 ' A' ' 34' ' ' VAL . 78.8 t -130.3 145.23 35.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 56.7 p -97.95 151.01 37.34 Favored Pre-proline 0 N--CA 1.428 -1.544 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 176.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.36 -21.8 54.94 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 122.705 2.27 . . . . 0.0 111.551 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -73.64 -35.2 65.25 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.641 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.435 ' CE ' HG13 ' A' ' 36' ' ' VAL . 36.7 ttp -72.96 -38.9 66.56 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -176.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.88 -46.21 82.03 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.782 -1.099 . . . . 0.0 112.434 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -83.13 -17.5 42.78 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -112.55 -30.12 7.23 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -173.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -123.03 168.54 12.22 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.554 0.692 . . . . 0.0 112.728 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -90.03 115.35 27.24 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.405 -1.27 . . . . 0.0 109.214 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 51.2 t80 -79.34 108.89 13.2 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -178.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.9 mm -96.02 141.73 14.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 173.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.6 p -103.3 177.05 4.95 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.057 -176.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.2 tt -56.12 -38.13 52.35 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 O-C-N 123.887 0.742 . . . . 0.0 112.346 177.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -77.88 -34.19 51.67 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 122.212 -0.305 . . . . 0.0 111.37 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 61.6 m -72.21 -29.52 64.04 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.571 0.7 . . . . 0.0 110.301 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.074 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.828 -176.017 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.4 t . . . . . 0 N--CA 1.44 -0.955 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.404 ' SG ' ' HA ' ' A' ' 29' ' ' PHE . 0.5 OUTLIER -93.69 -173.96 3.32 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -177.678 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.65 119.98 32.61 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -177.55 144.15 0.38 Allowed 'General case' 0 CA--C 1.501 -0.912 0 C-N-CA 124.23 1.012 . . . . 0.0 108.76 172.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -47.88 -44.09 29.17 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 123.925 0.766 . . . . 0.0 110.468 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -135.53 102.29 5.07 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.328 173.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.541 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 43.3 t -95.52 118.88 33.04 Favored 'General case' 0 N--CA 1.407 -2.599 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.834 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -69.38 -9.42 53.39 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.834 178.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.556 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 79.1 ttt180 46.38 51.55 10.08 Favored Pre-proline 0 CA--C 1.574 1.897 0 C-N-CA 125.036 1.335 . . . . 0.0 112.692 -175.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.556 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 2.7 Cg_exo -81.61 134.42 8.68 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 121.839 1.693 . . . . 0.0 109.927 177.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 45.4 t -130.05 113.76 14.94 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -138.63 170.82 15.32 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -71.97 -59.46 2.73 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 171.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -74.56 87.87 2.14 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.29 177.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.2 p -172.28 100.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 122.109 0.957 . . . . 0.0 112.654 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -70.14 138.68 52.1 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.461 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 15.9 m95 -103.76 160.19 14.99 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 124.724 1.21 . . . . 0.0 108.552 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.5 m -126.02 139.63 50.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.574 0.226 . . . . 0.0 110.41 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -108.93 138.23 45.6 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.44 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.7 p -89.02 105.48 17.81 Favored 'General case' 0 C--O 1.249 1.037 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.145 177.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -85.1 22.81 1.35 Allowed 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 121.423 0.63 . . . . 0.0 110.25 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.53 -13.69 56.64 Favored Glycine 0 N--CA 1.426 -1.994 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.562 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.63 -27.71 0.42 Allowed Glycine 0 CA--C 1.533 1.205 0 C-N-CA 118.79 -1.672 . . . . 0.0 115.813 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.44 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 9.4 m -88.89 -30.14 19.11 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 118.533 1.167 . . . . 0.0 110.609 -176.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 60.63 19.15 9.11 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.723 0.809 . . . . 0.0 111.939 -175.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -90.0 163.48 14.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.446 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -108.66 128.94 55.29 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.504 -175.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.404 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . 4.9 m-85 -120.22 159.78 24.25 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.745 -176.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.931 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 44.9 m80 -95.76 138.57 33.23 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 173.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.544 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 48.9 mt-30 -54.52 -50.06 68.75 Favored 'General case' 0 C--O 1.19 -2.07 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 177.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 p -67.45 -41.95 86.64 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.305 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.931 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 6.6 p -70.67 -27.84 64.34 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.384 -175.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.628 HG13 HG23 ' A' ' 36' ' ' VAL . 1.4 p -106.9 11.6 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.871 0 CA-C-O 121.311 0.577 . . . . 0.0 110.574 178.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.67 38.32 95.5 Favored Glycine 0 CA--C 1.547 2.032 0 N-CA-C 117.25 1.66 . . . . 0.0 117.25 177.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.628 HG23 HG13 ' A' ' 34' ' ' VAL . 77.6 t -97.4 149.2 5.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 123.536 0.735 . . . . 0.0 109.44 176.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.4 p -99.73 152.14 37.71 Favored Pre-proline 0 N--CA 1.421 -1.907 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.544 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 24.9 Cg_endo -59.14 -22.32 63.77 Favored 'Trans proline' 0 N--CA 1.482 0.833 0 C-N-CA 122.173 1.915 . . . . 0.0 112.163 -178.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -73.8 -34.0 64.44 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.857 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 50.3 ttp -73.77 -39.33 64.27 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.422 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.44 -48.02 77.89 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -175.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -89.0 -14.21 37.05 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -110.05 -31.26 7.43 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -173.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -128.48 165.87 19.86 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 118.289 0.495 . . . . 0.0 112.153 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -75.2 115.31 14.7 Favored 'General case' 0 C--O 1.248 0.977 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.578 -176.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -79.54 108.93 13.45 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.938 0.875 . . . . 0.0 112.265 175.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.0 mm -105.45 148.73 9.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 173.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.3 p -109.24 177.3 4.8 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 119.238 0.926 . . . . 0.0 108.935 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.7 tt -55.94 -41.72 68.59 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 C-N-CA 124.026 0.93 . . . . 0.0 112.491 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -75.0 -32.67 61.7 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.13 0.491 . . . . 0.0 111.003 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 66.7 m -76.27 -28.91 57.23 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.827 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.519 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.264 -176.914 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.449 -0.508 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.412 ' SG ' ' HA ' ' A' ' 29' ' ' PHE . 0.5 OUTLIER -96.84 -172.5 2.48 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 119.394 -0.922 . . . . 0.0 108.62 -178.065 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.14 118.69 26.7 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -177.22 145.96 0.48 Allowed 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 171.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -48.6 -44.16 36.77 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.689 0.757 . . . . 0.0 109.118 173.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -131.55 101.52 5.54 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.159 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.52 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 50.5 t -98.34 112.23 24.3 Favored 'General case' 0 N--CA 1.406 -2.66 0 C-N-CA 118.36 -1.336 . . . . 0.0 110.262 177.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -67.12 -11.57 57.6 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.48 -1.237 . . . . 0.0 111.191 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.555 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 65.3 mtp180 52.34 44.76 2.21 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 123.834 0.854 . . . . 0.0 111.881 -173.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.555 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 23.7 Cg_exo -65.58 131.76 28.84 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 121.134 1.223 . . . . 0.0 110.341 -176.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 86.1 m -114.47 98.16 6.74 Favored 'General case' 0 N--CA 1.413 -2.292 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.885 -177.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -136.21 153.05 51.34 Favored 'General case' 0 CA--C 1.479 -1.753 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 172.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -81.13 -43.11 19.88 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 176.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -85.23 87.9 7.43 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.7 p -168.76 112.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.569 0.699 . . . . 0.0 111.427 177.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -74.22 144.79 44.56 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.685 -1.143 . . . . 0.0 112.852 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -110.31 159.94 16.98 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 125.2 1.4 . . . . 0.0 109.331 -176.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.6 m -126.62 137.09 58.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.062 0.458 . . . . 0.0 110.625 -178.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.427 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 52.0 tt0 -104.57 139.09 39.96 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 176.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.6 p -88.01 99.93 12.53 Favored 'General case' 0 C--O 1.25 1.085 0 C-N-CA 118.261 -1.376 . . . . 0.0 110.006 176.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -80.9 19.36 0.87 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.971 -176.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.35 3.25 50.6 Favored Glycine 0 N--CA 1.418 -2.507 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.697 -177.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 152.6 -34.33 0.82 Allowed Glycine 0 CA--C 1.536 1.402 0 C-N-CA 118.183 -1.961 . . . . 0.0 116.551 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.462 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 5.1 m -94.51 -30.11 14.58 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 118.799 1.3 . . . . 0.0 110.033 -176.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 60.31 22.09 11.57 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.577 0.751 . . . . 0.0 112.377 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 20' ' ' GLN . 46.2 mt-10 -86.65 164.78 16.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.483 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -108.46 123.39 48.81 Favored 'General case' 0 C--O 1.245 0.836 0 O-C-N 123.575 0.547 . . . . 0.0 111.681 -174.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.412 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . 2.9 m-85 -117.63 160.07 21.89 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.562 -176.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.908 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 40.0 m80 -94.4 138.74 31.98 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 173.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.414 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 48.6 mt-30 -55.43 -48.36 74.55 Favored 'General case' 0 C--O 1.184 -2.365 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.216 177.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.412 ' CG1' ' HG2' ' A' ' 11' ' ' PRO . 11.0 p -69.54 -38.27 76.42 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.272 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.287 -178.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.908 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 4.4 p -73.67 -28.97 62.04 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.811 -174.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.602 HG13 HG23 ' A' ' 36' ' ' VAL . 1.6 p -105.95 7.61 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.697 0 CA-C-O 121.524 0.678 . . . . 0.0 109.982 178.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.33 45.1 95.82 Favored Glycine 0 CA--C 1.546 1.984 0 N-CA-C 116.627 1.411 . . . . 0.0 116.627 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.602 HG23 HG13 ' A' ' 34' ' ' VAL . 84.4 t -96.2 148.17 5.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 173.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.5 p -100.86 153.03 37.97 Favored Pre-proline 0 N--CA 1.425 -1.711 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 175.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 10.2 Cg_endo -48.48 -39.83 36.66 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 123.267 2.644 . . . . 0.0 112.813 -176.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -65.92 -31.0 71.67 Favored 'General case' 0 C--O 1.202 -1.428 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.508 ' HB3' HG13 ' A' ' 36' ' ' VAL . 38.2 ttp -73.54 -33.96 64.97 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 118.481 -1.288 . . . . 0.0 108.77 -176.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.84 -47.85 79.1 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.467 175.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -86.93 -27.93 23.05 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -176.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -105.99 -27.41 11.18 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -171.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -127.69 173.37 9.98 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 119.821 -0.752 . . . . 0.0 112.32 -175.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -86.2 116.03 24.13 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.895 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -75.38 114.9 14.45 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 122.237 1.018 . . . . 0.0 113.301 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.8 mm -110.13 145.68 16.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 175.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.471 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 11.0 p -109.61 179.55 4.1 Favored 'General case' 0 C--O 1.217 -0.633 0 O-C-N 121.292 -0.88 . . . . 0.0 109.306 -176.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.6 tt -54.97 -40.16 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.512 0 C-N-CA 124.157 0.983 . . . . 0.0 112.626 177.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -78.06 -30.51 49.77 Favored 'General case' 0 C--O 1.212 -0.883 0 CA-C-O 120.911 0.386 . . . . 0.0 110.65 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.471 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 65.5 m -78.27 -31.09 48.88 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.054 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.669 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.582 -176.46 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 C--O 1.235 0.309 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.423 ' SG ' ' HA ' ' A' ' 29' ' ' PHE . 0.5 OUTLIER -93.74 -172.16 2.8 Favored 'General case' 0 C--O 1.255 1.361 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -178.435 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.8 119.07 30.72 Favored 'General case' 0 C--O 1.2 -1.504 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 176.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -176.68 142.85 0.43 Allowed 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 172.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -48.71 -44.67 38.34 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.613 0.765 . . . . 0.0 109.749 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -128.84 98.12 4.87 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.649 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.559 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 50.5 t -99.26 112.11 24.34 Favored 'General case' 0 N--CA 1.413 -2.307 0 C-N-CA 117.941 -1.504 . . . . 0.0 111.242 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -69.76 -7.89 43.41 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.608 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.588 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 76.7 mtp180 53.08 42.39 1.19 Allowed Pre-proline 0 CA--C 1.573 1.848 0 C-N-CA 124.348 1.059 . . . . 0.0 113.438 -175.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.588 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 11.8 Cg_exo -71.76 136.52 28.05 Favored 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 121.866 1.711 . . . . 0.0 111.951 -176.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 51.3 t -126.48 116.58 21.34 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.497 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -148.73 164.07 35.45 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 176.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -85.64 -7.66 58.7 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 176.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -128.73 88.49 2.74 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 114.691 -1.141 . . . . 0.0 108.698 -177.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 16' ' ' VAL . 6.9 p -178.14 96.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.657 0 CA-C-O 121.637 0.732 . . . . 0.0 110.124 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.79 144.01 57.39 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -109.16 159.52 16.84 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.242 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.8 m -129.58 135.36 61.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.036 0.446 . . . . 0.0 111.002 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 53.9 tt0 -100.28 139.28 36.19 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 176.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.3 p -89.7 102.7 15.39 Favored 'General case' 0 C--O 1.258 1.55 0 C-N-CA 118.617 -1.233 . . . . 0.0 110.742 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.64 18.79 0.54 Allowed 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.841 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.76 -10.26 60.35 Favored Glycine 0 N--CA 1.426 -1.988 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.886 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 147.06 -16.01 1.53 Allowed Glycine 0 C--O 1.213 -1.164 0 C-N-CA 118.459 -1.829 . . . . 0.0 116.486 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.524 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 13.6 m -92.29 -28.92 16.66 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.023 1.412 . . . . 0.0 109.332 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 58.68 18.5 5.96 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 124.289 1.036 . . . . 0.0 112.148 -174.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.409 ' O ' ' HA ' ' A' ' 20' ' ' GLN . 46.0 mt-10 -84.16 162.26 20.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.291 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -108.89 126.56 53.19 Favored 'General case' 0 C--O 1.246 0.916 0 CA-C-O 121.302 0.572 . . . . 0.0 112.036 -175.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.423 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . 2.8 m-85 -118.78 161.05 20.77 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.351 -177.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.9 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 45.7 m80 -95.64 142.56 27.81 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.088 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.456 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 48.6 mt-30 -58.04 -48.44 80.07 Favored 'General case' 0 C--O 1.189 -2.124 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.7 p -70.16 -38.61 75.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.236 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.9 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 2.9 p -72.74 -31.72 65.16 Favored 'General case' 0 C--O 1.213 -0.817 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.665 -173.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.501 HG13 HG23 ' A' ' 36' ' ' VAL . 1.7 p -104.09 5.35 10.45 Favored 'Isoleucine or valine' 0 C--O 1.254 1.311 0 CA-C-O 121.219 0.533 . . . . 0.0 110.361 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.35 70.91 0.89 Allowed Glycine 0 CA--C 1.54 1.618 0 CA-C-N 115.079 -0.964 . . . . 0.0 115.014 -176.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.501 HG23 HG13 ' A' ' 34' ' ' VAL . 54.5 t -119.38 147.65 22.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 174.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.7 p -98.1 151.98 37.8 Favored Pre-proline 0 N--CA 1.426 -1.647 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.417 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 13.2 Cg_endo -51.12 -36.8 56.45 Favored 'Trans proline' 0 N--CA 1.483 0.908 0 C-N-CA 123.052 2.501 . . . . 0.0 112.831 -176.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -73.13 -26.87 61.38 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.425 ' HB3' HG13 ' A' ' 36' ' ' VAL . 46.6 ttp -73.84 -34.19 64.44 Favored 'General case' 0 C--O 1.209 -1.071 0 C-N-CA 118.583 -1.247 . . . . 0.0 108.339 -177.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.6 -45.01 81.68 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -94.78 -32.27 13.38 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -98.05 -22.86 16.02 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -170.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -128.37 168.12 16.01 Favored 'General case' 0 C--N 1.311 -1.109 0 C-N-CA 119.92 -0.712 . . . . 0.0 112.12 -176.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -89.74 120.34 30.92 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.831 -174.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.425 ' CE2' ' HB3' ' A' ' 21' ' ' CYS . 89.0 t80 -81.97 108.23 15.31 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.5 mm -101.02 146.72 8.99 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 172.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.536 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 10.2 p -111.41 178.66 4.26 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 121.095 -1.003 . . . . 0.0 108.885 -177.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.9 tt -54.1 -42.36 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.358 0 C-N-CA 124.028 0.931 . . . . 0.0 112.315 177.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -76.78 -34.76 57.98 Favored 'General case' 0 C--O 1.212 -0.874 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.215 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.536 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 59.4 m -72.56 -26.03 61.58 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 121.164 0.507 . . . . 0.0 111.258 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.103 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.545 -179.023 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 57.8 t . . . . . 0 N--CA 1.446 -0.662 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -90.79 -172.16 3.28 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.17 119.48 31.85 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -176.58 146.49 0.6 Allowed 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.45 0.7 . . . . 0.0 109.237 172.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -47.65 -40.7 20.48 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 124.083 0.953 . . . . 0.0 109.834 174.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -139.46 111.55 7.45 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.244 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.568 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 46.8 t -106.15 116.06 31.28 Favored 'General case' 0 N--CA 1.416 -2.154 0 C-N-CA 117.93 -1.508 . . . . 0.0 112.355 177.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -72.89 -9.28 58.52 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 113.906 -1.497 . . . . 0.0 111.216 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.551 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 82.1 mtp180 53.21 51.85 9.51 Favored Pre-proline 0 N--CA 1.493 1.709 0 C-N-CA 124.175 0.99 . . . . 0.0 112.821 -174.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.551 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 4.2 Cg_exo -80.79 131.84 8.35 Favored 'Trans proline' 0 C--O 1.261 1.672 0 C-N-CA 122.032 1.821 . . . . 0.0 110.474 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 51.6 t -125.12 111.07 14.89 Favored 'General case' 0 N--CA 1.427 -1.613 0 O-C-N 123.661 0.601 . . . . 0.0 110.174 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.43 ' O ' HG12 ' A' ' 16' ' ' VAL . 97.1 mttt -140.35 157.53 45.41 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 175.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -87.81 2.86 50.28 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.082 0.468 . . . . 0.0 111.285 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -117.65 5.79 12.39 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.531 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 13' ' ' LYS . 7.9 p -97.38 105.37 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-O 121.978 0.894 . . . . 0.0 111.699 -178.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -76.17 153.31 36.27 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.629 175.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -115.23 159.55 20.83 Favored 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 124.445 1.098 . . . . 0.0 110.213 -172.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.3 m -127.44 138.91 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-O 120.738 0.304 . . . . 0.0 110.244 -177.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -106.56 139.35 41.16 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.471 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.6 p -90.0 103.51 16.17 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 118.89 -1.124 . . . . 0.0 109.113 174.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.0 26.96 0.57 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.812 0.845 . . . . 0.0 111.152 -175.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -111.21 7.25 28.81 Favored Glycine 0 N--CA 1.429 -1.774 0 CA-C-N 115.468 -0.787 . . . . 0.0 113.311 -176.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 148.45 -39.7 0.96 Allowed Glycine 0 CA--C 1.535 1.34 0 C-N-CA 118.116 -1.993 . . . . 0.0 115.375 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.471 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 7.9 m -85.88 -34.75 20.91 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 118.168 0.984 . . . . 0.0 108.457 -176.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 57.46 25.03 10.92 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.042 -177.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -87.51 168.35 13.15 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.949 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -110.87 126.42 54.66 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 122.782 0.433 . . . . 0.0 111.499 -176.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -118.83 159.27 24.05 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.689 -174.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.977 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 35.1 m80 -96.59 137.15 36.1 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 174.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.469 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 50.6 mt-30 -52.84 -46.43 67.8 Favored 'General case' 0 C--O 1.188 -2.156 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.3 p -72.97 -40.35 59.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 O-C-N 121.406 -0.809 . . . . 0.0 112.299 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.977 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 12.0 p -70.82 -27.59 63.99 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.87 -174.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.514 HG13 HG23 ' A' ' 36' ' ' VAL . 1.4 p -108.55 7.97 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 CA-C-O 121.394 0.616 . . . . 0.0 110.721 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.01 64.66 4.09 Favored Glycine 0 CA--C 1.559 2.828 0 N-CA-C 116.481 1.352 . . . . 0.0 116.481 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.655 HG13 ' SD ' ' A' ' 40' ' ' MET . 79.2 t -117.18 146.73 21.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 125.75 1.62 . . . . 0.0 107.193 175.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.0 p -98.31 155.42 36.91 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 177.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -55.54 -31.88 80.47 Favored 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 122.959 2.439 . . . . 0.0 113.142 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 45.6 mt-10 -71.83 -28.63 63.7 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 120.951 0.405 . . . . 0.0 110.79 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.655 ' SD ' HG13 ' A' ' 36' ' ' VAL . 28.2 ttt -69.99 -46.89 64.2 Favored 'General case' 0 C--O 1.208 -1.126 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -176.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.95 -45.25 90.93 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -86.31 -14.65 43.01 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -177.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 39' ' ' GLU . 93.0 m-20 -119.16 -34.33 3.9 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -174.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -124.6 158.55 32.79 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -172.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -72.23 114.23 10.12 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.794 -176.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -80.26 112.1 17.27 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 122.166 0.984 . . . . 0.0 113.438 177.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.1 mm -112.93 140.93 30.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 174.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.5 p -96.97 176.39 5.98 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -174.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.7 tt -54.06 -38.01 36.55 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 C-N-CA 123.965 0.906 . . . . 0.0 112.721 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -80.61 -30.82 36.79 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.0 0.429 . . . . 0.0 111.136 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 84.5 m -78.35 -27.83 47.09 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.323 0.582 . . . . 0.0 111.129 176.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.867 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.748 -177.758 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 49.0 t . . . . . 0 N--CA 1.442 -0.857 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.02 -176.3 4.85 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.04 -175.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.3 119.67 33.41 Favored 'General case' 0 C--O 1.198 -1.634 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -175.37 148.79 0.97 Allowed 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 173.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -47.4 -42.82 22.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 123.958 0.786 . . . . 0.0 110.533 174.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -141.56 105.32 4.72 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.635 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.581 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 53.2 t -97.43 110.17 22.78 Favored 'General case' 0 N--CA 1.419 -2.02 0 C-N-CA 118.771 -1.172 . . . . 0.0 111.47 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -67.56 -8.34 33.32 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.6 1.16 . . . . 0.0 111.016 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.59 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 88.7 mtm180 51.0 44.54 2.23 Favored Pre-proline 0 CA--C 1.563 1.457 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -178.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.59 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 8.4 Cg_exo -76.36 137.4 18.75 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 122.205 1.937 . . . . 0.0 111.248 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 45.6 t -130.89 114.54 15.39 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.313 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -148.24 166.84 26.74 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -71.07 -61.69 1.67 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.728 0.775 . . . . 0.0 108.958 173.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -65.55 30.07 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 126.197 1.799 . . . . 0.0 115.53 -175.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.0 p -123.55 109.0 22.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 119.444 1.02 . . . . 0.0 112.983 178.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -73.94 146.62 43.79 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.231 -1.35 . . . . 0.0 111.928 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.0 m95 -113.13 159.21 19.47 Favored 'General case' 0 C--O 1.216 -0.699 0 C-N-CA 124.365 1.066 . . . . 0.0 109.047 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.3 m -125.05 138.02 55.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 O-C-N 121.945 -0.472 . . . . 0.0 110.535 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -105.76 138.94 41.1 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.47 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.4 p -91.92 107.28 19.09 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 119.329 -0.948 . . . . 0.0 110.742 178.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -87.86 27.02 1.22 Allowed 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.517 0.675 . . . . 0.0 110.312 -176.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.4 -7.9 57.84 Favored Glycine 0 N--CA 1.425 -2.086 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.377 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 151.16 -20.82 0.96 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 118.899 -1.62 . . . . 0.0 115.65 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.47 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 8.4 m -94.32 -32.19 13.73 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 118.771 1.286 . . . . 0.0 111.478 -176.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 60.42 19.54 9.2 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 123.856 0.862 . . . . 0.0 111.905 -174.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -86.68 161.11 18.62 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.236 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 80.0 m95 -105.97 127.16 52.97 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.235 -176.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -120.12 157.71 28.42 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.112 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.878 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 51.9 m80 -93.09 138.72 31.28 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 174.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.488 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 48.1 mt-30 -52.88 -55.19 25.01 Favored 'General case' 0 C--O 1.198 -1.632 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 177.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.65 -36.96 78.85 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.489 0 CA-C-O 121.736 0.779 . . . . 0.0 111.755 -177.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.878 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 1.7 p -73.95 -24.65 59.67 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.045 -175.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.59 HG13 HG23 ' A' ' 36' ' ' VAL . 1.7 p -111.31 12.51 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.834 0 CA-C-O 121.484 0.659 . . . . 0.0 110.875 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.12 36.19 91.55 Favored Glycine 0 CA--C 1.555 2.577 0 N-CA-C 117.598 1.799 . . . . 0.0 117.598 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.686 HG13 ' SD ' ' A' ' 40' ' ' MET . 94.3 t -97.03 144.05 11.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 174.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.3 p -98.93 152.14 37.68 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 176.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.488 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 17.8 Cg_endo -57.32 -26.8 72.37 Favored 'Trans proline' 0 N--CA 1.486 1.032 0 C-N-CA 122.409 2.072 . . . . 0.0 112.629 -177.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -74.97 -25.87 59.17 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 121.549 0.69 . . . . 0.0 109.94 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.686 ' SD ' HG13 ' A' ' 36' ' ' VAL . 28.0 ttt -73.71 -46.23 47.46 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 124.313 1.045 . . . . 0.0 110.114 -178.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.92 -47.15 81.28 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.243 -0.889 . . . . 0.0 112.021 -176.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -78.55 -13.39 59.85 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -116.11 -39.88 3.37 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 116.755 2.131 . . . . 0.0 116.755 -173.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -124.16 165.32 17.76 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.007 0.821 . . . . 0.0 112.641 -174.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -74.11 115.32 13.45 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.178 -177.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.426 ' OH ' HG21 ' A' ' 34' ' ' VAL . 81.1 t80 -72.28 111.52 7.56 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-O 121.946 0.879 . . . . 0.0 112.272 172.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.5 mm -108.44 138.54 34.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 174.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 11.1 p -98.21 176.23 5.8 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -174.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.6 tt -57.91 -35.87 53.56 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.644 0 C-N-CA 123.586 0.755 . . . . 0.0 112.276 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -79.66 -34.34 40.47 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 120.824 0.345 . . . . 0.0 110.774 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 59.4 m -72.18 -26.0 61.9 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 121.326 0.584 . . . . 0.0 110.539 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.804 -177.602 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 CA--C 1.518 -0.283 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' A' ' 4' ' ' ALA . 0.4 OUTLIER -87.88 -177.79 5.87 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.792 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.419 ' N ' ' SG ' ' A' ' 3' ' ' CYS . . . -90.54 120.04 31.3 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 178.73 135.34 0.09 Allowed 'General case' 0 C--O 1.214 -0.768 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 171.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -49.93 -42.64 48.79 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 120.983 0.421 . . . . 0.0 111.086 177.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -121.54 90.62 3.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.906 173.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.503 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 44.2 t -93.94 117.03 29.54 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.529 177.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -69.32 -8.0 42.28 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.019 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.569 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 29.7 mtm180 47.82 46.21 3.4 Favored Pre-proline 0 CA--C 1.563 1.461 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -175.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.569 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 4.2 Cg_exo -76.35 131.86 13.15 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 121.942 1.761 . . . . 0.0 111.87 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 53.4 t -121.4 114.89 21.93 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -146.01 157.54 43.87 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -76.99 -10.04 59.1 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.434 0.635 . . . . 0.0 110.827 177.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -124.51 84.73 2.31 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.159 177.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.1 p -172.31 97.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 122.149 0.976 . . . . 0.0 111.239 176.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -71.06 146.66 49.17 Favored 'General case' 0 C--N 1.279 -2.464 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.242 174.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -107.01 159.51 16.23 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.482 -174.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.9 m -125.48 132.82 70.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 120.69 0.281 . . . . 0.0 110.573 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -99.34 137.87 37.23 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.0 p -86.98 104.45 16.31 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 118.681 -1.208 . . . . 0.0 110.077 176.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -82.46 16.99 1.87 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.849 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.96 -7.31 74.35 Favored Glycine 0 N--CA 1.431 -1.644 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.973 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.19 -13.24 1.86 Allowed Glycine 0 CA--C 1.54 1.63 0 C-N-CA 119.063 -1.541 . . . . 0.0 116.907 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.475 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 17.3 m -95.23 -27.65 15.41 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 119.669 1.734 . . . . 0.0 110.444 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 63.94 16.4 9.86 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.655 0.782 . . . . 0.0 111.53 -176.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -91.36 159.4 16.01 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -176.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -106.33 126.35 52.12 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.638 -175.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -118.05 159.06 23.85 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.629 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.935 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 36.5 m80 -93.51 139.2 31.01 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 174.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.454 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 50.5 mt-30 -57.63 -42.91 84.3 Favored 'General case' 0 C--O 1.192 -1.959 0 O-C-N 123.579 0.55 . . . . 0.0 112.077 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.0 p -73.59 -41.02 55.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.603 -0.685 . . . . 0.0 112.197 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.935 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 11.3 p -71.55 -31.33 66.89 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.407 -173.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.5 HG13 HG23 ' A' ' 36' ' ' VAL . 1.2 p -104.23 6.51 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.715 0 CA-C-O 121.312 0.577 . . . . 0.0 111.066 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.29 67.75 1.96 Allowed Glycine 0 CA--C 1.547 2.093 0 N-CA-C 115.95 1.14 . . . . 0.0 115.95 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.5 HG23 HG13 ' A' ' 34' ' ' VAL . 70.6 t -124.22 149.51 28.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 174.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.1 p -103.81 151.61 38.86 Favored Pre-proline 0 N--CA 1.421 -1.884 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 175.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.454 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 73.3 Cg_exo -52.52 -22.97 17.93 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.771 2.314 . . . . 0.0 112.231 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 34.1 tt0 -74.1 -36.62 64.25 Favored 'General case' 0 C--O 1.187 -2.215 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.091 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.429 ' HB3' HG13 ' A' ' 36' ' ' VAL . 39.4 ttp -73.83 -37.64 64.79 Favored 'General case' 0 CA--C 1.503 -0.859 0 O-C-N 121.097 -1.002 . . . . 0.0 110.092 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.96 -48.59 78.01 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.154 -0.93 . . . . 0.0 113.242 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -94.6 -16.05 23.54 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 119.82 -0.752 . . . . 0.0 112.833 -176.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.492 ' HB2' ' O ' ' A' ' 39' ' ' GLU . 27.4 m-80 -105.39 -19.09 13.9 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -173.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -138.3 177.02 8.19 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.174 0.512 . . . . 0.0 111.706 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -92.11 121.6 33.81 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.791 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.403 ' OH ' HG21 ' A' ' 34' ' ' VAL . 80.4 t80 -75.72 104.86 6.46 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.017 1.118 . . . . 0.0 114.017 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.9 mm -94.6 139.05 19.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 170.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.421 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 13.2 p -101.19 173.66 6.36 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 119.061 -1.056 . . . . 0.0 108.751 -177.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.4 tt -57.53 -37.51 58.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 123.057 0.543 . . . . 0.0 112.042 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -75.44 -29.79 59.8 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-O 120.981 0.419 . . . . 0.0 110.535 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.421 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 52.4 m -77.76 -27.38 50.34 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.296 0.57 . . . . 0.0 110.61 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.082 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.531 -176.481 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.4 t . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -88.75 -172.25 3.64 Favored 'General case' 0 C--O 1.248 1.023 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -177.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.59 119.79 33.06 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -179.98 132.02 0.1 Allowed 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 171.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -50.04 -42.82 50.33 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 121.411 0.624 . . . . 0.0 110.99 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -123.9 97.62 5.44 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 173.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.52 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 46.6 t -99.25 121.06 40.54 Favored 'General case' 0 N--CA 1.423 -1.821 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.238 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -70.41 -8.02 47.62 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 124.122 0.969 . . . . 0.0 110.29 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.528 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 32.8 ttp180 42.88 56.22 11.17 Favored Pre-proline 0 CA--C 1.568 1.663 0 C-N-CA 126.084 1.754 . . . . 0.0 114.592 -177.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.528 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 6.3 Cg_exo -87.87 144.96 6.45 Favored 'Trans proline' 0 C--O 1.26 1.577 0 C-N-CA 122.896 2.397 . . . . 0.0 112.307 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 59.0 m -127.44 125.73 41.08 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -144.15 162.13 37.08 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 176.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -84.55 -9.26 58.48 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 174.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -129.11 84.99 2.27 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.031 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.41 ' O ' HG13 ' A' ' 16' ' ' VAL . 8.1 p -172.02 104.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.738 0.78 . . . . 0.0 111.312 177.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -73.11 145.89 46.12 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.471 176.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -107.48 159.82 16.12 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 124.568 1.147 . . . . 0.0 109.206 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.9 m -123.06 141.95 41.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 120.607 0.242 . . . . 0.0 110.413 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 64.2 tt0 -112.28 139.32 47.93 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.427 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 29.1 p -89.6 105.58 17.89 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.806 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -77.58 29.1 0.16 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.869 0.868 . . . . 0.0 111.391 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.523 ' HA3' ' SG ' ' A' ' 51' ' ' CYS . . . -95.08 -22.78 21.94 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 141.51 1.82 1.38 Allowed Glycine 0 CA--C 1.542 1.745 0 C-N-CA 119.875 -1.155 . . . . 0.0 115.581 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.427 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 24.7 m -94.66 -29.69 14.7 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 118.74 1.27 . . . . 0.0 109.208 177.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 64.68 16.46 10.37 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.107 0.963 . . . . 0.0 112.117 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 20' ' ' GLN . 46.6 mt-10 -82.24 161.95 22.51 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.045 0.45 . . . . 0.0 111.638 -177.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -114.9 124.31 51.37 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.63 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -115.56 156.51 25.63 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -175.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.959 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 40.9 m80 -89.98 138.75 31.24 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.419 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 49.3 mt-30 -56.88 -49.93 74.04 Favored 'General case' 0 C--O 1.194 -1.835 0 O-C-N 123.537 0.523 . . . . 0.0 112.276 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.9 p -67.55 -37.39 78.71 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.628 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.959 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 6.6 p -76.11 -25.58 55.55 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -175.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.489 HG13 HG23 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -108.68 10.05 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.976 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.72 177.783 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.93 39.55 93.33 Favored Glycine 0 CA--C 1.549 2.214 0 N-CA-C 117.032 1.573 . . . . 0.0 117.032 178.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.489 HG23 HG13 ' A' ' 34' ' ' VAL . 85.1 t -96.25 145.44 8.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 117.742 0.771 . . . . 0.0 108.983 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.6 p -97.88 147.66 33.36 Favored Pre-proline 0 N--CA 1.414 -2.269 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 19.7 Cg_endo -57.21 -25.08 62.65 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 C-N-CA 123.008 2.472 . . . . 0.0 112.497 -176.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -74.56 -29.49 61.37 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.441 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 37.3 ttp -74.6 -39.22 62.31 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-O 121.107 0.479 . . . . 0.0 110.509 -176.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.44 -45.29 80.87 Favored 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -87.62 -13.36 42.97 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -117.31 -20.93 8.96 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -172.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -135.07 164.02 28.59 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.22 -176.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -83.19 119.79 24.99 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.212 -175.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -76.64 114.13 15.05 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 122.124 0.964 . . . . 0.0 112.379 174.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.6 mm -109.97 143.75 19.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 173.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.429 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 11.5 p -104.72 172.54 6.73 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 118.671 -1.211 . . . . 0.0 109.379 -176.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.5 tt -52.44 -37.38 23.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 C-N-CA 124.052 0.941 . . . . 0.0 112.73 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -79.93 -29.67 39.81 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-O 121.099 0.476 . . . . 0.0 110.918 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.523 ' SG ' ' HA3' ' A' ' 23' ' ' GLY . 54.5 m -77.29 -31.44 54.79 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.339 178.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.865 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.567 -176.749 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.9 t . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.31 -173.0 2.23 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.239 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.93 120.54 35.33 Favored 'General case' 0 C--O 1.2 -1.548 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -173.81 145.52 1.15 Allowed 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 173.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -48.29 -39.12 20.67 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 123.515 0.509 . . . . 0.0 110.725 174.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -138.48 100.19 4.03 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.855 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.561 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 48.1 t -99.65 113.57 26.1 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 118.359 -1.336 . . . . 0.0 111.557 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -69.29 -10.77 59.39 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 124.889 1.276 . . . . 0.0 111.402 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.496 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 71.4 mtp180 47.32 54.77 15.96 Favored Pre-proline 0 N--CA 1.484 1.23 0 C-N-CA 123.692 0.797 . . . . 0.0 112.649 -172.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.496 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 14.1 Cg_exo -72.95 131.29 16.68 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 121.257 1.305 . . . . 0.0 110.559 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 81.1 m -111.67 105.48 14.01 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.442 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -143.66 143.09 31.29 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -68.67 -54.4 16.52 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 176.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -85.12 96.66 9.51 Favored 'General case' 0 N--CA 1.424 -1.73 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.633 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.5 p -168.66 116.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 123.482 0.713 . . . . 0.0 110.326 174.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -78.86 140.78 38.08 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.234 -0.894 . . . . 0.0 113.279 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -107.75 160.41 15.74 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 125.557 1.543 . . . . 0.0 108.429 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.7 m -124.43 138.46 53.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 117.962 0.346 . . . . 0.0 110.513 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 8.6 tt0 -106.44 138.82 41.92 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 30.6 p -90.23 113.86 25.75 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.979 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -85.67 27.6 0.84 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.813 0.845 . . . . 0.0 110.631 -177.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.429 ' HA3' ' SG ' ' A' ' 51' ' ' CYS . . . -96.63 -19.71 26.53 Favored Glycine 0 N--CA 1.432 -1.605 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.333 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.76 -14.81 0.91 Allowed Glycine 0 CA--C 1.539 1.556 0 C-N-CA 119.711 -1.233 . . . . 0.0 115.371 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.455 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 7.9 m -89.82 -29.62 18.5 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 118.709 1.254 . . . . 0.0 110.544 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 59.54 19.77 8.26 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.54 -177.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 20' ' ' GLN . 42.7 mt-10 -89.7 165.37 14.24 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.918 -178.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -106.25 127.29 53.13 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.276 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -118.76 155.64 30.76 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.47 -176.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.902 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 57.5 m80 -92.3 139.07 30.98 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 174.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.521 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 50.1 mt-30 -55.17 -51.87 65.11 Favored 'General case' 0 C--O 1.2 -1.533 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.9 p -66.38 -37.72 80.25 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.621 0 CA-C-O 121.587 0.708 . . . . 0.0 112.188 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.902 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 2.7 p -74.06 -25.16 59.68 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.029 -174.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.591 HG13 HG23 ' A' ' 36' ' ' VAL . 1.6 p -112.86 13.24 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 CA-C-O 121.494 0.664 . . . . 0.0 110.882 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.11 38.51 96.07 Favored Glycine 0 CA--C 1.556 2.633 0 N-CA-C 117.014 1.566 . . . . 0.0 117.014 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.603 HG13 ' SD ' ' A' ' 40' ' ' MET . 95.2 t -95.93 147.13 6.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 174.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 52.3 p -98.22 151.46 37.53 Favored Pre-proline 0 C--N 1.298 -1.673 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 174.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.521 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 14.6 Cg_endo -54.41 -31.43 68.24 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.801 2.334 . . . . 0.0 113.416 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -69.43 -32.45 71.41 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 123.932 0.893 . . . . 0.0 110.153 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.603 ' SD ' HG13 ' A' ' 36' ' ' VAL . 28.2 ttt -69.1 -42.85 75.59 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.033 0.933 . . . . 0.0 110.191 -176.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.52 -38.78 69.67 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -177.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -92.1 -47.0 7.48 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 119.053 -1.059 . . . . 0.0 113.712 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -71.15 -37.55 72.25 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -174.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -126.7 160.76 29.84 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.071 -1.052 . . . . 0.0 112.111 -171.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -78.02 115.53 17.83 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 121.294 0.569 . . . . 0.0 110.868 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -72.72 118.4 15.6 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.886 0.851 . . . . 0.0 112.796 175.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.2 mm -113.35 139.16 40.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 173.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.1 p -97.85 178.67 5.06 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.508 -174.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.1 tt -57.0 -37.63 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.622 0 C-N-CA 124.076 0.95 . . . . 0.0 112.805 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -83.36 -28.1 29.22 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 121.255 0.55 . . . . 0.0 110.849 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.429 ' SG ' ' HA3' ' A' ' 23' ' ' GLY . 60.2 m -77.11 -24.99 51.7 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.339 0.59 . . . . 0.0 110.693 177.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.58 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.873 -178.347 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 C--O 1.245 0.821 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.32 -174.41 4.38 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 119.676 -0.81 . . . . 0.0 109.027 -177.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.96 119.22 30.97 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -175.6 142.03 0.54 Allowed 'General case' 0 CA--C 1.496 -1.105 0 C-N-CA 123.432 0.693 . . . . 0.0 109.303 174.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -47.61 -44.27 26.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 124.264 0.978 . . . . 0.0 110.239 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -135.38 95.77 3.34 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.373 176.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.54 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 49.5 t -92.81 115.65 28.31 Favored 'General case' 0 N--CA 1.419 -1.992 0 C-N-CA 119.15 -1.02 . . . . 0.0 110.678 178.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -72.07 -8.74 56.34 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.415 177.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.5 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 58.9 ttt180 47.89 52.64 12.81 Favored Pre-proline 0 CA--C 1.565 1.548 0 C-N-CA 125.345 1.458 . . . . 0.0 112.073 -177.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.5 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 14.9 Cg_exo -70.97 132.76 22.0 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 121.503 1.469 . . . . 0.0 110.398 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 46.3 t -119.39 106.27 12.11 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.45 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -149.57 163.35 38.1 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -83.9 -55.91 3.98 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 173.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -68.19 82.95 0.23 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 121.333 -0.147 . . . . 0.0 111.206 172.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.7 p -173.1 104.52 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 122.052 0.929 . . . . 0.0 110.752 175.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -74.56 149.68 40.07 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 114.947 -1.024 . . . . 0.0 113.334 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -113.59 160.69 18.29 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 125.262 1.425 . . . . 0.0 109.793 -175.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.5 m -123.63 136.96 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-O 120.715 0.293 . . . . 0.0 110.274 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.474 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 54.1 tt0 -103.79 138.68 40.06 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 175.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 46' ' ' TYR . 29.4 p -90.73 103.56 16.25 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 118.976 -1.09 . . . . 0.0 110.688 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -82.82 21.03 1.06 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.052 -0.977 . . . . 0.0 111.18 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.49 -8.08 61.33 Favored Glycine 0 N--CA 1.434 -1.464 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.694 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 151.72 -23.7 0.93 Allowed Glycine 0 CA--C 1.54 1.627 0 C-N-CA 118.646 -1.74 . . . . 0.0 115.412 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.477 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 8.5 m -91.99 -29.59 16.53 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 118.839 1.319 . . . . 0.0 109.462 -176.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 58.07 26.47 13.64 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.921 -176.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 20' ' ' GLN . 37.7 mt-10 -94.43 167.19 11.67 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.4 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -108.39 129.31 55.25 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.374 -175.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -122.9 156.94 33.64 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.844 -177.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.905 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 56.1 m80 -94.0 141.19 28.81 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.592 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 51.0 mt-30 -58.38 -44.08 88.75 Favored 'General case' 0 C--O 1.187 -2.213 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.6 p -76.02 -37.8 34.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 118.862 -1.135 . . . . 0.0 111.273 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.905 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 1.8 p -70.76 -33.16 70.5 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.793 -174.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.494 HG13 HG23 ' A' ' 36' ' ' VAL . 1.5 p -106.16 12.25 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.803 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.42 66.12 3.07 Favored Glycine 0 CA--C 1.55 2.219 0 N-CA-C 116.586 1.394 . . . . 0.0 116.586 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.494 HG23 HG13 ' A' ' 34' ' ' VAL . 78.7 t -116.98 149.15 19.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 175.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.4 p -95.97 147.99 33.84 Favored Pre-proline 0 N--CA 1.418 -2.044 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.592 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 18.2 Cg_endo -56.3 -27.19 65.67 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 C-N-CA 122.725 2.283 . . . . 0.0 112.231 -176.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -74.54 -28.81 61.12 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.82 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.414 ' CE ' HG13 ' A' ' 36' ' ' VAL . 34.6 ttp -72.33 -39.0 68.51 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -176.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.73 -30.61 65.69 Favored 'General case' 0 CA--C 1.564 1.5 0 CA-C-N 114.633 -1.167 . . . . 0.0 113.431 -176.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -95.26 -13.18 25.09 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -118.03 -35.85 3.76 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 -172.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -131.17 153.48 49.38 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.584 0.629 . . . . 0.0 110.974 -173.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -71.72 126.9 30.9 Favored 'General case' 0 C--O 1.251 1.154 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.495 -176.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 54.1 t80 -76.36 110.93 11.29 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-O 122.028 0.918 . . . . 0.0 113.454 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.4 mm -95.21 134.93 30.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 173.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.44 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 13.4 p -101.57 -179.79 4.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 119.326 0.966 . . . . 0.0 109.095 -175.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.5 tt -54.43 -42.79 60.42 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 C-N-CA 123.862 0.865 . . . . 0.0 112.131 177.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -77.5 -28.5 52.17 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-O 120.656 0.265 . . . . 0.0 111.121 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.44 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 56.5 m -77.01 -26.25 53.58 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-O 121.06 0.457 . . . . 0.0 110.916 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.738 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.0 -178.145 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 44.1 t . . . . . 0 C--O 1.244 0.784 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.434 ' SG ' ' N ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -86.31 -172.89 4.27 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.575 -178.559 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.434 ' N ' ' SG ' ' A' ' 3' ' ' CYS . . . -97.4 123.07 41.11 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 176.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -172.32 141.66 1.24 Allowed 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 172.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -48.2 -28.22 2.87 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.967 0.907 . . . . 0.0 110.8 173.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -153.43 104.45 2.75 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.927 174.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.595 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 52.2 t -101.35 123.69 45.85 Favored 'General case' 0 N--CA 1.412 -2.341 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.566 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -75.64 -7.35 54.05 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.176 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.569 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 36.5 ttt180 47.93 48.78 6.32 Favored Pre-proline 0 CA--C 1.573 1.861 0 C-N-CA 125.751 1.62 . . . . 0.0 112.197 -176.056 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.569 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 6.1 Cg_exo -77.42 141.6 20.28 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.252 1.968 . . . . 0.0 111.818 -177.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.5 t -134.38 116.59 15.36 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.968 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -139.11 158.36 44.31 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 174.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -81.42 -3.0 51.59 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 122.056 0.932 . . . . 0.0 108.772 175.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -128.91 85.47 2.33 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.128 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.3 p -175.79 111.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 122.015 0.912 . . . . 0.0 111.003 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -73.01 159.26 33.94 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 114.116 -1.402 . . . . 0.0 111.953 176.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 17.8 m95 -125.51 159.35 32.21 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.068 0.947 . . . . 0.0 109.905 -174.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.1 m -129.19 136.42 59.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 120.79 0.329 . . . . 0.0 110.249 -178.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -101.48 139.74 36.72 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 29.9 p -88.06 103.14 15.44 Favored 'General case' 0 C--O 1.248 1.006 0 C-N-CA 118.698 -1.201 . . . . 0.0 110.124 176.072 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -81.66 21.51 0.81 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.066 -175.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.22 -12.94 55.66 Favored Glycine 0 N--CA 1.423 -2.217 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.87 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 149.78 -16.14 1.07 Allowed Glycine 0 CA--C 1.537 1.408 0 C-N-CA 118.509 -1.805 . . . . 0.0 116.143 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.462 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 13.5 m -90.63 -30.33 17.23 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 119.014 1.407 . . . . 0.0 109.454 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 60.83 22.55 12.6 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.52 -175.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -88.66 161.42 16.87 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.953 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -108.93 127.87 54.44 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.438 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -118.63 160.18 22.28 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.376 -176.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.93 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 48.9 m80 -94.77 134.71 37.09 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 174.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -54.27 -38.26 65.64 Favored 'General case' 0 C--O 1.203 -1.389 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 178.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.5 p -77.14 -42.16 31.3 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.315 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.696 178.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.93 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 10.0 p -71.71 -30.98 66.24 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.805 -172.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.521 HG13 HG23 ' A' ' 36' ' ' VAL . 1.4 p -103.99 10.85 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.073 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.636 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.34 60.33 9.14 Favored Glycine 0 CA--C 1.543 1.793 0 N-CA-C 116.187 1.235 . . . . 0.0 116.187 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.521 HG23 HG13 ' A' ' 34' ' ' VAL . 77.4 t -107.93 146.63 13.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 174.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.7 p -99.38 156.33 35.53 Favored Pre-proline 0 N--CA 1.413 -2.276 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -58.49 -25.88 75.84 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.458 2.105 . . . . 0.0 111.307 177.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -71.33 -34.41 70.52 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.015 -178.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 35.1 ttp -75.1 -47.42 28.79 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.696 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.7 -45.18 90.07 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -175.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -79.23 -18.69 52.36 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -177.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -116.43 -30.99 5.73 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 -173.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -131.42 166.34 21.51 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 119.638 1.108 . . . . 0.0 113.806 -172.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.82 117.64 17.77 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.463 -177.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.456 ' OH ' HG21 ' A' ' 34' ' ' VAL . 82.6 t80 -73.91 117.11 15.31 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-O 122.184 0.992 . . . . 0.0 113.598 178.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.5 mm -107.03 148.06 11.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 106.16 -1.792 . . . . 0.0 106.16 174.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.487 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 11.8 p -111.55 177.32 4.69 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 119.123 0.874 . . . . 0.0 108.756 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.2 tt -55.2 -41.17 59.23 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.339 0 C-N-CA 124.047 0.939 . . . . 0.0 112.358 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -76.15 -32.79 59.26 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.048 0.451 . . . . 0.0 110.808 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.487 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 64.2 m -74.46 -25.38 59.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.219 0.533 . . . . 0.0 110.448 176.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.49 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.401 -178.525 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.4 t . . . . . 0 N--CA 1.442 -0.864 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.412 ' SG ' ' N ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -96.01 -172.48 2.58 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.776 -176.147 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.412 ' N ' ' SG ' ' A' ' 3' ' ' CYS . . . -91.77 120.53 32.58 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -177.08 146.38 0.51 Allowed 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 172.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -47.9 -43.01 28.4 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 124.019 0.824 . . . . 0.0 110.802 174.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -140.12 99.96 3.8 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.91 173.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.552 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 47.3 t -91.5 120.42 32.31 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.892 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -71.06 -8.17 51.55 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.791 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.504 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 68.7 ttt180 48.99 53.99 15.47 Favored Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 125.51 1.524 . . . . 0.0 112.012 -175.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.504 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 10.8 Cg_exo -73.91 131.93 16.31 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 121.825 1.683 . . . . 0.0 111.037 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.3 t -125.36 110.21 13.7 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.003 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -137.44 156.59 47.99 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 174.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -68.52 -50.48 51.77 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.6 0.714 . . . . 0.0 110.236 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -103.11 92.73 4.65 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.227 0.537 . . . . 0.0 110.499 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.4 p -156.42 123.89 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.939 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.532 ' HB2' ' NE2' ' A' ' 31' ' ' GLN . 6.9 m-20 -69.62 157.63 36.84 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.747 -1.115 . . . . 0.0 113.204 177.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -133.29 159.67 39.56 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 125.524 1.53 . . . . 0.0 107.798 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.417 HG23 ' HB2' ' A' ' 29' ' ' PHE . 22.5 m -131.06 130.93 64.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 120.987 0.422 . . . . 0.0 110.577 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.455 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 50.4 tt0 -98.7 138.58 35.66 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 175.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.469 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 32.0 p -87.7 108.27 19.03 Favored 'General case' 0 C--O 1.25 1.121 0 C-N-CA 118.404 -1.318 . . . . 0.0 110.155 177.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -82.99 23.73 0.82 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.385 -177.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.32 -9.8 61.45 Favored Glycine 0 N--CA 1.417 -2.595 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.3 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 139.9 -14.35 3.1 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 119.12 -1.514 . . . . 0.0 115.567 177.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.469 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 19.1 m -87.41 -28.12 22.33 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 119.14 1.47 . . . . 0.0 108.709 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 59.5 21.59 10.08 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.961 -177.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' ' 20' ' ' GLN . 42.9 mt-10 -88.99 163.96 15.31 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 120.951 0.405 . . . . 0.0 111.653 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 44.9 m95 -108.14 128.69 54.91 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.239 -175.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.417 ' HB2' HG23 ' A' ' 19' ' ' VAL . 11.1 m-85 -121.89 158.54 28.77 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.913 -178.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.927 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 49.0 m80 -97.56 140.19 32.34 Favored 'General case' 0 CA--C 1.488 -1.413 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 174.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.532 ' NE2' ' HB2' ' A' ' 17' ' ' ASP . 50.8 mt-30 -56.95 -45.62 82.71 Favored 'General case' 0 C--O 1.191 -2.023 0 O-C-N 123.771 0.67 . . . . 0.0 112.75 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.8 p -71.07 -40.17 75.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 O-C-N 121.575 -0.703 . . . . 0.0 112.086 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.927 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 9.4 p -70.85 -33.95 71.16 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.837 -174.315 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.566 HG13 HG23 ' A' ' 36' ' ' VAL . 1.7 p -104.13 10.23 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 CA-C-O 121.291 0.567 . . . . 0.0 110.497 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.08 60.52 8.49 Favored Glycine 0 CA--C 1.551 2.339 0 N-CA-C 116.501 1.36 . . . . 0.0 116.501 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.566 HG23 HG13 ' A' ' 34' ' ' VAL . 74.6 t -115.87 148.3 18.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 175.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.1 p -100.13 149.83 36.36 Favored Pre-proline 0 N--CA 1.421 -1.912 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.477 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 72.9 Cg_exo -53.94 -30.23 57.68 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 122.961 2.441 . . . . 0.0 112.507 -178.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -69.3 -31.88 70.66 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.062 -178.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 35.2 ttp -74.84 -42.3 58.23 Favored 'General case' 0 C--O 1.208 -1.112 0 CA-C-O 121.269 0.557 . . . . 0.0 110.185 -177.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.42 -41.24 79.99 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -176.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -86.21 -14.02 45.19 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -113.37 -34.18 5.69 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -174.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -130.02 144.21 51.21 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 118.654 0.661 . . . . 0.0 111.105 -174.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -70.45 115.61 9.83 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.293 -178.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -69.74 120.2 15.13 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -176.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.8 mm -102.41 139.87 22.3 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.904 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 173.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.2 p -102.19 178.57 4.56 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.875 0.761 . . . . 0.0 109.88 -176.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.7 tt -55.98 -39.45 57.7 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.476 0 C-N-CA 123.769 0.828 . . . . 0.0 112.247 177.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -74.55 -38.47 62.72 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 121.159 0.504 . . . . 0.0 110.848 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 63.7 m -69.33 -27.18 65.14 Favored 'General case' 0 C--O 1.213 -0.819 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.89 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.109 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.67 -177.362 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.8 t . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.42 ' SG ' ' N ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -90.45 -175.21 4.39 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.502 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.42 ' N ' ' SG ' ' A' ' 3' ' ' CYS . . . -95.67 123.17 39.1 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -176.11 151.31 1.04 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 172.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -47.13 -42.91 20.17 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.259 0.624 . . . . 0.0 110.928 173.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -141.58 107.57 5.18 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.801 176.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.589 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 47.0 t -101.19 116.85 33.77 Favored 'General case' 0 N--CA 1.42 -1.938 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.976 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -74.38 -11.38 60.23 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.156 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.521 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 31.5 mtm180 49.11 53.51 14.67 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 125.511 1.524 . . . . 0.0 114.388 -174.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 8.5 Cg_exo -78.05 139.7 17.36 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 121.826 1.684 . . . . 0.0 111.265 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.4 t -132.86 115.81 15.73 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -149.68 156.83 42.54 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.39 -15.38 63.53 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.194 0.598 . . . . 0.0 111.667 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -116.75 18.98 14.71 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -170.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.8 p -114.76 106.18 20.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.945 0.878 . . . . 0.0 112.465 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -72.75 148.37 44.69 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.355 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -113.18 158.97 19.77 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.511 1.125 . . . . 0.0 110.182 -174.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.2 m -125.98 132.16 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-O 120.678 0.275 . . . . 0.0 110.77 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -99.23 138.88 35.69 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.489 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 28.8 p -83.88 108.77 17.08 Favored 'General case' 0 C--O 1.255 1.345 0 C-N-CA 118.708 -1.197 . . . . 0.0 111.667 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -76.39 18.87 0.28 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.315 1.046 . . . . 0.0 112.17 -176.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.575 ' HA3' ' SG ' ' A' ' 51' ' ' CYS . . . -92.93 -18.67 39.36 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.117 -179.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 141.41 -6.83 2.5 Favored Glycine 0 CA--C 1.545 1.93 0 C-N-CA 119.185 -1.483 . . . . 0.0 115.978 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.489 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 16.9 m -88.89 -25.1 22.31 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 119.133 1.467 . . . . 0.0 109.315 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 59.92 18.48 7.53 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.299 1.04 . . . . 0.0 113.051 -176.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -85.91 159.36 19.68 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.212 0.529 . . . . 0.0 111.181 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -106.39 126.24 52.0 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.06 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.402 ' CD1' ' HE2' ' A' ' 46' ' ' TYR . 3.0 m-85 -118.64 159.31 23.83 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.706 -177.05 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.923 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 41.6 m80 -96.28 135.86 37.54 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.46 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 50.8 mt-30 -55.02 -40.05 69.76 Favored 'General case' 0 C--O 1.188 -2.148 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 177.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.415 ' CG1' ' HG2' ' A' ' 11' ' ' PRO . 11.7 p -76.43 -38.86 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.454 0 C-N-CA 119.692 -0.803 . . . . 0.0 112.092 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.923 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 7.7 p -75.08 -29.5 60.68 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -174.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.564 HG21 ' OH ' ' A' ' 46' ' ' TYR . 2.1 p -104.7 1.95 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 CA-C-O 121.678 0.751 . . . . 0.0 110.117 178.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.7 75.03 0.35 Allowed Glycine 0 CA--C 1.55 2.233 0 N-CA-C 115.813 1.085 . . . . 0.0 115.813 -176.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.563 HG23 HG13 ' A' ' 34' ' ' VAL . 64.3 t -127.97 147.94 32.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 175.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 52.2 p -99.54 150.97 37.27 Favored Pre-proline 0 N--CA 1.421 -1.886 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.46 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 18.2 Cg_endo -56.09 -23.75 45.86 Favored 'Trans proline' 0 N--CA 1.485 0.988 0 C-N-CA 122.925 2.417 . . . . 0.0 112.32 -177.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -74.2 -32.97 63.25 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.186 -178.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 35.4 ttp -73.91 -41.32 62.29 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -176.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.26 -43.06 87.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.214 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -83.58 -21.35 32.66 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -177.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -110.38 -27.68 8.93 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 -174.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -132.7 166.08 23.02 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.461 1.028 . . . . 0.0 111.927 -174.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -81.91 115.64 21.19 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.564 ' OH ' HG21 ' A' ' 34' ' ' VAL . 49.7 t80 -68.72 113.37 6.13 Favored 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.4 mm -101.28 140.5 19.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.48 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 8.3 p -107.9 178.53 4.49 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.171 -177.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.2 tt -55.36 -41.83 63.98 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 C-N-CA 124.131 0.972 . . . . 0.0 112.245 177.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -77.64 -25.31 49.58 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 121.25 0.548 . . . . 0.0 110.393 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.575 ' SG ' ' HA3' ' A' ' 23' ' ' GLY . 55.5 m -78.03 -26.93 48.68 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.191 177.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.779 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.023 -176.638 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.0 t . . . . . 0 N--CA 1.441 -0.914 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.16 -173.56 3.29 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.43 119.73 33.6 Favored 'General case' 0 C--O 1.207 -1.162 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -177.64 142.26 0.31 Allowed 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 173.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -47.87 -45.1 29.94 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 124.046 0.841 . . . . 0.0 110.895 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -130.67 94.91 3.73 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.69 176.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.5 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 51.8 t -93.63 123.21 36.8 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 118.995 -1.082 . . . . 0.0 111.181 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -81.45 -11.68 59.15 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.831 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.569 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 62.4 mtm180 52.9 43.57 1.61 Allowed Pre-proline 0 CA--C 1.566 1.584 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -176.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.569 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 10.4 Cg_exo -76.86 143.63 23.57 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 121.619 1.546 . . . . 0.0 110.608 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 53.2 t -137.7 113.32 9.56 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.407 ' O ' HG12 ' A' ' 16' ' ' VAL . 97.7 mttt -142.69 151.38 41.3 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 177.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.24 -4.85 15.52 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 178.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -121.25 8.92 10.33 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -176.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 13' ' ' LYS . 7.2 p -102.86 107.18 21.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-O 121.756 0.789 . . . . 0.0 112.044 -178.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -74.07 146.8 43.38 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.592 176.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -111.95 159.16 18.67 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 124.638 1.175 . . . . 0.0 109.676 -174.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 23.1 m -123.86 132.65 71.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 O-C-N 121.949 -0.469 . . . . 0.0 110.763 -177.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -101.15 138.82 37.67 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.1 p -90.66 107.81 19.41 Favored 'General case' 0 C--O 1.255 1.35 0 C-N-CA 119.161 -1.016 . . . . 0.0 110.741 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -86.79 23.83 1.62 Allowed 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.926 -176.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.72 -14.09 60.14 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.11 -9.11 1.74 Allowed Glycine 0 CA--C 1.542 1.755 0 C-N-CA 119.032 -1.556 . . . . 0.0 116.234 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.479 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 13.9 m -92.58 -28.71 16.57 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 119.641 1.72 . . . . 0.0 110.209 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 61.91 17.69 9.15 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.831 1.253 . . . . 0.0 111.69 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -87.8 161.48 17.53 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.134 0.493 . . . . 0.0 111.598 -178.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -107.33 127.9 53.97 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.004 -176.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.411 ' HE1' ' SG ' ' A' ' 21' ' ' CYS . 3.5 m-85 -119.48 155.32 32.31 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -178.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.911 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 42.5 m80 -91.18 139.85 30.36 Favored 'General case' 0 CA--C 1.476 -1.867 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 174.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.493 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 48.4 mt-30 -54.45 -51.32 65.35 Favored 'General case' 0 C--O 1.192 -1.947 0 O-C-N 123.666 0.604 . . . . 0.0 111.806 177.015 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.8 p -68.2 -39.51 81.32 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 CA-C-O 121.125 0.488 . . . . 0.0 112.136 -178.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.911 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 3.4 p -72.76 -25.05 61.05 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.336 -174.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.486 HG13 HG23 ' A' ' 36' ' ' VAL . 0.9 OUTLIER -110.81 11.72 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.821 177.259 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.54 39.98 95.85 Favored Glycine 0 CA--C 1.546 2.021 0 N-CA-C 117.34 1.696 . . . . 0.0 117.34 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.486 HG23 HG13 ' A' ' 34' ' ' VAL . 69.4 t -93.92 147.95 5.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 118.153 0.976 . . . . 0.0 109.378 175.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.9 p -99.37 147.35 33.2 Favored Pre-proline 0 N--CA 1.414 -2.249 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 175.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.493 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 74.9 Cg_exo -51.41 -32.27 41.83 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.312 2.675 . . . . 0.0 114.062 -175.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.57 -26.02 60.63 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 35.9 ttp -73.38 -38.17 65.74 Favored 'General case' 0 C--O 1.213 -0.822 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.42 -43.98 79.9 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.659 -177.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -90.46 -12.28 37.82 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -113.59 -27.0 8.02 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -128.77 151.19 49.84 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.06 0.457 . . . . 0.0 110.324 -175.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -79.15 115.71 18.98 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.659 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.423 ' OH ' HG21 ' A' ' 34' ' ' VAL . 90.5 t80 -67.01 114.86 6.13 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-O 122.812 1.292 . . . . 0.0 114.428 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.0 mm -103.64 141.65 18.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 172.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.457 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 9.3 p -106.83 179.21 4.33 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.361 -176.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.5 tt -56.04 -43.28 74.94 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 C-N-CA 123.684 0.794 . . . . 0.0 112.269 177.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -76.04 -28.23 57.61 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.095 0.474 . . . . 0.0 110.943 -178.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.457 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 58.0 m -76.59 -25.56 54.07 Favored 'General case' 0 C--O 1.213 -0.83 0 CA-C-O 121.524 0.678 . . . . 0.0 110.901 176.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.293 -1.877 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.753 -176.809 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.5 t . . . . . 0 N--CA 1.449 -0.511 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.633 ' SG ' ' HA ' ' A' ' 29' ' ' PHE . 0.5 OUTLIER -100.77 -172.43 2.18 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 119.108 -1.037 . . . . 0.0 109.767 -176.204 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.99 121.94 31.85 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -173.78 145.3 1.14 Allowed 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 172.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -47.99 -42.0 26.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 123.771 0.669 . . . . 0.0 109.439 173.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -136.06 97.93 3.74 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.337 174.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.595 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 53.4 t -94.19 156.92 16.31 Favored 'General case' 0 N--CA 1.422 -1.843 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.24 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.646 ' C ' ' HD3' ' A' ' 11' ' ' PRO . 25.2 mt-30 -119.2 173.27 7.03 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.772 -177.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.422 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 19.2 mmm180 -116.69 62.88 2.77 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 123.416 0.686 . . . . 0.0 111.085 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.646 ' HD3' ' C ' ' A' ' 9' ' ' GLN . 5.0 Cg_exo -88.6 145.43 5.76 Favored 'Trans proline' 0 C--N 1.359 1.099 0 C-N-CA 123.389 2.726 . . . . 0.0 112.077 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.6 t -130.16 107.44 9.31 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.801 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -152.97 156.57 39.12 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 124.862 1.265 . . . . 0.0 108.581 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -87.77 -51.1 6.05 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 172.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -72.32 79.55 1.01 Allowed 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.992 175.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.6 p -165.61 102.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 122.125 0.964 . . . . 0.0 110.604 176.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -67.88 137.89 55.61 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 114.191 -1.368 . . . . 0.0 112.283 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 21.4 m95 -106.53 160.3 15.53 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.015 1.326 . . . . 0.0 108.945 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.5 m -127.83 132.72 68.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.115 0.483 . . . . 0.0 110.851 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -100.45 138.99 36.76 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 30.6 p -87.69 102.67 14.87 Favored 'General case' 0 C--O 1.256 1.416 0 C-N-CA 118.997 -1.081 . . . . 0.0 110.595 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.52 24.44 0.57 Allowed 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.122 -175.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.64 -18.27 41.91 Favored Glycine 0 N--CA 1.437 -1.253 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 147.61 -10.65 1.27 Allowed Glycine 0 C--N 1.351 1.41 0 N-CA-C 116.951 1.54 . . . . 0.0 116.951 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.455 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 15.9 m -88.9 -26.8 21.4 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 119.754 1.777 . . . . 0.0 109.724 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 61.1 20.53 11.0 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.859 0.863 . . . . 0.0 112.417 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -91.77 158.08 16.55 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.744 -178.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -107.77 132.78 53.02 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.896 -177.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.633 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . 3.5 m-85 -120.72 159.72 24.79 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.152 -177.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.874 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 42.4 m80 -93.35 134.49 35.52 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -56.87 -33.04 66.46 Favored 'General case' 0 C--O 1.197 -1.7 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 176.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.6 p -77.2 -41.6 30.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-O 121.336 0.589 . . . . 0.0 111.968 177.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.874 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 4.2 p -75.52 -29.17 59.37 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.992 -173.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.49 HG13 HG23 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -106.66 2.79 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.764 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.485 179.66 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.31 72.49 0.62 Allowed Glycine 0 CA--C 1.555 2.586 0 N-CA-C 116.316 1.286 . . . . 0.0 116.316 -176.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.49 HG23 HG13 ' A' ' 34' ' ' VAL . 59.3 t -121.2 148.77 24.34 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 C-N-CA 124.547 1.139 . . . . 0.0 108.176 175.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.6 p -99.99 150.83 37.22 Favored Pre-proline 0 N--CA 1.42 -1.946 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -49.95 -42.71 44.3 Favored 'Trans proline' 0 C--N 1.358 1.066 0 C-N-CA 123.051 2.501 . . . . 0.0 112.115 -177.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -60.07 -35.04 74.29 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 42.2 ttp -69.25 -43.33 74.19 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.617 -176.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.13 -48.24 80.84 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 123.792 0.683 . . . . 0.0 112.072 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -77.91 -13.78 59.77 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -176.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -122.19 -43.03 2.34 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 117.021 2.23 . . . . 0.0 117.021 -172.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -126.89 171.31 11.38 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -168.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -68.35 115.14 7.44 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.48 0.712 . . . . 0.0 112.184 -173.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.481 ' OH ' HG21 ' A' ' 34' ' ' VAL . 79.3 t80 -82.81 105.66 14.01 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 122.239 1.019 . . . . 0.0 111.757 172.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.0 mm -98.92 145.14 10.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 175.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.441 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 13.5 p -105.32 178.28 4.61 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 119.306 -0.958 . . . . 0.0 108.872 -178.069 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.0 tt -55.83 -41.31 65.94 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 124.071 0.948 . . . . 0.0 111.928 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -75.62 -39.89 57.15 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.912 0.485 . . . . 0.0 111.433 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.441 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 52.1 m -63.21 -29.81 71.08 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.023 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.696 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.587 -175.399 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.7 t . . . . . 0 N--CA 1.45 -0.438 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -87.68 -173.68 4.43 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -178.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.59 119.98 34.1 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 174.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -173.25 140.91 0.89 Allowed 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 171.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -48.99 -43.61 40.38 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.931 0.769 . . . . 0.0 109.474 176.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -127.96 104.88 8.04 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.797 177.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.563 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 42.1 t -105.9 125.23 50.75 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 117.738 -1.585 . . . . 0.0 112.614 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -81.23 -6.06 58.45 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.161 -1.381 . . . . 0.0 110.571 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.587 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 73.3 mtp180 53.11 39.9 0.69 Allowed Pre-proline 0 CA--C 1.57 1.712 0 C-N-CA 124.465 1.106 . . . . 0.0 113.787 -176.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.587 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 7.2 Cg_exo -74.67 134.0 17.85 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 121.687 1.591 . . . . 0.0 112.076 -175.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 51.2 t -127.69 125.1 39.44 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -149.04 164.23 35.23 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -77.35 -14.63 59.69 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.498 0.666 . . . . 0.0 109.253 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -131.45 91.44 3.01 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.929 -177.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.2 p -171.56 103.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 122.164 0.983 . . . . 0.0 111.143 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.678 ' HB2' ' NE2' ' A' ' 31' ' ' GLN . 4.1 m-20 -68.85 140.56 55.22 Favored 'General case' 0 C--N 1.275 -2.665 0 CA-C-N 114.433 -1.258 . . . . 0.0 111.722 177.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -107.55 159.82 16.14 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 124.198 0.999 . . . . 0.0 108.825 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.4 m -127.26 134.08 66.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 120.905 0.383 . . . . 0.0 110.397 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -101.0 139.07 37.2 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 30.1 p -91.63 99.68 12.54 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 118.875 -1.13 . . . . 0.0 109.951 176.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -85.07 22.45 1.42 Allowed 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.698 -175.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.21 -2.75 62.02 Favored Glycine 0 N--CA 1.426 -2.022 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.562 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.15 -23.74 1.12 Allowed Glycine 0 CA--C 1.541 1.675 0 C-N-CA 118.878 -1.629 . . . . 0.0 116.203 178.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.458 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 5.6 m -95.09 -31.84 13.38 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 119.089 1.444 . . . . 0.0 110.015 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 61.59 19.39 10.36 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 124.019 0.825 . . . . 0.0 111.908 -176.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -85.73 158.95 19.9 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.716 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -104.67 127.63 52.49 Favored 'General case' 0 C--O 1.242 0.669 0 O-C-N 123.619 0.574 . . . . 0.0 112.342 -176.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.411 ' HE1' ' SG ' ' A' ' 21' ' ' CYS . 8.9 m-85 -118.12 156.38 28.77 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.889 -1.051 . . . . 0.0 108.786 -177.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.937 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 47.2 m80 -93.56 139.11 31.13 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 174.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.678 ' NE2' ' HB2' ' A' ' 17' ' ' ASP . 50.6 mt-30 -56.12 -46.24 79.23 Favored 'General case' 0 C--O 1.188 -2.137 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.0 p -72.66 -37.85 57.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.738 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.937 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 5.4 p -72.24 -31.75 66.09 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.832 -175.079 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.463 HG13 HG23 ' A' ' 36' ' ' VAL . 1.4 p -104.47 5.69 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.659 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.36 72.12 0.73 Allowed Glycine 0 CA--C 1.548 2.142 0 N-CA-C 115.408 0.923 . . . . 0.0 115.408 -176.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.463 HG23 HG13 ' A' ' 34' ' ' VAL . 74.5 t -127.61 147.3 32.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 173.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.4 p -100.25 150.56 37.02 Favored Pre-proline 0 N--CA 1.422 -1.832 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 176.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.418 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 11.0 Cg_endo -53.58 -25.2 32.0 Favored 'Trans proline' 0 N--CA 1.488 1.148 0 C-N-CA 123.513 2.809 . . . . 0.0 112.735 -177.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -73.53 -34.27 65.14 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.364 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 39.8 ttp -74.43 -38.16 63.12 Favored 'General case' 0 C--O 1.21 -0.986 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.206 -176.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.88 -44.11 77.84 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -176.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -85.82 -46.14 10.92 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 176.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -75.1 -35.48 61.76 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 -173.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -128.08 164.07 23.22 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -171.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -82.93 115.67 21.89 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.877 0.871 . . . . 0.0 111.512 -174.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.445 ' OH ' HG21 ' A' ' 34' ' ' VAL . 77.8 t80 -78.49 110.77 13.86 Favored 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.2 mm -102.29 146.22 10.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 172.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.481 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 7.9 p -111.0 179.83 3.94 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 119.226 -0.99 . . . . 0.0 109.737 -175.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.6 tt -55.02 -40.05 52.43 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.538 0 C-N-CA 124.448 1.099 . . . . 0.0 112.636 177.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -82.93 -29.13 29.38 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.481 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 56.7 m -73.98 -27.98 61.25 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-O 120.887 0.375 . . . . 0.0 111.198 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.423 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.578 -176.043 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.4 p -87.72 -172.16 3.75 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -176.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.61 118.87 32.38 Favored 'General case' 0 C--O 1.206 -1.206 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 172.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -177.03 135.56 0.2 Allowed 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 171.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -51.36 -43.31 61.79 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.287 0.565 . . . . 0.0 110.483 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -121.91 103.11 8.61 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.886 175.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.579 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 42.2 t -107.49 122.16 46.08 Favored 'General case' 0 N--CA 1.417 -2.083 0 C-N-CA 118.024 -1.47 . . . . 0.0 111.993 177.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -79.49 -8.46 59.15 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.33 178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.487 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 38.1 ttp180 46.1 61.81 12.22 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 126.763 2.025 . . . . 0.0 111.997 -175.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.487 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 17.0 Cg_exo -76.23 132.98 14.32 Favored 'Trans proline' 0 C--O 1.252 1.184 0 C-N-CA 123.048 2.499 . . . . 0.0 111.752 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.4 t -123.82 102.66 7.92 Favored 'General case' 0 N--CA 1.44 -0.971 0 O-C-N 123.894 0.746 . . . . 0.0 110.479 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -141.03 159.6 41.87 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 175.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -81.74 -50.1 9.66 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.826 -0.75 . . . . 0.0 112.031 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -73.39 18.83 0.11 Allowed 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.5 p -102.74 111.21 31.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 119.287 0.949 . . . . 0.0 111.928 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -71.39 146.93 48.43 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.047 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -113.69 159.2 19.95 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.262 1.025 . . . . 0.0 109.822 -175.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.7 137.59 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-O 120.71 0.29 . . . . 0.0 110.546 -177.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -110.52 138.3 47.09 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.572 178.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.411 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.4 p -93.22 102.42 14.71 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.497 176.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -86.68 25.26 1.29 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.808 0.813 . . . . 0.0 109.881 -176.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.11 1.68 57.71 Favored Glycine 0 N--CA 1.431 -1.643 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.699 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 151.75 -35.28 0.86 Allowed Glycine 0 CA--C 1.534 1.256 0 C-N-CA 118.726 -1.702 . . . . 0.0 115.608 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.411 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 7.4 m -89.27 -32.75 17.23 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 118.548 1.174 . . . . 0.0 109.488 -176.391 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 59.95 21.39 10.43 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.748 1.219 . . . . 0.0 111.634 -177.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -88.15 163.7 16.06 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.731 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -105.29 127.52 52.99 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.115 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -117.12 155.15 29.8 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.684 -178.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.95 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 44.2 m80 -92.54 137.73 32.11 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 174.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -52.46 -51.74 57.76 Favored 'General case' 0 C--O 1.198 -1.62 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.3 p -68.63 -37.02 77.04 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 CA-C-N 118.533 0.606 . . . . 0.0 112.246 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.95 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 8.1 p -72.51 -27.29 62.17 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.23 -175.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.528 HG13 HG23 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -109.68 12.92 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.944 0 CA-C-O 121.753 0.787 . . . . 0.0 110.727 177.779 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.18 35.98 92.65 Favored Glycine 0 CA--C 1.553 2.433 0 N-CA-C 117.257 1.663 . . . . 0.0 117.257 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.528 HG23 HG13 ' A' ' 34' ' ' VAL . 86.5 t -93.97 147.48 5.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 117.775 0.788 . . . . 0.0 109.74 176.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.3 p -104.36 150.69 38.72 Favored Pre-proline 0 N--CA 1.415 -2.198 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 175.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -47.59 -39.63 29.74 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 123.475 2.783 . . . . 0.0 112.987 -177.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -58.15 -38.86 77.41 Favored 'General case' 0 C--O 1.214 -0.809 0 C-N-CA 124.475 1.11 . . . . 0.0 111.609 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.415 ' HB3' HG13 ' A' ' 36' ' ' VAL . 33.3 ttp -72.36 -39.54 67.99 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.813 -175.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.83 -49.05 77.96 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 123.741 0.651 . . . . 0.0 112.71 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -90.13 -24.01 21.2 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -177.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -98.53 -28.03 13.77 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.177 -1.009 . . . . 0.0 113.684 -172.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -139.05 -179.83 6.07 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -176.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -83.92 118.26 23.88 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 113.586 -1.643 . . . . 0.0 112.477 -174.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -88.18 110.37 20.64 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 122.272 1.035 . . . . 0.0 113.551 175.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.401 HG23 ' HB3' ' A' ' 51' ' ' CYS . 47.2 mm -107.89 141.15 23.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 172.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.9 p -97.9 176.56 5.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.276 -175.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.8 tt -54.15 -36.25 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.343 0 C-N-CA 124.255 1.022 . . . . 0.0 112.596 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -81.71 -35.67 29.51 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-O 120.881 0.372 . . . . 0.0 110.095 -178.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.401 ' HB3' HG23 ' A' ' 47' ' ' ILE . 64.6 m -74.39 -25.05 59.25 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-O 121.422 0.63 . . . . 0.0 111.482 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.1 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -178.812 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 99.6 t . . . . . 0 N--CA 1.446 -0.657 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.49 ' SG ' ' HA ' ' A' ' 29' ' ' PHE . 0.5 OUTLIER -94.28 -174.83 3.48 Favored 'General case' 0 N--CA 1.433 -1.313 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.35 -176.08 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.07 120.06 31.72 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -175.25 147.19 0.88 Allowed 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 123.166 0.586 . . . . 0.0 109.454 171.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -48.04 -41.52 25.97 Favored 'General case' 0 CA--C 1.558 1.267 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.825 173.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -137.69 98.27 3.64 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.488 173.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.528 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 43.8 t -94.33 117.82 30.69 Favored 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.284 -178.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -85.67 164.34 17.73 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.47 83.64 11.07 Favored Pre-proline 0 C--N 1.311 -1.073 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -70.4 157.43 59.16 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.759 2.973 . . . . 0.0 111.49 172.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.9 p -135.72 27.73 3.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.127 0.489 . . . . 0.0 111.28 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -94.54 146.48 24.08 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 120.475 -0.49 . . . . 0.0 112.022 -177.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -68.33 -53.93 20.87 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 174.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -76.05 91.49 3.1 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.366 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.8 p -170.43 98.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 122.409 1.099 . . . . 0.0 110.961 173.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -66.52 142.71 57.43 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 114.252 -1.34 . . . . 0.0 113.589 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 15.7 m95 -109.12 160.3 16.18 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.763 1.225 . . . . 0.0 109.899 -177.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.3 m -130.35 143.61 40.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 121.291 0.567 . . . . 0.0 111.898 -178.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -112.62 138.73 48.99 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.547 ' HB3' ' O ' ' A' ' 25' ' ' CYS . 43.4 t -77.67 101.31 6.55 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.424 0.631 . . . . 0.0 111.401 -178.247 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -88.74 10.57 20.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 122.524 1.154 . . . . 0.0 108.435 -178.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.9 -2.14 78.75 Favored Glycine 0 N--CA 1.419 -2.436 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.338 177.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 144.74 -26.25 1.94 Allowed Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 119.919 -1.134 . . . . 0.0 114.929 176.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.547 ' O ' ' HB3' ' A' ' 21' ' ' CYS . 17.2 p -114.87 90.09 3.25 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 117.151 -1.82 . . . . 0.0 111.955 -177.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -39.73 13.96 0.0 OUTLIER 'General case' 0 N--CA 1.532 3.631 0 N-CA-C 117.806 2.521 . . . . 0.0 117.806 173.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 25' ' ' CYS . 40.4 mt-10 -81.73 160.91 23.52 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-N 118.769 0.713 . . . . 0.0 109.725 176.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -105.73 130.21 53.78 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.49 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . 17.6 m-85 -118.95 151.62 37.84 Favored 'General case' 0 CA--C 1.562 1.407 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.646 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.884 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 35.2 m80 -88.5 141.87 28.18 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 173.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.466 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 49.8 mt-30 -56.94 -52.11 66.5 Favored 'General case' 0 C--O 1.192 -1.932 0 C-N-CA 120.3 -0.56 . . . . 0.0 112.015 176.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.5 p -67.12 -40.52 85.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.884 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 2.1 p -71.1 -27.31 63.51 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.215 -174.317 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.476 ' CG1' HG23 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -109.96 9.15 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.123 0 CA-C-O 121.255 0.55 . . . . 0.0 111.448 178.781 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.38 40.54 96.47 Favored Glycine 0 CA--C 1.557 2.675 0 N-CA-C 117.392 1.717 . . . . 0.0 117.392 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.476 HG23 ' CG1' ' A' ' 34' ' ' VAL . 78.5 t -92.13 149.18 4.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.029 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.9 p -100.7 150.42 36.98 Favored Pre-proline 0 N--CA 1.426 -1.666 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 176.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.71 -34.58 54.49 Favored 'Trans proline' 0 N--CA 1.483 0.855 0 C-N-CA 123.031 2.488 . . . . 0.0 112.733 -176.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -72.98 -27.86 62.05 Favored 'General case' 0 N--CA 1.414 -2.235 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.287 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.427 ' HE1' HG22 ' A' ' 36' ' ' VAL . 49.9 ttp -73.12 -37.3 66.73 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -177.478 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.02 -32.11 70.58 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.823 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -95.7 -21.31 18.26 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -113.32 -33.81 5.83 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 115.729 1.752 . . . . 0.0 115.729 -171.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -123.33 163.52 20.59 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 118.809 -1.156 . . . . 0.0 113.045 -173.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -82.63 115.13 21.45 Favored 'General case' 0 C--O 1.253 1.266 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.153 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.491 ' HD2' ' HA ' ' A' ' 21' ' ' CYS . 63.5 t80 -71.59 108.97 5.23 Favored 'General case' 0 C--O 1.249 1.079 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.6 mm -98.61 146.21 8.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 170.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 18.2 p -107.04 178.68 4.49 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.509 -0.877 . . . . 0.0 110.6 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.3 tt -50.5 -34.79 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.368 0 C-N-CA 125.399 1.48 . . . . 0.0 113.126 177.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -89.79 -37.92 14.16 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 80.1 m -78.04 -23.5 48.12 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.889 0.376 . . . . 0.0 111.155 -177.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.685 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.357 179.553 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.8 t . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.446 ' SG ' ' HA ' ' A' ' 29' ' ' PHE . 0.5 OUTLIER -100.08 -172.38 2.21 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 119.544 -0.862 . . . . 0.0 108.731 -178.506 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.54 119.45 29.0 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -177.88 143.8 0.33 Allowed 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 172.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -47.58 -40.91 20.38 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 123.63 0.582 . . . . 0.0 110.956 175.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -136.8 102.03 4.77 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.118 174.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.588 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 50.3 t -96.48 117.49 31.01 Favored 'General case' 0 N--CA 1.412 -2.345 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.846 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -76.16 -5.35 46.3 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.379 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.564 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 80.7 mtp180 54.92 38.25 0.46 Allowed Pre-proline 0 CA--C 1.573 1.856 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 14.0 Cg_exo -69.99 139.16 38.74 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 121.213 1.275 . . . . 0.0 112.24 -176.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 53.3 t -139.67 118.72 12.62 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.223 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -145.06 174.08 11.35 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -70.29 -66.16 0.63 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.239 0.542 . . . . 0.0 110.794 175.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -87.35 94.0 9.56 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -178.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.3 p -165.07 103.85 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.981 0.896 . . . . 0.0 111.305 176.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -69.16 146.3 52.57 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 114.233 -1.349 . . . . 0.0 113.238 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -115.71 160.4 20.12 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 125.779 1.631 . . . . 0.0 109.201 -177.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.3 m -126.64 136.93 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 120.772 0.32 . . . . 0.0 110.772 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -104.55 138.05 41.48 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 174.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 28.8 p -87.81 106.58 18.17 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 118.728 -1.189 . . . . 0.0 108.973 176.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -83.82 17.24 2.4 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.685 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.63 -1.27 66.12 Favored Glycine 0 N--CA 1.435 -1.397 0 C-N-CA 121.049 -0.596 . . . . 0.0 113.159 -176.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.23 -31.17 1.07 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 118.581 -1.771 . . . . 0.0 115.793 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.4 m -86.74 -28.66 22.91 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 118.934 1.367 . . . . 0.0 110.167 -175.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 60.02 22.28 11.42 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.763 1.225 . . . . 0.0 112.11 -176.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -93.87 165.79 12.5 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -108.93 130.87 55.45 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.446 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . 6.3 m-85 -122.83 153.62 39.33 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.493 -177.098 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.905 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 49.5 m80 -91.18 137.61 32.23 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 173.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.594 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 50.6 mt-30 -55.38 -45.67 76.55 Favored 'General case' 0 C--O 1.189 -2.104 0 O-C-N 123.892 0.745 . . . . 0.0 112.623 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.4 p -72.01 -40.42 67.52 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.39 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.751 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.905 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 2.8 p -72.8 -32.36 65.5 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.476 -173.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.55 HG13 HG23 ' A' ' 36' ' ' VAL . 2.5 p -103.61 6.9 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-O 121.256 0.55 . . . . 0.0 110.136 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.87 73.85 0.43 Allowed Glycine 0 CA--C 1.543 1.825 0 N-CA-C 115.452 0.941 . . . . 0.0 115.452 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.55 HG23 HG13 ' A' ' 34' ' ' VAL . 56.5 t -127.15 145.15 35.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.7 p -92.22 147.57 34.88 Favored Pre-proline 0 N--CA 1.425 -1.69 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 175.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.594 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 10.7 Cg_endo -51.22 -39.39 62.0 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.424 2.749 . . . . 0.0 113.457 -174.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -74.03 -25.38 59.84 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -178.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.484 ' CE ' HG13 ' A' ' 36' ' ' VAL . 37.5 ttp -68.48 -36.73 79.36 Favored 'General case' 0 C--O 1.211 -0.951 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.77 -39.76 81.97 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.286 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -88.4 -21.97 24.0 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 -177.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -115.64 -31.71 5.76 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -172.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.437 ' HB2' ' HG3' ' A' ' 40' ' ' MET . 37.5 mt-10 -117.96 157.11 27.35 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.975 -171.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -83.36 116.25 22.38 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.139 -176.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -82.82 103.81 12.58 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.2 mm -94.32 137.87 21.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 113.581 -1.645 . . . . 0.0 106.692 172.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.8 p -99.0 178.34 4.97 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 119.406 -0.917 . . . . 0.0 109.3 -174.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.8 tt -55.76 -41.45 65.83 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.287 0 C-N-CA 123.969 0.908 . . . . 0.0 112.383 178.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -76.61 -33.14 58.42 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 121.395 0.617 . . . . 0.0 110.88 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 61.4 m -72.75 -26.67 61.64 Favored 'General case' 0 C--O 1.211 -0.944 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.156 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.296 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -177.243 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.8 t . . . . . 0 C--O 1.218 -0.595 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -92.17 -172.24 3.07 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.61 118.78 28.51 Favored 'General case' 0 C--O 1.213 -0.859 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -176.65 145.7 0.55 Allowed 'General case' 0 CA--C 1.492 -1.251 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 171.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -48.09 -43.58 30.9 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 123.732 0.645 . . . . 0.0 110.324 175.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -137.39 105.75 5.77 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.228 175.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.608 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 53.4 t -97.71 117.12 31.29 Favored 'General case' 0 N--CA 1.402 -2.83 0 C-N-CA 119.734 -0.787 . . . . 0.0 111.512 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -69.48 -8.6 48.35 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.936 177.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.568 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 46.3 ttt180 52.64 43.21 1.46 Allowed Pre-proline 0 CA--C 1.604 3.057 0 C-N-CA 124.727 1.211 . . . . 0.0 113.768 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.568 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 2.8 Cg_exo -78.84 145.54 20.08 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.072 1.848 . . . . 0.0 112.622 -178.089 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.9 t -133.47 115.96 15.41 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.122 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -146.84 154.02 40.85 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 174.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.15 -12.55 61.77 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.225 0.536 . . . . 0.0 110.509 176.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -125.36 51.27 1.71 Allowed 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.21 -173.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.5 p -141.51 99.57 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 121.809 0.814 . . . . 0.0 110.718 175.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -68.72 145.0 54.22 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 114.817 -1.083 . . . . 0.0 112.07 176.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -106.93 159.73 16.05 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 124.577 1.151 . . . . 0.0 109.34 -176.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.0 m -125.76 141.37 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.602 -178.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.447 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 61.4 tt0 -111.29 137.85 48.5 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.474 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.6 p -94.81 104.48 16.38 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.882 178.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -88.22 23.97 2.0 Allowed 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.264 0.554 . . . . 0.0 110.322 -177.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.4 -4.98 73.01 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 148.6 -17.48 1.27 Allowed Glycine 0 CA--C 1.539 1.586 0 C-N-CA 119.68 -1.247 . . . . 0.0 115.64 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.474 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 9.6 m -97.8 -33.37 11.29 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.505 1.152 . . . . 0.0 110.495 -178.005 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 62.24 19.03 10.67 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 123.767 0.827 . . . . 0.0 111.877 -176.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 20' ' ' GLN . 47.8 mt-10 -85.05 168.14 15.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.831 -176.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -114.49 125.9 54.33 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-O 121.283 0.563 . . . . 0.0 111.915 -176.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -119.32 159.03 24.91 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.505 -176.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.939 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 38.1 m80 -94.37 136.17 34.97 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 173.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.437 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 50.3 mt-30 -55.34 -41.06 71.97 Favored 'General case' 0 C--O 1.191 -2.017 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 177.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.8 p -74.77 -41.74 47.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.914 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.939 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 9.2 p -72.0 -29.27 64.05 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.574 -174.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.53 HG13 HG23 ' A' ' 36' ' ' VAL . 1.4 p -105.0 5.48 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.958 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.87 73.64 0.46 Allowed Glycine 0 CA--C 1.553 2.443 0 N-CA-C 115.452 0.941 . . . . 0.0 115.452 -176.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.53 HG23 HG13 ' A' ' 34' ' ' VAL . 54.9 t -125.58 149.46 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 174.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.7 p -101.25 147.97 34.51 Favored Pre-proline 0 N--CA 1.418 -2.056 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 176.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.437 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 19.4 Cg_endo -55.84 -27.47 62.76 Favored 'Trans proline' 0 N--CA 1.487 1.132 0 C-N-CA 123.11 2.54 . . . . 0.0 112.283 -176.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -73.7 -28.36 61.69 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.719 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 44.2 ttp -74.13 -39.67 63.16 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.07 -43.91 82.58 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -176.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -88.12 -13.62 40.86 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -111.39 -39.24 4.74 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -175.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -126.07 166.32 17.21 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -170.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -74.98 118.58 18.1 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.907 0.883 . . . . 0.0 112.473 -178.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -83.11 103.8 12.81 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 122.383 1.087 . . . . 0.0 111.979 175.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.6 mm -100.21 143.57 13.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 173.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.416 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 12.4 p -103.93 176.97 4.98 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -176.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.2 tt -54.0 -38.23 36.75 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.343 0 C-N-CA 123.979 0.912 . . . . 0.0 112.89 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -87.04 -26.5 23.7 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.982 -0.448 . . . . 0.0 111.683 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.416 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 52.1 m -72.41 -25.63 61.55 Favored 'General case' 0 C--O 1.213 -0.828 0 CA-C-O 121.101 0.476 . . . . 0.0 110.796 176.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -1.001 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -177.766 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.4 m . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.792 0.806 . . . . 0.0 111.948 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.3 t -107.95 135.54 46.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -87.37 -175.87 5.42 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.46 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.402 ' N ' ' SG ' ' A' ' 3' ' ' CYS . . . -90.65 119.68 31.09 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 178.34 134.24 0.08 Allowed 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 125.225 1.41 . . . . 0.0 107.956 172.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -49.41 -33.92 15.12 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 123.457 0.473 . . . . 0.0 111.433 176.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -133.3 92.07 2.95 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.948 174.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.487 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 44.4 t -95.41 119.19 33.49 Favored 'General case' 0 N--CA 1.413 -2.284 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.129 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -69.09 -10.69 58.87 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.387 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.567 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 68.3 mtm180 49.38 46.03 3.38 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.567 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 3.2 Cg_exo -78.48 132.05 10.88 Favored 'Trans proline' 0 C--O 1.266 1.912 0 C-N-CA 121.521 1.48 . . . . 0.0 110.755 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.3 t -116.42 111.02 19.43 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -138.41 156.1 47.89 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -91.47 -6.62 52.37 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.078 0.466 . . . . 0.0 110.394 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -114.03 16.18 18.26 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.35 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.1 p -107.83 106.13 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 121.832 0.825 . . . . 0.0 111.071 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -71.84 146.13 48.17 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.983 173.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -108.87 160.74 15.75 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 124.556 1.142 . . . . 0.0 110.261 -174.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.3 m -124.31 139.19 51.4 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.535 0 CA-C-O 120.651 0.263 . . . . 0.0 111.09 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -106.97 139.48 41.31 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 46' ' ' TYR . 31.1 p -91.27 102.02 14.73 Favored 'General case' 0 C--O 1.256 1.407 0 C-N-CA 119.012 -1.075 . . . . 0.0 109.727 175.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -83.41 24.68 0.81 Allowed 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.386 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.32 -4.42 61.02 Favored Glycine 0 N--CA 1.432 -1.605 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.229 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.08 -20.18 1.94 Allowed Glycine 0 CA--C 1.539 1.533 0 C-N-CA 118.898 -1.62 . . . . 0.0 116.056 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.429 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 12.0 m -91.0 -34.05 15.29 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 118.806 1.303 . . . . 0.0 109.558 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 62.6 21.01 12.41 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.494 -176.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -88.08 159.41 18.26 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.257 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -108.96 130.14 55.45 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.273 0.559 . . . . 0.0 111.95 -176.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -118.47 157.46 27.19 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.975 -1.012 . . . . 0.0 109.82 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.916 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 40.3 m80 -92.11 140.32 29.76 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 173.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.423 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 51.0 mt-30 -62.43 -36.8 83.52 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.7 p -75.57 -40.76 41.31 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.662 0 O-C-N 121.243 -0.911 . . . . 0.0 111.873 176.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.916 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 9.2 p -72.09 -32.91 67.46 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.706 -173.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.442 HG13 HG23 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -104.95 3.2 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-O 121.135 0.493 . . . . 0.0 110.884 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.65 72.86 0.61 Allowed Glycine 0 CA--C 1.557 2.689 0 N-CA-C 116.129 1.211 . . . . 0.0 116.129 -176.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.442 HG23 HG13 ' A' ' 34' ' ' VAL . 78.8 t -130.3 145.23 35.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 56.7 p -97.95 151.01 37.34 Favored Pre-proline 0 N--CA 1.428 -1.544 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 176.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.36 -21.8 54.94 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 122.705 2.27 . . . . 0.0 111.551 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -73.64 -35.2 65.25 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.641 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.435 ' CE ' HG13 ' A' ' 36' ' ' VAL . 36.7 ttp -72.96 -38.9 66.56 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -176.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.88 -46.21 82.03 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.782 -1.099 . . . . 0.0 112.434 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -83.13 -17.5 42.78 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -112.55 -30.12 7.23 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -173.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -123.03 168.54 12.22 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.554 0.692 . . . . 0.0 112.728 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -90.03 115.35 27.24 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.405 -1.27 . . . . 0.0 109.214 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 51.2 t80 -79.34 108.89 13.2 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -178.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.9 mm -96.02 141.73 14.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 173.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.6 p -103.3 177.05 4.95 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.057 -176.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.2 tt -56.12 -38.13 52.35 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 O-C-N 123.887 0.742 . . . . 0.0 112.346 177.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -77.88 -34.19 51.67 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 122.212 -0.305 . . . . 0.0 111.37 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 61.6 m -72.21 -29.52 64.04 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.571 0.7 . . . . 0.0 110.301 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.074 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.828 -176.017 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.7 m . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 121.432 0.634 . . . . 0.0 111.285 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.4 t -104.28 135.26 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.404 ' SG ' ' HA ' ' A' ' 29' ' ' PHE . 0.5 OUTLIER -93.69 -173.96 3.32 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -177.678 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.65 119.98 32.61 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -177.55 144.15 0.38 Allowed 'General case' 0 CA--C 1.501 -0.912 0 C-N-CA 124.23 1.012 . . . . 0.0 108.76 172.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -47.88 -44.09 29.17 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 123.925 0.766 . . . . 0.0 110.468 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -135.53 102.29 5.07 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.328 173.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.541 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 43.3 t -95.52 118.88 33.04 Favored 'General case' 0 N--CA 1.407 -2.599 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.834 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -69.38 -9.42 53.39 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.834 178.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.556 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 79.1 ttt180 46.38 51.55 10.08 Favored Pre-proline 0 CA--C 1.574 1.897 0 C-N-CA 125.036 1.335 . . . . 0.0 112.692 -175.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.556 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 2.7 Cg_exo -81.61 134.42 8.68 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 121.839 1.693 . . . . 0.0 109.927 177.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 45.4 t -130.05 113.76 14.94 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -138.63 170.82 15.32 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -71.97 -59.46 2.73 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 171.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -74.56 87.87 2.14 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.29 177.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.2 p -172.28 100.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 122.109 0.957 . . . . 0.0 112.654 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -70.14 138.68 52.1 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.461 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 15.9 m95 -103.76 160.19 14.99 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 124.724 1.21 . . . . 0.0 108.552 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.5 m -126.02 139.63 50.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.574 0.226 . . . . 0.0 110.41 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -108.93 138.23 45.6 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.439 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.7 p -89.02 105.48 17.81 Favored 'General case' 0 C--O 1.249 1.037 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.145 177.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -85.1 22.81 1.35 Allowed 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 121.423 0.63 . . . . 0.0 110.25 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.53 -13.69 56.64 Favored Glycine 0 N--CA 1.426 -1.994 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.562 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.63 -27.71 0.42 Allowed Glycine 0 CA--C 1.533 1.205 0 C-N-CA 118.79 -1.672 . . . . 0.0 115.813 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.439 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 9.4 m -88.89 -30.14 19.11 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 118.533 1.167 . . . . 0.0 110.609 -176.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 60.63 19.15 9.11 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.723 0.809 . . . . 0.0 111.939 -175.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -90.0 163.48 14.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.446 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -108.66 128.94 55.29 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.504 -175.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.404 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . 4.9 m-85 -120.22 159.78 24.25 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.745 -176.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.931 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 44.9 m80 -95.76 138.57 33.23 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 173.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.544 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 48.9 mt-30 -54.52 -50.06 68.75 Favored 'General case' 0 C--O 1.19 -2.07 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 177.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 p -67.45 -41.95 86.64 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.305 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.931 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 6.6 p -70.67 -27.84 64.34 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.384 -175.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.628 HG13 HG23 ' A' ' 36' ' ' VAL . 1.4 p -106.9 11.6 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.871 0 CA-C-O 121.311 0.577 . . . . 0.0 110.574 178.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.67 38.32 95.5 Favored Glycine 0 CA--C 1.547 2.032 0 N-CA-C 117.25 1.66 . . . . 0.0 117.25 177.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.628 HG23 HG13 ' A' ' 34' ' ' VAL . 77.6 t -97.4 149.2 5.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 123.536 0.735 . . . . 0.0 109.44 176.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.4 p -99.73 152.14 37.71 Favored Pre-proline 0 N--CA 1.421 -1.907 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.544 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 24.9 Cg_endo -59.14 -22.32 63.77 Favored 'Trans proline' 0 N--CA 1.482 0.833 0 C-N-CA 122.173 1.915 . . . . 0.0 112.163 -178.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -73.8 -34.0 64.44 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.857 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 50.3 ttp -73.77 -39.33 64.27 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.422 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.44 -48.02 77.89 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -175.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -89.0 -14.21 37.05 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -110.05 -31.26 7.43 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -173.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -128.48 165.87 19.86 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 118.289 0.495 . . . . 0.0 112.153 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -75.2 115.31 14.7 Favored 'General case' 0 C--O 1.248 0.977 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.578 -176.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -79.54 108.93 13.45 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.938 0.875 . . . . 0.0 112.265 175.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.0 mm -105.45 148.73 9.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 173.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.3 p -109.24 177.3 4.8 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 119.238 0.926 . . . . 0.0 108.935 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.7 tt -55.94 -41.72 68.59 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 C-N-CA 124.026 0.93 . . . . 0.0 112.491 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -75.0 -32.67 61.7 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.13 0.491 . . . . 0.0 111.003 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 66.7 m -76.27 -28.91 57.23 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.827 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.519 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.264 -176.914 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 28.7 t . . . . . 0 CA--C 1.558 1.271 0 CA-C-O 122.523 1.154 . . . . 0.0 109.202 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.9 t -122.97 136.34 60.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.412 ' SG ' ' HA ' ' A' ' 29' ' ' PHE . 0.5 OUTLIER -96.84 -172.5 2.48 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 119.394 -0.922 . . . . 0.0 108.62 -178.065 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.14 118.69 26.7 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -177.22 145.96 0.48 Allowed 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 171.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -48.6 -44.16 36.77 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.689 0.757 . . . . 0.0 109.118 173.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -131.55 101.52 5.54 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.159 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.52 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 50.5 t -98.34 112.23 24.3 Favored 'General case' 0 N--CA 1.406 -2.66 0 C-N-CA 118.36 -1.336 . . . . 0.0 110.262 177.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -67.12 -11.57 57.6 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.48 -1.237 . . . . 0.0 111.191 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.555 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 65.3 mtp180 52.34 44.76 2.21 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 123.834 0.854 . . . . 0.0 111.881 -173.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.555 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 23.7 Cg_exo -65.58 131.76 28.84 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 121.134 1.223 . . . . 0.0 110.341 -176.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 86.1 m -114.47 98.16 6.74 Favored 'General case' 0 N--CA 1.413 -2.292 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.885 -177.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -136.21 153.05 51.34 Favored 'General case' 0 CA--C 1.479 -1.753 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 172.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -81.13 -43.11 19.88 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 176.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -85.23 87.9 7.43 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.7 p -168.76 112.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.569 0.699 . . . . 0.0 111.427 177.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -74.22 144.79 44.56 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.685 -1.143 . . . . 0.0 112.852 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -110.31 159.94 16.98 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 125.2 1.4 . . . . 0.0 109.331 -176.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.6 m -126.62 137.09 58.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.062 0.458 . . . . 0.0 110.625 -178.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.427 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 52.0 tt0 -104.57 139.09 39.96 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 176.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.6 p -88.01 99.93 12.53 Favored 'General case' 0 C--O 1.25 1.085 0 C-N-CA 118.261 -1.376 . . . . 0.0 110.006 176.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -80.9 19.36 0.87 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.971 -176.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.35 3.25 50.6 Favored Glycine 0 N--CA 1.418 -2.507 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.697 -177.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 152.6 -34.33 0.82 Allowed Glycine 0 CA--C 1.536 1.402 0 C-N-CA 118.183 -1.961 . . . . 0.0 116.551 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.462 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 5.1 m -94.51 -30.11 14.58 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 118.799 1.3 . . . . 0.0 110.033 -176.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 60.31 22.09 11.57 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.577 0.751 . . . . 0.0 112.377 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 20' ' ' GLN . 46.2 mt-10 -86.65 164.78 16.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.483 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -108.46 123.39 48.81 Favored 'General case' 0 C--O 1.245 0.836 0 O-C-N 123.575 0.547 . . . . 0.0 111.681 -174.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.412 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . 2.9 m-85 -117.63 160.07 21.89 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.562 -176.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.908 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 40.0 m80 -94.4 138.74 31.98 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 173.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.414 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 48.6 mt-30 -55.43 -48.36 74.55 Favored 'General case' 0 C--O 1.184 -2.365 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.216 177.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.412 ' CG1' ' HG2' ' A' ' 11' ' ' PRO . 11.0 p -69.54 -38.27 76.42 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.272 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.287 -178.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.908 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 4.4 p -73.67 -28.97 62.04 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.811 -174.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.602 HG13 HG23 ' A' ' 36' ' ' VAL . 1.6 p -105.95 7.61 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.697 0 CA-C-O 121.524 0.678 . . . . 0.0 109.982 178.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.33 45.1 95.82 Favored Glycine 0 CA--C 1.546 1.984 0 N-CA-C 116.627 1.411 . . . . 0.0 116.627 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.602 HG23 HG13 ' A' ' 34' ' ' VAL . 84.4 t -96.2 148.17 5.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 173.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.5 p -100.86 153.03 37.97 Favored Pre-proline 0 N--CA 1.425 -1.711 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 175.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 10.2 Cg_endo -48.48 -39.83 36.66 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 123.267 2.644 . . . . 0.0 112.813 -176.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -65.92 -31.0 71.67 Favored 'General case' 0 C--O 1.202 -1.428 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.508 ' HB3' HG13 ' A' ' 36' ' ' VAL . 38.2 ttp -73.54 -33.96 64.97 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 118.481 -1.288 . . . . 0.0 108.77 -176.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.84 -47.85 79.1 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.467 175.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -86.93 -27.93 23.05 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -176.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -105.99 -27.41 11.18 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -171.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -127.69 173.37 9.98 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 119.821 -0.752 . . . . 0.0 112.32 -175.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -86.2 116.03 24.13 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.895 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -75.38 114.9 14.45 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 122.237 1.018 . . . . 0.0 113.301 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.8 mm -110.13 145.68 16.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 175.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.471 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 11.0 p -109.61 179.55 4.1 Favored 'General case' 0 C--O 1.217 -0.633 0 O-C-N 121.292 -0.88 . . . . 0.0 109.306 -176.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.6 tt -54.97 -40.16 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.512 0 C-N-CA 124.157 0.983 . . . . 0.0 112.626 177.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -78.06 -30.51 49.77 Favored 'General case' 0 C--O 1.212 -0.883 0 CA-C-O 120.911 0.386 . . . . 0.0 110.65 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.471 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 65.5 m -78.27 -31.09 48.88 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.054 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.669 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.582 -176.46 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.3 p . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.642 0.734 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.5 t -131.27 135.53 59.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.423 ' SG ' ' HA ' ' A' ' 29' ' ' PHE . 0.5 OUTLIER -93.74 -172.16 2.8 Favored 'General case' 0 C--O 1.255 1.361 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -178.435 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.8 119.07 30.72 Favored 'General case' 0 C--O 1.2 -1.504 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 176.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -176.68 142.85 0.43 Allowed 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 172.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -48.71 -44.67 38.34 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.613 0.765 . . . . 0.0 109.749 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -128.84 98.12 4.87 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.649 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.559 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 50.5 t -99.26 112.11 24.34 Favored 'General case' 0 N--CA 1.413 -2.307 0 C-N-CA 117.941 -1.504 . . . . 0.0 111.242 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -69.76 -7.89 43.41 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.608 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.588 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 76.7 mtp180 53.08 42.39 1.19 Allowed Pre-proline 0 CA--C 1.573 1.848 0 C-N-CA 124.348 1.059 . . . . 0.0 113.438 -175.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.588 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 11.8 Cg_exo -71.76 136.52 28.05 Favored 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 121.866 1.711 . . . . 0.0 111.951 -176.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 51.3 t -126.48 116.58 21.34 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.497 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -148.73 164.07 35.45 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 176.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -85.64 -7.66 58.7 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 176.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -128.73 88.49 2.74 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 114.691 -1.141 . . . . 0.0 108.698 -177.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 16' ' ' VAL . 6.9 p -178.14 96.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.657 0 CA-C-O 121.637 0.732 . . . . 0.0 110.124 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.79 144.01 57.39 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -109.16 159.52 16.84 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.242 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.8 m -129.58 135.36 61.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.036 0.446 . . . . 0.0 111.002 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 53.9 tt0 -100.28 139.28 36.19 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 176.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.3 p -89.7 102.7 15.39 Favored 'General case' 0 C--O 1.258 1.55 0 C-N-CA 118.617 -1.233 . . . . 0.0 110.742 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.64 18.79 0.54 Allowed 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.841 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.76 -10.26 60.35 Favored Glycine 0 N--CA 1.426 -1.988 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.886 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 147.06 -16.01 1.53 Allowed Glycine 0 C--O 1.213 -1.164 0 C-N-CA 118.459 -1.829 . . . . 0.0 116.486 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.524 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 13.6 m -92.29 -28.92 16.66 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.023 1.412 . . . . 0.0 109.332 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 58.68 18.5 5.96 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 124.289 1.036 . . . . 0.0 112.148 -174.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.409 ' O ' ' HA ' ' A' ' 20' ' ' GLN . 46.0 mt-10 -84.16 162.26 20.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.291 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -108.89 126.56 53.19 Favored 'General case' 0 C--O 1.246 0.916 0 CA-C-O 121.302 0.572 . . . . 0.0 112.036 -175.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.423 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . 2.8 m-85 -118.78 161.05 20.77 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.351 -177.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.9 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 45.7 m80 -95.64 142.56 27.81 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.456 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 48.6 mt-30 -58.04 -48.44 80.07 Favored 'General case' 0 C--O 1.189 -2.124 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.7 p -70.16 -38.61 75.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.236 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.9 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 2.9 p -72.74 -31.72 65.16 Favored 'General case' 0 C--O 1.213 -0.817 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.665 -173.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.501 HG13 HG23 ' A' ' 36' ' ' VAL . 1.7 p -104.09 5.35 10.45 Favored 'Isoleucine or valine' 0 C--O 1.254 1.311 0 CA-C-O 121.219 0.533 . . . . 0.0 110.361 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.35 70.91 0.89 Allowed Glycine 0 CA--C 1.54 1.618 0 CA-C-N 115.079 -0.964 . . . . 0.0 115.014 -176.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.501 HG23 HG13 ' A' ' 34' ' ' VAL . 54.5 t -119.38 147.65 22.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 174.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.7 p -98.1 151.98 37.8 Favored Pre-proline 0 N--CA 1.426 -1.647 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.417 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 13.2 Cg_endo -51.12 -36.8 56.45 Favored 'Trans proline' 0 N--CA 1.483 0.908 0 C-N-CA 123.052 2.501 . . . . 0.0 112.831 -176.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -73.13 -26.87 61.38 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.425 ' HB3' HG13 ' A' ' 36' ' ' VAL . 46.6 ttp -73.84 -34.19 64.44 Favored 'General case' 0 C--O 1.209 -1.071 0 C-N-CA 118.583 -1.247 . . . . 0.0 108.339 -177.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.6 -45.01 81.68 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -94.78 -32.27 13.38 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -98.05 -22.86 16.02 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -170.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -128.37 168.12 16.01 Favored 'General case' 0 C--N 1.311 -1.109 0 C-N-CA 119.92 -0.712 . . . . 0.0 112.12 -176.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -89.74 120.34 30.92 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.831 -174.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.425 ' CE2' ' HB3' ' A' ' 21' ' ' CYS . 89.0 t80 -81.97 108.23 15.31 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.5 mm -101.02 146.72 8.99 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 172.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.536 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 10.2 p -111.41 178.66 4.26 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 121.095 -1.003 . . . . 0.0 108.885 -177.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.9 tt -54.1 -42.36 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.358 0 C-N-CA 124.028 0.931 . . . . 0.0 112.315 177.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -76.78 -34.76 57.98 Favored 'General case' 0 C--O 1.212 -0.874 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.215 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.536 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 59.4 m -72.56 -26.03 61.58 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 121.164 0.507 . . . . 0.0 111.258 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.103 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.545 -179.023 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 121.136 0.494 . . . . 0.0 111.616 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 57.8 t -118.8 140.46 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -178.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -90.79 -172.16 3.28 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.17 119.48 31.85 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -176.58 146.49 0.6 Allowed 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.45 0.7 . . . . 0.0 109.237 172.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -47.65 -40.7 20.48 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 124.083 0.953 . . . . 0.0 109.834 174.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -139.46 111.55 7.45 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.244 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.568 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 46.8 t -106.15 116.06 31.28 Favored 'General case' 0 N--CA 1.416 -2.154 0 C-N-CA 117.93 -1.508 . . . . 0.0 112.355 177.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -72.89 -9.28 58.52 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 113.906 -1.497 . . . . 0.0 111.216 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.551 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 82.1 mtp180 53.21 51.85 9.51 Favored Pre-proline 0 N--CA 1.493 1.709 0 C-N-CA 124.175 0.99 . . . . 0.0 112.821 -174.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.551 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 4.2 Cg_exo -80.79 131.84 8.35 Favored 'Trans proline' 0 C--O 1.261 1.672 0 C-N-CA 122.032 1.821 . . . . 0.0 110.474 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 51.6 t -125.12 111.07 14.89 Favored 'General case' 0 N--CA 1.427 -1.613 0 O-C-N 123.661 0.601 . . . . 0.0 110.174 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.43 ' O ' HG12 ' A' ' 16' ' ' VAL . 97.1 mttt -140.35 157.53 45.41 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 175.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -87.81 2.86 50.28 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.082 0.468 . . . . 0.0 111.285 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -117.65 5.79 12.39 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.531 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 13' ' ' LYS . 7.9 p -97.38 105.37 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-O 121.978 0.894 . . . . 0.0 111.699 -178.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -76.17 153.31 36.27 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.629 175.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -115.23 159.55 20.83 Favored 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 124.445 1.098 . . . . 0.0 110.213 -172.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.3 m -127.44 138.91 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-O 120.738 0.304 . . . . 0.0 110.244 -177.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -106.56 139.35 41.16 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.47 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.6 p -90.0 103.51 16.17 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 118.89 -1.124 . . . . 0.0 109.113 174.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.0 26.96 0.57 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.812 0.845 . . . . 0.0 111.152 -175.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -111.21 7.25 28.81 Favored Glycine 0 N--CA 1.429 -1.774 0 CA-C-N 115.468 -0.787 . . . . 0.0 113.311 -176.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 148.45 -39.7 0.96 Allowed Glycine 0 CA--C 1.535 1.34 0 C-N-CA 118.116 -1.993 . . . . 0.0 115.375 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.47 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 7.9 m -85.88 -34.75 20.91 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 118.168 0.984 . . . . 0.0 108.457 -176.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 57.46 25.03 10.92 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.042 -177.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -87.51 168.35 13.15 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.949 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -110.87 126.42 54.66 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 122.782 0.433 . . . . 0.0 111.499 -176.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -118.83 159.27 24.05 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.689 -174.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.977 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 35.1 m80 -96.59 137.15 36.1 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 174.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.469 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 50.6 mt-30 -52.84 -46.43 67.8 Favored 'General case' 0 C--O 1.188 -2.156 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.3 p -72.97 -40.35 59.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 O-C-N 121.406 -0.809 . . . . 0.0 112.299 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.977 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 12.0 p -70.82 -27.59 63.99 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.87 -174.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.514 HG13 HG23 ' A' ' 36' ' ' VAL . 1.4 p -108.55 7.97 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 CA-C-O 121.394 0.616 . . . . 0.0 110.721 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.01 64.66 4.09 Favored Glycine 0 CA--C 1.559 2.828 0 N-CA-C 116.481 1.352 . . . . 0.0 116.481 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.655 HG13 ' SD ' ' A' ' 40' ' ' MET . 79.2 t -117.18 146.73 21.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 125.75 1.62 . . . . 0.0 107.193 175.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.0 p -98.31 155.42 36.91 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 177.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -55.54 -31.88 80.47 Favored 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 122.959 2.439 . . . . 0.0 113.142 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 45.6 mt-10 -71.83 -28.63 63.7 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 120.951 0.405 . . . . 0.0 110.79 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.655 ' SD ' HG13 ' A' ' 36' ' ' VAL . 28.2 ttt -69.99 -46.89 64.2 Favored 'General case' 0 C--O 1.208 -1.126 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -176.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.95 -45.25 90.93 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -86.31 -14.65 43.01 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -177.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 39' ' ' GLU . 93.0 m-20 -119.16 -34.33 3.9 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -174.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -124.6 158.55 32.79 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -172.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -72.23 114.23 10.12 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.794 -176.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -80.26 112.1 17.27 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 122.166 0.984 . . . . 0.0 113.438 177.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.1 mm -112.93 140.93 30.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 174.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.5 p -96.97 176.39 5.98 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -174.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.7 tt -54.06 -38.01 36.55 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 C-N-CA 123.965 0.906 . . . . 0.0 112.721 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -80.61 -30.82 36.79 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.0 0.429 . . . . 0.0 111.136 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 84.5 m -78.35 -27.83 47.09 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.323 0.582 . . . . 0.0 111.129 176.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.867 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.748 -177.758 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.1 t . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 121.332 0.587 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 49.0 t -98.95 132.84 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.02 -176.3 4.85 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.04 -175.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.3 119.67 33.41 Favored 'General case' 0 C--O 1.198 -1.634 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -175.37 148.79 0.97 Allowed 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 173.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -47.4 -42.82 22.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 123.958 0.786 . . . . 0.0 110.533 174.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -141.56 105.32 4.72 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.635 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.581 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 53.2 t -97.43 110.17 22.78 Favored 'General case' 0 N--CA 1.419 -2.02 0 C-N-CA 118.771 -1.172 . . . . 0.0 111.47 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -67.56 -8.34 33.32 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.6 1.16 . . . . 0.0 111.016 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.59 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 88.7 mtm180 51.0 44.54 2.23 Favored Pre-proline 0 CA--C 1.563 1.457 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -178.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.59 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 8.4 Cg_exo -76.36 137.4 18.75 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 122.205 1.937 . . . . 0.0 111.248 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 45.6 t -130.89 114.54 15.39 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.313 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -148.24 166.84 26.74 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -71.07 -61.69 1.67 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.728 0.775 . . . . 0.0 108.958 173.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -65.55 30.07 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 126.197 1.799 . . . . 0.0 115.53 -175.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.0 p -123.55 109.0 22.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 119.444 1.02 . . . . 0.0 112.983 178.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -73.94 146.62 43.79 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.231 -1.35 . . . . 0.0 111.928 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.0 m95 -113.13 159.21 19.47 Favored 'General case' 0 C--O 1.216 -0.699 0 C-N-CA 124.365 1.066 . . . . 0.0 109.047 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.3 m -125.05 138.02 55.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 O-C-N 121.945 -0.472 . . . . 0.0 110.535 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -105.76 138.94 41.1 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.47 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.4 p -91.92 107.28 19.09 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 119.329 -0.948 . . . . 0.0 110.742 178.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -87.86 27.02 1.22 Allowed 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.517 0.675 . . . . 0.0 110.312 -176.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.4 -7.9 57.84 Favored Glycine 0 N--CA 1.425 -2.086 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.377 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 151.16 -20.82 0.96 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 118.899 -1.62 . . . . 0.0 115.65 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.47 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 8.4 m -94.32 -32.19 13.73 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 118.771 1.286 . . . . 0.0 111.478 -176.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 60.42 19.54 9.2 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 123.856 0.862 . . . . 0.0 111.905 -174.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -86.68 161.11 18.62 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.236 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 80.0 m95 -105.97 127.16 52.97 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.235 -176.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -120.12 157.71 28.42 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.112 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.878 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 51.9 m80 -93.09 138.72 31.28 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 174.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.488 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 48.1 mt-30 -52.88 -55.19 25.01 Favored 'General case' 0 C--O 1.198 -1.632 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 177.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.65 -36.96 78.85 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.489 0 CA-C-O 121.736 0.779 . . . . 0.0 111.755 -177.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.878 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 1.7 p -73.95 -24.65 59.67 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.045 -175.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.59 HG13 HG23 ' A' ' 36' ' ' VAL . 1.7 p -111.31 12.51 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.834 0 CA-C-O 121.484 0.659 . . . . 0.0 110.875 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.12 36.19 91.55 Favored Glycine 0 CA--C 1.555 2.577 0 N-CA-C 117.598 1.799 . . . . 0.0 117.598 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.686 HG13 ' SD ' ' A' ' 40' ' ' MET . 94.3 t -97.03 144.05 11.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 174.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.3 p -98.93 152.14 37.68 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 176.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.488 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 17.8 Cg_endo -57.32 -26.8 72.37 Favored 'Trans proline' 0 N--CA 1.486 1.032 0 C-N-CA 122.409 2.072 . . . . 0.0 112.629 -177.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -74.97 -25.87 59.17 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 121.549 0.69 . . . . 0.0 109.94 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.686 ' SD ' HG13 ' A' ' 36' ' ' VAL . 28.0 ttt -73.71 -46.23 47.46 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 124.313 1.045 . . . . 0.0 110.114 -178.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.92 -47.15 81.28 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.243 -0.889 . . . . 0.0 112.021 -176.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -78.55 -13.39 59.85 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -116.11 -39.88 3.37 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 116.755 2.131 . . . . 0.0 116.755 -173.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -124.16 165.32 17.76 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.007 0.821 . . . . 0.0 112.641 -174.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -74.11 115.32 13.45 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.178 -177.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.426 ' OH ' HG21 ' A' ' 34' ' ' VAL . 81.1 t80 -72.28 111.52 7.56 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-O 121.946 0.879 . . . . 0.0 112.272 172.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.5 mm -108.44 138.54 34.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 174.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 11.1 p -98.21 176.23 5.8 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -174.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.6 tt -57.91 -35.87 53.56 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.644 0 C-N-CA 123.586 0.755 . . . . 0.0 112.276 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -79.66 -34.34 40.47 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 120.824 0.345 . . . . 0.0 110.774 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 59.4 m -72.18 -26.0 61.9 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 121.326 0.584 . . . . 0.0 110.539 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.804 -177.602 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.483 1.214 0 CA-C-O 121.295 0.569 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.2 t -113.59 135.56 52.79 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' A' ' 4' ' ' ALA . 0.4 OUTLIER -87.88 -177.79 5.87 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.792 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.419 ' N ' ' SG ' ' A' ' 3' ' ' CYS . . . -90.54 120.04 31.3 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 178.73 135.34 0.09 Allowed 'General case' 0 C--O 1.214 -0.768 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 171.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -49.93 -42.64 48.79 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 120.983 0.421 . . . . 0.0 111.086 177.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -121.54 90.62 3.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.906 173.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.503 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 44.2 t -93.94 117.03 29.54 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.529 177.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -69.32 -8.0 42.28 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.019 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.569 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 29.7 mtm180 47.82 46.21 3.4 Favored Pre-proline 0 CA--C 1.563 1.461 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -175.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.569 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 4.2 Cg_exo -76.35 131.86 13.15 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 121.942 1.761 . . . . 0.0 111.87 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 53.4 t -121.4 114.89 21.93 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -146.01 157.54 43.87 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -76.99 -10.04 59.1 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.434 0.635 . . . . 0.0 110.827 177.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -124.51 84.73 2.31 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.159 177.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.1 p -172.31 97.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 122.149 0.976 . . . . 0.0 111.239 176.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -71.06 146.66 49.17 Favored 'General case' 0 C--N 1.279 -2.464 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.242 174.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -107.01 159.51 16.23 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.482 -174.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.9 m -125.48 132.82 70.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 120.69 0.281 . . . . 0.0 110.573 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -99.34 137.87 37.23 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.0 p -86.98 104.45 16.31 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 118.681 -1.208 . . . . 0.0 110.077 176.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -82.46 16.99 1.87 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.849 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.96 -7.31 74.35 Favored Glycine 0 N--CA 1.431 -1.644 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.973 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.19 -13.24 1.86 Allowed Glycine 0 CA--C 1.54 1.63 0 C-N-CA 119.063 -1.541 . . . . 0.0 116.907 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.475 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 17.3 m -95.23 -27.65 15.41 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 119.669 1.734 . . . . 0.0 110.444 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 63.94 16.4 9.86 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.655 0.782 . . . . 0.0 111.53 -176.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -91.36 159.4 16.01 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -176.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -106.33 126.35 52.12 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.638 -175.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -118.05 159.06 23.85 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.629 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.935 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 36.5 m80 -93.51 139.2 31.01 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 174.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.454 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 50.5 mt-30 -57.63 -42.91 84.3 Favored 'General case' 0 C--O 1.192 -1.959 0 O-C-N 123.579 0.55 . . . . 0.0 112.077 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.0 p -73.59 -41.02 55.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.603 -0.685 . . . . 0.0 112.197 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.935 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 11.3 p -71.55 -31.33 66.89 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.407 -173.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.5 HG13 HG23 ' A' ' 36' ' ' VAL . 1.2 p -104.23 6.51 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.715 0 CA-C-O 121.312 0.577 . . . . 0.0 111.066 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.29 67.75 1.96 Allowed Glycine 0 CA--C 1.547 2.093 0 N-CA-C 115.95 1.14 . . . . 0.0 115.95 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.5 HG23 HG13 ' A' ' 34' ' ' VAL . 70.6 t -124.22 149.51 28.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 174.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.1 p -103.81 151.61 38.86 Favored Pre-proline 0 N--CA 1.421 -1.884 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 175.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.454 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 73.3 Cg_exo -52.52 -22.97 17.93 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.771 2.314 . . . . 0.0 112.231 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 34.1 tt0 -74.1 -36.62 64.25 Favored 'General case' 0 C--O 1.187 -2.215 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.091 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.429 ' HB3' HG13 ' A' ' 36' ' ' VAL . 39.4 ttp -73.83 -37.64 64.79 Favored 'General case' 0 CA--C 1.503 -0.859 0 O-C-N 121.097 -1.002 . . . . 0.0 110.092 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.96 -48.59 78.01 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.154 -0.93 . . . . 0.0 113.242 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -94.6 -16.05 23.54 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 119.82 -0.752 . . . . 0.0 112.833 -176.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.492 ' HB2' ' O ' ' A' ' 39' ' ' GLU . 27.4 m-80 -105.39 -19.09 13.9 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -173.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -138.3 177.02 8.19 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.174 0.512 . . . . 0.0 111.706 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -92.11 121.6 33.81 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.791 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.403 ' OH ' HG21 ' A' ' 34' ' ' VAL . 80.4 t80 -75.72 104.86 6.46 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.017 1.118 . . . . 0.0 114.017 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.9 mm -94.6 139.05 19.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 170.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.421 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 13.2 p -101.19 173.66 6.36 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 119.061 -1.056 . . . . 0.0 108.751 -177.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.4 tt -57.53 -37.51 58.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 123.057 0.543 . . . . 0.0 112.042 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -75.44 -29.79 59.8 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-O 120.981 0.419 . . . . 0.0 110.535 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.421 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 52.4 m -77.76 -27.38 50.34 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.296 0.57 . . . . 0.0 110.61 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.082 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.531 -176.481 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 31.9 m . . . . . 0 CA--C 1.555 1.144 0 CA-C-O 121.696 0.76 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.4 t -131.23 129.74 62.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -88.75 -172.25 3.64 Favored 'General case' 0 C--O 1.248 1.023 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -177.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.59 119.79 33.06 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -179.98 132.02 0.1 Allowed 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 171.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -50.04 -42.82 50.33 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 121.411 0.624 . . . . 0.0 110.99 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -123.9 97.62 5.44 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 173.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.52 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 46.6 t -99.25 121.06 40.54 Favored 'General case' 0 N--CA 1.423 -1.821 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.238 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -70.41 -8.02 47.62 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 124.122 0.969 . . . . 0.0 110.29 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.528 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 32.8 ttp180 42.88 56.22 11.17 Favored Pre-proline 0 CA--C 1.568 1.663 0 C-N-CA 126.084 1.754 . . . . 0.0 114.592 -177.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.528 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 6.3 Cg_exo -87.87 144.96 6.45 Favored 'Trans proline' 0 C--O 1.26 1.577 0 C-N-CA 122.896 2.397 . . . . 0.0 112.307 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 59.0 m -127.44 125.73 41.08 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -144.15 162.13 37.08 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 176.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -84.55 -9.26 58.48 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 174.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -129.11 84.99 2.27 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.031 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.41 ' O ' HG13 ' A' ' 16' ' ' VAL . 8.1 p -172.02 104.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.738 0.78 . . . . 0.0 111.312 177.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -73.11 145.89 46.12 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.471 176.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -107.48 159.82 16.12 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 124.568 1.147 . . . . 0.0 109.206 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.9 m -123.06 141.95 41.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 120.607 0.242 . . . . 0.0 110.413 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 64.2 tt0 -112.28 139.32 47.93 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 29.1 p -89.6 105.58 17.89 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.806 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -77.58 29.1 0.16 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.869 0.868 . . . . 0.0 111.391 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.523 ' HA3' ' SG ' ' A' ' 51' ' ' CYS . . . -95.08 -22.78 21.94 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 141.51 1.82 1.38 Allowed Glycine 0 CA--C 1.542 1.745 0 C-N-CA 119.875 -1.155 . . . . 0.0 115.581 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.424 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 24.7 m -94.66 -29.69 14.7 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 118.74 1.27 . . . . 0.0 109.208 177.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 64.68 16.46 10.37 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.107 0.963 . . . . 0.0 112.117 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 20' ' ' GLN . 46.6 mt-10 -82.24 161.95 22.51 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.045 0.45 . . . . 0.0 111.638 -177.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -114.9 124.31 51.37 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.63 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -115.56 156.51 25.63 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -175.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.959 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 40.9 m80 -89.98 138.75 31.24 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.419 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 49.3 mt-30 -56.88 -49.93 74.04 Favored 'General case' 0 C--O 1.194 -1.835 0 O-C-N 123.537 0.523 . . . . 0.0 112.276 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.9 p -67.55 -37.39 78.71 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.628 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.959 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 6.6 p -76.11 -25.58 55.55 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -175.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.489 HG13 HG23 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -108.68 10.05 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.976 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.72 177.783 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.93 39.55 93.33 Favored Glycine 0 CA--C 1.549 2.214 0 N-CA-C 117.032 1.573 . . . . 0.0 117.032 178.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.489 HG23 HG13 ' A' ' 34' ' ' VAL . 85.1 t -96.25 145.44 8.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 117.742 0.771 . . . . 0.0 108.983 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.6 p -97.88 147.66 33.36 Favored Pre-proline 0 N--CA 1.414 -2.269 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 19.7 Cg_endo -57.21 -25.08 62.65 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 C-N-CA 123.008 2.472 . . . . 0.0 112.497 -176.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -74.56 -29.49 61.37 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.441 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 37.3 ttp -74.6 -39.22 62.31 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-O 121.107 0.479 . . . . 0.0 110.509 -176.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.44 -45.29 80.87 Favored 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -87.62 -13.36 42.97 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -117.31 -20.93 8.96 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -172.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -135.07 164.02 28.59 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.22 -176.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -83.19 119.79 24.99 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.212 -175.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -76.64 114.13 15.05 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 122.124 0.964 . . . . 0.0 112.379 174.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.6 mm -109.97 143.75 19.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 173.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.429 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 11.5 p -104.72 172.54 6.73 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 118.671 -1.211 . . . . 0.0 109.379 -176.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.5 tt -52.44 -37.38 23.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 C-N-CA 124.052 0.941 . . . . 0.0 112.73 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -79.93 -29.67 39.81 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-O 121.099 0.476 . . . . 0.0 110.918 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.523 ' SG ' ' HA3' ' A' ' 23' ' ' GLY . 54.5 m -77.29 -31.44 54.79 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.339 178.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.865 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.567 -176.749 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.1 p . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 120.872 0.367 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.9 t -120.38 139.54 47.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.31 -173.0 2.23 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.239 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.93 120.54 35.33 Favored 'General case' 0 C--O 1.2 -1.548 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -173.81 145.52 1.15 Allowed 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 173.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -48.29 -39.12 20.67 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 123.515 0.509 . . . . 0.0 110.725 174.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -138.48 100.19 4.03 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.855 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.561 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 48.1 t -99.65 113.57 26.1 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 118.359 -1.336 . . . . 0.0 111.557 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -69.29 -10.77 59.39 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 124.889 1.276 . . . . 0.0 111.402 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.496 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 71.4 mtp180 47.32 54.77 15.96 Favored Pre-proline 0 N--CA 1.484 1.23 0 C-N-CA 123.692 0.797 . . . . 0.0 112.649 -172.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.496 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 14.1 Cg_exo -72.95 131.29 16.68 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 121.257 1.305 . . . . 0.0 110.559 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 81.1 m -111.67 105.48 14.01 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.442 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -143.66 143.09 31.29 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -68.67 -54.4 16.52 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 176.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -85.12 96.66 9.51 Favored 'General case' 0 N--CA 1.424 -1.73 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.633 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.5 p -168.66 116.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 123.482 0.713 . . . . 0.0 110.326 174.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -78.86 140.78 38.08 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.234 -0.894 . . . . 0.0 113.279 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -107.75 160.41 15.74 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 125.557 1.543 . . . . 0.0 108.429 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.7 m -124.43 138.46 53.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 117.962 0.346 . . . . 0.0 110.513 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 8.6 tt0 -106.44 138.82 41.92 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.451 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 30.6 p -90.23 113.86 25.75 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.979 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -85.67 27.6 0.84 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.813 0.845 . . . . 0.0 110.631 -177.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.429 ' HA3' ' SG ' ' A' ' 51' ' ' CYS . . . -96.63 -19.71 26.53 Favored Glycine 0 N--CA 1.432 -1.605 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.333 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.76 -14.81 0.91 Allowed Glycine 0 CA--C 1.539 1.556 0 C-N-CA 119.711 -1.233 . . . . 0.0 115.371 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.451 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 7.9 m -89.82 -29.62 18.5 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 118.709 1.254 . . . . 0.0 110.544 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 59.54 19.77 8.26 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.54 -177.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 20' ' ' GLN . 42.7 mt-10 -89.7 165.37 14.24 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.918 -178.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -106.25 127.29 53.13 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.276 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -118.76 155.64 30.76 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.47 -176.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.902 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 57.5 m80 -92.3 139.07 30.98 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 174.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.521 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 50.1 mt-30 -55.17 -51.87 65.11 Favored 'General case' 0 C--O 1.2 -1.533 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.9 p -66.38 -37.72 80.25 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.621 0 CA-C-O 121.587 0.708 . . . . 0.0 112.188 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.902 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 2.7 p -74.06 -25.16 59.68 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.029 -174.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.591 HG13 HG23 ' A' ' 36' ' ' VAL . 1.6 p -112.86 13.24 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 CA-C-O 121.494 0.664 . . . . 0.0 110.882 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.11 38.51 96.07 Favored Glycine 0 CA--C 1.556 2.633 0 N-CA-C 117.014 1.566 . . . . 0.0 117.014 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.603 HG13 ' SD ' ' A' ' 40' ' ' MET . 95.2 t -95.93 147.13 6.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 174.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 52.3 p -98.22 151.46 37.53 Favored Pre-proline 0 C--N 1.298 -1.673 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 174.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.521 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 14.6 Cg_endo -54.41 -31.43 68.24 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.801 2.334 . . . . 0.0 113.416 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -69.43 -32.45 71.41 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 123.932 0.893 . . . . 0.0 110.153 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.603 ' SD ' HG13 ' A' ' 36' ' ' VAL . 28.2 ttt -69.1 -42.85 75.59 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.033 0.933 . . . . 0.0 110.191 -176.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.52 -38.78 69.67 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -177.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -92.1 -47.0 7.48 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 119.053 -1.059 . . . . 0.0 113.712 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -71.15 -37.55 72.25 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -174.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -126.7 160.76 29.84 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.071 -1.052 . . . . 0.0 112.111 -171.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -78.02 115.53 17.83 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 121.294 0.569 . . . . 0.0 110.868 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -72.72 118.4 15.6 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.886 0.851 . . . . 0.0 112.796 175.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.2 mm -113.35 139.16 40.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 173.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.1 p -97.85 178.67 5.06 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.508 -174.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.1 tt -57.0 -37.63 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.622 0 C-N-CA 124.076 0.95 . . . . 0.0 112.805 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -83.36 -28.1 29.22 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 121.255 0.55 . . . . 0.0 110.849 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.429 ' SG ' ' HA3' ' A' ' 23' ' ' GLY . 60.2 m -77.11 -24.99 51.7 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.339 0.59 . . . . 0.0 110.693 177.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.58 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.873 -178.347 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.51 ' N ' HH21 ' A' ' 10' ' ' ARG . 48.7 m . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 121.362 0.601 . . . . 0.0 111.302 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.7 t -112.58 136.3 49.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 177.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.32 -174.41 4.38 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 119.676 -0.81 . . . . 0.0 109.027 -177.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.96 119.22 30.97 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -175.6 142.03 0.54 Allowed 'General case' 0 CA--C 1.496 -1.105 0 C-N-CA 123.432 0.693 . . . . 0.0 109.303 174.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -47.61 -44.27 26.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 124.264 0.978 . . . . 0.0 110.239 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -135.38 95.77 3.34 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.373 176.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.54 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 49.5 t -92.81 115.65 28.31 Favored 'General case' 0 N--CA 1.419 -1.992 0 C-N-CA 119.15 -1.02 . . . . 0.0 110.678 178.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -72.07 -8.74 56.34 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.415 177.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.51 HH21 ' N ' ' A' ' 1' ' ' SER . 58.9 ttt180 47.89 52.64 12.81 Favored Pre-proline 0 CA--C 1.565 1.548 0 C-N-CA 125.345 1.458 . . . . 0.0 112.073 -177.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.5 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 14.9 Cg_exo -70.97 132.76 22.0 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 121.503 1.469 . . . . 0.0 110.398 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 46.3 t -119.39 106.27 12.11 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.45 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -149.57 163.35 38.1 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -83.9 -55.91 3.98 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 173.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -68.19 82.95 0.23 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 121.333 -0.147 . . . . 0.0 111.206 172.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.7 p -173.1 104.52 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 122.052 0.929 . . . . 0.0 110.752 175.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -74.56 149.68 40.07 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 114.947 -1.024 . . . . 0.0 113.334 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -113.59 160.69 18.29 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 125.262 1.425 . . . . 0.0 109.793 -175.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.5 m -123.63 136.96 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-O 120.715 0.293 . . . . 0.0 110.274 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.474 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 54.1 tt0 -103.79 138.68 40.06 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 175.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 46' ' ' TYR . 29.4 p -90.73 103.56 16.25 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 118.976 -1.09 . . . . 0.0 110.688 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -82.82 21.03 1.06 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.052 -0.977 . . . . 0.0 111.18 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.49 -8.08 61.33 Favored Glycine 0 N--CA 1.434 -1.464 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.694 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 151.72 -23.7 0.93 Allowed Glycine 0 CA--C 1.54 1.627 0 C-N-CA 118.646 -1.74 . . . . 0.0 115.412 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.477 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 8.5 m -91.99 -29.59 16.53 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 118.839 1.319 . . . . 0.0 109.462 -176.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 58.07 26.47 13.64 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.921 -176.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 20' ' ' GLN . 37.7 mt-10 -94.43 167.19 11.67 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.4 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -108.39 129.31 55.25 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.374 -175.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -122.9 156.94 33.64 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.844 -177.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.905 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 56.1 m80 -94.0 141.19 28.81 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.592 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 51.0 mt-30 -58.38 -44.08 88.75 Favored 'General case' 0 C--O 1.187 -2.213 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.6 p -76.02 -37.8 34.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 118.862 -1.135 . . . . 0.0 111.273 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.905 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 1.8 p -70.76 -33.16 70.5 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.793 -174.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.494 HG13 HG23 ' A' ' 36' ' ' VAL . 1.5 p -106.16 12.25 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.803 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.42 66.12 3.07 Favored Glycine 0 CA--C 1.55 2.219 0 N-CA-C 116.586 1.394 . . . . 0.0 116.586 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.494 HG23 HG13 ' A' ' 34' ' ' VAL . 78.7 t -116.98 149.15 19.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 175.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.4 p -95.97 147.99 33.84 Favored Pre-proline 0 N--CA 1.418 -2.044 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.592 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 18.2 Cg_endo -56.3 -27.19 65.67 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 C-N-CA 122.725 2.283 . . . . 0.0 112.231 -176.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -74.54 -28.81 61.12 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.82 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.414 ' CE ' HG13 ' A' ' 36' ' ' VAL . 34.6 ttp -72.33 -39.0 68.51 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -176.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.73 -30.61 65.69 Favored 'General case' 0 CA--C 1.564 1.5 0 CA-C-N 114.633 -1.167 . . . . 0.0 113.431 -176.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -95.26 -13.18 25.09 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -118.03 -35.85 3.76 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 -172.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -131.17 153.48 49.38 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.584 0.629 . . . . 0.0 110.974 -173.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -71.72 126.9 30.9 Favored 'General case' 0 C--O 1.251 1.154 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.495 -176.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 54.1 t80 -76.36 110.93 11.29 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-O 122.028 0.918 . . . . 0.0 113.454 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.4 mm -95.21 134.93 30.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 173.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.44 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 13.4 p -101.57 -179.79 4.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 119.326 0.966 . . . . 0.0 109.095 -175.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.5 tt -54.43 -42.79 60.42 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 C-N-CA 123.862 0.865 . . . . 0.0 112.131 177.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -77.5 -28.5 52.17 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-O 120.656 0.265 . . . . 0.0 111.121 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.44 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 56.5 m -77.01 -26.25 53.58 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-O 121.06 0.457 . . . . 0.0 110.916 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.738 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.0 -178.145 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.7 t . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 122.317 1.056 . . . . 0.0 108.21 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 44.1 t -131.45 140.4 48.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.434 ' SG ' ' N ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -86.31 -172.89 4.27 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.575 -178.559 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.434 ' N ' ' SG ' ' A' ' 3' ' ' CYS . . . -97.4 123.07 41.11 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 176.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -172.32 141.66 1.24 Allowed 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 172.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -48.2 -28.22 2.87 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.967 0.907 . . . . 0.0 110.8 173.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -153.43 104.45 2.75 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.927 174.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.595 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 52.2 t -101.35 123.69 45.85 Favored 'General case' 0 N--CA 1.412 -2.341 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.566 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -75.64 -7.35 54.05 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.176 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.569 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 36.5 ttt180 47.93 48.78 6.32 Favored Pre-proline 0 CA--C 1.573 1.861 0 C-N-CA 125.751 1.62 . . . . 0.0 112.197 -176.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.569 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 6.1 Cg_exo -77.42 141.6 20.28 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.252 1.968 . . . . 0.0 111.818 -177.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.5 t -134.38 116.59 15.36 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.968 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -139.11 158.36 44.31 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 174.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -81.42 -3.0 51.59 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 122.056 0.932 . . . . 0.0 108.772 175.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -128.91 85.47 2.33 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.128 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.3 p -175.79 111.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 122.015 0.912 . . . . 0.0 111.003 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -73.01 159.26 33.94 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 114.116 -1.402 . . . . 0.0 111.953 176.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 17.8 m95 -125.51 159.35 32.21 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.068 0.947 . . . . 0.0 109.905 -174.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.1 m -129.19 136.42 59.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 120.79 0.329 . . . . 0.0 110.249 -178.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -101.48 139.74 36.72 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 29.9 p -88.06 103.14 15.44 Favored 'General case' 0 C--O 1.248 1.006 0 C-N-CA 118.698 -1.201 . . . . 0.0 110.124 176.072 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -81.66 21.51 0.81 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.066 -175.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.22 -12.94 55.66 Favored Glycine 0 N--CA 1.423 -2.217 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.87 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 149.78 -16.14 1.07 Allowed Glycine 0 CA--C 1.537 1.408 0 C-N-CA 118.509 -1.805 . . . . 0.0 116.143 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.462 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 13.5 m -90.63 -30.33 17.23 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 119.014 1.407 . . . . 0.0 109.454 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 60.83 22.55 12.6 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.52 -175.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -88.66 161.42 16.87 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.953 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -108.93 127.87 54.44 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.438 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -118.63 160.18 22.28 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.376 -176.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.93 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 48.9 m80 -94.77 134.71 37.09 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 174.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -54.27 -38.26 65.64 Favored 'General case' 0 C--O 1.203 -1.389 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 178.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.5 p -77.14 -42.16 31.3 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.315 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.696 178.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.93 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 10.0 p -71.71 -30.98 66.24 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.805 -172.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.521 HG13 HG23 ' A' ' 36' ' ' VAL . 1.4 p -103.99 10.85 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.073 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.636 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.34 60.33 9.14 Favored Glycine 0 CA--C 1.543 1.793 0 N-CA-C 116.187 1.235 . . . . 0.0 116.187 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.521 HG23 HG13 ' A' ' 34' ' ' VAL . 77.4 t -107.93 146.63 13.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 174.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.7 p -99.38 156.33 35.53 Favored Pre-proline 0 N--CA 1.413 -2.276 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -58.49 -25.88 75.84 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.458 2.105 . . . . 0.0 111.307 177.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -71.33 -34.41 70.52 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.015 -178.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 35.1 ttp -75.1 -47.42 28.79 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.696 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.7 -45.18 90.07 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -175.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -79.23 -18.69 52.36 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -177.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -116.43 -30.99 5.73 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 -173.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -131.42 166.34 21.51 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 119.638 1.108 . . . . 0.0 113.806 -172.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.82 117.64 17.77 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.463 -177.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.456 ' OH ' HG21 ' A' ' 34' ' ' VAL . 82.6 t80 -73.91 117.11 15.31 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-O 122.184 0.992 . . . . 0.0 113.598 178.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.5 mm -107.03 148.06 11.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 106.16 -1.792 . . . . 0.0 106.16 174.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.487 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 11.8 p -111.55 177.32 4.69 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 119.123 0.874 . . . . 0.0 108.756 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.2 tt -55.2 -41.17 59.23 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.339 0 C-N-CA 124.047 0.939 . . . . 0.0 112.358 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -76.15 -32.79 59.26 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.048 0.451 . . . . 0.0 110.808 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.487 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 64.2 m -74.46 -25.38 59.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.219 0.533 . . . . 0.0 110.448 176.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.49 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.401 -178.525 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 C--O 1.249 1.072 0 CA-C-O 121.617 0.722 . . . . 0.0 110.563 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.4 t -119.02 139.57 45.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.412 ' SG ' ' N ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -96.01 -172.48 2.58 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.776 -176.147 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.412 ' N ' ' SG ' ' A' ' 3' ' ' CYS . . . -91.77 120.53 32.58 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -177.08 146.38 0.51 Allowed 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 172.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -47.9 -43.01 28.4 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 124.019 0.824 . . . . 0.0 110.802 174.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -140.12 99.96 3.8 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.91 173.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.552 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 47.3 t -91.5 120.42 32.31 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.892 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -71.06 -8.17 51.55 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.791 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.504 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 68.7 ttt180 48.99 53.99 15.47 Favored Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 125.51 1.524 . . . . 0.0 112.012 -175.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.504 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 10.8 Cg_exo -73.91 131.93 16.31 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 121.825 1.683 . . . . 0.0 111.037 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.3 t -125.36 110.21 13.7 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.003 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -137.44 156.59 47.99 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 174.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -68.52 -50.48 51.77 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.6 0.714 . . . . 0.0 110.236 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -103.11 92.73 4.65 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.227 0.537 . . . . 0.0 110.499 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.4 p -156.42 123.89 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.939 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.532 ' HB2' ' NE2' ' A' ' 31' ' ' GLN . 6.9 m-20 -69.62 157.63 36.84 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.747 -1.115 . . . . 0.0 113.204 177.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -133.29 159.67 39.56 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 125.524 1.53 . . . . 0.0 107.798 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.417 HG23 ' HB2' ' A' ' 29' ' ' PHE . 22.5 m -131.06 130.93 64.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 120.987 0.422 . . . . 0.0 110.577 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.455 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 50.4 tt0 -98.7 138.58 35.66 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 175.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.469 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 32.0 p -87.7 108.27 19.03 Favored 'General case' 0 C--O 1.25 1.121 0 C-N-CA 118.404 -1.318 . . . . 0.0 110.155 177.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -82.99 23.73 0.82 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.385 -177.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.32 -9.8 61.45 Favored Glycine 0 N--CA 1.417 -2.595 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.3 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 139.9 -14.35 3.1 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 119.12 -1.514 . . . . 0.0 115.567 177.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.469 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 19.1 m -87.41 -28.12 22.33 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 119.14 1.47 . . . . 0.0 108.709 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 59.5 21.59 10.08 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.961 -177.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' ' 20' ' ' GLN . 42.9 mt-10 -88.99 163.96 15.31 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 120.951 0.405 . . . . 0.0 111.653 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 44.9 m95 -108.14 128.69 54.91 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.239 -175.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.417 ' HB2' HG23 ' A' ' 19' ' ' VAL . 11.1 m-85 -121.89 158.54 28.77 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.913 -178.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.927 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 49.0 m80 -97.56 140.19 32.34 Favored 'General case' 0 CA--C 1.488 -1.413 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 174.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.532 ' NE2' ' HB2' ' A' ' 17' ' ' ASP . 50.8 mt-30 -56.95 -45.62 82.71 Favored 'General case' 0 C--O 1.191 -2.023 0 O-C-N 123.771 0.67 . . . . 0.0 112.75 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.8 p -71.07 -40.17 75.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 O-C-N 121.575 -0.703 . . . . 0.0 112.086 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.927 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 9.4 p -70.85 -33.95 71.16 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.837 -174.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.566 HG13 HG23 ' A' ' 36' ' ' VAL . 1.7 p -104.13 10.23 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 CA-C-O 121.291 0.567 . . . . 0.0 110.497 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.08 60.52 8.49 Favored Glycine 0 CA--C 1.551 2.339 0 N-CA-C 116.501 1.36 . . . . 0.0 116.501 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.566 HG23 HG13 ' A' ' 34' ' ' VAL . 74.6 t -115.87 148.3 18.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 175.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.1 p -100.13 149.83 36.36 Favored Pre-proline 0 N--CA 1.421 -1.912 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.477 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 72.9 Cg_exo -53.94 -30.23 57.68 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 122.961 2.441 . . . . 0.0 112.507 -178.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -69.3 -31.88 70.66 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.062 -178.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 35.2 ttp -74.84 -42.3 58.23 Favored 'General case' 0 C--O 1.208 -1.112 0 CA-C-O 121.269 0.557 . . . . 0.0 110.185 -177.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.42 -41.24 79.99 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -176.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -86.21 -14.02 45.19 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -113.37 -34.18 5.69 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -174.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -130.02 144.21 51.21 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 118.654 0.661 . . . . 0.0 111.105 -174.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -70.45 115.61 9.83 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.293 -178.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -69.74 120.2 15.13 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -176.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.8 mm -102.41 139.87 22.3 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.904 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 173.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.2 p -102.19 178.57 4.56 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.875 0.761 . . . . 0.0 109.88 -176.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.7 tt -55.98 -39.45 57.7 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.476 0 C-N-CA 123.769 0.828 . . . . 0.0 112.247 177.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -74.55 -38.47 62.72 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 121.159 0.504 . . . . 0.0 110.848 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 63.7 m -69.33 -27.18 65.14 Favored 'General case' 0 C--O 1.213 -0.819 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.89 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.109 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.67 -177.362 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.407 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 36.0 t . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 120.761 0.315 . . . . 0.0 110.324 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.8 t -123.81 130.69 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -178.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.42 ' SG ' ' N ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -90.45 -175.21 4.39 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.502 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.42 ' N ' ' SG ' ' A' ' 3' ' ' CYS . . . -95.67 123.17 39.1 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -176.11 151.31 1.04 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 172.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -47.13 -42.91 20.17 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.259 0.624 . . . . 0.0 110.928 173.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -141.58 107.57 5.18 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.801 176.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.589 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 47.0 t -101.19 116.85 33.77 Favored 'General case' 0 N--CA 1.42 -1.938 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.976 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -74.38 -11.38 60.23 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.156 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.521 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 31.5 mtm180 49.11 53.51 14.67 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 125.511 1.524 . . . . 0.0 114.388 -174.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 8.5 Cg_exo -78.05 139.7 17.36 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 121.826 1.684 . . . . 0.0 111.265 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.4 t -132.86 115.81 15.73 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -149.68 156.83 42.54 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.39 -15.38 63.53 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.194 0.598 . . . . 0.0 111.667 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -116.75 18.98 14.71 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -170.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.8 p -114.76 106.18 20.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.945 0.878 . . . . 0.0 112.465 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -72.75 148.37 44.69 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.355 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -113.18 158.97 19.77 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.511 1.125 . . . . 0.0 110.182 -174.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.2 m -125.98 132.16 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-O 120.678 0.275 . . . . 0.0 110.77 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -99.23 138.88 35.69 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.489 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 28.8 p -83.88 108.77 17.08 Favored 'General case' 0 C--O 1.255 1.345 0 C-N-CA 118.708 -1.197 . . . . 0.0 111.667 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -76.39 18.87 0.28 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.315 1.046 . . . . 0.0 112.17 -176.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.575 ' HA3' ' SG ' ' A' ' 51' ' ' CYS . . . -92.93 -18.67 39.36 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.117 -179.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 141.41 -6.83 2.5 Favored Glycine 0 CA--C 1.545 1.93 0 C-N-CA 119.185 -1.483 . . . . 0.0 115.978 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.489 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 16.9 m -88.89 -25.1 22.31 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 119.133 1.467 . . . . 0.0 109.315 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 59.92 18.48 7.53 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.299 1.04 . . . . 0.0 113.051 -176.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -85.91 159.36 19.68 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.212 0.529 . . . . 0.0 111.181 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -106.39 126.24 52.0 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.06 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.402 ' CD1' ' HE2' ' A' ' 46' ' ' TYR . 3.0 m-85 -118.64 159.31 23.83 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.706 -177.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.923 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 41.6 m80 -96.28 135.86 37.54 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.46 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 50.8 mt-30 -55.02 -40.05 69.76 Favored 'General case' 0 C--O 1.188 -2.148 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 177.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.415 ' CG1' ' HG2' ' A' ' 11' ' ' PRO . 11.7 p -76.43 -38.86 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.454 0 C-N-CA 119.692 -0.803 . . . . 0.0 112.092 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.923 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 7.7 p -75.08 -29.5 60.68 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -174.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.564 HG21 ' OH ' ' A' ' 46' ' ' TYR . 2.1 p -104.7 1.95 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 CA-C-O 121.678 0.751 . . . . 0.0 110.117 178.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.7 75.03 0.35 Allowed Glycine 0 CA--C 1.55 2.233 0 N-CA-C 115.813 1.085 . . . . 0.0 115.813 -176.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.563 HG23 HG13 ' A' ' 34' ' ' VAL . 64.3 t -127.97 147.94 32.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 175.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 52.2 p -99.54 150.97 37.27 Favored Pre-proline 0 N--CA 1.421 -1.886 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.46 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 18.2 Cg_endo -56.09 -23.75 45.86 Favored 'Trans proline' 0 N--CA 1.485 0.988 0 C-N-CA 122.925 2.417 . . . . 0.0 112.32 -177.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -74.2 -32.97 63.25 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.186 -178.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 35.4 ttp -73.91 -41.32 62.29 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -176.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.26 -43.06 87.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.214 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -83.58 -21.35 32.66 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -177.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -110.38 -27.68 8.93 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 -174.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -132.7 166.08 23.02 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.461 1.028 . . . . 0.0 111.927 -174.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -81.91 115.64 21.19 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.564 ' OH ' HG21 ' A' ' 34' ' ' VAL . 49.7 t80 -68.72 113.37 6.13 Favored 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.4 mm -101.28 140.5 19.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.48 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 8.3 p -107.9 178.53 4.49 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.171 -177.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.2 tt -55.36 -41.83 63.98 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 C-N-CA 124.131 0.972 . . . . 0.0 112.245 177.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -77.64 -25.31 49.58 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 121.25 0.548 . . . . 0.0 110.393 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.575 ' SG ' ' HA3' ' A' ' 23' ' ' GLY . 55.5 m -78.03 -26.93 48.68 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.191 177.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.779 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.023 -176.638 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.5 p . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.516 0.674 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.0 t -124.0 134.67 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.16 -173.56 3.29 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.43 119.73 33.6 Favored 'General case' 0 C--O 1.207 -1.162 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -177.64 142.26 0.31 Allowed 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 173.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -47.87 -45.1 29.94 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 124.046 0.841 . . . . 0.0 110.895 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -130.67 94.91 3.73 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.69 176.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.5 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 51.8 t -93.63 123.21 36.8 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 118.995 -1.082 . . . . 0.0 111.181 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -81.45 -11.68 59.15 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.831 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.569 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 62.4 mtm180 52.9 43.57 1.61 Allowed Pre-proline 0 CA--C 1.566 1.584 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -176.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.569 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 10.4 Cg_exo -76.86 143.63 23.57 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 121.619 1.546 . . . . 0.0 110.608 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 53.2 t -137.7 113.32 9.56 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.407 ' O ' HG12 ' A' ' 16' ' ' VAL . 97.7 mttt -142.69 151.38 41.3 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 177.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.24 -4.85 15.52 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 178.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -121.25 8.92 10.33 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -176.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 13' ' ' LYS . 7.2 p -102.86 107.18 21.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-O 121.756 0.789 . . . . 0.0 112.044 -178.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -74.07 146.8 43.38 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.592 176.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -111.95 159.16 18.67 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 124.638 1.175 . . . . 0.0 109.676 -174.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 23.1 m -123.86 132.65 71.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 O-C-N 121.949 -0.469 . . . . 0.0 110.763 -177.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -101.15 138.82 37.67 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.1 p -90.66 107.81 19.41 Favored 'General case' 0 C--O 1.255 1.35 0 C-N-CA 119.161 -1.016 . . . . 0.0 110.741 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -86.79 23.83 1.62 Allowed 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.926 -176.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.72 -14.09 60.14 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.11 -9.11 1.74 Allowed Glycine 0 CA--C 1.542 1.755 0 C-N-CA 119.032 -1.556 . . . . 0.0 116.234 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.479 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 13.9 m -92.58 -28.71 16.57 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 119.641 1.72 . . . . 0.0 110.209 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 61.91 17.69 9.15 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.831 1.253 . . . . 0.0 111.69 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -87.8 161.48 17.53 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.134 0.493 . . . . 0.0 111.598 -178.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -107.33 127.9 53.97 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.004 -176.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.411 ' HE1' ' SG ' ' A' ' 21' ' ' CYS . 3.5 m-85 -119.48 155.32 32.31 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -178.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.911 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 42.5 m80 -91.18 139.85 30.36 Favored 'General case' 0 CA--C 1.476 -1.867 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 174.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.493 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 48.4 mt-30 -54.45 -51.32 65.35 Favored 'General case' 0 C--O 1.192 -1.947 0 O-C-N 123.666 0.604 . . . . 0.0 111.806 177.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.8 p -68.2 -39.51 81.32 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 CA-C-O 121.125 0.488 . . . . 0.0 112.136 -178.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.911 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 3.4 p -72.76 -25.05 61.05 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.336 -174.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.486 HG13 HG23 ' A' ' 36' ' ' VAL . 0.9 OUTLIER -110.81 11.72 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.821 177.259 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.54 39.98 95.85 Favored Glycine 0 CA--C 1.546 2.021 0 N-CA-C 117.34 1.696 . . . . 0.0 117.34 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.486 HG23 HG13 ' A' ' 34' ' ' VAL . 69.4 t -93.92 147.95 5.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 118.153 0.976 . . . . 0.0 109.378 175.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.9 p -99.37 147.35 33.2 Favored Pre-proline 0 N--CA 1.414 -2.249 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 175.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.493 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 74.9 Cg_exo -51.41 -32.27 41.83 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.312 2.675 . . . . 0.0 114.062 -175.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.57 -26.02 60.63 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 35.9 ttp -73.38 -38.17 65.74 Favored 'General case' 0 C--O 1.213 -0.822 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.42 -43.98 79.9 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.659 -177.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -90.46 -12.28 37.82 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -113.59 -27.0 8.02 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -128.77 151.19 49.84 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.06 0.457 . . . . 0.0 110.324 -175.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -79.15 115.71 18.98 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.659 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.423 ' OH ' HG21 ' A' ' 34' ' ' VAL . 90.5 t80 -67.01 114.86 6.13 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-O 122.812 1.292 . . . . 0.0 114.428 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.0 mm -103.64 141.65 18.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 172.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.457 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 9.3 p -106.83 179.21 4.33 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.361 -176.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.5 tt -56.04 -43.28 74.94 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 C-N-CA 123.684 0.794 . . . . 0.0 112.269 177.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -76.04 -28.23 57.61 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.095 0.474 . . . . 0.0 110.943 -178.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.457 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 58.0 m -76.59 -25.56 54.07 Favored 'General case' 0 C--O 1.213 -0.83 0 CA-C-O 121.524 0.678 . . . . 0.0 110.901 176.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.293 -1.877 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.753 -176.809 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 121.644 0.735 . . . . 0.0 110.372 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.5 t -129.43 137.71 56.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.633 ' SG ' ' HA ' ' A' ' 29' ' ' PHE . 0.5 OUTLIER -100.77 -172.43 2.18 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 119.108 -1.037 . . . . 0.0 109.767 -176.204 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.99 121.94 31.85 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -173.78 145.3 1.14 Allowed 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 172.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -47.99 -42.0 26.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 123.771 0.669 . . . . 0.0 109.439 173.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -136.06 97.93 3.74 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.337 174.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.595 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 53.4 t -94.19 156.92 16.31 Favored 'General case' 0 N--CA 1.422 -1.843 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.24 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.646 ' C ' ' HD3' ' A' ' 11' ' ' PRO . 25.2 mt-30 -119.2 173.27 7.03 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.772 -177.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.422 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 19.2 mmm180 -116.69 62.88 2.77 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 123.416 0.686 . . . . 0.0 111.085 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.646 ' HD3' ' C ' ' A' ' 9' ' ' GLN . 5.0 Cg_exo -88.6 145.43 5.76 Favored 'Trans proline' 0 C--N 1.359 1.099 0 C-N-CA 123.389 2.726 . . . . 0.0 112.077 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.6 t -130.16 107.44 9.31 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.801 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -152.97 156.57 39.12 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 124.862 1.265 . . . . 0.0 108.581 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -87.77 -51.1 6.05 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 172.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -72.32 79.55 1.01 Allowed 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.992 175.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.6 p -165.61 102.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 122.125 0.964 . . . . 0.0 110.604 176.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -67.88 137.89 55.61 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 114.191 -1.368 . . . . 0.0 112.283 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 21.4 m95 -106.53 160.3 15.53 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.015 1.326 . . . . 0.0 108.945 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.5 m -127.83 132.72 68.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.115 0.483 . . . . 0.0 110.851 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -100.45 138.99 36.76 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 30.6 p -87.69 102.67 14.87 Favored 'General case' 0 C--O 1.256 1.416 0 C-N-CA 118.997 -1.081 . . . . 0.0 110.595 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.52 24.44 0.57 Allowed 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.122 -175.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.64 -18.27 41.91 Favored Glycine 0 N--CA 1.437 -1.253 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 147.61 -10.65 1.27 Allowed Glycine 0 C--N 1.351 1.41 0 N-CA-C 116.951 1.54 . . . . 0.0 116.951 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.455 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 15.9 m -88.9 -26.8 21.4 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 119.754 1.777 . . . . 0.0 109.724 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 61.1 20.53 11.0 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.859 0.863 . . . . 0.0 112.417 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -91.77 158.08 16.55 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.744 -178.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -107.77 132.78 53.02 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.896 -177.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.633 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . 3.5 m-85 -120.72 159.72 24.79 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.152 -177.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.874 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 42.4 m80 -93.35 134.49 35.52 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -56.87 -33.04 66.46 Favored 'General case' 0 C--O 1.197 -1.7 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 176.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.6 p -77.2 -41.6 30.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-O 121.336 0.589 . . . . 0.0 111.968 177.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.874 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 4.2 p -75.52 -29.17 59.37 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.992 -173.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.49 HG13 HG23 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -106.66 2.79 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.764 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.485 179.66 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.31 72.49 0.62 Allowed Glycine 0 CA--C 1.555 2.586 0 N-CA-C 116.316 1.286 . . . . 0.0 116.316 -176.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.49 HG23 HG13 ' A' ' 34' ' ' VAL . 59.3 t -121.2 148.77 24.34 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 C-N-CA 124.547 1.139 . . . . 0.0 108.176 175.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.6 p -99.99 150.83 37.22 Favored Pre-proline 0 N--CA 1.42 -1.946 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -49.95 -42.71 44.3 Favored 'Trans proline' 0 C--N 1.358 1.066 0 C-N-CA 123.051 2.501 . . . . 0.0 112.115 -177.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -60.07 -35.04 74.29 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 42.2 ttp -69.25 -43.33 74.19 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.617 -176.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.13 -48.24 80.84 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 123.792 0.683 . . . . 0.0 112.072 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -77.91 -13.78 59.77 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -176.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -122.19 -43.03 2.34 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 117.021 2.23 . . . . 0.0 117.021 -172.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -126.89 171.31 11.38 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -168.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -68.35 115.14 7.44 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.48 0.712 . . . . 0.0 112.184 -173.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.481 ' OH ' HG21 ' A' ' 34' ' ' VAL . 79.3 t80 -82.81 105.66 14.01 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 122.239 1.019 . . . . 0.0 111.757 172.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.0 mm -98.92 145.14 10.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 175.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.441 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 13.5 p -105.32 178.28 4.61 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 119.306 -0.958 . . . . 0.0 108.872 -178.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.0 tt -55.83 -41.31 65.94 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 124.071 0.948 . . . . 0.0 111.928 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -75.62 -39.89 57.15 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.912 0.485 . . . . 0.0 111.433 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.441 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 52.1 m -63.21 -29.81 71.08 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.023 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.696 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.587 -175.399 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.9 m . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 121.174 0.511 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.7 t -132.08 139.93 49.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -87.68 -173.68 4.43 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -178.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.59 119.98 34.1 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 174.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -173.25 140.91 0.89 Allowed 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 171.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -48.99 -43.61 40.38 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.931 0.769 . . . . 0.0 109.474 176.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -127.96 104.88 8.04 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.797 177.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.563 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 42.1 t -105.9 125.23 50.75 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 117.738 -1.585 . . . . 0.0 112.614 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -81.23 -6.06 58.45 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.161 -1.381 . . . . 0.0 110.571 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.587 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 73.3 mtp180 53.11 39.9 0.69 Allowed Pre-proline 0 CA--C 1.57 1.712 0 C-N-CA 124.465 1.106 . . . . 0.0 113.787 -176.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.587 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 7.2 Cg_exo -74.67 134.0 17.85 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 121.687 1.591 . . . . 0.0 112.076 -175.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 51.2 t -127.69 125.1 39.44 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -149.04 164.23 35.23 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -77.35 -14.63 59.69 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.498 0.666 . . . . 0.0 109.253 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -131.45 91.44 3.01 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.929 -177.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.2 p -171.56 103.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 122.164 0.983 . . . . 0.0 111.143 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.678 ' HB2' ' NE2' ' A' ' 31' ' ' GLN . 4.1 m-20 -68.85 140.56 55.22 Favored 'General case' 0 C--N 1.275 -2.665 0 CA-C-N 114.433 -1.258 . . . . 0.0 111.722 177.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -107.55 159.82 16.14 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 124.198 0.999 . . . . 0.0 108.825 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.4 m -127.26 134.08 66.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 120.905 0.383 . . . . 0.0 110.397 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -101.0 139.07 37.2 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 30.1 p -91.63 99.68 12.54 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 118.875 -1.13 . . . . 0.0 109.951 176.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -85.07 22.45 1.42 Allowed 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.698 -175.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.21 -2.75 62.02 Favored Glycine 0 N--CA 1.426 -2.022 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.562 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.15 -23.74 1.12 Allowed Glycine 0 CA--C 1.541 1.675 0 C-N-CA 118.878 -1.629 . . . . 0.0 116.203 178.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.458 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 5.6 m -95.09 -31.84 13.38 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 119.089 1.444 . . . . 0.0 110.015 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 61.59 19.39 10.36 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 124.019 0.825 . . . . 0.0 111.908 -176.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -85.73 158.95 19.9 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.716 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -104.67 127.63 52.49 Favored 'General case' 0 C--O 1.242 0.669 0 O-C-N 123.619 0.574 . . . . 0.0 112.342 -176.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.411 ' HE1' ' SG ' ' A' ' 21' ' ' CYS . 8.9 m-85 -118.12 156.38 28.77 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.889 -1.051 . . . . 0.0 108.786 -177.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.937 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 47.2 m80 -93.56 139.11 31.13 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 174.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.678 ' NE2' ' HB2' ' A' ' 17' ' ' ASP . 50.6 mt-30 -56.12 -46.24 79.23 Favored 'General case' 0 C--O 1.188 -2.137 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.0 p -72.66 -37.85 57.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.738 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.937 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 5.4 p -72.24 -31.75 66.09 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.832 -175.079 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.463 HG13 HG23 ' A' ' 36' ' ' VAL . 1.4 p -104.47 5.69 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.659 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.36 72.12 0.73 Allowed Glycine 0 CA--C 1.548 2.142 0 N-CA-C 115.408 0.923 . . . . 0.0 115.408 -176.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.463 HG23 HG13 ' A' ' 34' ' ' VAL . 74.5 t -127.61 147.3 32.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 173.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.4 p -100.25 150.56 37.02 Favored Pre-proline 0 N--CA 1.422 -1.832 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 176.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.418 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 11.0 Cg_endo -53.58 -25.2 32.0 Favored 'Trans proline' 0 N--CA 1.488 1.148 0 C-N-CA 123.513 2.809 . . . . 0.0 112.735 -177.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -73.53 -34.27 65.14 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.364 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 39.8 ttp -74.43 -38.16 63.12 Favored 'General case' 0 C--O 1.21 -0.986 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.206 -176.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.88 -44.11 77.84 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -176.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -85.82 -46.14 10.92 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 176.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -75.1 -35.48 61.76 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 -173.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -128.08 164.07 23.22 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -171.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -82.93 115.67 21.89 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.877 0.871 . . . . 0.0 111.512 -174.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.445 ' OH ' HG21 ' A' ' 34' ' ' VAL . 77.8 t80 -78.49 110.77 13.86 Favored 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.2 mm -102.29 146.22 10.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 172.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.481 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 7.9 p -111.0 179.83 3.94 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 119.226 -0.99 . . . . 0.0 109.737 -175.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.6 tt -55.02 -40.05 52.43 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.538 0 C-N-CA 124.448 1.099 . . . . 0.0 112.636 177.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -82.93 -29.13 29.38 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.481 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 56.7 m -73.98 -27.98 61.25 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-O 120.887 0.375 . . . . 0.0 111.198 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.423 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.578 -176.043 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 40.6 m . . . . . 0 N--CA 1.495 1.825 0 CA-C-O 121.951 0.881 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.2 t -123.53 139.84 48.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -178.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.4 p -87.72 -172.16 3.75 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -176.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.61 118.87 32.38 Favored 'General case' 0 C--O 1.206 -1.206 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 172.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -177.03 135.56 0.2 Allowed 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 171.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -51.36 -43.31 61.79 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.287 0.565 . . . . 0.0 110.483 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -121.91 103.11 8.61 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.886 175.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.579 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 42.2 t -107.49 122.16 46.08 Favored 'General case' 0 N--CA 1.417 -2.083 0 C-N-CA 118.024 -1.47 . . . . 0.0 111.993 177.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -79.49 -8.46 59.15 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.33 178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.487 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 38.1 ttp180 46.1 61.81 12.22 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 126.763 2.025 . . . . 0.0 111.997 -175.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.487 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 17.0 Cg_exo -76.23 132.98 14.32 Favored 'Trans proline' 0 C--O 1.252 1.184 0 C-N-CA 123.048 2.499 . . . . 0.0 111.752 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.4 t -123.82 102.66 7.92 Favored 'General case' 0 N--CA 1.44 -0.971 0 O-C-N 123.894 0.746 . . . . 0.0 110.479 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -141.03 159.6 41.87 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 175.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -81.74 -50.1 9.66 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.826 -0.75 . . . . 0.0 112.031 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -73.39 18.83 0.11 Allowed 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.5 p -102.74 111.21 31.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 119.287 0.949 . . . . 0.0 111.928 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -71.39 146.93 48.43 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.047 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -113.69 159.2 19.95 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.262 1.025 . . . . 0.0 109.822 -175.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.7 137.59 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-O 120.71 0.29 . . . . 0.0 110.546 -177.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -110.52 138.3 47.09 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.572 178.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.4 p -93.22 102.42 14.71 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.497 176.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -86.68 25.26 1.29 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.808 0.813 . . . . 0.0 109.881 -176.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.11 1.68 57.71 Favored Glycine 0 N--CA 1.431 -1.643 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.699 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 151.75 -35.28 0.86 Allowed Glycine 0 CA--C 1.534 1.256 0 C-N-CA 118.726 -1.702 . . . . 0.0 115.608 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.4 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 7.4 m -89.27 -32.75 17.23 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 118.548 1.174 . . . . 0.0 109.488 -176.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 59.95 21.39 10.43 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.748 1.219 . . . . 0.0 111.634 -177.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -88.15 163.7 16.06 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.731 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -105.29 127.52 52.99 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.115 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -117.12 155.15 29.8 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.684 -178.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.95 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 44.2 m80 -92.54 137.73 32.11 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 174.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -52.46 -51.74 57.76 Favored 'General case' 0 C--O 1.198 -1.62 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.3 p -68.63 -37.02 77.04 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 CA-C-N 118.533 0.606 . . . . 0.0 112.246 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.95 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 8.1 p -72.51 -27.29 62.17 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.23 -175.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.528 HG13 HG23 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -109.68 12.92 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.944 0 CA-C-O 121.753 0.787 . . . . 0.0 110.727 177.779 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.18 35.98 92.65 Favored Glycine 0 CA--C 1.553 2.433 0 N-CA-C 117.257 1.663 . . . . 0.0 117.257 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.528 HG23 HG13 ' A' ' 34' ' ' VAL . 86.5 t -93.97 147.48 5.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 117.775 0.788 . . . . 0.0 109.74 176.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.3 p -104.36 150.69 38.72 Favored Pre-proline 0 N--CA 1.415 -2.198 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 175.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -47.59 -39.63 29.74 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 123.475 2.783 . . . . 0.0 112.987 -177.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -58.15 -38.86 77.41 Favored 'General case' 0 C--O 1.214 -0.809 0 C-N-CA 124.475 1.11 . . . . 0.0 111.609 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.415 ' HB3' HG13 ' A' ' 36' ' ' VAL . 33.3 ttp -72.36 -39.54 67.99 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.813 -175.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.83 -49.05 77.96 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 123.741 0.651 . . . . 0.0 112.71 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -90.13 -24.01 21.2 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -177.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -98.53 -28.03 13.77 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.177 -1.009 . . . . 0.0 113.684 -172.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -139.05 -179.83 6.07 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -176.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -83.92 118.26 23.88 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 113.586 -1.643 . . . . 0.0 112.477 -174.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -88.18 110.37 20.64 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 122.272 1.035 . . . . 0.0 113.551 175.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.401 HG23 ' HB3' ' A' ' 51' ' ' CYS . 47.2 mm -107.89 141.15 23.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 172.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.9 p -97.9 176.56 5.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.276 -175.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.8 tt -54.15 -36.25 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.343 0 C-N-CA 124.255 1.022 . . . . 0.0 112.596 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -81.71 -35.67 29.51 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-O 120.881 0.372 . . . . 0.0 110.095 -178.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.401 ' HB3' HG23 ' A' ' 47' ' ' ILE . 64.6 m -74.39 -25.05 59.25 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-O 121.422 0.63 . . . . 0.0 111.482 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.1 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -178.812 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 37.4 t . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 120.934 0.397 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 99.6 t -99.12 127.72 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -178.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.49 ' SG ' ' HA ' ' A' ' 29' ' ' PHE . 0.5 OUTLIER -94.28 -174.83 3.48 Favored 'General case' 0 N--CA 1.433 -1.313 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.35 -176.08 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.07 120.06 31.72 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -175.25 147.19 0.88 Allowed 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 123.166 0.586 . . . . 0.0 109.454 171.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -48.04 -41.52 25.97 Favored 'General case' 0 CA--C 1.558 1.267 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.825 173.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -137.69 98.27 3.64 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.488 173.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.528 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 43.8 t -94.33 117.82 30.69 Favored 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.284 -178.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -85.67 164.34 17.73 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.47 83.64 11.07 Favored Pre-proline 0 C--N 1.311 -1.073 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -70.4 157.43 59.16 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.759 2.973 . . . . 0.0 111.49 172.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.9 p -135.72 27.73 3.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.127 0.489 . . . . 0.0 111.28 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -94.54 146.48 24.08 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 120.475 -0.49 . . . . 0.0 112.022 -177.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -68.33 -53.93 20.87 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 174.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -76.05 91.49 3.1 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.366 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.8 p -170.43 98.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 122.409 1.099 . . . . 0.0 110.961 173.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -66.52 142.71 57.43 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 114.252 -1.34 . . . . 0.0 113.589 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 15.7 m95 -109.12 160.3 16.18 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.763 1.225 . . . . 0.0 109.899 -177.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.3 m -130.35 143.61 40.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 121.291 0.567 . . . . 0.0 111.898 -178.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -112.62 138.73 48.99 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.547 ' HB3' ' O ' ' A' ' 25' ' ' CYS . 43.4 t -77.67 101.31 6.55 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.424 0.631 . . . . 0.0 111.401 -178.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -88.74 10.57 20.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 122.524 1.154 . . . . 0.0 108.435 -178.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.9 -2.14 78.75 Favored Glycine 0 N--CA 1.419 -2.436 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.338 177.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 144.74 -26.25 1.94 Allowed Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 119.919 -1.134 . . . . 0.0 114.929 176.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.547 ' O ' ' HB3' ' A' ' 21' ' ' CYS . 17.2 p -114.87 90.09 3.25 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 117.151 -1.82 . . . . 0.0 111.955 -177.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -39.73 13.96 0.0 OUTLIER 'General case' 0 N--CA 1.532 3.631 0 N-CA-C 117.806 2.521 . . . . 0.0 117.806 173.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 25' ' ' CYS . 40.4 mt-10 -81.73 160.91 23.52 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-N 118.769 0.713 . . . . 0.0 109.725 176.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -105.73 130.21 53.78 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.49 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . 17.6 m-85 -118.95 151.62 37.84 Favored 'General case' 0 CA--C 1.562 1.407 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.646 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.884 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 35.2 m80 -88.5 141.87 28.18 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 173.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.466 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 49.8 mt-30 -56.94 -52.11 66.5 Favored 'General case' 0 C--O 1.192 -1.932 0 C-N-CA 120.3 -0.56 . . . . 0.0 112.015 176.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.5 p -67.12 -40.52 85.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.884 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 2.1 p -71.1 -27.31 63.51 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.215 -174.317 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.476 ' CG1' HG23 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -109.96 9.15 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.123 0 CA-C-O 121.255 0.55 . . . . 0.0 111.448 178.781 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.38 40.54 96.47 Favored Glycine 0 CA--C 1.557 2.675 0 N-CA-C 117.392 1.717 . . . . 0.0 117.392 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.476 HG23 ' CG1' ' A' ' 34' ' ' VAL . 78.5 t -92.13 149.18 4.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.029 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.9 p -100.7 150.42 36.98 Favored Pre-proline 0 N--CA 1.426 -1.666 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 176.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.71 -34.58 54.49 Favored 'Trans proline' 0 N--CA 1.483 0.855 0 C-N-CA 123.031 2.488 . . . . 0.0 112.733 -176.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -72.98 -27.86 62.05 Favored 'General case' 0 N--CA 1.414 -2.235 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.287 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.427 ' HE1' HG22 ' A' ' 36' ' ' VAL . 49.9 ttp -73.12 -37.3 66.73 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -177.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.02 -32.11 70.58 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.823 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -95.7 -21.31 18.26 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -113.32 -33.81 5.83 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 115.729 1.752 . . . . 0.0 115.729 -171.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -123.33 163.52 20.59 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 118.809 -1.156 . . . . 0.0 113.045 -173.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -82.63 115.13 21.45 Favored 'General case' 0 C--O 1.253 1.266 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.153 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.491 ' HD2' ' HA ' ' A' ' 21' ' ' CYS . 63.5 t80 -71.59 108.97 5.23 Favored 'General case' 0 C--O 1.249 1.079 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.6 mm -98.61 146.21 8.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 170.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 18.2 p -107.04 178.68 4.49 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.509 -0.877 . . . . 0.0 110.6 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.3 tt -50.5 -34.79 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.368 0 C-N-CA 125.399 1.48 . . . . 0.0 113.126 177.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -89.79 -37.92 14.16 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 80.1 m -78.04 -23.5 48.12 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.889 0.376 . . . . 0.0 111.155 -177.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.685 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.357 179.553 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.41 ' N ' HH21 ' A' ' 10' ' ' ARG . 51.0 m . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 120.923 0.392 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.8 t -129.46 137.35 57.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.446 ' SG ' ' HA ' ' A' ' 29' ' ' PHE . 0.5 OUTLIER -100.08 -172.38 2.21 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 119.544 -0.862 . . . . 0.0 108.731 -178.506 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.54 119.45 29.0 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -177.88 143.8 0.33 Allowed 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 172.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -47.58 -40.91 20.38 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 123.63 0.582 . . . . 0.0 110.956 175.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -136.8 102.03 4.77 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.118 174.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.588 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 50.3 t -96.48 117.49 31.01 Favored 'General case' 0 N--CA 1.412 -2.345 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.846 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -76.16 -5.35 46.3 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.379 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.564 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 80.7 mtp180 54.92 38.25 0.46 Allowed Pre-proline 0 CA--C 1.573 1.856 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 14.0 Cg_exo -69.99 139.16 38.74 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 121.213 1.275 . . . . 0.0 112.24 -176.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 53.3 t -139.67 118.72 12.62 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.223 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -145.06 174.08 11.35 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -70.29 -66.16 0.63 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.239 0.542 . . . . 0.0 110.794 175.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -87.35 94.0 9.56 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -178.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.3 p -165.07 103.85 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.981 0.896 . . . . 0.0 111.305 176.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -69.16 146.3 52.57 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 114.233 -1.349 . . . . 0.0 113.238 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -115.71 160.4 20.12 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 125.779 1.631 . . . . 0.0 109.201 -177.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.3 m -126.64 136.93 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 120.772 0.32 . . . . 0.0 110.772 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -104.55 138.05 41.48 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 174.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.402 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 28.8 p -87.81 106.58 18.17 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 118.728 -1.189 . . . . 0.0 108.973 176.312 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -83.82 17.24 2.4 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.685 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.63 -1.27 66.12 Favored Glycine 0 N--CA 1.435 -1.397 0 C-N-CA 121.049 -0.596 . . . . 0.0 113.159 -176.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.23 -31.17 1.07 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 118.581 -1.771 . . . . 0.0 115.793 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.4 m -86.74 -28.66 22.91 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 118.934 1.367 . . . . 0.0 110.167 -175.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 60.02 22.28 11.42 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.763 1.225 . . . . 0.0 112.11 -176.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -93.87 165.79 12.5 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -108.93 130.87 55.45 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.446 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . 6.3 m-85 -122.83 153.62 39.33 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.493 -177.098 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.905 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 49.5 m80 -91.18 137.61 32.23 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 173.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.594 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 50.6 mt-30 -55.38 -45.67 76.55 Favored 'General case' 0 C--O 1.189 -2.104 0 O-C-N 123.892 0.745 . . . . 0.0 112.623 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.4 p -72.01 -40.42 67.52 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.39 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.751 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.905 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 2.8 p -72.8 -32.36 65.5 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.476 -173.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.55 HG13 HG23 ' A' ' 36' ' ' VAL . 2.5 p -103.61 6.9 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-O 121.256 0.55 . . . . 0.0 110.136 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.87 73.85 0.43 Allowed Glycine 0 CA--C 1.543 1.825 0 N-CA-C 115.452 0.941 . . . . 0.0 115.452 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.55 HG23 HG13 ' A' ' 34' ' ' VAL . 56.5 t -127.15 145.15 35.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.7 p -92.22 147.57 34.88 Favored Pre-proline 0 N--CA 1.425 -1.69 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 175.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.594 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 10.7 Cg_endo -51.22 -39.39 62.0 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.424 2.749 . . . . 0.0 113.457 -174.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -74.03 -25.38 59.84 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -178.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.484 ' CE ' HG13 ' A' ' 36' ' ' VAL . 37.5 ttp -68.48 -36.73 79.36 Favored 'General case' 0 C--O 1.211 -0.951 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.77 -39.76 81.97 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.286 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -88.4 -21.97 24.0 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 -177.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -115.64 -31.71 5.76 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -172.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.437 ' HB2' ' HG3' ' A' ' 40' ' ' MET . 37.5 mt-10 -117.96 157.11 27.35 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.975 -171.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -83.36 116.25 22.38 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.139 -176.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -82.82 103.81 12.58 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.2 mm -94.32 137.87 21.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 113.581 -1.645 . . . . 0.0 106.692 172.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.8 p -99.0 178.34 4.97 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 119.406 -0.917 . . . . 0.0 109.3 -174.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.8 tt -55.76 -41.45 65.83 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.287 0 C-N-CA 123.969 0.908 . . . . 0.0 112.383 178.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -76.61 -33.14 58.42 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 121.395 0.617 . . . . 0.0 110.88 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 61.4 m -72.75 -26.67 61.64 Favored 'General case' 0 C--O 1.211 -0.944 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.156 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.296 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -177.243 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.444 ' N ' HH21 ' A' ' 10' ' ' ARG . 22.5 m . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.737 0.303 . . . . 0.0 110.604 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.8 t -125.75 140.68 47.76 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -178.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -92.17 -172.24 3.07 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.61 118.78 28.51 Favored 'General case' 0 C--O 1.213 -0.859 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -176.65 145.7 0.55 Allowed 'General case' 0 CA--C 1.492 -1.251 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 171.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -48.09 -43.58 30.9 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 123.732 0.645 . . . . 0.0 110.324 175.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -137.39 105.75 5.77 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.228 175.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.608 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 53.4 t -97.71 117.12 31.29 Favored 'General case' 0 N--CA 1.402 -2.83 0 C-N-CA 119.734 -0.787 . . . . 0.0 111.512 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -69.48 -8.6 48.35 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.936 177.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.568 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 46.3 ttt180 52.64 43.21 1.46 Allowed Pre-proline 0 CA--C 1.604 3.057 0 C-N-CA 124.727 1.211 . . . . 0.0 113.768 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.568 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 2.8 Cg_exo -78.84 145.54 20.08 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.072 1.848 . . . . 0.0 112.622 -178.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.9 t -133.47 115.96 15.41 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.122 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -146.84 154.02 40.85 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 174.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.15 -12.55 61.77 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.225 0.536 . . . . 0.0 110.509 176.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -125.36 51.27 1.71 Allowed 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.21 -173.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.5 p -141.51 99.57 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 121.809 0.814 . . . . 0.0 110.718 175.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -68.72 145.0 54.22 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 114.817 -1.083 . . . . 0.0 112.07 176.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -106.93 159.73 16.05 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 124.577 1.151 . . . . 0.0 109.34 -176.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.0 m -125.76 141.37 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.602 -178.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.447 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 61.4 tt0 -111.29 137.85 48.5 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.474 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.6 p -94.81 104.48 16.38 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.882 178.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -88.22 23.97 2.0 Allowed 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.264 0.554 . . . . 0.0 110.322 -177.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.4 -4.98 73.01 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 148.6 -17.48 1.27 Allowed Glycine 0 CA--C 1.539 1.586 0 C-N-CA 119.68 -1.247 . . . . 0.0 115.64 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.474 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 9.6 m -97.8 -33.37 11.29 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.505 1.152 . . . . 0.0 110.495 -178.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 62.24 19.03 10.67 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 123.767 0.827 . . . . 0.0 111.877 -176.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 20' ' ' GLN . 47.8 mt-10 -85.05 168.14 15.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.831 -176.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -114.49 125.9 54.33 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-O 121.283 0.563 . . . . 0.0 111.915 -176.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -119.32 159.03 24.91 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.505 -176.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.939 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 38.1 m80 -94.37 136.17 34.97 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 173.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.437 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 50.3 mt-30 -55.34 -41.06 71.97 Favored 'General case' 0 C--O 1.191 -2.017 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 177.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.8 p -74.77 -41.74 47.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.914 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.939 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 9.2 p -72.0 -29.27 64.05 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.574 -174.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.53 HG13 HG23 ' A' ' 36' ' ' VAL . 1.4 p -105.0 5.48 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.958 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.87 73.64 0.46 Allowed Glycine 0 CA--C 1.553 2.443 0 N-CA-C 115.452 0.941 . . . . 0.0 115.452 -176.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.53 HG23 HG13 ' A' ' 34' ' ' VAL . 54.9 t -125.58 149.46 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 174.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.7 p -101.25 147.97 34.51 Favored Pre-proline 0 N--CA 1.418 -2.056 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 176.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.437 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 19.4 Cg_endo -55.84 -27.47 62.76 Favored 'Trans proline' 0 N--CA 1.487 1.132 0 C-N-CA 123.11 2.54 . . . . 0.0 112.283 -176.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -73.7 -28.36 61.69 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.719 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 44.2 ttp -74.13 -39.67 63.16 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.07 -43.91 82.58 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -176.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -88.12 -13.62 40.86 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -111.39 -39.24 4.74 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -175.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -126.07 166.32 17.21 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -170.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -74.98 118.58 18.1 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.907 0.883 . . . . 0.0 112.473 -178.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -83.11 103.8 12.81 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 122.383 1.087 . . . . 0.0 111.979 175.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.6 mm -100.21 143.57 13.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 173.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.416 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 12.4 p -103.93 176.97 4.98 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -176.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.2 tt -54.0 -38.23 36.75 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.343 0 C-N-CA 123.979 0.912 . . . . 0.0 112.89 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -87.04 -26.5 23.7 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.982 -0.448 . . . . 0.0 111.683 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.416 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 52.1 m -72.41 -25.63 61.55 Favored 'General case' 0 C--O 1.213 -0.828 0 CA-C-O 121.101 0.476 . . . . 0.0 110.796 176.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -1.001 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -177.766 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 N--CA 1.445 -0.721 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -87.37 -175.87 5.42 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.46 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.402 ' N ' ' SG ' ' A' ' 3' ' ' CYS . . . -90.65 119.68 31.09 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 178.34 134.24 0.08 Allowed 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 125.225 1.41 . . . . 0.0 107.956 172.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -49.41 -33.92 15.12 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 123.457 0.473 . . . . 0.0 111.433 176.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -133.3 92.07 2.95 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.948 174.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.487 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 44.4 t -95.41 119.19 33.49 Favored 'General case' 0 N--CA 1.413 -2.284 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.129 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.427 HE22 HG22 ' A' ' 32' ' ' VAL . 73.3 mt-30 -69.09 -10.69 58.87 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.387 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.567 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 68.3 mtm180 49.38 46.03 3.38 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.567 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 3.2 Cg_exo -78.48 132.05 10.88 Favored 'Trans proline' 0 C--O 1.266 1.912 0 C-N-CA 121.521 1.48 . . . . 0.0 110.755 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.3 t -116.42 111.02 19.43 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -138.41 156.1 47.89 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -91.47 -6.62 52.37 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.078 0.466 . . . . 0.0 110.394 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -114.03 16.18 18.26 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.35 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.1 p -107.83 106.13 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 121.832 0.825 . . . . 0.0 111.071 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -71.84 146.13 48.17 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.983 173.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -108.87 160.74 15.75 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 124.556 1.142 . . . . 0.0 110.261 -174.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.3 m -124.31 139.19 51.4 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.535 0 CA-C-O 120.651 0.263 . . . . 0.0 111.09 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -106.97 139.48 41.31 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 46' ' ' TYR . 31.1 p -91.27 102.02 14.73 Favored 'General case' 0 C--O 1.256 1.407 0 C-N-CA 119.012 -1.075 . . . . 0.0 109.727 175.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -83.41 24.68 0.81 Allowed 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.386 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.32 -4.42 61.02 Favored Glycine 0 N--CA 1.432 -1.605 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.229 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.08 -20.18 1.94 Allowed Glycine 0 CA--C 1.539 1.533 0 C-N-CA 118.898 -1.62 . . . . 0.0 116.056 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.429 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 12.0 m -91.0 -34.05 15.29 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 118.806 1.303 . . . . 0.0 109.558 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 62.6 21.01 12.41 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.494 -176.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -88.08 159.41 18.26 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.257 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -108.96 130.14 55.45 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.273 0.559 . . . . 0.0 111.95 -176.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -118.47 157.46 27.19 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.975 -1.012 . . . . 0.0 109.82 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.916 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 40.3 m80 -92.11 140.32 29.76 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 173.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.423 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 51.0 mt-30 -62.43 -36.8 83.52 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.427 HG22 HE22 ' A' ' 9' ' ' GLN . 8.7 p -75.57 -40.76 41.31 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.662 0 O-C-N 121.243 -0.911 . . . . 0.0 111.873 176.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.916 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 9.2 p -72.09 -32.91 67.46 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.706 -173.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.442 HG13 HG23 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -104.95 3.2 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-O 121.135 0.493 . . . . 0.0 110.884 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.65 72.86 0.61 Allowed Glycine 0 CA--C 1.557 2.689 0 N-CA-C 116.129 1.211 . . . . 0.0 116.129 -176.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.442 HG23 HG13 ' A' ' 34' ' ' VAL . 78.8 t -130.3 145.23 35.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 56.7 p -97.95 151.01 37.34 Favored Pre-proline 0 N--CA 1.428 -1.544 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 176.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.36 -21.8 54.94 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 122.705 2.27 . . . . 0.0 111.551 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -73.64 -35.2 65.25 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.641 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.435 ' CE ' HG13 ' A' ' 36' ' ' VAL . 36.7 ttp -72.96 -38.9 66.56 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -176.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.88 -46.21 82.03 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.782 -1.099 . . . . 0.0 112.434 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -83.13 -17.5 42.78 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -112.55 -30.12 7.23 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -173.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -123.03 168.54 12.22 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.554 0.692 . . . . 0.0 112.728 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -90.03 115.35 27.24 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.405 -1.27 . . . . 0.0 109.214 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 51.2 t80 -79.34 108.89 13.2 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -178.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.9 mm -96.02 141.73 14.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 173.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.6 p -103.3 177.05 4.95 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.057 -176.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.2 tt -56.12 -38.13 52.35 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 O-C-N 123.887 0.742 . . . . 0.0 112.346 177.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -77.88 -34.19 51.67 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 122.212 -0.305 . . . . 0.0 111.37 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 61.6 m -72.21 -29.52 64.04 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.571 0.7 . . . . 0.0 110.301 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.074 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.828 -176.017 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.4 t . . . . . 0 N--CA 1.44 -0.955 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.404 ' SG ' ' HA ' ' A' ' 29' ' ' PHE . 0.5 OUTLIER -93.69 -173.96 3.32 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -177.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.65 119.98 32.61 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -177.55 144.15 0.38 Allowed 'General case' 0 CA--C 1.501 -0.912 0 C-N-CA 124.23 1.012 . . . . 0.0 108.76 172.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -47.88 -44.09 29.17 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 123.925 0.766 . . . . 0.0 110.468 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -135.53 102.29 5.07 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.328 173.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.541 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 43.3 t -95.52 118.88 33.04 Favored 'General case' 0 N--CA 1.407 -2.599 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.834 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -69.38 -9.42 53.39 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.834 178.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.556 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 79.1 ttt180 46.38 51.55 10.08 Favored Pre-proline 0 CA--C 1.574 1.897 0 C-N-CA 125.036 1.335 . . . . 0.0 112.692 -175.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.556 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 2.7 Cg_exo -81.61 134.42 8.68 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 121.839 1.693 . . . . 0.0 109.927 177.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 45.4 t -130.05 113.76 14.94 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -138.63 170.82 15.32 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -71.97 -59.46 2.73 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 171.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -74.56 87.87 2.14 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.29 177.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.2 p -172.28 100.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 122.109 0.957 . . . . 0.0 112.654 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -70.14 138.68 52.1 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.461 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 15.9 m95 -103.76 160.19 14.99 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 124.724 1.21 . . . . 0.0 108.552 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.5 m -126.02 139.63 50.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.574 0.226 . . . . 0.0 110.41 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -108.93 138.23 45.6 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.44 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.7 p -89.02 105.48 17.81 Favored 'General case' 0 C--O 1.249 1.037 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.145 177.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -85.1 22.81 1.35 Allowed 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 121.423 0.63 . . . . 0.0 110.25 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.53 -13.69 56.64 Favored Glycine 0 N--CA 1.426 -1.994 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.562 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.63 -27.71 0.42 Allowed Glycine 0 CA--C 1.533 1.205 0 C-N-CA 118.79 -1.672 . . . . 0.0 115.813 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.44 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 9.4 m -88.89 -30.14 19.11 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 118.533 1.167 . . . . 0.0 110.609 -176.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 60.63 19.15 9.11 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.723 0.809 . . . . 0.0 111.939 -175.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -90.0 163.48 14.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.446 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -108.66 128.94 55.29 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.504 -175.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.404 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . 4.9 m-85 -120.22 159.78 24.25 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.745 -176.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.931 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 44.9 m80 -95.76 138.57 33.23 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 173.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.544 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 48.9 mt-30 -54.52 -50.06 68.75 Favored 'General case' 0 C--O 1.19 -2.07 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 177.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 p -67.45 -41.95 86.64 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.305 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.931 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 6.6 p -70.67 -27.84 64.34 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.384 -175.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.628 HG13 HG23 ' A' ' 36' ' ' VAL . 1.4 p -106.9 11.6 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.871 0 CA-C-O 121.311 0.577 . . . . 0.0 110.574 178.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.67 38.32 95.5 Favored Glycine 0 CA--C 1.547 2.032 0 N-CA-C 117.25 1.66 . . . . 0.0 117.25 177.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.628 HG23 HG13 ' A' ' 34' ' ' VAL . 77.6 t -97.4 149.2 5.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 123.536 0.735 . . . . 0.0 109.44 176.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.4 p -99.73 152.14 37.71 Favored Pre-proline 0 N--CA 1.421 -1.907 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.544 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 24.9 Cg_endo -59.14 -22.32 63.77 Favored 'Trans proline' 0 N--CA 1.482 0.833 0 C-N-CA 122.173 1.915 . . . . 0.0 112.163 -178.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -73.8 -34.0 64.44 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.857 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 50.3 ttp -73.77 -39.33 64.27 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.422 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.44 -48.02 77.89 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -175.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -89.0 -14.21 37.05 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -110.05 -31.26 7.43 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -173.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -128.48 165.87 19.86 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 118.289 0.495 . . . . 0.0 112.153 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -75.2 115.31 14.7 Favored 'General case' 0 C--O 1.248 0.977 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.578 -176.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -79.54 108.93 13.45 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.938 0.875 . . . . 0.0 112.265 175.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.0 mm -105.45 148.73 9.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 173.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.3 p -109.24 177.3 4.8 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 119.238 0.926 . . . . 0.0 108.935 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.7 tt -55.94 -41.72 68.59 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 C-N-CA 124.026 0.93 . . . . 0.0 112.491 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -75.0 -32.67 61.7 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.13 0.491 . . . . 0.0 111.003 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 66.7 m -76.27 -28.91 57.23 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.827 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.519 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.264 -176.914 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.449 -0.508 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.412 ' SG ' ' HA ' ' A' ' 29' ' ' PHE . 0.5 OUTLIER -96.84 -172.5 2.48 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 119.394 -0.922 . . . . 0.0 108.62 -178.065 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.14 118.69 26.7 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -177.22 145.96 0.48 Allowed 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 171.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -48.6 -44.16 36.77 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.689 0.757 . . . . 0.0 109.118 173.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -131.55 101.52 5.54 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.159 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.52 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 50.5 t -98.34 112.23 24.3 Favored 'General case' 0 N--CA 1.406 -2.66 0 C-N-CA 118.36 -1.336 . . . . 0.0 110.262 177.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -67.12 -11.57 57.6 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.48 -1.237 . . . . 0.0 111.191 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.555 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 65.3 mtp180 52.34 44.76 2.21 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 123.834 0.854 . . . . 0.0 111.881 -173.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.555 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 23.7 Cg_exo -65.58 131.76 28.84 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 121.134 1.223 . . . . 0.0 110.341 -176.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 86.1 m -114.47 98.16 6.74 Favored 'General case' 0 N--CA 1.413 -2.292 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.885 -177.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -136.21 153.05 51.34 Favored 'General case' 0 CA--C 1.479 -1.753 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 172.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -81.13 -43.11 19.88 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 176.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -85.23 87.9 7.43 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.7 p -168.76 112.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.569 0.699 . . . . 0.0 111.427 177.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -74.22 144.79 44.56 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.685 -1.143 . . . . 0.0 112.852 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -110.31 159.94 16.98 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 125.2 1.4 . . . . 0.0 109.331 -176.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.6 m -126.62 137.09 58.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.062 0.458 . . . . 0.0 110.625 -178.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.427 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 52.0 tt0 -104.57 139.09 39.96 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 176.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.6 p -88.01 99.93 12.53 Favored 'General case' 0 C--O 1.25 1.085 0 C-N-CA 118.261 -1.376 . . . . 0.0 110.006 176.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -80.9 19.36 0.87 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.971 -176.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.35 3.25 50.6 Favored Glycine 0 N--CA 1.418 -2.507 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.697 -177.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 152.6 -34.33 0.82 Allowed Glycine 0 CA--C 1.536 1.402 0 C-N-CA 118.183 -1.961 . . . . 0.0 116.551 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.462 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 5.1 m -94.51 -30.11 14.58 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 118.799 1.3 . . . . 0.0 110.033 -176.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 60.31 22.09 11.57 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.577 0.751 . . . . 0.0 112.377 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 20' ' ' GLN . 46.2 mt-10 -86.65 164.78 16.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.483 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -108.46 123.39 48.81 Favored 'General case' 0 C--O 1.245 0.836 0 O-C-N 123.575 0.547 . . . . 0.0 111.681 -174.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.412 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . 2.9 m-85 -117.63 160.07 21.89 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.562 -176.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.908 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 40.0 m80 -94.4 138.74 31.98 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 173.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.414 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 48.6 mt-30 -55.43 -48.36 74.55 Favored 'General case' 0 C--O 1.184 -2.365 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.216 177.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.412 ' CG1' ' HG2' ' A' ' 11' ' ' PRO . 11.0 p -69.54 -38.27 76.42 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.272 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.287 -178.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.908 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 4.4 p -73.67 -28.97 62.04 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.811 -174.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.602 HG13 HG23 ' A' ' 36' ' ' VAL . 1.6 p -105.95 7.61 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.697 0 CA-C-O 121.524 0.678 . . . . 0.0 109.982 178.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.33 45.1 95.82 Favored Glycine 0 CA--C 1.546 1.984 0 N-CA-C 116.627 1.411 . . . . 0.0 116.627 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.602 HG23 HG13 ' A' ' 34' ' ' VAL . 84.4 t -96.2 148.17 5.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 173.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.5 p -100.86 153.03 37.97 Favored Pre-proline 0 N--CA 1.425 -1.711 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 175.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 10.2 Cg_endo -48.48 -39.83 36.66 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 123.267 2.644 . . . . 0.0 112.813 -176.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -65.92 -31.0 71.67 Favored 'General case' 0 C--O 1.202 -1.428 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.508 ' HB3' HG13 ' A' ' 36' ' ' VAL . 38.2 ttp -73.54 -33.96 64.97 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 118.481 -1.288 . . . . 0.0 108.77 -176.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.84 -47.85 79.1 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.467 175.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -86.93 -27.93 23.05 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -176.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -105.99 -27.41 11.18 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -171.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -127.69 173.37 9.98 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 119.821 -0.752 . . . . 0.0 112.32 -175.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -86.2 116.03 24.13 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.895 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -75.38 114.9 14.45 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 122.237 1.018 . . . . 0.0 113.301 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.8 mm -110.13 145.68 16.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 175.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.471 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 11.0 p -109.61 179.55 4.1 Favored 'General case' 0 C--O 1.217 -0.633 0 O-C-N 121.292 -0.88 . . . . 0.0 109.306 -176.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.6 tt -54.97 -40.16 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.512 0 C-N-CA 124.157 0.983 . . . . 0.0 112.626 177.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -78.06 -30.51 49.77 Favored 'General case' 0 C--O 1.212 -0.883 0 CA-C-O 120.911 0.386 . . . . 0.0 110.65 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.471 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 65.5 m -78.27 -31.09 48.88 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.054 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.669 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.582 -176.46 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 C--O 1.235 0.309 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.423 ' SG ' ' HA ' ' A' ' 29' ' ' PHE . 0.5 OUTLIER -93.74 -172.16 2.8 Favored 'General case' 0 C--O 1.255 1.361 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -178.435 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.8 119.07 30.72 Favored 'General case' 0 C--O 1.2 -1.504 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 176.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -176.68 142.85 0.43 Allowed 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 172.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -48.71 -44.67 38.34 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.613 0.765 . . . . 0.0 109.749 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -128.84 98.12 4.87 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.649 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.559 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 50.5 t -99.26 112.11 24.34 Favored 'General case' 0 N--CA 1.413 -2.307 0 C-N-CA 117.941 -1.504 . . . . 0.0 111.242 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -69.76 -7.89 43.41 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.608 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.588 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 76.7 mtp180 53.08 42.39 1.19 Allowed Pre-proline 0 CA--C 1.573 1.848 0 C-N-CA 124.348 1.059 . . . . 0.0 113.438 -175.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.588 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 11.8 Cg_exo -71.76 136.52 28.05 Favored 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 121.866 1.711 . . . . 0.0 111.951 -176.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 51.3 t -126.48 116.58 21.34 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.497 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -148.73 164.07 35.45 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 176.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -85.64 -7.66 58.7 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 176.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -128.73 88.49 2.74 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 114.691 -1.141 . . . . 0.0 108.698 -177.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 16' ' ' VAL . 6.9 p -178.14 96.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.657 0 CA-C-O 121.637 0.732 . . . . 0.0 110.124 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.79 144.01 57.39 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -109.16 159.52 16.84 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.242 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.8 m -129.58 135.36 61.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.036 0.446 . . . . 0.0 111.002 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 53.9 tt0 -100.28 139.28 36.19 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 176.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.3 p -89.7 102.7 15.39 Favored 'General case' 0 C--O 1.258 1.55 0 C-N-CA 118.617 -1.233 . . . . 0.0 110.742 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.64 18.79 0.54 Allowed 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.841 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.76 -10.26 60.35 Favored Glycine 0 N--CA 1.426 -1.988 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.886 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 147.06 -16.01 1.53 Allowed Glycine 0 C--O 1.213 -1.164 0 C-N-CA 118.459 -1.829 . . . . 0.0 116.486 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.524 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 13.6 m -92.29 -28.92 16.66 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.023 1.412 . . . . 0.0 109.332 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 58.68 18.5 5.96 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 124.289 1.036 . . . . 0.0 112.148 -174.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.409 ' O ' ' HA ' ' A' ' 20' ' ' GLN . 46.0 mt-10 -84.16 162.26 20.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.291 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -108.89 126.56 53.19 Favored 'General case' 0 C--O 1.246 0.916 0 CA-C-O 121.302 0.572 . . . . 0.0 112.036 -175.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.423 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . 2.8 m-85 -118.78 161.05 20.77 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.351 -177.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.9 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 45.7 m80 -95.64 142.56 27.81 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.456 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 48.6 mt-30 -58.04 -48.44 80.07 Favored 'General case' 0 C--O 1.189 -2.124 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.7 p -70.16 -38.61 75.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.236 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.9 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 2.9 p -72.74 -31.72 65.16 Favored 'General case' 0 C--O 1.213 -0.817 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.665 -173.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.501 HG13 HG23 ' A' ' 36' ' ' VAL . 1.7 p -104.09 5.35 10.45 Favored 'Isoleucine or valine' 0 C--O 1.254 1.311 0 CA-C-O 121.219 0.533 . . . . 0.0 110.361 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.35 70.91 0.89 Allowed Glycine 0 CA--C 1.54 1.618 0 CA-C-N 115.079 -0.964 . . . . 0.0 115.014 -176.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.501 HG23 HG13 ' A' ' 34' ' ' VAL . 54.5 t -119.38 147.65 22.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 174.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.7 p -98.1 151.98 37.8 Favored Pre-proline 0 N--CA 1.426 -1.647 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.417 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 13.2 Cg_endo -51.12 -36.8 56.45 Favored 'Trans proline' 0 N--CA 1.483 0.908 0 C-N-CA 123.052 2.501 . . . . 0.0 112.831 -176.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -73.13 -26.87 61.38 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.425 ' HB3' HG13 ' A' ' 36' ' ' VAL . 46.6 ttp -73.84 -34.19 64.44 Favored 'General case' 0 C--O 1.209 -1.071 0 C-N-CA 118.583 -1.247 . . . . 0.0 108.339 -177.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.6 -45.01 81.68 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -94.78 -32.27 13.38 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -98.05 -22.86 16.02 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -170.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -128.37 168.12 16.01 Favored 'General case' 0 C--N 1.311 -1.109 0 C-N-CA 119.92 -0.712 . . . . 0.0 112.12 -176.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -89.74 120.34 30.92 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.831 -174.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.425 ' CE2' ' HB3' ' A' ' 21' ' ' CYS . 89.0 t80 -81.97 108.23 15.31 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.5 mm -101.02 146.72 8.99 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 172.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.536 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 10.2 p -111.41 178.66 4.26 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 121.095 -1.003 . . . . 0.0 108.885 -177.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.9 tt -54.1 -42.36 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.358 0 C-N-CA 124.028 0.931 . . . . 0.0 112.315 177.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -76.78 -34.76 57.98 Favored 'General case' 0 C--O 1.212 -0.874 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.215 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.536 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 59.4 m -72.56 -26.03 61.58 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 121.164 0.507 . . . . 0.0 111.258 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.103 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.545 -179.023 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 57.8 t . . . . . 0 N--CA 1.446 -0.662 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -90.79 -172.16 3.28 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.17 119.48 31.85 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -176.58 146.49 0.6 Allowed 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.45 0.7 . . . . 0.0 109.237 172.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -47.65 -40.7 20.48 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 124.083 0.953 . . . . 0.0 109.834 174.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -139.46 111.55 7.45 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.244 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.568 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 46.8 t -106.15 116.06 31.28 Favored 'General case' 0 N--CA 1.416 -2.154 0 C-N-CA 117.93 -1.508 . . . . 0.0 112.355 177.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.435 HE22 HG22 ' A' ' 32' ' ' VAL . 70.2 mt-30 -72.89 -9.28 58.52 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 113.906 -1.497 . . . . 0.0 111.216 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.551 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 82.1 mtp180 53.21 51.85 9.51 Favored Pre-proline 0 N--CA 1.493 1.709 0 C-N-CA 124.175 0.99 . . . . 0.0 112.821 -174.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.551 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 4.2 Cg_exo -80.79 131.84 8.35 Favored 'Trans proline' 0 C--O 1.261 1.672 0 C-N-CA 122.032 1.821 . . . . 0.0 110.474 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 51.6 t -125.12 111.07 14.89 Favored 'General case' 0 N--CA 1.427 -1.613 0 O-C-N 123.661 0.601 . . . . 0.0 110.174 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.43 ' O ' HG12 ' A' ' 16' ' ' VAL . 97.1 mttt -140.35 157.53 45.41 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 175.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -87.81 2.86 50.28 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.082 0.468 . . . . 0.0 111.285 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -117.65 5.79 12.39 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.531 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 13' ' ' LYS . 7.9 p -97.38 105.37 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-O 121.978 0.894 . . . . 0.0 111.699 -178.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -76.17 153.31 36.27 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.629 175.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -115.23 159.55 20.83 Favored 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 124.445 1.098 . . . . 0.0 110.213 -172.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.3 m -127.44 138.91 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-O 120.738 0.304 . . . . 0.0 110.244 -177.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -106.56 139.35 41.16 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.471 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.6 p -90.0 103.51 16.17 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 118.89 -1.124 . . . . 0.0 109.113 174.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.0 26.96 0.57 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.812 0.845 . . . . 0.0 111.152 -175.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -111.21 7.25 28.81 Favored Glycine 0 N--CA 1.429 -1.774 0 CA-C-N 115.468 -0.787 . . . . 0.0 113.311 -176.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 148.45 -39.7 0.96 Allowed Glycine 0 CA--C 1.535 1.34 0 C-N-CA 118.116 -1.993 . . . . 0.0 115.375 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.471 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 7.9 m -85.88 -34.75 20.91 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 118.168 0.984 . . . . 0.0 108.457 -176.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 57.46 25.03 10.92 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.042 -177.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -87.51 168.35 13.15 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.949 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -110.87 126.42 54.66 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 122.782 0.433 . . . . 0.0 111.499 -176.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -118.83 159.27 24.05 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.689 -174.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.977 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 35.1 m80 -96.59 137.15 36.1 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 174.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.469 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 50.6 mt-30 -52.84 -46.43 67.8 Favored 'General case' 0 C--O 1.188 -2.156 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.435 HG22 HE22 ' A' ' 9' ' ' GLN . 9.3 p -72.97 -40.35 59.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 O-C-N 121.406 -0.809 . . . . 0.0 112.299 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.977 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 12.0 p -70.82 -27.59 63.99 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.87 -174.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.514 HG13 HG23 ' A' ' 36' ' ' VAL . 1.4 p -108.55 7.97 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 CA-C-O 121.394 0.616 . . . . 0.0 110.721 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.01 64.66 4.09 Favored Glycine 0 CA--C 1.559 2.828 0 N-CA-C 116.481 1.352 . . . . 0.0 116.481 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.655 HG13 ' SD ' ' A' ' 40' ' ' MET . 79.2 t -117.18 146.73 21.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 125.75 1.62 . . . . 0.0 107.193 175.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.0 p -98.31 155.42 36.91 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 177.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -55.54 -31.88 80.47 Favored 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 122.959 2.439 . . . . 0.0 113.142 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 45.6 mt-10 -71.83 -28.63 63.7 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 120.951 0.405 . . . . 0.0 110.79 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.655 ' SD ' HG13 ' A' ' 36' ' ' VAL . 28.2 ttt -69.99 -46.89 64.2 Favored 'General case' 0 C--O 1.208 -1.126 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -176.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.95 -45.25 90.93 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -86.31 -14.65 43.01 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -177.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 39' ' ' GLU . 93.0 m-20 -119.16 -34.33 3.9 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -174.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -124.6 158.55 32.79 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -172.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -72.23 114.23 10.12 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.794 -176.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -80.26 112.1 17.27 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 122.166 0.984 . . . . 0.0 113.438 177.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.1 mm -112.93 140.93 30.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 174.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.5 p -96.97 176.39 5.98 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -174.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.7 tt -54.06 -38.01 36.55 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 C-N-CA 123.965 0.906 . . . . 0.0 112.721 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -80.61 -30.82 36.79 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.0 0.429 . . . . 0.0 111.136 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 84.5 m -78.35 -27.83 47.09 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.323 0.582 . . . . 0.0 111.129 176.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.867 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.748 -177.758 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 49.0 t . . . . . 0 N--CA 1.442 -0.857 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.02 -176.3 4.85 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.04 -175.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.3 119.67 33.41 Favored 'General case' 0 C--O 1.198 -1.634 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -175.37 148.79 0.97 Allowed 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 173.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -47.4 -42.82 22.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 123.958 0.786 . . . . 0.0 110.533 174.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -141.56 105.32 4.72 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.635 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.581 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 53.2 t -97.43 110.17 22.78 Favored 'General case' 0 N--CA 1.419 -2.02 0 C-N-CA 118.771 -1.172 . . . . 0.0 111.47 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.463 HE22 HG22 ' A' ' 32' ' ' VAL . 72.5 mt-30 -67.56 -8.34 33.32 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.6 1.16 . . . . 0.0 111.016 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.59 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 88.7 mtm180 51.0 44.54 2.23 Favored Pre-proline 0 CA--C 1.563 1.457 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -178.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.59 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 8.4 Cg_exo -76.36 137.4 18.75 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 122.205 1.937 . . . . 0.0 111.248 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 45.6 t -130.89 114.54 15.39 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.313 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -148.24 166.84 26.74 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -71.07 -61.69 1.67 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.728 0.775 . . . . 0.0 108.958 173.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -65.55 30.07 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 126.197 1.799 . . . . 0.0 115.53 -175.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.0 p -123.55 109.0 22.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 119.444 1.02 . . . . 0.0 112.983 178.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -73.94 146.62 43.79 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.231 -1.35 . . . . 0.0 111.928 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.0 m95 -113.13 159.21 19.47 Favored 'General case' 0 C--O 1.216 -0.699 0 C-N-CA 124.365 1.066 . . . . 0.0 109.047 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.3 m -125.05 138.02 55.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 O-C-N 121.945 -0.472 . . . . 0.0 110.535 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -105.76 138.94 41.1 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.47 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.4 p -91.92 107.28 19.09 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 119.329 -0.948 . . . . 0.0 110.742 178.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -87.86 27.02 1.22 Allowed 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.517 0.675 . . . . 0.0 110.312 -176.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.4 -7.9 57.84 Favored Glycine 0 N--CA 1.425 -2.086 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.377 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 151.16 -20.82 0.96 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 118.899 -1.62 . . . . 0.0 115.65 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.47 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 8.4 m -94.32 -32.19 13.73 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 118.771 1.286 . . . . 0.0 111.478 -176.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 60.42 19.54 9.2 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 123.856 0.862 . . . . 0.0 111.905 -174.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -86.68 161.11 18.62 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.236 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 80.0 m95 -105.97 127.16 52.97 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.235 -176.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -120.12 157.71 28.42 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.112 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.878 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 51.9 m80 -93.09 138.72 31.28 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 174.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.488 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 48.1 mt-30 -52.88 -55.19 25.01 Favored 'General case' 0 C--O 1.198 -1.632 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 177.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.463 HG22 HE22 ' A' ' 9' ' ' GLN . 7.3 p -65.65 -36.96 78.85 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.489 0 CA-C-O 121.736 0.779 . . . . 0.0 111.755 -177.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.878 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 1.7 p -73.95 -24.65 59.67 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.045 -175.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.59 HG13 HG23 ' A' ' 36' ' ' VAL . 1.7 p -111.31 12.51 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.834 0 CA-C-O 121.484 0.659 . . . . 0.0 110.875 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.12 36.19 91.55 Favored Glycine 0 CA--C 1.555 2.577 0 N-CA-C 117.598 1.799 . . . . 0.0 117.598 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.686 HG13 ' SD ' ' A' ' 40' ' ' MET . 94.3 t -97.03 144.05 11.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 174.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.3 p -98.93 152.14 37.68 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 176.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.488 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 17.8 Cg_endo -57.32 -26.8 72.37 Favored 'Trans proline' 0 N--CA 1.486 1.032 0 C-N-CA 122.409 2.072 . . . . 0.0 112.629 -177.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -74.97 -25.87 59.17 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 121.549 0.69 . . . . 0.0 109.94 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.686 ' SD ' HG13 ' A' ' 36' ' ' VAL . 28.0 ttt -73.71 -46.23 47.46 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 124.313 1.045 . . . . 0.0 110.114 -178.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.92 -47.15 81.28 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.243 -0.889 . . . . 0.0 112.021 -176.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -78.55 -13.39 59.85 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -116.11 -39.88 3.37 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 116.755 2.131 . . . . 0.0 116.755 -173.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -124.16 165.32 17.76 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.007 0.821 . . . . 0.0 112.641 -174.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -74.11 115.32 13.45 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.178 -177.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.426 ' OH ' HG21 ' A' ' 34' ' ' VAL . 81.1 t80 -72.28 111.52 7.56 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-O 121.946 0.879 . . . . 0.0 112.272 172.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.5 mm -108.44 138.54 34.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 174.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 11.1 p -98.21 176.23 5.8 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -174.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.6 tt -57.91 -35.87 53.56 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.644 0 C-N-CA 123.586 0.755 . . . . 0.0 112.276 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -79.66 -34.34 40.47 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 120.824 0.345 . . . . 0.0 110.774 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 59.4 m -72.18 -26.0 61.9 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 121.326 0.584 . . . . 0.0 110.539 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.804 -177.602 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 CA--C 1.518 -0.283 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' A' ' 4' ' ' ALA . 0.4 OUTLIER -87.88 -177.79 5.87 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.419 ' N ' ' SG ' ' A' ' 3' ' ' CYS . . . -90.54 120.04 31.3 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 178.73 135.34 0.09 Allowed 'General case' 0 C--O 1.214 -0.768 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 171.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -49.93 -42.64 48.79 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 120.983 0.421 . . . . 0.0 111.086 177.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -121.54 90.62 3.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.906 173.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.503 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 44.2 t -93.94 117.03 29.54 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.529 177.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -69.32 -8.0 42.28 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.019 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.569 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 29.7 mtm180 47.82 46.21 3.4 Favored Pre-proline 0 CA--C 1.563 1.461 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -175.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.569 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 4.2 Cg_exo -76.35 131.86 13.15 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 121.942 1.761 . . . . 0.0 111.87 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 53.4 t -121.4 114.89 21.93 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -146.01 157.54 43.87 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -76.99 -10.04 59.1 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.434 0.635 . . . . 0.0 110.827 177.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -124.51 84.73 2.31 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.159 177.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.1 p -172.31 97.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 122.149 0.976 . . . . 0.0 111.239 176.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -71.06 146.66 49.17 Favored 'General case' 0 C--N 1.279 -2.464 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.242 174.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -107.01 159.51 16.23 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.482 -174.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.9 m -125.48 132.82 70.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 120.69 0.281 . . . . 0.0 110.573 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -99.34 137.87 37.23 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.0 p -86.98 104.45 16.31 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 118.681 -1.208 . . . . 0.0 110.077 176.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -82.46 16.99 1.87 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.849 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.96 -7.31 74.35 Favored Glycine 0 N--CA 1.431 -1.644 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.973 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.19 -13.24 1.86 Allowed Glycine 0 CA--C 1.54 1.63 0 C-N-CA 119.063 -1.541 . . . . 0.0 116.907 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.475 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 17.3 m -95.23 -27.65 15.41 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 119.669 1.734 . . . . 0.0 110.444 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 63.94 16.4 9.86 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.655 0.782 . . . . 0.0 111.53 -176.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -91.36 159.4 16.01 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -176.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -106.33 126.35 52.12 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.638 -175.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -118.05 159.06 23.85 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.629 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.935 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 36.5 m80 -93.51 139.2 31.01 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 174.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.454 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 50.5 mt-30 -57.63 -42.91 84.3 Favored 'General case' 0 C--O 1.192 -1.959 0 O-C-N 123.579 0.55 . . . . 0.0 112.077 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.0 p -73.59 -41.02 55.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.603 -0.685 . . . . 0.0 112.197 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.935 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 11.3 p -71.55 -31.33 66.89 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.407 -173.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.5 HG13 HG23 ' A' ' 36' ' ' VAL . 1.2 p -104.23 6.51 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.715 0 CA-C-O 121.312 0.577 . . . . 0.0 111.066 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.29 67.75 1.96 Allowed Glycine 0 CA--C 1.547 2.093 0 N-CA-C 115.95 1.14 . . . . 0.0 115.95 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.5 HG23 HG13 ' A' ' 34' ' ' VAL . 70.6 t -124.22 149.51 28.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 174.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.1 p -103.81 151.61 38.86 Favored Pre-proline 0 N--CA 1.421 -1.884 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 175.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.454 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 73.3 Cg_exo -52.52 -22.97 17.93 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.771 2.314 . . . . 0.0 112.231 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 34.1 tt0 -74.1 -36.62 64.25 Favored 'General case' 0 C--O 1.187 -2.215 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.091 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.429 ' HB3' HG13 ' A' ' 36' ' ' VAL . 39.4 ttp -73.83 -37.64 64.79 Favored 'General case' 0 CA--C 1.503 -0.859 0 O-C-N 121.097 -1.002 . . . . 0.0 110.092 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.96 -48.59 78.01 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.154 -0.93 . . . . 0.0 113.242 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -94.6 -16.05 23.54 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 119.82 -0.752 . . . . 0.0 112.833 -176.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.492 ' HB2' ' O ' ' A' ' 39' ' ' GLU . 16.3 m120 -105.39 -19.09 13.9 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -173.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -138.3 177.02 8.19 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.174 0.512 . . . . 0.0 111.706 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -92.11 121.6 33.81 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.791 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.403 ' OH ' HG21 ' A' ' 34' ' ' VAL . 80.4 t80 -75.72 104.86 6.46 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.017 1.118 . . . . 0.0 114.017 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.9 mm -94.6 139.05 19.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 170.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.421 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 13.2 p -101.19 173.66 6.36 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 119.061 -1.056 . . . . 0.0 108.751 -177.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.4 tt -57.53 -37.51 58.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 123.057 0.543 . . . . 0.0 112.042 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -75.44 -29.79 59.8 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-O 120.981 0.419 . . . . 0.0 110.535 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.421 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 52.4 m -77.76 -27.38 50.34 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.296 0.57 . . . . 0.0 110.61 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.082 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.531 -176.481 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.4 t . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -88.75 -172.25 3.64 Favored 'General case' 0 C--O 1.248 1.023 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -177.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.59 119.79 33.06 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -179.98 132.02 0.1 Allowed 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 171.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -50.04 -42.82 50.33 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 121.411 0.624 . . . . 0.0 110.99 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -123.9 97.62 5.44 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 173.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.52 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 46.6 t -99.25 121.06 40.54 Favored 'General case' 0 N--CA 1.423 -1.821 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.238 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -70.41 -8.02 47.62 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 124.122 0.969 . . . . 0.0 110.29 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.528 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 32.8 ttp180 42.88 56.22 11.17 Favored Pre-proline 0 CA--C 1.568 1.663 0 C-N-CA 126.084 1.754 . . . . 0.0 114.592 -177.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.528 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 6.3 Cg_exo -87.87 144.96 6.45 Favored 'Trans proline' 0 C--O 1.26 1.577 0 C-N-CA 122.896 2.397 . . . . 0.0 112.307 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 59.0 m -127.44 125.73 41.08 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -144.15 162.13 37.08 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 176.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -84.55 -9.26 58.48 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 174.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -129.11 84.99 2.27 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.031 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.41 ' O ' HG13 ' A' ' 16' ' ' VAL . 8.1 p -172.02 104.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.738 0.78 . . . . 0.0 111.312 177.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -73.11 145.89 46.12 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.471 176.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -107.48 159.82 16.12 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 124.568 1.147 . . . . 0.0 109.206 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.9 m -123.06 141.95 41.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 120.607 0.242 . . . . 0.0 110.413 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 64.2 tt0 -112.28 139.32 47.93 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.427 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 29.1 p -89.6 105.58 17.89 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.806 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -77.58 29.1 0.16 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.869 0.868 . . . . 0.0 111.391 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.523 ' HA3' ' SG ' ' A' ' 51' ' ' CYS . . . -95.08 -22.78 21.94 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 141.51 1.82 1.38 Allowed Glycine 0 CA--C 1.542 1.745 0 C-N-CA 119.875 -1.155 . . . . 0.0 115.581 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.427 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 24.7 m -94.66 -29.69 14.7 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 118.74 1.27 . . . . 0.0 109.208 177.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 64.68 16.46 10.37 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.107 0.963 . . . . 0.0 112.117 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 20' ' ' GLN . 46.6 mt-10 -82.24 161.95 22.51 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.045 0.45 . . . . 0.0 111.638 -177.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -114.9 124.31 51.37 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.63 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -115.56 156.51 25.63 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -175.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.959 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 40.9 m80 -89.98 138.75 31.24 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.419 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 49.3 mt-30 -56.88 -49.93 74.04 Favored 'General case' 0 C--O 1.194 -1.835 0 O-C-N 123.537 0.523 . . . . 0.0 112.276 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.9 p -67.55 -37.39 78.71 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.628 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.959 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 6.6 p -76.11 -25.58 55.55 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -175.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.489 HG13 HG23 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -108.68 10.05 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.976 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.72 177.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.93 39.55 93.33 Favored Glycine 0 CA--C 1.549 2.214 0 N-CA-C 117.032 1.573 . . . . 0.0 117.032 178.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.489 HG23 HG13 ' A' ' 34' ' ' VAL . 85.1 t -96.25 145.44 8.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 117.742 0.771 . . . . 0.0 108.983 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.6 p -97.88 147.66 33.36 Favored Pre-proline 0 N--CA 1.414 -2.269 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 19.7 Cg_endo -57.21 -25.08 62.65 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 C-N-CA 123.008 2.472 . . . . 0.0 112.497 -176.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -74.56 -29.49 61.37 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.441 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 37.3 ttp -74.6 -39.22 62.31 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-O 121.107 0.479 . . . . 0.0 110.509 -176.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.44 -45.29 80.87 Favored 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -87.62 -13.36 42.97 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -117.31 -20.93 8.96 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -172.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -135.07 164.02 28.59 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.22 -176.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -83.19 119.79 24.99 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.212 -175.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -76.64 114.13 15.05 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 122.124 0.964 . . . . 0.0 112.379 174.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.6 mm -109.97 143.75 19.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 173.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.429 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 11.5 p -104.72 172.54 6.73 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 118.671 -1.211 . . . . 0.0 109.379 -176.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.5 tt -52.44 -37.38 23.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 C-N-CA 124.052 0.941 . . . . 0.0 112.73 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -79.93 -29.67 39.81 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-O 121.099 0.476 . . . . 0.0 110.918 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.523 ' SG ' ' HA3' ' A' ' 23' ' ' GLY . 54.5 m -77.29 -31.44 54.79 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.339 178.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.865 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.567 -176.749 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.9 t . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.31 -173.0 2.23 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.239 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.93 120.54 35.33 Favored 'General case' 0 C--O 1.2 -1.548 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -173.81 145.52 1.15 Allowed 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 173.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -48.29 -39.12 20.67 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 123.515 0.509 . . . . 0.0 110.725 174.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -138.48 100.19 4.03 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.855 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.561 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 48.1 t -99.65 113.57 26.1 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 118.359 -1.336 . . . . 0.0 111.557 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.445 HE22 HG22 ' A' ' 32' ' ' VAL . 74.2 mt-30 -69.29 -10.77 59.39 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 124.889 1.276 . . . . 0.0 111.402 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.496 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 71.4 mtp180 47.32 54.77 15.96 Favored Pre-proline 0 N--CA 1.484 1.23 0 C-N-CA 123.692 0.797 . . . . 0.0 112.649 -172.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.496 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 14.1 Cg_exo -72.95 131.29 16.68 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 121.257 1.305 . . . . 0.0 110.559 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 81.1 m -111.67 105.48 14.01 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.442 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -143.66 143.09 31.29 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -68.67 -54.4 16.52 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 176.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -85.12 96.66 9.51 Favored 'General case' 0 N--CA 1.424 -1.73 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.633 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.5 p -168.66 116.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 123.482 0.713 . . . . 0.0 110.326 174.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -78.86 140.78 38.08 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.234 -0.894 . . . . 0.0 113.279 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -107.75 160.41 15.74 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 125.557 1.543 . . . . 0.0 108.429 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.7 m -124.43 138.46 53.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 117.962 0.346 . . . . 0.0 110.513 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 53.4 tt0 -106.44 138.82 41.92 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 30.6 p -90.23 113.86 25.75 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.979 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -85.67 27.6 0.84 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.813 0.845 . . . . 0.0 110.631 -177.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.429 ' HA3' ' SG ' ' A' ' 51' ' ' CYS . . . -96.63 -19.71 26.53 Favored Glycine 0 N--CA 1.432 -1.605 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.333 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.76 -14.81 0.91 Allowed Glycine 0 CA--C 1.539 1.556 0 C-N-CA 119.711 -1.233 . . . . 0.0 115.371 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.455 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 7.9 m -89.82 -29.62 18.5 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 118.709 1.254 . . . . 0.0 110.544 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 59.54 19.77 8.26 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.54 -177.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 20' ' ' GLN . 42.7 mt-10 -89.7 165.37 14.24 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.918 -178.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -106.25 127.29 53.13 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.276 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -118.76 155.64 30.76 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.47 -176.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.902 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 57.5 m80 -92.3 139.07 30.98 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 174.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.521 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 50.1 mt-30 -55.17 -51.87 65.11 Favored 'General case' 0 C--O 1.2 -1.533 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.445 HG22 HE22 ' A' ' 9' ' ' GLN . 8.9 p -66.38 -37.72 80.25 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.621 0 CA-C-O 121.587 0.708 . . . . 0.0 112.188 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.902 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 2.7 p -74.06 -25.16 59.68 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.029 -174.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.591 HG13 HG23 ' A' ' 36' ' ' VAL . 1.6 p -112.86 13.24 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 CA-C-O 121.494 0.664 . . . . 0.0 110.882 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.11 38.51 96.07 Favored Glycine 0 CA--C 1.556 2.633 0 N-CA-C 117.014 1.566 . . . . 0.0 117.014 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.603 HG13 ' SD ' ' A' ' 40' ' ' MET . 95.2 t -95.93 147.13 6.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 174.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 52.3 p -98.22 151.46 37.53 Favored Pre-proline 0 C--N 1.298 -1.673 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 174.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.521 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 14.6 Cg_endo -54.41 -31.43 68.24 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.801 2.334 . . . . 0.0 113.416 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -69.43 -32.45 71.41 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 123.932 0.893 . . . . 0.0 110.153 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.603 ' SD ' HG13 ' A' ' 36' ' ' VAL . 28.2 ttt -69.1 -42.85 75.59 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.033 0.933 . . . . 0.0 110.191 -176.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.52 -38.78 69.67 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -177.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -92.1 -47.0 7.48 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 119.053 -1.059 . . . . 0.0 113.712 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -71.15 -37.55 72.25 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -174.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -126.7 160.76 29.84 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.071 -1.052 . . . . 0.0 112.111 -171.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -78.02 115.53 17.83 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 121.294 0.569 . . . . 0.0 110.868 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -72.72 118.4 15.6 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.886 0.851 . . . . 0.0 112.796 175.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.2 mm -113.35 139.16 40.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 173.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.1 p -97.85 178.67 5.06 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.508 -174.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.1 tt -57.0 -37.63 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.622 0 C-N-CA 124.076 0.95 . . . . 0.0 112.805 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -83.36 -28.1 29.22 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 121.255 0.55 . . . . 0.0 110.849 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.429 ' SG ' ' HA3' ' A' ' 23' ' ' GLY . 60.2 m -77.11 -24.99 51.7 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.339 0.59 . . . . 0.0 110.693 177.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.58 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.873 -178.347 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 C--O 1.245 0.821 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.32 -174.41 4.38 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 119.676 -0.81 . . . . 0.0 109.027 -177.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.96 119.22 30.97 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -175.6 142.03 0.54 Allowed 'General case' 0 CA--C 1.496 -1.105 0 C-N-CA 123.432 0.693 . . . . 0.0 109.303 174.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -47.61 -44.27 26.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 124.264 0.978 . . . . 0.0 110.239 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -135.38 95.77 3.34 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.373 176.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.54 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 49.5 t -92.81 115.65 28.31 Favored 'General case' 0 N--CA 1.419 -1.992 0 C-N-CA 119.15 -1.02 . . . . 0.0 110.678 178.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -72.07 -8.74 56.34 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.415 177.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.5 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 58.9 ttt180 47.89 52.64 12.81 Favored Pre-proline 0 CA--C 1.565 1.548 0 C-N-CA 125.345 1.458 . . . . 0.0 112.073 -177.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.5 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 14.9 Cg_exo -70.97 132.76 22.0 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 121.503 1.469 . . . . 0.0 110.398 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 46.3 t -119.39 106.27 12.11 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.45 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -149.57 163.35 38.1 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -83.9 -55.91 3.98 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 173.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -68.19 82.95 0.23 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 121.333 -0.147 . . . . 0.0 111.206 172.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.7 p -173.1 104.52 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 122.052 0.929 . . . . 0.0 110.752 175.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -74.56 149.68 40.07 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 114.947 -1.024 . . . . 0.0 113.334 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -113.59 160.69 18.29 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 125.262 1.425 . . . . 0.0 109.793 -175.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.5 m -123.63 136.96 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-O 120.715 0.293 . . . . 0.0 110.274 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.474 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 54.1 tt0 -103.79 138.68 40.06 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 175.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 46' ' ' TYR . 29.4 p -90.73 103.56 16.25 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 118.976 -1.09 . . . . 0.0 110.688 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -82.82 21.03 1.06 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.052 -0.977 . . . . 0.0 111.18 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.49 -8.08 61.33 Favored Glycine 0 N--CA 1.434 -1.464 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.694 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 151.72 -23.7 0.93 Allowed Glycine 0 CA--C 1.54 1.627 0 C-N-CA 118.646 -1.74 . . . . 0.0 115.412 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.477 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 8.5 m -91.99 -29.59 16.53 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 118.839 1.319 . . . . 0.0 109.462 -176.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 58.07 26.47 13.64 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.921 -176.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 20' ' ' GLN . 37.7 mt-10 -94.43 167.19 11.67 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.4 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -108.39 129.31 55.25 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.374 -175.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -122.9 156.94 33.64 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.844 -177.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.905 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 56.1 m80 -94.0 141.19 28.81 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.592 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 51.0 mt-30 -58.38 -44.08 88.75 Favored 'General case' 0 C--O 1.187 -2.213 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.6 p -76.02 -37.8 34.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 118.862 -1.135 . . . . 0.0 111.273 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.905 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 1.8 p -70.76 -33.16 70.5 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.793 -174.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.494 HG13 HG23 ' A' ' 36' ' ' VAL . 1.5 p -106.16 12.25 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.803 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.42 66.12 3.07 Favored Glycine 0 CA--C 1.55 2.219 0 N-CA-C 116.586 1.394 . . . . 0.0 116.586 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.494 HG23 HG13 ' A' ' 34' ' ' VAL . 78.7 t -116.98 149.15 19.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 175.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.4 p -95.97 147.99 33.84 Favored Pre-proline 0 N--CA 1.418 -2.044 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.592 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 18.2 Cg_endo -56.3 -27.19 65.67 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 C-N-CA 122.725 2.283 . . . . 0.0 112.231 -176.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -74.54 -28.81 61.12 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.82 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.414 ' CE ' HG13 ' A' ' 36' ' ' VAL . 34.6 ttp -72.33 -39.0 68.51 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -176.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.73 -30.61 65.69 Favored 'General case' 0 CA--C 1.564 1.5 0 CA-C-N 114.633 -1.167 . . . . 0.0 113.431 -176.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -95.26 -13.18 25.09 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -118.03 -35.85 3.76 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 -172.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -131.17 153.48 49.38 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.584 0.629 . . . . 0.0 110.974 -173.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -71.72 126.9 30.9 Favored 'General case' 0 C--O 1.251 1.154 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.495 -176.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 54.1 t80 -76.36 110.93 11.29 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-O 122.028 0.918 . . . . 0.0 113.454 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.4 mm -95.21 134.93 30.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 173.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.44 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 13.4 p -101.57 -179.79 4.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 119.326 0.966 . . . . 0.0 109.095 -175.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.5 tt -54.43 -42.79 60.42 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 C-N-CA 123.862 0.865 . . . . 0.0 112.131 177.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -77.5 -28.5 52.17 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-O 120.656 0.265 . . . . 0.0 111.121 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.44 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 56.5 m -77.01 -26.25 53.58 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-O 121.06 0.457 . . . . 0.0 110.916 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.738 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.0 -178.145 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 44.1 t . . . . . 0 C--O 1.244 0.784 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.434 ' SG ' ' N ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -86.31 -172.89 4.27 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.575 -178.559 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.434 ' N ' ' SG ' ' A' ' 3' ' ' CYS . . . -97.4 123.07 41.11 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 176.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -172.32 141.66 1.24 Allowed 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 172.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -48.2 -28.22 2.87 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.967 0.907 . . . . 0.0 110.8 173.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -153.43 104.45 2.75 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.927 174.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.595 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 52.2 t -101.35 123.69 45.85 Favored 'General case' 0 N--CA 1.412 -2.341 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.566 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.413 HE22 HG22 ' A' ' 32' ' ' VAL . 70.2 mt-30 -75.64 -7.35 54.05 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.176 178.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.569 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 36.5 ttt180 47.93 48.78 6.32 Favored Pre-proline 0 CA--C 1.573 1.861 0 C-N-CA 125.751 1.62 . . . . 0.0 112.197 -176.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.569 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 6.1 Cg_exo -77.42 141.6 20.28 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.252 1.968 . . . . 0.0 111.818 -177.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.5 t -134.38 116.59 15.36 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.968 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -139.11 158.36 44.31 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 174.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -81.42 -3.0 51.59 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 122.056 0.932 . . . . 0.0 108.772 175.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -128.91 85.47 2.33 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.128 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.3 p -175.79 111.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 122.015 0.912 . . . . 0.0 111.003 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -73.01 159.26 33.94 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 114.116 -1.402 . . . . 0.0 111.953 176.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 17.8 m95 -125.51 159.35 32.21 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.068 0.947 . . . . 0.0 109.905 -174.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.1 m -129.19 136.42 59.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 120.79 0.329 . . . . 0.0 110.249 -178.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -101.48 139.74 36.72 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 29.9 p -88.06 103.14 15.44 Favored 'General case' 0 C--O 1.248 1.006 0 C-N-CA 118.698 -1.201 . . . . 0.0 110.124 176.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -81.66 21.51 0.81 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.066 -175.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.22 -12.94 55.66 Favored Glycine 0 N--CA 1.423 -2.217 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.87 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 149.78 -16.14 1.07 Allowed Glycine 0 CA--C 1.537 1.408 0 C-N-CA 118.509 -1.805 . . . . 0.0 116.143 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.462 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 13.5 m -90.63 -30.33 17.23 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 119.014 1.407 . . . . 0.0 109.454 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 60.83 22.55 12.6 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.52 -175.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -88.66 161.42 16.87 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.953 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -108.93 127.87 54.44 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.438 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -118.63 160.18 22.28 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.376 -176.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.93 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 48.9 m80 -94.77 134.71 37.09 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 174.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -54.27 -38.26 65.64 Favored 'General case' 0 C--O 1.203 -1.389 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 178.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.413 HG22 HE22 ' A' ' 9' ' ' GLN . 10.5 p -77.14 -42.16 31.3 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.315 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.696 178.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.93 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 10.0 p -71.71 -30.98 66.24 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.805 -172.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.521 HG13 HG23 ' A' ' 36' ' ' VAL . 1.4 p -103.99 10.85 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.073 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.636 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.34 60.33 9.14 Favored Glycine 0 CA--C 1.543 1.793 0 N-CA-C 116.187 1.235 . . . . 0.0 116.187 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.521 HG23 HG13 ' A' ' 34' ' ' VAL . 77.4 t -107.93 146.63 13.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 174.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.7 p -99.38 156.33 35.53 Favored Pre-proline 0 N--CA 1.413 -2.276 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -58.49 -25.88 75.84 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.458 2.105 . . . . 0.0 111.307 177.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -71.33 -34.41 70.52 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.015 -178.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 35.1 ttp -75.1 -47.42 28.79 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.696 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.7 -45.18 90.07 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -175.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -79.23 -18.69 52.36 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -177.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -116.43 -30.99 5.73 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 -173.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -131.42 166.34 21.51 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 119.638 1.108 . . . . 0.0 113.806 -172.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.82 117.64 17.77 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.463 -177.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.456 ' OH ' HG21 ' A' ' 34' ' ' VAL . 82.6 t80 -73.91 117.11 15.31 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-O 122.184 0.992 . . . . 0.0 113.598 178.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.5 mm -107.03 148.06 11.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 106.16 -1.792 . . . . 0.0 106.16 174.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.487 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 11.8 p -111.55 177.32 4.69 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 119.123 0.874 . . . . 0.0 108.756 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.2 tt -55.2 -41.17 59.23 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.339 0 C-N-CA 124.047 0.939 . . . . 0.0 112.358 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -76.15 -32.79 59.26 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.048 0.451 . . . . 0.0 110.808 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.487 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 64.2 m -74.46 -25.38 59.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.219 0.533 . . . . 0.0 110.448 176.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.49 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.401 -178.525 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.4 t . . . . . 0 N--CA 1.442 -0.864 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.412 ' SG ' ' N ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -96.01 -172.48 2.58 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.776 -176.147 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.412 ' N ' ' SG ' ' A' ' 3' ' ' CYS . . . -91.77 120.53 32.58 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -177.08 146.38 0.51 Allowed 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 172.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -47.9 -43.01 28.4 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 124.019 0.824 . . . . 0.0 110.802 174.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -140.12 99.96 3.8 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.91 173.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.552 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 47.3 t -91.5 120.42 32.31 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.892 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.442 HE22 HG22 ' A' ' 32' ' ' VAL . 70.7 mt-30 -71.06 -8.17 51.55 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.791 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.504 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 68.7 ttt180 48.99 53.99 15.47 Favored Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 125.51 1.524 . . . . 0.0 112.012 -175.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.504 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 10.8 Cg_exo -73.91 131.93 16.31 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 121.825 1.683 . . . . 0.0 111.037 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.3 t -125.36 110.21 13.7 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.003 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -137.44 156.59 47.99 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 174.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -68.52 -50.48 51.77 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.6 0.714 . . . . 0.0 110.236 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -103.11 92.73 4.65 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.227 0.537 . . . . 0.0 110.499 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.4 p -156.42 123.89 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.939 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.532 ' HB2' ' NE2' ' A' ' 31' ' ' GLN . 6.9 m-20 -69.62 157.63 36.84 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.747 -1.115 . . . . 0.0 113.204 177.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -133.29 159.67 39.56 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 125.524 1.53 . . . . 0.0 107.798 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.417 HG23 ' HB2' ' A' ' 29' ' ' PHE . 22.5 m -131.06 130.93 64.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 120.987 0.422 . . . . 0.0 110.577 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.455 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 50.4 tt0 -98.7 138.58 35.66 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 175.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.469 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 32.0 p -87.7 108.27 19.03 Favored 'General case' 0 C--O 1.25 1.121 0 C-N-CA 118.404 -1.318 . . . . 0.0 110.155 177.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -82.99 23.73 0.82 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.385 -177.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.32 -9.8 61.45 Favored Glycine 0 N--CA 1.417 -2.595 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.3 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 139.9 -14.35 3.1 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 119.12 -1.514 . . . . 0.0 115.567 177.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.469 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 19.1 m -87.41 -28.12 22.33 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 119.14 1.47 . . . . 0.0 108.709 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 59.5 21.59 10.08 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.961 -177.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' ' 20' ' ' GLN . 42.9 mt-10 -88.99 163.96 15.31 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 120.951 0.405 . . . . 0.0 111.653 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 44.9 m95 -108.14 128.69 54.91 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.239 -175.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.417 ' HB2' HG23 ' A' ' 19' ' ' VAL . 11.1 m-85 -121.89 158.54 28.77 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.913 -178.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.927 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 49.0 m80 -97.56 140.19 32.34 Favored 'General case' 0 CA--C 1.488 -1.413 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 174.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.532 ' NE2' ' HB2' ' A' ' 17' ' ' ASP . 50.8 mt-30 -56.95 -45.62 82.71 Favored 'General case' 0 C--O 1.191 -2.023 0 O-C-N 123.771 0.67 . . . . 0.0 112.75 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.442 HG22 HE22 ' A' ' 9' ' ' GLN . 9.8 p -71.07 -40.17 75.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 O-C-N 121.575 -0.703 . . . . 0.0 112.086 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.927 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 9.4 p -70.85 -33.95 71.16 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.837 -174.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.566 HG13 HG23 ' A' ' 36' ' ' VAL . 1.7 p -104.13 10.23 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 CA-C-O 121.291 0.567 . . . . 0.0 110.497 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.08 60.52 8.49 Favored Glycine 0 CA--C 1.551 2.339 0 N-CA-C 116.501 1.36 . . . . 0.0 116.501 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.566 HG23 HG13 ' A' ' 34' ' ' VAL . 74.6 t -115.87 148.3 18.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 175.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.1 p -100.13 149.83 36.36 Favored Pre-proline 0 N--CA 1.421 -1.912 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.477 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 72.9 Cg_exo -53.94 -30.23 57.68 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 122.961 2.441 . . . . 0.0 112.507 -178.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -69.3 -31.88 70.66 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.062 -178.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 35.2 ttp -74.84 -42.3 58.23 Favored 'General case' 0 C--O 1.208 -1.112 0 CA-C-O 121.269 0.557 . . . . 0.0 110.185 -177.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.42 -41.24 79.99 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -176.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -86.21 -14.02 45.19 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -113.37 -34.18 5.69 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -174.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -130.02 144.21 51.21 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 118.654 0.661 . . . . 0.0 111.105 -174.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -70.45 115.61 9.83 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.293 -178.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -69.74 120.2 15.13 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -176.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.8 mm -102.41 139.87 22.3 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.904 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 173.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.2 p -102.19 178.57 4.56 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.875 0.761 . . . . 0.0 109.88 -176.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.7 tt -55.98 -39.45 57.7 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.476 0 C-N-CA 123.769 0.828 . . . . 0.0 112.247 177.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -74.55 -38.47 62.72 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 121.159 0.504 . . . . 0.0 110.848 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 63.7 m -69.33 -27.18 65.14 Favored 'General case' 0 C--O 1.213 -0.819 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.89 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.109 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.67 -177.362 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.8 t . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.42 ' SG ' ' N ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -90.45 -175.21 4.39 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.502 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.42 ' N ' ' SG ' ' A' ' 3' ' ' CYS . . . -95.67 123.17 39.1 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -176.11 151.31 1.04 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 172.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -47.13 -42.91 20.17 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.259 0.624 . . . . 0.0 110.928 173.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -141.58 107.57 5.18 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.801 176.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.589 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 47.0 t -101.19 116.85 33.77 Favored 'General case' 0 N--CA 1.42 -1.938 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.976 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -74.38 -11.38 60.23 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.156 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.521 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 31.5 mtm180 49.11 53.51 14.67 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 125.511 1.524 . . . . 0.0 114.388 -174.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 8.5 Cg_exo -78.05 139.7 17.36 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 121.826 1.684 . . . . 0.0 111.265 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.4 t -132.86 115.81 15.73 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -149.68 156.83 42.54 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.39 -15.38 63.53 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.194 0.598 . . . . 0.0 111.667 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -116.75 18.98 14.71 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -170.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.8 p -114.76 106.18 20.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.945 0.878 . . . . 0.0 112.465 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -72.75 148.37 44.69 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.355 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -113.18 158.97 19.77 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.511 1.125 . . . . 0.0 110.182 -174.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.2 m -125.98 132.16 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-O 120.678 0.275 . . . . 0.0 110.77 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -99.23 138.88 35.69 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.489 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 28.8 p -83.88 108.77 17.08 Favored 'General case' 0 C--O 1.255 1.345 0 C-N-CA 118.708 -1.197 . . . . 0.0 111.667 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -76.39 18.87 0.28 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.315 1.046 . . . . 0.0 112.17 -176.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.575 ' HA3' ' SG ' ' A' ' 51' ' ' CYS . . . -92.93 -18.67 39.36 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.117 -179.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 141.41 -6.83 2.5 Favored Glycine 0 CA--C 1.545 1.93 0 C-N-CA 119.185 -1.483 . . . . 0.0 115.978 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.489 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 16.9 m -88.89 -25.1 22.31 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 119.133 1.467 . . . . 0.0 109.315 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 59.92 18.48 7.53 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.299 1.04 . . . . 0.0 113.051 -176.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -85.91 159.36 19.68 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.212 0.529 . . . . 0.0 111.181 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -106.39 126.24 52.0 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.06 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.402 ' CD1' ' HE2' ' A' ' 46' ' ' TYR . 3.0 m-85 -118.64 159.31 23.83 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.706 -177.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.923 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 41.6 m80 -96.28 135.86 37.54 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.46 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 50.8 mt-30 -55.02 -40.05 69.76 Favored 'General case' 0 C--O 1.188 -2.148 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 177.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.415 ' CG1' ' HG2' ' A' ' 11' ' ' PRO . 11.7 p -76.43 -38.86 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.454 0 C-N-CA 119.692 -0.803 . . . . 0.0 112.092 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.923 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 7.7 p -75.08 -29.5 60.68 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -174.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.564 HG21 ' OH ' ' A' ' 46' ' ' TYR . 2.1 p -104.7 1.95 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 CA-C-O 121.678 0.751 . . . . 0.0 110.117 178.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.7 75.03 0.35 Allowed Glycine 0 CA--C 1.55 2.233 0 N-CA-C 115.813 1.085 . . . . 0.0 115.813 -176.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.563 HG23 HG13 ' A' ' 34' ' ' VAL . 64.3 t -127.97 147.94 32.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 175.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 52.2 p -99.54 150.97 37.27 Favored Pre-proline 0 N--CA 1.421 -1.886 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.46 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 18.2 Cg_endo -56.09 -23.75 45.86 Favored 'Trans proline' 0 N--CA 1.485 0.988 0 C-N-CA 122.925 2.417 . . . . 0.0 112.32 -177.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -74.2 -32.97 63.25 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.186 -178.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 35.4 ttp -73.91 -41.32 62.29 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -176.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.26 -43.06 87.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.214 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -83.58 -21.35 32.66 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -177.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -110.38 -27.68 8.93 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 -174.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -132.7 166.08 23.02 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.461 1.028 . . . . 0.0 111.927 -174.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -81.91 115.64 21.19 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.564 ' OH ' HG21 ' A' ' 34' ' ' VAL . 49.7 t80 -68.72 113.37 6.13 Favored 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.4 mm -101.28 140.5 19.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.48 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 8.3 p -107.9 178.53 4.49 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.171 -177.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.2 tt -55.36 -41.83 63.98 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 C-N-CA 124.131 0.972 . . . . 0.0 112.245 177.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -77.64 -25.31 49.58 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 121.25 0.548 . . . . 0.0 110.393 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.575 ' SG ' ' HA3' ' A' ' 23' ' ' GLY . 55.5 m -78.03 -26.93 48.68 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.191 177.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.779 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.023 -176.638 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.0 t . . . . . 0 N--CA 1.441 -0.914 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.16 -173.56 3.29 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.43 119.73 33.6 Favored 'General case' 0 C--O 1.207 -1.162 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -177.64 142.26 0.31 Allowed 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 173.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -47.87 -45.1 29.94 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 124.046 0.841 . . . . 0.0 110.895 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -130.67 94.91 3.73 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.69 176.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.5 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 51.8 t -93.63 123.21 36.8 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 118.995 -1.082 . . . . 0.0 111.181 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -81.45 -11.68 59.15 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.831 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.569 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 62.4 mtm180 52.9 43.57 1.61 Allowed Pre-proline 0 CA--C 1.566 1.584 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -176.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.569 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 10.4 Cg_exo -76.86 143.63 23.57 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 121.619 1.546 . . . . 0.0 110.608 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 53.2 t -137.7 113.32 9.56 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.407 ' O ' HG12 ' A' ' 16' ' ' VAL . 97.7 mttt -142.69 151.38 41.3 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 177.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.24 -4.85 15.52 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 178.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -121.25 8.92 10.33 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -176.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 13' ' ' LYS . 7.2 p -102.86 107.18 21.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-O 121.756 0.789 . . . . 0.0 112.044 -178.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -74.07 146.8 43.38 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.592 176.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -111.95 159.16 18.67 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 124.638 1.175 . . . . 0.0 109.676 -174.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 23.1 m -123.86 132.65 71.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 O-C-N 121.949 -0.469 . . . . 0.0 110.763 -177.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -101.15 138.82 37.67 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.1 p -90.66 107.81 19.41 Favored 'General case' 0 C--O 1.255 1.35 0 C-N-CA 119.161 -1.016 . . . . 0.0 110.741 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -86.79 23.83 1.62 Allowed 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.926 -176.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.72 -14.09 60.14 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.11 -9.11 1.74 Allowed Glycine 0 CA--C 1.542 1.755 0 C-N-CA 119.032 -1.556 . . . . 0.0 116.234 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.479 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 13.9 m -92.58 -28.71 16.57 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 119.641 1.72 . . . . 0.0 110.209 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 61.91 17.69 9.15 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.831 1.253 . . . . 0.0 111.69 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -87.8 161.48 17.53 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.134 0.493 . . . . 0.0 111.598 -178.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -107.33 127.9 53.97 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.004 -176.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.411 ' HE1' ' SG ' ' A' ' 21' ' ' CYS . 3.5 m-85 -119.48 155.32 32.31 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -178.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.911 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 42.5 m80 -91.18 139.85 30.36 Favored 'General case' 0 CA--C 1.476 -1.867 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 174.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.493 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 48.4 mt-30 -54.45 -51.32 65.35 Favored 'General case' 0 C--O 1.192 -1.947 0 O-C-N 123.666 0.604 . . . . 0.0 111.806 177.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.8 p -68.2 -39.51 81.32 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 CA-C-O 121.125 0.488 . . . . 0.0 112.136 -178.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.911 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 3.4 p -72.76 -25.05 61.05 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.336 -174.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.486 HG13 HG23 ' A' ' 36' ' ' VAL . 0.9 OUTLIER -110.81 11.72 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.821 177.259 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.54 39.98 95.85 Favored Glycine 0 CA--C 1.546 2.021 0 N-CA-C 117.34 1.696 . . . . 0.0 117.34 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.486 HG23 HG13 ' A' ' 34' ' ' VAL . 69.4 t -93.92 147.95 5.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 118.153 0.976 . . . . 0.0 109.378 175.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.9 p -99.37 147.35 33.2 Favored Pre-proline 0 N--CA 1.414 -2.249 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 175.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.493 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 74.9 Cg_exo -51.41 -32.27 41.83 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.312 2.675 . . . . 0.0 114.062 -175.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.57 -26.02 60.63 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 35.9 ttp -73.38 -38.17 65.74 Favored 'General case' 0 C--O 1.213 -0.822 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.42 -43.98 79.9 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.659 -177.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -90.46 -12.28 37.82 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -113.59 -27.0 8.02 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -128.77 151.19 49.84 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.06 0.457 . . . . 0.0 110.324 -175.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -79.15 115.71 18.98 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.659 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.423 ' OH ' HG21 ' A' ' 34' ' ' VAL . 90.5 t80 -67.01 114.86 6.13 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-O 122.812 1.292 . . . . 0.0 114.428 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.0 mm -103.64 141.65 18.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 172.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.457 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 9.3 p -106.83 179.21 4.33 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.361 -176.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.5 tt -56.04 -43.28 74.94 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 C-N-CA 123.684 0.794 . . . . 0.0 112.269 177.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -76.04 -28.23 57.61 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.095 0.474 . . . . 0.0 110.943 -178.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.457 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 58.0 m -76.59 -25.56 54.07 Favored 'General case' 0 C--O 1.213 -0.83 0 CA-C-O 121.524 0.678 . . . . 0.0 110.901 176.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.293 -1.877 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.753 -176.809 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.5 t . . . . . 0 N--CA 1.449 -0.511 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.633 ' SG ' ' HA ' ' A' ' 29' ' ' PHE . 0.5 OUTLIER -100.77 -172.43 2.18 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 119.108 -1.037 . . . . 0.0 109.767 -176.204 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.99 121.94 31.85 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -173.78 145.3 1.14 Allowed 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 172.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -47.99 -42.0 26.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 123.771 0.669 . . . . 0.0 109.439 173.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -136.06 97.93 3.74 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.337 174.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.595 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 53.4 t -94.19 156.92 16.31 Favored 'General case' 0 N--CA 1.422 -1.843 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.24 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.646 ' C ' ' HD3' ' A' ' 11' ' ' PRO . 76.6 mt-30 -119.2 173.27 7.03 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.772 -177.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.422 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 19.2 mmm180 -116.69 62.88 2.77 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 123.416 0.686 . . . . 0.0 111.085 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.646 ' HD3' ' C ' ' A' ' 9' ' ' GLN . 5.0 Cg_exo -88.6 145.43 5.76 Favored 'Trans proline' 0 C--N 1.359 1.099 0 C-N-CA 123.389 2.726 . . . . 0.0 112.077 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.6 t -130.16 107.44 9.31 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.801 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -152.97 156.57 39.12 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 124.862 1.265 . . . . 0.0 108.581 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -87.77 -51.1 6.05 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 172.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -72.32 79.55 1.01 Allowed 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.992 175.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.6 p -165.61 102.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 122.125 0.964 . . . . 0.0 110.604 176.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -67.88 137.89 55.61 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 114.191 -1.368 . . . . 0.0 112.283 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 21.4 m95 -106.53 160.3 15.53 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.015 1.326 . . . . 0.0 108.945 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.5 m -127.83 132.72 68.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.115 0.483 . . . . 0.0 110.851 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.412 HE21 ' HA ' ' A' ' 26' ' ' ASP . 53.9 tt0 -100.45 138.99 36.76 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 30.6 p -87.69 102.67 14.87 Favored 'General case' 0 C--O 1.256 1.416 0 C-N-CA 118.997 -1.081 . . . . 0.0 110.595 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.52 24.44 0.57 Allowed 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.122 -175.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.64 -18.27 41.91 Favored Glycine 0 N--CA 1.437 -1.253 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 147.61 -10.65 1.27 Allowed Glycine 0 C--N 1.351 1.41 0 N-CA-C 116.951 1.54 . . . . 0.0 116.951 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.455 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 15.9 m -88.9 -26.8 21.4 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 119.754 1.777 . . . . 0.0 109.724 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.412 ' HA ' HE21 ' A' ' 20' ' ' GLN . 13.6 m-20 61.1 20.53 11.0 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.859 0.863 . . . . 0.0 112.417 -176.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -91.77 158.08 16.55 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.744 -178.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -107.77 132.78 53.02 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.896 -177.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.633 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . 3.5 m-85 -120.72 159.72 24.79 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.152 -177.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.874 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 42.4 m80 -93.35 134.49 35.52 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -56.87 -33.04 66.46 Favored 'General case' 0 C--O 1.197 -1.7 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 176.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.6 p -77.2 -41.6 30.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-O 121.336 0.589 . . . . 0.0 111.968 177.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.874 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 4.2 p -75.52 -29.17 59.37 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.992 -173.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.49 HG13 HG23 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -106.66 2.79 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.764 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.485 179.66 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.31 72.49 0.62 Allowed Glycine 0 CA--C 1.555 2.586 0 N-CA-C 116.316 1.286 . . . . 0.0 116.316 -176.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.49 HG23 HG13 ' A' ' 34' ' ' VAL . 59.3 t -121.2 148.77 24.34 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 C-N-CA 124.547 1.139 . . . . 0.0 108.176 175.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.6 p -99.99 150.83 37.22 Favored Pre-proline 0 N--CA 1.42 -1.946 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -49.95 -42.71 44.3 Favored 'Trans proline' 0 C--N 1.358 1.066 0 C-N-CA 123.051 2.501 . . . . 0.0 112.115 -177.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -60.07 -35.04 74.29 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 42.2 ttp -69.25 -43.33 74.19 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.617 -176.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.13 -48.24 80.84 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 123.792 0.683 . . . . 0.0 112.072 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -77.91 -13.78 59.77 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -176.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -122.19 -43.03 2.34 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 117.021 2.23 . . . . 0.0 117.021 -172.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -126.89 171.31 11.38 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -168.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -68.35 115.14 7.44 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.48 0.712 . . . . 0.0 112.184 -173.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.481 ' OH ' HG21 ' A' ' 34' ' ' VAL . 79.3 t80 -82.81 105.66 14.01 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 122.239 1.019 . . . . 0.0 111.757 172.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.0 mm -98.92 145.14 10.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 175.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.441 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 13.5 p -105.32 178.28 4.61 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 119.306 -0.958 . . . . 0.0 108.872 -178.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.0 tt -55.83 -41.31 65.94 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 124.071 0.948 . . . . 0.0 111.928 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -75.62 -39.89 57.15 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.912 0.485 . . . . 0.0 111.433 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.441 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 52.1 m -63.21 -29.81 71.08 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.023 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.696 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.587 -175.399 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.7 t . . . . . 0 N--CA 1.45 -0.438 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -87.68 -173.68 4.43 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -178.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.59 119.98 34.1 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 174.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -173.25 140.91 0.89 Allowed 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 171.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -48.99 -43.61 40.38 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.931 0.769 . . . . 0.0 109.474 176.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -127.96 104.88 8.04 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.797 177.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.563 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 42.1 t -105.9 125.23 50.75 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 117.738 -1.585 . . . . 0.0 112.614 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -81.23 -6.06 58.45 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.161 -1.381 . . . . 0.0 110.571 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.587 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 73.3 mtp180 53.11 39.9 0.69 Allowed Pre-proline 0 CA--C 1.57 1.712 0 C-N-CA 124.465 1.106 . . . . 0.0 113.787 -176.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.587 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 7.2 Cg_exo -74.67 134.0 17.85 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 121.687 1.591 . . . . 0.0 112.076 -175.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 51.2 t -127.69 125.1 39.44 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -149.04 164.23 35.23 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -77.35 -14.63 59.69 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.498 0.666 . . . . 0.0 109.253 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -131.45 91.44 3.01 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.929 -177.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.2 p -171.56 103.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 122.164 0.983 . . . . 0.0 111.143 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.678 ' HB2' ' NE2' ' A' ' 31' ' ' GLN . 4.1 m-20 -68.85 140.56 55.22 Favored 'General case' 0 C--N 1.275 -2.665 0 CA-C-N 114.433 -1.258 . . . . 0.0 111.722 177.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -107.55 159.82 16.14 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 124.198 0.999 . . . . 0.0 108.825 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.4 m -127.26 134.08 66.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 120.905 0.383 . . . . 0.0 110.397 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -101.0 139.07 37.2 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 30.1 p -91.63 99.68 12.54 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 118.875 -1.13 . . . . 0.0 109.951 176.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -85.07 22.45 1.42 Allowed 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.698 -175.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.21 -2.75 62.02 Favored Glycine 0 N--CA 1.426 -2.022 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.562 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.15 -23.74 1.12 Allowed Glycine 0 CA--C 1.541 1.675 0 C-N-CA 118.878 -1.629 . . . . 0.0 116.203 178.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.458 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 5.6 m -95.09 -31.84 13.38 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 119.089 1.444 . . . . 0.0 110.015 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 61.59 19.39 10.36 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 124.019 0.825 . . . . 0.0 111.908 -176.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -85.73 158.95 19.9 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.716 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -104.67 127.63 52.49 Favored 'General case' 0 C--O 1.242 0.669 0 O-C-N 123.619 0.574 . . . . 0.0 112.342 -176.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.411 ' HE1' ' SG ' ' A' ' 21' ' ' CYS . 8.9 m-85 -118.12 156.38 28.77 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.889 -1.051 . . . . 0.0 108.786 -177.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.937 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 47.2 m80 -93.56 139.11 31.13 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 174.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.678 ' NE2' ' HB2' ' A' ' 17' ' ' ASP . 50.6 mt-30 -56.12 -46.24 79.23 Favored 'General case' 0 C--O 1.188 -2.137 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.0 p -72.66 -37.85 57.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.738 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.937 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 5.4 p -72.24 -31.75 66.09 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.832 -175.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.463 HG13 HG23 ' A' ' 36' ' ' VAL . 1.4 p -104.47 5.69 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.659 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.36 72.12 0.73 Allowed Glycine 0 CA--C 1.548 2.142 0 N-CA-C 115.408 0.923 . . . . 0.0 115.408 -176.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.463 HG23 HG13 ' A' ' 34' ' ' VAL . 74.5 t -127.61 147.3 32.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 173.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.4 p -100.25 150.56 37.02 Favored Pre-proline 0 N--CA 1.422 -1.832 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 176.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.418 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 11.0 Cg_endo -53.58 -25.2 32.0 Favored 'Trans proline' 0 N--CA 1.488 1.148 0 C-N-CA 123.513 2.809 . . . . 0.0 112.735 -177.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -73.53 -34.27 65.14 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.364 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 39.8 ttp -74.43 -38.16 63.12 Favored 'General case' 0 C--O 1.21 -0.986 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.206 -176.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.88 -44.11 77.84 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -176.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -85.82 -46.14 10.92 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 176.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -75.1 -35.48 61.76 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 -173.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -128.08 164.07 23.22 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -171.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -82.93 115.67 21.89 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.877 0.871 . . . . 0.0 111.512 -174.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.445 ' OH ' HG21 ' A' ' 34' ' ' VAL . 77.8 t80 -78.49 110.77 13.86 Favored 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.2 mm -102.29 146.22 10.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 172.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.481 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 7.9 p -111.0 179.83 3.94 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 119.226 -0.99 . . . . 0.0 109.737 -175.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.6 tt -55.02 -40.05 52.43 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.538 0 C-N-CA 124.448 1.099 . . . . 0.0 112.636 177.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -82.93 -29.13 29.38 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.481 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 56.7 m -73.98 -27.98 61.25 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-O 120.887 0.375 . . . . 0.0 111.198 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.423 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.578 -176.043 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.4 p -87.72 -172.16 3.75 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -176.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.61 118.87 32.38 Favored 'General case' 0 C--O 1.206 -1.206 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 172.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -177.03 135.56 0.2 Allowed 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 171.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -51.36 -43.31 61.79 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.287 0.565 . . . . 0.0 110.483 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -121.91 103.11 8.61 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.886 175.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.579 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 42.2 t -107.49 122.16 46.08 Favored 'General case' 0 N--CA 1.417 -2.083 0 C-N-CA 118.024 -1.47 . . . . 0.0 111.993 177.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -79.49 -8.46 59.15 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.33 178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.487 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 38.1 ttp180 46.1 61.81 12.22 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 126.763 2.025 . . . . 0.0 111.997 -175.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.487 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 17.0 Cg_exo -76.23 132.98 14.32 Favored 'Trans proline' 0 C--O 1.252 1.184 0 C-N-CA 123.048 2.499 . . . . 0.0 111.752 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.4 t -123.82 102.66 7.92 Favored 'General case' 0 N--CA 1.44 -0.971 0 O-C-N 123.894 0.746 . . . . 0.0 110.479 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -141.03 159.6 41.87 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 175.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -81.74 -50.1 9.66 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.826 -0.75 . . . . 0.0 112.031 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -73.39 18.83 0.11 Allowed 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.5 p -102.74 111.21 31.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 119.287 0.949 . . . . 0.0 111.928 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -71.39 146.93 48.43 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.047 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -113.69 159.2 19.95 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.262 1.025 . . . . 0.0 109.822 -175.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.7 137.59 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-O 120.71 0.29 . . . . 0.0 110.546 -177.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -110.52 138.3 47.09 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.572 178.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.411 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.4 p -93.22 102.42 14.71 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.497 176.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -86.68 25.26 1.29 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.808 0.813 . . . . 0.0 109.881 -176.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.11 1.68 57.71 Favored Glycine 0 N--CA 1.431 -1.643 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.699 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 151.75 -35.28 0.86 Allowed Glycine 0 CA--C 1.534 1.256 0 C-N-CA 118.726 -1.702 . . . . 0.0 115.608 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.411 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 7.4 m -89.27 -32.75 17.23 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 118.548 1.174 . . . . 0.0 109.488 -176.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 59.95 21.39 10.43 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.748 1.219 . . . . 0.0 111.634 -177.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -88.15 163.7 16.06 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.731 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -105.29 127.52 52.99 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.115 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -117.12 155.15 29.8 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.684 -178.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.95 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 44.2 m80 -92.54 137.73 32.11 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 174.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -52.46 -51.74 57.76 Favored 'General case' 0 C--O 1.198 -1.62 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.3 p -68.63 -37.02 77.04 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 CA-C-N 118.533 0.606 . . . . 0.0 112.246 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.95 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 8.1 p -72.51 -27.29 62.17 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.23 -175.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.528 HG13 HG23 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -109.68 12.92 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.944 0 CA-C-O 121.753 0.787 . . . . 0.0 110.727 177.779 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.18 35.98 92.65 Favored Glycine 0 CA--C 1.553 2.433 0 N-CA-C 117.257 1.663 . . . . 0.0 117.257 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.528 HG23 HG13 ' A' ' 34' ' ' VAL . 86.5 t -93.97 147.48 5.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 117.775 0.788 . . . . 0.0 109.74 176.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.3 p -104.36 150.69 38.72 Favored Pre-proline 0 N--CA 1.415 -2.198 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 175.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -47.59 -39.63 29.74 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 123.475 2.783 . . . . 0.0 112.987 -177.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -58.15 -38.86 77.41 Favored 'General case' 0 C--O 1.214 -0.809 0 C-N-CA 124.475 1.11 . . . . 0.0 111.609 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.415 ' HB3' HG13 ' A' ' 36' ' ' VAL . 33.3 ttp -72.36 -39.54 67.99 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.813 -175.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.83 -49.05 77.96 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 123.741 0.651 . . . . 0.0 112.71 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -90.13 -24.01 21.2 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -177.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -98.53 -28.03 13.77 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.177 -1.009 . . . . 0.0 113.684 -172.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -139.05 -179.83 6.07 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -176.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -83.92 118.26 23.88 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 113.586 -1.643 . . . . 0.0 112.477 -174.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -88.18 110.37 20.64 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 122.272 1.035 . . . . 0.0 113.551 175.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.401 HG23 ' HB3' ' A' ' 51' ' ' CYS . 47.2 mm -107.89 141.15 23.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 172.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.9 p -97.9 176.56 5.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.276 -175.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.8 tt -54.15 -36.25 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.343 0 C-N-CA 124.255 1.022 . . . . 0.0 112.596 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -81.71 -35.67 29.51 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-O 120.881 0.372 . . . . 0.0 110.095 -178.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.401 ' HB3' HG23 ' A' ' 47' ' ' ILE . 64.6 m -74.39 -25.05 59.25 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-O 121.422 0.63 . . . . 0.0 111.482 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.1 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -178.812 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 99.6 t . . . . . 0 N--CA 1.446 -0.657 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.49 ' SG ' ' HA ' ' A' ' 29' ' ' PHE . 0.5 OUTLIER -94.28 -174.83 3.48 Favored 'General case' 0 N--CA 1.433 -1.313 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.35 -176.08 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.07 120.06 31.72 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -175.25 147.19 0.88 Allowed 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 123.166 0.586 . . . . 0.0 109.454 171.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -48.04 -41.52 25.97 Favored 'General case' 0 CA--C 1.558 1.267 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.825 173.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -137.69 98.27 3.64 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.488 173.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.528 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 43.8 t -94.33 117.82 30.69 Favored 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.284 -178.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -85.67 164.34 17.73 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.47 83.64 11.07 Favored Pre-proline 0 C--N 1.311 -1.073 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -70.4 157.43 59.16 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.759 2.973 . . . . 0.0 111.49 172.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.9 p -135.72 27.73 3.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.127 0.489 . . . . 0.0 111.28 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -94.54 146.48 24.08 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 120.475 -0.49 . . . . 0.0 112.022 -177.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -68.33 -53.93 20.87 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 174.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -76.05 91.49 3.1 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.366 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.8 p -170.43 98.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 122.409 1.099 . . . . 0.0 110.961 173.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -66.52 142.71 57.43 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 114.252 -1.34 . . . . 0.0 113.589 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 15.7 m95 -109.12 160.3 16.18 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.763 1.225 . . . . 0.0 109.899 -177.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.3 m -130.35 143.61 40.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 121.291 0.567 . . . . 0.0 111.898 -178.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -112.62 138.73 48.99 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.547 ' HB3' ' O ' ' A' ' 25' ' ' CYS . 43.4 t -77.67 101.31 6.55 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.424 0.631 . . . . 0.0 111.401 -178.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -88.74 10.57 20.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 122.524 1.154 . . . . 0.0 108.435 -178.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.9 -2.14 78.75 Favored Glycine 0 N--CA 1.419 -2.436 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.338 177.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 144.74 -26.25 1.94 Allowed Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 119.919 -1.134 . . . . 0.0 114.929 176.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.547 ' O ' ' HB3' ' A' ' 21' ' ' CYS . 17.2 p -114.87 90.09 3.25 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 117.151 -1.82 . . . . 0.0 111.955 -177.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -39.73 13.96 0.0 OUTLIER 'General case' 0 N--CA 1.532 3.631 0 N-CA-C 117.806 2.521 . . . . 0.0 117.806 173.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 25' ' ' CYS . 40.4 mt-10 -81.73 160.91 23.52 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-N 118.769 0.713 . . . . 0.0 109.725 176.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -105.73 130.21 53.78 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.49 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . 17.6 m-85 -118.95 151.62 37.84 Favored 'General case' 0 CA--C 1.562 1.407 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.646 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.884 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 35.2 m80 -88.5 141.87 28.18 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 173.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.466 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 49.8 mt-30 -56.94 -52.11 66.5 Favored 'General case' 0 C--O 1.192 -1.932 0 C-N-CA 120.3 -0.56 . . . . 0.0 112.015 176.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.5 p -67.12 -40.52 85.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.884 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 2.1 p -71.1 -27.31 63.51 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.215 -174.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.476 ' CG1' HG23 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -109.96 9.15 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.123 0 CA-C-O 121.255 0.55 . . . . 0.0 111.448 178.781 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.38 40.54 96.47 Favored Glycine 0 CA--C 1.557 2.675 0 N-CA-C 117.392 1.717 . . . . 0.0 117.392 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.476 HG23 ' CG1' ' A' ' 34' ' ' VAL . 78.5 t -92.13 149.18 4.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.9 p -100.7 150.42 36.98 Favored Pre-proline 0 N--CA 1.426 -1.666 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 176.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.71 -34.58 54.49 Favored 'Trans proline' 0 N--CA 1.483 0.855 0 C-N-CA 123.031 2.488 . . . . 0.0 112.733 -176.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -72.98 -27.86 62.05 Favored 'General case' 0 N--CA 1.414 -2.235 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.287 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.427 ' HE1' HG22 ' A' ' 36' ' ' VAL . 49.9 ttp -73.12 -37.3 66.73 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -177.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.02 -32.11 70.58 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.823 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -95.7 -21.31 18.26 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -113.32 -33.81 5.83 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 115.729 1.752 . . . . 0.0 115.729 -171.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -123.33 163.52 20.59 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 118.809 -1.156 . . . . 0.0 113.045 -173.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -82.63 115.13 21.45 Favored 'General case' 0 C--O 1.253 1.266 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.153 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.491 ' HD2' ' HA ' ' A' ' 21' ' ' CYS . 63.5 t80 -71.59 108.97 5.23 Favored 'General case' 0 C--O 1.249 1.079 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.6 mm -98.61 146.21 8.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 170.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 18.2 p -107.04 178.68 4.49 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.509 -0.877 . . . . 0.0 110.6 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.3 tt -50.5 -34.79 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.368 0 C-N-CA 125.399 1.48 . . . . 0.0 113.126 177.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -89.79 -37.92 14.16 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 80.1 m -78.04 -23.5 48.12 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.889 0.376 . . . . 0.0 111.155 -177.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.685 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.357 179.553 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.8 t . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.446 ' SG ' ' HA ' ' A' ' 29' ' ' PHE . 0.5 OUTLIER -100.08 -172.38 2.21 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 119.544 -0.862 . . . . 0.0 108.731 -178.506 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.54 119.45 29.0 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -177.88 143.8 0.33 Allowed 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 172.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -47.58 -40.91 20.38 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 123.63 0.582 . . . . 0.0 110.956 175.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -136.8 102.03 4.77 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.118 174.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.588 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 50.3 t -96.48 117.49 31.01 Favored 'General case' 0 N--CA 1.412 -2.345 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.846 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -76.16 -5.35 46.3 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.379 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.564 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 80.7 mtp180 54.92 38.25 0.46 Allowed Pre-proline 0 CA--C 1.573 1.856 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 14.0 Cg_exo -69.99 139.16 38.74 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 121.213 1.275 . . . . 0.0 112.24 -176.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 53.3 t -139.67 118.72 12.62 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.223 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -145.06 174.08 11.35 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -70.29 -66.16 0.63 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.239 0.542 . . . . 0.0 110.794 175.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -87.35 94.0 9.56 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -178.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.3 p -165.07 103.85 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.981 0.896 . . . . 0.0 111.305 176.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -69.16 146.3 52.57 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 114.233 -1.349 . . . . 0.0 113.238 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -115.71 160.4 20.12 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 125.779 1.631 . . . . 0.0 109.201 -177.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.3 m -126.64 136.93 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 120.772 0.32 . . . . 0.0 110.772 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -104.55 138.05 41.48 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 174.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 28.8 p -87.81 106.58 18.17 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 118.728 -1.189 . . . . 0.0 108.973 176.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -83.82 17.24 2.4 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.685 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.63 -1.27 66.12 Favored Glycine 0 N--CA 1.435 -1.397 0 C-N-CA 121.049 -0.596 . . . . 0.0 113.159 -176.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.23 -31.17 1.07 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 118.581 -1.771 . . . . 0.0 115.793 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.4 m -86.74 -28.66 22.91 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 118.934 1.367 . . . . 0.0 110.167 -175.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 60.02 22.28 11.42 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.763 1.225 . . . . 0.0 112.11 -176.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -93.87 165.79 12.5 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -108.93 130.87 55.45 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.446 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . 6.3 m-85 -122.83 153.62 39.33 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.493 -177.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.905 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 49.5 m80 -91.18 137.61 32.23 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 173.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.594 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 50.6 mt-30 -55.38 -45.67 76.55 Favored 'General case' 0 C--O 1.189 -2.104 0 O-C-N 123.892 0.745 . . . . 0.0 112.623 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.4 p -72.01 -40.42 67.52 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.39 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.751 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.905 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 2.8 p -72.8 -32.36 65.5 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.476 -173.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.55 HG13 HG23 ' A' ' 36' ' ' VAL . 2.5 p -103.61 6.9 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-O 121.256 0.55 . . . . 0.0 110.136 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.87 73.85 0.43 Allowed Glycine 0 CA--C 1.543 1.825 0 N-CA-C 115.452 0.941 . . . . 0.0 115.452 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.55 HG23 HG13 ' A' ' 34' ' ' VAL . 56.5 t -127.15 145.15 35.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.7 p -92.22 147.57 34.88 Favored Pre-proline 0 N--CA 1.425 -1.69 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 175.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.594 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 10.7 Cg_endo -51.22 -39.39 62.0 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.424 2.749 . . . . 0.0 113.457 -174.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -74.03 -25.38 59.84 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -178.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.484 ' CE ' HG13 ' A' ' 36' ' ' VAL . 37.5 ttp -68.48 -36.73 79.36 Favored 'General case' 0 C--O 1.211 -0.951 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.77 -39.76 81.97 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.286 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -88.4 -21.97 24.0 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 -177.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -115.64 -31.71 5.76 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -172.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.437 ' HB2' ' HG3' ' A' ' 40' ' ' MET . 37.5 mt-10 -117.96 157.11 27.35 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.975 -171.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -83.36 116.25 22.38 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.139 -176.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -82.82 103.81 12.58 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.2 mm -94.32 137.87 21.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 113.581 -1.645 . . . . 0.0 106.692 172.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.8 p -99.0 178.34 4.97 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 119.406 -0.917 . . . . 0.0 109.3 -174.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.8 tt -55.76 -41.45 65.83 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.287 0 C-N-CA 123.969 0.908 . . . . 0.0 112.383 178.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -76.61 -33.14 58.42 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 121.395 0.617 . . . . 0.0 110.88 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 61.4 m -72.75 -26.67 61.64 Favored 'General case' 0 C--O 1.211 -0.944 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.156 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.296 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -177.243 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.8 t . . . . . 0 C--O 1.218 -0.595 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -92.17 -172.24 3.07 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.61 118.78 28.51 Favored 'General case' 0 C--O 1.213 -0.859 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -176.65 145.7 0.55 Allowed 'General case' 0 CA--C 1.492 -1.251 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 171.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -48.09 -43.58 30.9 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 123.732 0.645 . . . . 0.0 110.324 175.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -137.39 105.75 5.77 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.228 175.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.608 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 53.4 t -97.71 117.12 31.29 Favored 'General case' 0 N--CA 1.402 -2.83 0 C-N-CA 119.734 -0.787 . . . . 0.0 111.512 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -69.48 -8.6 48.35 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.936 177.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.568 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 46.3 ttt180 52.64 43.21 1.46 Allowed Pre-proline 0 CA--C 1.604 3.057 0 C-N-CA 124.727 1.211 . . . . 0.0 113.768 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.568 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 2.8 Cg_exo -78.84 145.54 20.08 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.072 1.848 . . . . 0.0 112.622 -178.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.9 t -133.47 115.96 15.41 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.122 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -146.84 154.02 40.85 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 174.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.15 -12.55 61.77 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.225 0.536 . . . . 0.0 110.509 176.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -125.36 51.27 1.71 Allowed 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.21 -173.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.5 p -141.51 99.57 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 121.809 0.814 . . . . 0.0 110.718 175.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -68.72 145.0 54.22 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 114.817 -1.083 . . . . 0.0 112.07 176.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -106.93 159.73 16.05 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 124.577 1.151 . . . . 0.0 109.34 -176.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.0 m -125.76 141.37 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.602 -178.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.447 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 61.4 tt0 -111.29 137.85 48.5 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.474 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.6 p -94.81 104.48 16.38 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.882 178.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -88.22 23.97 2.0 Allowed 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.264 0.554 . . . . 0.0 110.322 -177.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.4 -4.98 73.01 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 148.6 -17.48 1.27 Allowed Glycine 0 CA--C 1.539 1.586 0 C-N-CA 119.68 -1.247 . . . . 0.0 115.64 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.474 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 9.6 m -97.8 -33.37 11.29 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.505 1.152 . . . . 0.0 110.495 -178.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 62.24 19.03 10.67 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 123.767 0.827 . . . . 0.0 111.877 -176.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 20' ' ' GLN . 47.8 mt-10 -85.05 168.14 15.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.831 -176.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -114.49 125.9 54.33 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-O 121.283 0.563 . . . . 0.0 111.915 -176.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -119.32 159.03 24.91 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.505 -176.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.939 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 38.1 m80 -94.37 136.17 34.97 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 173.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.437 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 50.3 mt-30 -55.34 -41.06 71.97 Favored 'General case' 0 C--O 1.191 -2.017 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 177.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.8 p -74.77 -41.74 47.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.914 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.939 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 9.2 p -72.0 -29.27 64.05 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.574 -174.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.53 HG13 HG23 ' A' ' 36' ' ' VAL . 1.4 p -105.0 5.48 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.958 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.87 73.64 0.46 Allowed Glycine 0 CA--C 1.553 2.443 0 N-CA-C 115.452 0.941 . . . . 0.0 115.452 -176.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.53 HG23 HG13 ' A' ' 34' ' ' VAL . 54.9 t -125.58 149.46 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 174.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.7 p -101.25 147.97 34.51 Favored Pre-proline 0 N--CA 1.418 -2.056 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 176.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.437 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 19.4 Cg_endo -55.84 -27.47 62.76 Favored 'Trans proline' 0 N--CA 1.487 1.132 0 C-N-CA 123.11 2.54 . . . . 0.0 112.283 -176.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -73.7 -28.36 61.69 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.719 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 44.2 ttp -74.13 -39.67 63.16 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.07 -43.91 82.58 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -176.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -88.12 -13.62 40.86 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -111.39 -39.24 4.74 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -175.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -126.07 166.32 17.21 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -170.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -74.98 118.58 18.1 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.907 0.883 . . . . 0.0 112.473 -178.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -83.11 103.8 12.81 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 122.383 1.087 . . . . 0.0 111.979 175.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.6 mm -100.21 143.57 13.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 173.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.416 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 12.4 p -103.93 176.97 4.98 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -176.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.2 tt -54.0 -38.23 36.75 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.343 0 C-N-CA 123.979 0.912 . . . . 0.0 112.89 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -87.04 -26.5 23.7 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.982 -0.448 . . . . 0.0 111.683 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.416 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 52.1 m -72.41 -25.63 61.55 Favored 'General case' 0 C--O 1.213 -0.828 0 CA-C-O 121.101 0.476 . . . . 0.0 110.796 176.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -1.001 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -177.766 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.4 m . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.792 0.806 . . . . 0.0 111.948 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.3 t -107.95 135.54 46.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -87.37 -175.87 5.42 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.46 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.402 ' N ' ' SG ' ' A' ' 3' ' ' CYS . . . -90.65 119.68 31.09 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 178.34 134.24 0.08 Allowed 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 125.225 1.41 . . . . 0.0 107.956 172.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -49.41 -33.92 15.12 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 123.457 0.473 . . . . 0.0 111.433 176.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -133.3 92.07 2.95 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.948 174.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.487 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 44.4 t -95.41 119.19 33.49 Favored 'General case' 0 N--CA 1.413 -2.284 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.129 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.427 HE22 HG22 ' A' ' 32' ' ' VAL . 73.3 mt-30 -69.09 -10.69 58.87 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.387 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.567 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 68.3 mtm180 49.38 46.03 3.38 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.567 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 3.2 Cg_exo -78.48 132.05 10.88 Favored 'Trans proline' 0 C--O 1.266 1.912 0 C-N-CA 121.521 1.48 . . . . 0.0 110.755 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.3 t -116.42 111.02 19.43 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -138.41 156.1 47.89 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -91.47 -6.62 52.37 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.078 0.466 . . . . 0.0 110.394 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -114.03 16.18 18.26 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.35 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.1 p -107.83 106.13 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 121.832 0.825 . . . . 0.0 111.071 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -71.84 146.13 48.17 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.983 173.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -108.87 160.74 15.75 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 124.556 1.142 . . . . 0.0 110.261 -174.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.3 m -124.31 139.19 51.4 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.535 0 CA-C-O 120.651 0.263 . . . . 0.0 111.09 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -106.97 139.48 41.31 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 46' ' ' TYR . 31.1 p -91.27 102.02 14.73 Favored 'General case' 0 C--O 1.256 1.407 0 C-N-CA 119.012 -1.075 . . . . 0.0 109.727 175.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -83.41 24.68 0.81 Allowed 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.386 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.32 -4.42 61.02 Favored Glycine 0 N--CA 1.432 -1.605 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.229 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.08 -20.18 1.94 Allowed Glycine 0 CA--C 1.539 1.533 0 C-N-CA 118.898 -1.62 . . . . 0.0 116.056 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.429 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 12.0 m -91.0 -34.05 15.29 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 118.806 1.303 . . . . 0.0 109.558 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 62.6 21.01 12.41 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.494 -176.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -88.08 159.41 18.26 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.257 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -108.96 130.14 55.45 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.273 0.559 . . . . 0.0 111.95 -176.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -118.47 157.46 27.19 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.975 -1.012 . . . . 0.0 109.82 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.916 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 40.3 m80 -92.11 140.32 29.76 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 173.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.423 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 51.0 mt-30 -62.43 -36.8 83.52 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.427 HG22 HE22 ' A' ' 9' ' ' GLN . 8.7 p -75.57 -40.76 41.31 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.662 0 O-C-N 121.243 -0.911 . . . . 0.0 111.873 176.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.916 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 9.2 p -72.09 -32.91 67.46 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.706 -173.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.442 HG13 HG23 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -104.95 3.2 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-O 121.135 0.493 . . . . 0.0 110.884 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.65 72.86 0.61 Allowed Glycine 0 CA--C 1.557 2.689 0 N-CA-C 116.129 1.211 . . . . 0.0 116.129 -176.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.442 HG23 HG13 ' A' ' 34' ' ' VAL . 78.8 t -130.3 145.23 35.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 56.7 p -97.95 151.01 37.34 Favored Pre-proline 0 N--CA 1.428 -1.544 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 176.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.36 -21.8 54.94 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 122.705 2.27 . . . . 0.0 111.551 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -73.64 -35.2 65.25 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.641 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.435 ' CE ' HG13 ' A' ' 36' ' ' VAL . 36.7 ttp -72.96 -38.9 66.56 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -176.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.88 -46.21 82.03 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.782 -1.099 . . . . 0.0 112.434 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -83.13 -17.5 42.78 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -112.55 -30.12 7.23 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -173.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -123.03 168.54 12.22 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.554 0.692 . . . . 0.0 112.728 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -90.03 115.35 27.24 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.405 -1.27 . . . . 0.0 109.214 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 51.2 t80 -79.34 108.89 13.2 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -178.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.9 mm -96.02 141.73 14.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 173.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.6 p -103.3 177.05 4.95 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.057 -176.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.2 tt -56.12 -38.13 52.35 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 O-C-N 123.887 0.742 . . . . 0.0 112.346 177.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -77.88 -34.19 51.67 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 122.212 -0.305 . . . . 0.0 111.37 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 61.6 m -72.21 -29.52 64.04 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.571 0.7 . . . . 0.0 110.301 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.074 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.828 -176.017 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.7 m . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 121.432 0.634 . . . . 0.0 111.285 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.4 t -104.28 135.26 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.404 ' SG ' ' HA ' ' A' ' 29' ' ' PHE . 0.5 OUTLIER -93.69 -173.96 3.32 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -177.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.65 119.98 32.61 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -177.55 144.15 0.38 Allowed 'General case' 0 CA--C 1.501 -0.912 0 C-N-CA 124.23 1.012 . . . . 0.0 108.76 172.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -47.88 -44.09 29.17 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 123.925 0.766 . . . . 0.0 110.468 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -135.53 102.29 5.07 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.328 173.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.541 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 43.3 t -95.52 118.88 33.04 Favored 'General case' 0 N--CA 1.407 -2.599 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.834 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -69.38 -9.42 53.39 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.834 178.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.556 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 79.1 ttt180 46.38 51.55 10.08 Favored Pre-proline 0 CA--C 1.574 1.897 0 C-N-CA 125.036 1.335 . . . . 0.0 112.692 -175.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.556 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 2.7 Cg_exo -81.61 134.42 8.68 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 121.839 1.693 . . . . 0.0 109.927 177.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 45.4 t -130.05 113.76 14.94 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -138.63 170.82 15.32 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -71.97 -59.46 2.73 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 171.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -74.56 87.87 2.14 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.29 177.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.2 p -172.28 100.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 122.109 0.957 . . . . 0.0 112.654 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -70.14 138.68 52.1 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.461 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 15.9 m95 -103.76 160.19 14.99 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 124.724 1.21 . . . . 0.0 108.552 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.5 m -126.02 139.63 50.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.574 0.226 . . . . 0.0 110.41 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -108.93 138.23 45.6 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.439 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.7 p -89.02 105.48 17.81 Favored 'General case' 0 C--O 1.249 1.037 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.145 177.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -85.1 22.81 1.35 Allowed 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 121.423 0.63 . . . . 0.0 110.25 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.53 -13.69 56.64 Favored Glycine 0 N--CA 1.426 -1.994 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.562 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.63 -27.71 0.42 Allowed Glycine 0 CA--C 1.533 1.205 0 C-N-CA 118.79 -1.672 . . . . 0.0 115.813 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.439 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 9.4 m -88.89 -30.14 19.11 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 118.533 1.167 . . . . 0.0 110.609 -176.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 60.63 19.15 9.11 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.723 0.809 . . . . 0.0 111.939 -175.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -90.0 163.48 14.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.446 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -108.66 128.94 55.29 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.504 -175.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.404 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . 4.9 m-85 -120.22 159.78 24.25 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.745 -176.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.931 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 44.9 m80 -95.76 138.57 33.23 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 173.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.544 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 48.9 mt-30 -54.52 -50.06 68.75 Favored 'General case' 0 C--O 1.19 -2.07 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 177.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 p -67.45 -41.95 86.64 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.305 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.931 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 6.6 p -70.67 -27.84 64.34 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.384 -175.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.628 HG13 HG23 ' A' ' 36' ' ' VAL . 1.4 p -106.9 11.6 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.871 0 CA-C-O 121.311 0.577 . . . . 0.0 110.574 178.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.67 38.32 95.5 Favored Glycine 0 CA--C 1.547 2.032 0 N-CA-C 117.25 1.66 . . . . 0.0 117.25 177.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.628 HG23 HG13 ' A' ' 34' ' ' VAL . 77.6 t -97.4 149.2 5.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 123.536 0.735 . . . . 0.0 109.44 176.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.4 p -99.73 152.14 37.71 Favored Pre-proline 0 N--CA 1.421 -1.907 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.544 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 24.9 Cg_endo -59.14 -22.32 63.77 Favored 'Trans proline' 0 N--CA 1.482 0.833 0 C-N-CA 122.173 1.915 . . . . 0.0 112.163 -178.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -73.8 -34.0 64.44 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.857 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 50.3 ttp -73.77 -39.33 64.27 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.422 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.44 -48.02 77.89 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -175.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -89.0 -14.21 37.05 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -110.05 -31.26 7.43 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -173.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -128.48 165.87 19.86 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 118.289 0.495 . . . . 0.0 112.153 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -75.2 115.31 14.7 Favored 'General case' 0 C--O 1.248 0.977 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.578 -176.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -79.54 108.93 13.45 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.938 0.875 . . . . 0.0 112.265 175.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.0 mm -105.45 148.73 9.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 173.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.3 p -109.24 177.3 4.8 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 119.238 0.926 . . . . 0.0 108.935 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.7 tt -55.94 -41.72 68.59 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 C-N-CA 124.026 0.93 . . . . 0.0 112.491 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -75.0 -32.67 61.7 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.13 0.491 . . . . 0.0 111.003 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 66.7 m -76.27 -28.91 57.23 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.827 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.519 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.264 -176.914 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 28.7 t . . . . . 0 CA--C 1.558 1.271 0 CA-C-O 122.523 1.154 . . . . 0.0 109.202 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.9 t -122.97 136.34 60.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.412 ' SG ' ' HA ' ' A' ' 29' ' ' PHE . 0.5 OUTLIER -96.84 -172.5 2.48 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 119.394 -0.922 . . . . 0.0 108.62 -178.065 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.14 118.69 26.7 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -177.22 145.96 0.48 Allowed 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 171.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -48.6 -44.16 36.77 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.689 0.757 . . . . 0.0 109.118 173.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -131.55 101.52 5.54 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.159 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.52 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 50.5 t -98.34 112.23 24.3 Favored 'General case' 0 N--CA 1.406 -2.66 0 C-N-CA 118.36 -1.336 . . . . 0.0 110.262 177.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -67.12 -11.57 57.6 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.48 -1.237 . . . . 0.0 111.191 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.555 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 65.3 mtp180 52.34 44.76 2.21 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 123.834 0.854 . . . . 0.0 111.881 -173.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.555 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 23.7 Cg_exo -65.58 131.76 28.84 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 121.134 1.223 . . . . 0.0 110.341 -176.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 86.1 m -114.47 98.16 6.74 Favored 'General case' 0 N--CA 1.413 -2.292 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.885 -177.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -136.21 153.05 51.34 Favored 'General case' 0 CA--C 1.479 -1.753 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 172.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -81.13 -43.11 19.88 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 176.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -85.23 87.9 7.43 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.7 p -168.76 112.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.569 0.699 . . . . 0.0 111.427 177.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -74.22 144.79 44.56 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.685 -1.143 . . . . 0.0 112.852 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -110.31 159.94 16.98 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 125.2 1.4 . . . . 0.0 109.331 -176.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.6 m -126.62 137.09 58.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.062 0.458 . . . . 0.0 110.625 -178.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.427 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 52.0 tt0 -104.57 139.09 39.96 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 176.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.6 p -88.01 99.93 12.53 Favored 'General case' 0 C--O 1.25 1.085 0 C-N-CA 118.261 -1.376 . . . . 0.0 110.006 176.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -80.9 19.36 0.87 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.971 -176.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.35 3.25 50.6 Favored Glycine 0 N--CA 1.418 -2.507 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.697 -177.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 152.6 -34.33 0.82 Allowed Glycine 0 CA--C 1.536 1.402 0 C-N-CA 118.183 -1.961 . . . . 0.0 116.551 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.462 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 5.1 m -94.51 -30.11 14.58 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 118.799 1.3 . . . . 0.0 110.033 -176.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 60.31 22.09 11.57 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.577 0.751 . . . . 0.0 112.377 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 20' ' ' GLN . 46.2 mt-10 -86.65 164.78 16.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.483 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -108.46 123.39 48.81 Favored 'General case' 0 C--O 1.245 0.836 0 O-C-N 123.575 0.547 . . . . 0.0 111.681 -174.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.412 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . 2.9 m-85 -117.63 160.07 21.89 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.562 -176.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.908 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 40.0 m80 -94.4 138.74 31.98 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 173.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.414 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 48.6 mt-30 -55.43 -48.36 74.55 Favored 'General case' 0 C--O 1.184 -2.365 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.216 177.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.412 ' CG1' ' HG2' ' A' ' 11' ' ' PRO . 11.0 p -69.54 -38.27 76.42 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.272 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.287 -178.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.908 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 4.4 p -73.67 -28.97 62.04 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.811 -174.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.602 HG13 HG23 ' A' ' 36' ' ' VAL . 1.6 p -105.95 7.61 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.697 0 CA-C-O 121.524 0.678 . . . . 0.0 109.982 178.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.33 45.1 95.82 Favored Glycine 0 CA--C 1.546 1.984 0 N-CA-C 116.627 1.411 . . . . 0.0 116.627 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.602 HG23 HG13 ' A' ' 34' ' ' VAL . 84.4 t -96.2 148.17 5.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 173.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.5 p -100.86 153.03 37.97 Favored Pre-proline 0 N--CA 1.425 -1.711 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 175.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 10.2 Cg_endo -48.48 -39.83 36.66 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 123.267 2.644 . . . . 0.0 112.813 -176.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -65.92 -31.0 71.67 Favored 'General case' 0 C--O 1.202 -1.428 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.508 ' HB3' HG13 ' A' ' 36' ' ' VAL . 38.2 ttp -73.54 -33.96 64.97 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 118.481 -1.288 . . . . 0.0 108.77 -176.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.84 -47.85 79.1 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.467 175.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -86.93 -27.93 23.05 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -176.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -105.99 -27.41 11.18 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -171.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -127.69 173.37 9.98 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 119.821 -0.752 . . . . 0.0 112.32 -175.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -86.2 116.03 24.13 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.895 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -75.38 114.9 14.45 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 122.237 1.018 . . . . 0.0 113.301 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.8 mm -110.13 145.68 16.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 175.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.471 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 11.0 p -109.61 179.55 4.1 Favored 'General case' 0 C--O 1.217 -0.633 0 O-C-N 121.292 -0.88 . . . . 0.0 109.306 -176.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.6 tt -54.97 -40.16 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.512 0 C-N-CA 124.157 0.983 . . . . 0.0 112.626 177.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -78.06 -30.51 49.77 Favored 'General case' 0 C--O 1.212 -0.883 0 CA-C-O 120.911 0.386 . . . . 0.0 110.65 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.471 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 65.5 m -78.27 -31.09 48.88 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.054 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.669 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.582 -176.46 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.3 p . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.642 0.734 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.5 t -131.27 135.53 59.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.423 ' SG ' ' HA ' ' A' ' 29' ' ' PHE . 0.5 OUTLIER -93.74 -172.16 2.8 Favored 'General case' 0 C--O 1.255 1.361 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -178.435 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.8 119.07 30.72 Favored 'General case' 0 C--O 1.2 -1.504 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 176.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -176.68 142.85 0.43 Allowed 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 172.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -48.71 -44.67 38.34 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.613 0.765 . . . . 0.0 109.749 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -128.84 98.12 4.87 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.649 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.559 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 50.5 t -99.26 112.11 24.34 Favored 'General case' 0 N--CA 1.413 -2.307 0 C-N-CA 117.941 -1.504 . . . . 0.0 111.242 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -69.76 -7.89 43.41 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.608 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.588 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 76.7 mtp180 53.08 42.39 1.19 Allowed Pre-proline 0 CA--C 1.573 1.848 0 C-N-CA 124.348 1.059 . . . . 0.0 113.438 -175.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.588 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 11.8 Cg_exo -71.76 136.52 28.05 Favored 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 121.866 1.711 . . . . 0.0 111.951 -176.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 51.3 t -126.48 116.58 21.34 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.497 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -148.73 164.07 35.45 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 176.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -85.64 -7.66 58.7 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 176.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -128.73 88.49 2.74 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 114.691 -1.141 . . . . 0.0 108.698 -177.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 16' ' ' VAL . 6.9 p -178.14 96.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.657 0 CA-C-O 121.637 0.732 . . . . 0.0 110.124 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.79 144.01 57.39 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -109.16 159.52 16.84 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.242 -177.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.8 m -129.58 135.36 61.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.036 0.446 . . . . 0.0 111.002 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 53.9 tt0 -100.28 139.28 36.19 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 176.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.3 p -89.7 102.7 15.39 Favored 'General case' 0 C--O 1.258 1.55 0 C-N-CA 118.617 -1.233 . . . . 0.0 110.742 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.64 18.79 0.54 Allowed 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.841 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.76 -10.26 60.35 Favored Glycine 0 N--CA 1.426 -1.988 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.886 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 147.06 -16.01 1.53 Allowed Glycine 0 C--O 1.213 -1.164 0 C-N-CA 118.459 -1.829 . . . . 0.0 116.486 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.524 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 13.6 m -92.29 -28.92 16.66 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.023 1.412 . . . . 0.0 109.332 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 58.68 18.5 5.96 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 124.289 1.036 . . . . 0.0 112.148 -174.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.409 ' O ' ' HA ' ' A' ' 20' ' ' GLN . 46.0 mt-10 -84.16 162.26 20.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.291 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -108.89 126.56 53.19 Favored 'General case' 0 C--O 1.246 0.916 0 CA-C-O 121.302 0.572 . . . . 0.0 112.036 -175.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.423 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . 2.8 m-85 -118.78 161.05 20.77 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.351 -177.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.9 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 45.7 m80 -95.64 142.56 27.81 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.456 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 48.6 mt-30 -58.04 -48.44 80.07 Favored 'General case' 0 C--O 1.189 -2.124 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.7 p -70.16 -38.61 75.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.236 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.9 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 2.9 p -72.74 -31.72 65.16 Favored 'General case' 0 C--O 1.213 -0.817 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.665 -173.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.501 HG13 HG23 ' A' ' 36' ' ' VAL . 1.7 p -104.09 5.35 10.45 Favored 'Isoleucine or valine' 0 C--O 1.254 1.311 0 CA-C-O 121.219 0.533 . . . . 0.0 110.361 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.35 70.91 0.89 Allowed Glycine 0 CA--C 1.54 1.618 0 CA-C-N 115.079 -0.964 . . . . 0.0 115.014 -176.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.501 HG23 HG13 ' A' ' 34' ' ' VAL . 54.5 t -119.38 147.65 22.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 174.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.7 p -98.1 151.98 37.8 Favored Pre-proline 0 N--CA 1.426 -1.647 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.417 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 13.2 Cg_endo -51.12 -36.8 56.45 Favored 'Trans proline' 0 N--CA 1.483 0.908 0 C-N-CA 123.052 2.501 . . . . 0.0 112.831 -176.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -73.13 -26.87 61.38 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.425 ' HB3' HG13 ' A' ' 36' ' ' VAL . 46.6 ttp -73.84 -34.19 64.44 Favored 'General case' 0 C--O 1.209 -1.071 0 C-N-CA 118.583 -1.247 . . . . 0.0 108.339 -177.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.6 -45.01 81.68 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -94.78 -32.27 13.38 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -98.05 -22.86 16.02 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -170.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -128.37 168.12 16.01 Favored 'General case' 0 C--N 1.311 -1.109 0 C-N-CA 119.92 -0.712 . . . . 0.0 112.12 -176.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -89.74 120.34 30.92 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.831 -174.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.425 ' CE2' ' HB3' ' A' ' 21' ' ' CYS . 89.0 t80 -81.97 108.23 15.31 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.5 mm -101.02 146.72 8.99 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 172.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.536 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 10.2 p -111.41 178.66 4.26 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 121.095 -1.003 . . . . 0.0 108.885 -177.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.9 tt -54.1 -42.36 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.358 0 C-N-CA 124.028 0.931 . . . . 0.0 112.315 177.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -76.78 -34.76 57.98 Favored 'General case' 0 C--O 1.212 -0.874 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.215 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.536 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 59.4 m -72.56 -26.03 61.58 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 121.164 0.507 . . . . 0.0 111.258 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.103 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.545 -179.023 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 121.136 0.494 . . . . 0.0 111.616 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 57.8 t -118.8 140.46 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -178.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -90.79 -172.16 3.28 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.17 119.48 31.85 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -176.58 146.49 0.6 Allowed 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.45 0.7 . . . . 0.0 109.237 172.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -47.65 -40.7 20.48 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 124.083 0.953 . . . . 0.0 109.834 174.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -139.46 111.55 7.45 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.244 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.568 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 46.8 t -106.15 116.06 31.28 Favored 'General case' 0 N--CA 1.416 -2.154 0 C-N-CA 117.93 -1.508 . . . . 0.0 112.355 177.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.435 HE22 HG22 ' A' ' 32' ' ' VAL . 70.2 mt-30 -72.89 -9.28 58.52 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 113.906 -1.497 . . . . 0.0 111.216 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.551 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 82.1 mtp180 53.21 51.85 9.51 Favored Pre-proline 0 N--CA 1.493 1.709 0 C-N-CA 124.175 0.99 . . . . 0.0 112.821 -174.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.551 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 4.2 Cg_exo -80.79 131.84 8.35 Favored 'Trans proline' 0 C--O 1.261 1.672 0 C-N-CA 122.032 1.821 . . . . 0.0 110.474 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 51.6 t -125.12 111.07 14.89 Favored 'General case' 0 N--CA 1.427 -1.613 0 O-C-N 123.661 0.601 . . . . 0.0 110.174 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.43 ' O ' HG12 ' A' ' 16' ' ' VAL . 97.1 mttt -140.35 157.53 45.41 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 175.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -87.81 2.86 50.28 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.082 0.468 . . . . 0.0 111.285 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -117.65 5.79 12.39 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.531 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 13' ' ' LYS . 7.9 p -97.38 105.37 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-O 121.978 0.894 . . . . 0.0 111.699 -178.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -76.17 153.31 36.27 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.629 175.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -115.23 159.55 20.83 Favored 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 124.445 1.098 . . . . 0.0 110.213 -172.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.3 m -127.44 138.91 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-O 120.738 0.304 . . . . 0.0 110.244 -177.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -106.56 139.35 41.16 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.47 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.6 p -90.0 103.51 16.17 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 118.89 -1.124 . . . . 0.0 109.113 174.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.0 26.96 0.57 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.812 0.845 . . . . 0.0 111.152 -175.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -111.21 7.25 28.81 Favored Glycine 0 N--CA 1.429 -1.774 0 CA-C-N 115.468 -0.787 . . . . 0.0 113.311 -176.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 148.45 -39.7 0.96 Allowed Glycine 0 CA--C 1.535 1.34 0 C-N-CA 118.116 -1.993 . . . . 0.0 115.375 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.47 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 7.9 m -85.88 -34.75 20.91 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 118.168 0.984 . . . . 0.0 108.457 -176.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 57.46 25.03 10.92 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.042 -177.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -87.51 168.35 13.15 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.949 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -110.87 126.42 54.66 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 122.782 0.433 . . . . 0.0 111.499 -176.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -118.83 159.27 24.05 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.689 -174.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.977 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 35.1 m80 -96.59 137.15 36.1 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 174.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.469 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 50.6 mt-30 -52.84 -46.43 67.8 Favored 'General case' 0 C--O 1.188 -2.156 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.435 HG22 HE22 ' A' ' 9' ' ' GLN . 9.3 p -72.97 -40.35 59.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 O-C-N 121.406 -0.809 . . . . 0.0 112.299 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.977 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 12.0 p -70.82 -27.59 63.99 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.87 -174.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.514 HG13 HG23 ' A' ' 36' ' ' VAL . 1.4 p -108.55 7.97 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 CA-C-O 121.394 0.616 . . . . 0.0 110.721 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.01 64.66 4.09 Favored Glycine 0 CA--C 1.559 2.828 0 N-CA-C 116.481 1.352 . . . . 0.0 116.481 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.655 HG13 ' SD ' ' A' ' 40' ' ' MET . 79.2 t -117.18 146.73 21.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 125.75 1.62 . . . . 0.0 107.193 175.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.0 p -98.31 155.42 36.91 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 177.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -55.54 -31.88 80.47 Favored 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 122.959 2.439 . . . . 0.0 113.142 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 45.6 mt-10 -71.83 -28.63 63.7 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 120.951 0.405 . . . . 0.0 110.79 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.655 ' SD ' HG13 ' A' ' 36' ' ' VAL . 28.2 ttt -69.99 -46.89 64.2 Favored 'General case' 0 C--O 1.208 -1.126 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -176.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.95 -45.25 90.93 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -86.31 -14.65 43.01 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -177.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 39' ' ' GLU . 93.0 m-20 -119.16 -34.33 3.9 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -174.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -124.6 158.55 32.79 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -172.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -72.23 114.23 10.12 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.794 -176.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -80.26 112.1 17.27 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 122.166 0.984 . . . . 0.0 113.438 177.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.1 mm -112.93 140.93 30.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 174.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.5 p -96.97 176.39 5.98 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -174.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.7 tt -54.06 -38.01 36.55 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 C-N-CA 123.965 0.906 . . . . 0.0 112.721 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -80.61 -30.82 36.79 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.0 0.429 . . . . 0.0 111.136 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 84.5 m -78.35 -27.83 47.09 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.323 0.582 . . . . 0.0 111.129 176.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.867 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.748 -177.758 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.1 t . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 121.332 0.587 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 49.0 t -98.95 132.84 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.02 -176.3 4.85 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.04 -175.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.3 119.67 33.41 Favored 'General case' 0 C--O 1.198 -1.634 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -175.37 148.79 0.97 Allowed 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 173.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -47.4 -42.82 22.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 123.958 0.786 . . . . 0.0 110.533 174.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -141.56 105.32 4.72 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.635 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.581 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 53.2 t -97.43 110.17 22.78 Favored 'General case' 0 N--CA 1.419 -2.02 0 C-N-CA 118.771 -1.172 . . . . 0.0 111.47 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.463 HE22 HG22 ' A' ' 32' ' ' VAL . 72.5 mt-30 -67.56 -8.34 33.32 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.6 1.16 . . . . 0.0 111.016 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.59 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 88.7 mtm180 51.0 44.54 2.23 Favored Pre-proline 0 CA--C 1.563 1.457 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -178.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.59 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 8.4 Cg_exo -76.36 137.4 18.75 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 122.205 1.937 . . . . 0.0 111.248 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 45.6 t -130.89 114.54 15.39 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.313 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -148.24 166.84 26.74 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -71.07 -61.69 1.67 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.728 0.775 . . . . 0.0 108.958 173.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -65.55 30.07 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 126.197 1.799 . . . . 0.0 115.53 -175.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.0 p -123.55 109.0 22.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 119.444 1.02 . . . . 0.0 112.983 178.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -73.94 146.62 43.79 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.231 -1.35 . . . . 0.0 111.928 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.0 m95 -113.13 159.21 19.47 Favored 'General case' 0 C--O 1.216 -0.699 0 C-N-CA 124.365 1.066 . . . . 0.0 109.047 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.3 m -125.05 138.02 55.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 O-C-N 121.945 -0.472 . . . . 0.0 110.535 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -105.76 138.94 41.1 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.47 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.4 p -91.92 107.28 19.09 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 119.329 -0.948 . . . . 0.0 110.742 178.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -87.86 27.02 1.22 Allowed 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.517 0.675 . . . . 0.0 110.312 -176.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.4 -7.9 57.84 Favored Glycine 0 N--CA 1.425 -2.086 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.377 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 151.16 -20.82 0.96 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 118.899 -1.62 . . . . 0.0 115.65 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.47 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 8.4 m -94.32 -32.19 13.73 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 118.771 1.286 . . . . 0.0 111.478 -176.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 60.42 19.54 9.2 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 123.856 0.862 . . . . 0.0 111.905 -174.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -86.68 161.11 18.62 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.236 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 80.0 m95 -105.97 127.16 52.97 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.235 -176.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -120.12 157.71 28.42 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.112 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.878 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 51.9 m80 -93.09 138.72 31.28 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 174.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.488 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 48.1 mt-30 -52.88 -55.19 25.01 Favored 'General case' 0 C--O 1.198 -1.632 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 177.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.463 HG22 HE22 ' A' ' 9' ' ' GLN . 7.3 p -65.65 -36.96 78.85 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.489 0 CA-C-O 121.736 0.779 . . . . 0.0 111.755 -177.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.878 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 1.7 p -73.95 -24.65 59.67 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.045 -175.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.59 HG13 HG23 ' A' ' 36' ' ' VAL . 1.7 p -111.31 12.51 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.834 0 CA-C-O 121.484 0.659 . . . . 0.0 110.875 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.12 36.19 91.55 Favored Glycine 0 CA--C 1.555 2.577 0 N-CA-C 117.598 1.799 . . . . 0.0 117.598 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.686 HG13 ' SD ' ' A' ' 40' ' ' MET . 94.3 t -97.03 144.05 11.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 174.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.3 p -98.93 152.14 37.68 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 176.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.488 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 17.8 Cg_endo -57.32 -26.8 72.37 Favored 'Trans proline' 0 N--CA 1.486 1.032 0 C-N-CA 122.409 2.072 . . . . 0.0 112.629 -177.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -74.97 -25.87 59.17 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 121.549 0.69 . . . . 0.0 109.94 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.686 ' SD ' HG13 ' A' ' 36' ' ' VAL . 28.0 ttt -73.71 -46.23 47.46 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 124.313 1.045 . . . . 0.0 110.114 -178.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.92 -47.15 81.28 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.243 -0.889 . . . . 0.0 112.021 -176.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -78.55 -13.39 59.85 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -116.11 -39.88 3.37 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 116.755 2.131 . . . . 0.0 116.755 -173.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -124.16 165.32 17.76 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.007 0.821 . . . . 0.0 112.641 -174.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -74.11 115.32 13.45 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.178 -177.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.426 ' OH ' HG21 ' A' ' 34' ' ' VAL . 81.1 t80 -72.28 111.52 7.56 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-O 121.946 0.879 . . . . 0.0 112.272 172.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.5 mm -108.44 138.54 34.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 174.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 11.1 p -98.21 176.23 5.8 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -174.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.6 tt -57.91 -35.87 53.56 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.644 0 C-N-CA 123.586 0.755 . . . . 0.0 112.276 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -79.66 -34.34 40.47 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 120.824 0.345 . . . . 0.0 110.774 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 59.4 m -72.18 -26.0 61.9 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 121.326 0.584 . . . . 0.0 110.539 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.804 -177.602 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.483 1.214 0 CA-C-O 121.295 0.569 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.2 t -113.59 135.56 52.79 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' A' ' 4' ' ' ALA . 0.4 OUTLIER -87.88 -177.79 5.87 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.419 ' N ' ' SG ' ' A' ' 3' ' ' CYS . . . -90.54 120.04 31.3 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 178.73 135.34 0.09 Allowed 'General case' 0 C--O 1.214 -0.768 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 171.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -49.93 -42.64 48.79 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 120.983 0.421 . . . . 0.0 111.086 177.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -121.54 90.62 3.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.906 173.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.503 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 44.2 t -93.94 117.03 29.54 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 119.096 -1.042 . . . . 0.0 110.529 177.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -69.32 -8.0 42.28 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.019 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.569 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 29.7 mtm180 47.82 46.21 3.4 Favored Pre-proline 0 CA--C 1.563 1.461 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 -175.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.569 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 4.2 Cg_exo -76.35 131.86 13.15 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 121.942 1.761 . . . . 0.0 111.87 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 53.4 t -121.4 114.89 21.93 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -146.01 157.54 43.87 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -76.99 -10.04 59.1 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.434 0.635 . . . . 0.0 110.827 177.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -124.51 84.73 2.31 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.159 177.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.1 p -172.31 97.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 122.149 0.976 . . . . 0.0 111.239 176.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -71.06 146.66 49.17 Favored 'General case' 0 C--N 1.279 -2.464 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.242 174.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -107.01 159.51 16.23 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.482 -174.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.9 m -125.48 132.82 70.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 120.69 0.281 . . . . 0.0 110.573 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -99.34 137.87 37.23 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.0 p -86.98 104.45 16.31 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 118.681 -1.208 . . . . 0.0 110.077 176.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -82.46 16.99 1.87 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.849 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.96 -7.31 74.35 Favored Glycine 0 N--CA 1.431 -1.644 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.973 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.19 -13.24 1.86 Allowed Glycine 0 CA--C 1.54 1.63 0 C-N-CA 119.063 -1.541 . . . . 0.0 116.907 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.475 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 17.3 m -95.23 -27.65 15.41 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 119.669 1.734 . . . . 0.0 110.444 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 63.94 16.4 9.86 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.655 0.782 . . . . 0.0 111.53 -176.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -91.36 159.4 16.01 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -176.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -106.33 126.35 52.12 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.638 -175.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -118.05 159.06 23.85 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.629 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.935 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 36.5 m80 -93.51 139.2 31.01 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 174.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.454 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 50.5 mt-30 -57.63 -42.91 84.3 Favored 'General case' 0 C--O 1.192 -1.959 0 O-C-N 123.579 0.55 . . . . 0.0 112.077 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.0 p -73.59 -41.02 55.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.603 -0.685 . . . . 0.0 112.197 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.935 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 11.3 p -71.55 -31.33 66.89 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.407 -173.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.5 HG13 HG23 ' A' ' 36' ' ' VAL . 1.2 p -104.23 6.51 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.715 0 CA-C-O 121.312 0.577 . . . . 0.0 111.066 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.29 67.75 1.96 Allowed Glycine 0 CA--C 1.547 2.093 0 N-CA-C 115.95 1.14 . . . . 0.0 115.95 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.5 HG23 HG13 ' A' ' 34' ' ' VAL . 70.6 t -124.22 149.51 28.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 174.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.1 p -103.81 151.61 38.86 Favored Pre-proline 0 N--CA 1.421 -1.884 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 175.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.454 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 73.3 Cg_exo -52.52 -22.97 17.93 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.771 2.314 . . . . 0.0 112.231 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 34.1 tt0 -74.1 -36.62 64.25 Favored 'General case' 0 C--O 1.187 -2.215 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.091 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.429 ' HB3' HG13 ' A' ' 36' ' ' VAL . 39.4 ttp -73.83 -37.64 64.79 Favored 'General case' 0 CA--C 1.503 -0.859 0 O-C-N 121.097 -1.002 . . . . 0.0 110.092 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.96 -48.59 78.01 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.154 -0.93 . . . . 0.0 113.242 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -94.6 -16.05 23.54 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 119.82 -0.752 . . . . 0.0 112.833 -176.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.492 ' HB2' ' O ' ' A' ' 39' ' ' GLU . 16.3 m120 -105.39 -19.09 13.9 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -173.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -138.3 177.02 8.19 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.174 0.512 . . . . 0.0 111.706 178.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -92.11 121.6 33.81 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.791 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.403 ' OH ' HG21 ' A' ' 34' ' ' VAL . 80.4 t80 -75.72 104.86 6.46 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.017 1.118 . . . . 0.0 114.017 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.9 mm -94.6 139.05 19.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 170.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.421 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 13.2 p -101.19 173.66 6.36 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 119.061 -1.056 . . . . 0.0 108.751 -177.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.4 tt -57.53 -37.51 58.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 123.057 0.543 . . . . 0.0 112.042 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -75.44 -29.79 59.8 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-O 120.981 0.419 . . . . 0.0 110.535 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.421 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 52.4 m -77.76 -27.38 50.34 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.296 0.57 . . . . 0.0 110.61 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.082 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.531 -176.481 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 31.9 m . . . . . 0 CA--C 1.555 1.144 0 CA-C-O 121.696 0.76 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.4 t -131.23 129.74 62.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -88.75 -172.25 3.64 Favored 'General case' 0 C--O 1.248 1.023 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -177.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.59 119.79 33.06 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -179.98 132.02 0.1 Allowed 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 171.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -50.04 -42.82 50.33 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 121.411 0.624 . . . . 0.0 110.99 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -123.9 97.62 5.44 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 173.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.52 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 46.6 t -99.25 121.06 40.54 Favored 'General case' 0 N--CA 1.423 -1.821 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.238 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -70.41 -8.02 47.62 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 124.122 0.969 . . . . 0.0 110.29 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.528 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 32.8 ttp180 42.88 56.22 11.17 Favored Pre-proline 0 CA--C 1.568 1.663 0 C-N-CA 126.084 1.754 . . . . 0.0 114.592 -177.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.528 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 6.3 Cg_exo -87.87 144.96 6.45 Favored 'Trans proline' 0 C--O 1.26 1.577 0 C-N-CA 122.896 2.397 . . . . 0.0 112.307 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 59.0 m -127.44 125.73 41.08 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -144.15 162.13 37.08 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 176.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -84.55 -9.26 58.48 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 174.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -129.11 84.99 2.27 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.031 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.41 ' O ' HG13 ' A' ' 16' ' ' VAL . 8.1 p -172.02 104.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.738 0.78 . . . . 0.0 111.312 177.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -73.11 145.89 46.12 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.471 176.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -107.48 159.82 16.12 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 124.568 1.147 . . . . 0.0 109.206 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.9 m -123.06 141.95 41.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 120.607 0.242 . . . . 0.0 110.413 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 64.2 tt0 -112.28 139.32 47.93 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 29.1 p -89.6 105.58 17.89 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.806 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -77.58 29.1 0.16 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.869 0.868 . . . . 0.0 111.391 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.523 ' HA3' ' SG ' ' A' ' 51' ' ' CYS . . . -95.08 -22.78 21.94 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 141.51 1.82 1.38 Allowed Glycine 0 CA--C 1.542 1.745 0 C-N-CA 119.875 -1.155 . . . . 0.0 115.581 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.424 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 24.7 m -94.66 -29.69 14.7 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 118.74 1.27 . . . . 0.0 109.208 177.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 64.68 16.46 10.37 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.107 0.963 . . . . 0.0 112.117 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 20' ' ' GLN . 46.6 mt-10 -82.24 161.95 22.51 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.045 0.45 . . . . 0.0 111.638 -177.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -114.9 124.31 51.37 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.63 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -115.56 156.51 25.63 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -175.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.959 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 40.9 m80 -89.98 138.75 31.24 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.419 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 49.3 mt-30 -56.88 -49.93 74.04 Favored 'General case' 0 C--O 1.194 -1.835 0 O-C-N 123.537 0.523 . . . . 0.0 112.276 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.9 p -67.55 -37.39 78.71 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.628 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.959 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 6.6 p -76.11 -25.58 55.55 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -175.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.489 HG13 HG23 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -108.68 10.05 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.976 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.72 177.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.93 39.55 93.33 Favored Glycine 0 CA--C 1.549 2.214 0 N-CA-C 117.032 1.573 . . . . 0.0 117.032 178.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.489 HG23 HG13 ' A' ' 34' ' ' VAL . 85.1 t -96.25 145.44 8.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 117.742 0.771 . . . . 0.0 108.983 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.6 p -97.88 147.66 33.36 Favored Pre-proline 0 N--CA 1.414 -2.269 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 19.7 Cg_endo -57.21 -25.08 62.65 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 C-N-CA 123.008 2.472 . . . . 0.0 112.497 -176.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -74.56 -29.49 61.37 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.441 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 37.3 ttp -74.6 -39.22 62.31 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-O 121.107 0.479 . . . . 0.0 110.509 -176.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.44 -45.29 80.87 Favored 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -87.62 -13.36 42.97 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -117.31 -20.93 8.96 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -172.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -135.07 164.02 28.59 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.22 -176.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -83.19 119.79 24.99 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.212 -175.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -76.64 114.13 15.05 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 122.124 0.964 . . . . 0.0 112.379 174.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.6 mm -109.97 143.75 19.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 173.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.429 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 11.5 p -104.72 172.54 6.73 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 118.671 -1.211 . . . . 0.0 109.379 -176.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.5 tt -52.44 -37.38 23.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 C-N-CA 124.052 0.941 . . . . 0.0 112.73 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -79.93 -29.67 39.81 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-O 121.099 0.476 . . . . 0.0 110.918 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.523 ' SG ' ' HA3' ' A' ' 23' ' ' GLY . 54.5 m -77.29 -31.44 54.79 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.339 178.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.865 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.567 -176.749 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.1 p . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 120.872 0.367 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.9 t -120.38 139.54 47.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.31 -173.0 2.23 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.239 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.93 120.54 35.33 Favored 'General case' 0 C--O 1.2 -1.548 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -173.81 145.52 1.15 Allowed 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 173.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -48.29 -39.12 20.67 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 123.515 0.509 . . . . 0.0 110.725 174.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -138.48 100.19 4.03 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.855 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.561 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 48.1 t -99.65 113.57 26.1 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 118.359 -1.336 . . . . 0.0 111.557 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.445 HE22 HG22 ' A' ' 32' ' ' VAL . 74.2 mt-30 -69.29 -10.77 59.39 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 124.889 1.276 . . . . 0.0 111.402 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.496 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 71.4 mtp180 47.32 54.77 15.96 Favored Pre-proline 0 N--CA 1.484 1.23 0 C-N-CA 123.692 0.797 . . . . 0.0 112.649 -172.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.496 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 14.1 Cg_exo -72.95 131.29 16.68 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 121.257 1.305 . . . . 0.0 110.559 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 81.1 m -111.67 105.48 14.01 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.442 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -143.66 143.09 31.29 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -68.67 -54.4 16.52 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 176.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -85.12 96.66 9.51 Favored 'General case' 0 N--CA 1.424 -1.73 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.633 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.5 p -168.66 116.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 123.482 0.713 . . . . 0.0 110.326 174.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -78.86 140.78 38.08 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.234 -0.894 . . . . 0.0 113.279 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -107.75 160.41 15.74 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 125.557 1.543 . . . . 0.0 108.429 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.7 m -124.43 138.46 53.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 117.962 0.346 . . . . 0.0 110.513 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 53.4 tt0 -106.44 138.82 41.92 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.451 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 30.6 p -90.23 113.86 25.75 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.979 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -85.67 27.6 0.84 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.813 0.845 . . . . 0.0 110.631 -177.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.429 ' HA3' ' SG ' ' A' ' 51' ' ' CYS . . . -96.63 -19.71 26.53 Favored Glycine 0 N--CA 1.432 -1.605 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.333 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.76 -14.81 0.91 Allowed Glycine 0 CA--C 1.539 1.556 0 C-N-CA 119.711 -1.233 . . . . 0.0 115.371 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.451 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 7.9 m -89.82 -29.62 18.5 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 118.709 1.254 . . . . 0.0 110.544 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 59.54 19.77 8.26 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.54 -177.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 20' ' ' GLN . 42.7 mt-10 -89.7 165.37 14.24 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.918 -178.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -106.25 127.29 53.13 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.276 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -118.76 155.64 30.76 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.47 -176.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.902 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 57.5 m80 -92.3 139.07 30.98 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 174.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.521 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 50.1 mt-30 -55.17 -51.87 65.11 Favored 'General case' 0 C--O 1.2 -1.533 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.445 HG22 HE22 ' A' ' 9' ' ' GLN . 8.9 p -66.38 -37.72 80.25 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.621 0 CA-C-O 121.587 0.708 . . . . 0.0 112.188 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.902 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 2.7 p -74.06 -25.16 59.68 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.029 -174.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.591 HG13 HG23 ' A' ' 36' ' ' VAL . 1.6 p -112.86 13.24 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 CA-C-O 121.494 0.664 . . . . 0.0 110.882 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.11 38.51 96.07 Favored Glycine 0 CA--C 1.556 2.633 0 N-CA-C 117.014 1.566 . . . . 0.0 117.014 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.603 HG13 ' SD ' ' A' ' 40' ' ' MET . 95.2 t -95.93 147.13 6.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 174.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 52.3 p -98.22 151.46 37.53 Favored Pre-proline 0 C--N 1.298 -1.673 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 174.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.521 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 14.6 Cg_endo -54.41 -31.43 68.24 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.801 2.334 . . . . 0.0 113.416 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -69.43 -32.45 71.41 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 123.932 0.893 . . . . 0.0 110.153 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.603 ' SD ' HG13 ' A' ' 36' ' ' VAL . 28.2 ttt -69.1 -42.85 75.59 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.033 0.933 . . . . 0.0 110.191 -176.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.52 -38.78 69.67 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -177.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -92.1 -47.0 7.48 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 119.053 -1.059 . . . . 0.0 113.712 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -71.15 -37.55 72.25 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 115.965 1.839 . . . . 0.0 115.965 -174.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -126.7 160.76 29.84 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.071 -1.052 . . . . 0.0 112.111 -171.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -78.02 115.53 17.83 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 121.294 0.569 . . . . 0.0 110.868 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -72.72 118.4 15.6 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.886 0.851 . . . . 0.0 112.796 175.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.2 mm -113.35 139.16 40.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 173.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.1 p -97.85 178.67 5.06 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.508 -174.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.1 tt -57.0 -37.63 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.622 0 C-N-CA 124.076 0.95 . . . . 0.0 112.805 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -83.36 -28.1 29.22 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 121.255 0.55 . . . . 0.0 110.849 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.429 ' SG ' ' HA3' ' A' ' 23' ' ' GLY . 60.2 m -77.11 -24.99 51.7 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.339 0.59 . . . . 0.0 110.693 177.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.58 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.873 -178.347 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.51 ' N ' HH21 ' A' ' 10' ' ' ARG . 48.7 m . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 121.362 0.601 . . . . 0.0 111.302 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.7 t -112.58 136.3 49.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 177.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.32 -174.41 4.38 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 119.676 -0.81 . . . . 0.0 109.027 -177.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.96 119.22 30.97 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -175.6 142.03 0.54 Allowed 'General case' 0 CA--C 1.496 -1.105 0 C-N-CA 123.432 0.693 . . . . 0.0 109.303 174.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -47.61 -44.27 26.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 124.264 0.978 . . . . 0.0 110.239 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -135.38 95.77 3.34 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.373 176.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.54 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 49.5 t -92.81 115.65 28.31 Favored 'General case' 0 N--CA 1.419 -1.992 0 C-N-CA 119.15 -1.02 . . . . 0.0 110.678 178.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -72.07 -8.74 56.34 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.415 177.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.51 HH21 ' N ' ' A' ' 1' ' ' SER . 58.9 ttt180 47.89 52.64 12.81 Favored Pre-proline 0 CA--C 1.565 1.548 0 C-N-CA 125.345 1.458 . . . . 0.0 112.073 -177.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.5 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 14.9 Cg_exo -70.97 132.76 22.0 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 121.503 1.469 . . . . 0.0 110.398 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 46.3 t -119.39 106.27 12.11 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.45 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -149.57 163.35 38.1 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -83.9 -55.91 3.98 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 173.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -68.19 82.95 0.23 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 121.333 -0.147 . . . . 0.0 111.206 172.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.7 p -173.1 104.52 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 122.052 0.929 . . . . 0.0 110.752 175.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -74.56 149.68 40.07 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 114.947 -1.024 . . . . 0.0 113.334 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -113.59 160.69 18.29 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 125.262 1.425 . . . . 0.0 109.793 -175.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.5 m -123.63 136.96 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-O 120.715 0.293 . . . . 0.0 110.274 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.474 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 54.1 tt0 -103.79 138.68 40.06 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 175.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 46' ' ' TYR . 29.4 p -90.73 103.56 16.25 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 118.976 -1.09 . . . . 0.0 110.688 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -82.82 21.03 1.06 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.052 -0.977 . . . . 0.0 111.18 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.49 -8.08 61.33 Favored Glycine 0 N--CA 1.434 -1.464 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.694 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 151.72 -23.7 0.93 Allowed Glycine 0 CA--C 1.54 1.627 0 C-N-CA 118.646 -1.74 . . . . 0.0 115.412 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.477 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 8.5 m -91.99 -29.59 16.53 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 118.839 1.319 . . . . 0.0 109.462 -176.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 58.07 26.47 13.64 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.921 -176.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 20' ' ' GLN . 37.7 mt-10 -94.43 167.19 11.67 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.4 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -108.39 129.31 55.25 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.374 -175.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -122.9 156.94 33.64 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.844 -177.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.905 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 56.1 m80 -94.0 141.19 28.81 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.592 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 51.0 mt-30 -58.38 -44.08 88.75 Favored 'General case' 0 C--O 1.187 -2.213 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.6 p -76.02 -37.8 34.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 118.862 -1.135 . . . . 0.0 111.273 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.905 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 1.8 p -70.76 -33.16 70.5 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.793 -174.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.494 HG13 HG23 ' A' ' 36' ' ' VAL . 1.5 p -106.16 12.25 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.803 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.42 66.12 3.07 Favored Glycine 0 CA--C 1.55 2.219 0 N-CA-C 116.586 1.394 . . . . 0.0 116.586 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.494 HG23 HG13 ' A' ' 34' ' ' VAL . 78.7 t -116.98 149.15 19.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 175.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.4 p -95.97 147.99 33.84 Favored Pre-proline 0 N--CA 1.418 -2.044 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.592 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 18.2 Cg_endo -56.3 -27.19 65.67 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 C-N-CA 122.725 2.283 . . . . 0.0 112.231 -176.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -74.54 -28.81 61.12 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.82 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.414 ' CE ' HG13 ' A' ' 36' ' ' VAL . 34.6 ttp -72.33 -39.0 68.51 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -176.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.73 -30.61 65.69 Favored 'General case' 0 CA--C 1.564 1.5 0 CA-C-N 114.633 -1.167 . . . . 0.0 113.431 -176.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -95.26 -13.18 25.09 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -118.03 -35.85 3.76 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 -172.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -131.17 153.48 49.38 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.584 0.629 . . . . 0.0 110.974 -173.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -71.72 126.9 30.9 Favored 'General case' 0 C--O 1.251 1.154 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.495 -176.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 54.1 t80 -76.36 110.93 11.29 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-O 122.028 0.918 . . . . 0.0 113.454 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.4 mm -95.21 134.93 30.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 173.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.44 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 13.4 p -101.57 -179.79 4.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 119.326 0.966 . . . . 0.0 109.095 -175.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.5 tt -54.43 -42.79 60.42 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 C-N-CA 123.862 0.865 . . . . 0.0 112.131 177.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -77.5 -28.5 52.17 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-O 120.656 0.265 . . . . 0.0 111.121 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.44 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 56.5 m -77.01 -26.25 53.58 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-O 121.06 0.457 . . . . 0.0 110.916 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.738 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.0 -178.145 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.7 t . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 122.317 1.056 . . . . 0.0 108.21 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 44.1 t -131.45 140.4 48.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.434 ' SG ' ' N ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -86.31 -172.89 4.27 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.575 -178.559 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.434 ' N ' ' SG ' ' A' ' 3' ' ' CYS . . . -97.4 123.07 41.11 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 176.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -172.32 141.66 1.24 Allowed 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 172.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -48.2 -28.22 2.87 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.967 0.907 . . . . 0.0 110.8 173.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -153.43 104.45 2.75 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.927 174.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.595 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 52.2 t -101.35 123.69 45.85 Favored 'General case' 0 N--CA 1.412 -2.341 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.566 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.413 HE22 HG22 ' A' ' 32' ' ' VAL . 70.2 mt-30 -75.64 -7.35 54.05 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.176 178.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.569 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 36.5 ttt180 47.93 48.78 6.32 Favored Pre-proline 0 CA--C 1.573 1.861 0 C-N-CA 125.751 1.62 . . . . 0.0 112.197 -176.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.569 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 6.1 Cg_exo -77.42 141.6 20.28 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.252 1.968 . . . . 0.0 111.818 -177.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.5 t -134.38 116.59 15.36 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.968 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -139.11 158.36 44.31 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 174.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -81.42 -3.0 51.59 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 122.056 0.932 . . . . 0.0 108.772 175.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -128.91 85.47 2.33 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.128 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.3 p -175.79 111.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 122.015 0.912 . . . . 0.0 111.003 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -73.01 159.26 33.94 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 114.116 -1.402 . . . . 0.0 111.953 176.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 17.8 m95 -125.51 159.35 32.21 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.068 0.947 . . . . 0.0 109.905 -174.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.1 m -129.19 136.42 59.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 120.79 0.329 . . . . 0.0 110.249 -178.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -101.48 139.74 36.72 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 29.9 p -88.06 103.14 15.44 Favored 'General case' 0 C--O 1.248 1.006 0 C-N-CA 118.698 -1.201 . . . . 0.0 110.124 176.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -81.66 21.51 0.81 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.066 -175.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.22 -12.94 55.66 Favored Glycine 0 N--CA 1.423 -2.217 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.87 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 149.78 -16.14 1.07 Allowed Glycine 0 CA--C 1.537 1.408 0 C-N-CA 118.509 -1.805 . . . . 0.0 116.143 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.462 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 13.5 m -90.63 -30.33 17.23 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 119.014 1.407 . . . . 0.0 109.454 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 60.83 22.55 12.6 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.52 -175.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -88.66 161.42 16.87 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.953 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -108.93 127.87 54.44 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.438 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -118.63 160.18 22.28 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.376 -176.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.93 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 48.9 m80 -94.77 134.71 37.09 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 174.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -54.27 -38.26 65.64 Favored 'General case' 0 C--O 1.203 -1.389 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 178.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.413 HG22 HE22 ' A' ' 9' ' ' GLN . 10.5 p -77.14 -42.16 31.3 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.315 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.696 178.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.93 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 10.0 p -71.71 -30.98 66.24 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.805 -172.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.521 HG13 HG23 ' A' ' 36' ' ' VAL . 1.4 p -103.99 10.85 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.073 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.636 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.34 60.33 9.14 Favored Glycine 0 CA--C 1.543 1.793 0 N-CA-C 116.187 1.235 . . . . 0.0 116.187 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.521 HG23 HG13 ' A' ' 34' ' ' VAL . 77.4 t -107.93 146.63 13.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 174.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.7 p -99.38 156.33 35.53 Favored Pre-proline 0 N--CA 1.413 -2.276 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -58.49 -25.88 75.84 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.458 2.105 . . . . 0.0 111.307 177.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -71.33 -34.41 70.52 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.015 -178.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 35.1 ttp -75.1 -47.42 28.79 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.696 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.7 -45.18 90.07 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -175.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -79.23 -18.69 52.36 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -177.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -116.43 -30.99 5.73 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 -173.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -131.42 166.34 21.51 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 119.638 1.108 . . . . 0.0 113.806 -172.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.82 117.64 17.77 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.463 -177.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.456 ' OH ' HG21 ' A' ' 34' ' ' VAL . 82.6 t80 -73.91 117.11 15.31 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-O 122.184 0.992 . . . . 0.0 113.598 178.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.5 mm -107.03 148.06 11.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 106.16 -1.792 . . . . 0.0 106.16 174.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.487 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 11.8 p -111.55 177.32 4.69 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 119.123 0.874 . . . . 0.0 108.756 -177.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.2 tt -55.2 -41.17 59.23 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.339 0 C-N-CA 124.047 0.939 . . . . 0.0 112.358 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -76.15 -32.79 59.26 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.048 0.451 . . . . 0.0 110.808 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.487 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 64.2 m -74.46 -25.38 59.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.219 0.533 . . . . 0.0 110.448 176.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.49 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.401 -178.525 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 C--O 1.249 1.072 0 CA-C-O 121.617 0.722 . . . . 0.0 110.563 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.4 t -119.02 139.57 45.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.412 ' SG ' ' N ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -96.01 -172.48 2.58 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.776 -176.147 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.412 ' N ' ' SG ' ' A' ' 3' ' ' CYS . . . -91.77 120.53 32.58 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -177.08 146.38 0.51 Allowed 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 172.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -47.9 -43.01 28.4 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 124.019 0.824 . . . . 0.0 110.802 174.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -140.12 99.96 3.8 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.91 173.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.552 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 47.3 t -91.5 120.42 32.31 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.892 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.442 HE22 HG22 ' A' ' 32' ' ' VAL . 70.7 mt-30 -71.06 -8.17 51.55 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.791 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.504 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 68.7 ttt180 48.99 53.99 15.47 Favored Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 125.51 1.524 . . . . 0.0 112.012 -175.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.504 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 10.8 Cg_exo -73.91 131.93 16.31 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 121.825 1.683 . . . . 0.0 111.037 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.3 t -125.36 110.21 13.7 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.003 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -137.44 156.59 47.99 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 174.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -68.52 -50.48 51.77 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.6 0.714 . . . . 0.0 110.236 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -103.11 92.73 4.65 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.227 0.537 . . . . 0.0 110.499 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.4 p -156.42 123.89 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.939 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.532 ' HB2' ' NE2' ' A' ' 31' ' ' GLN . 6.9 m-20 -69.62 157.63 36.84 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.747 -1.115 . . . . 0.0 113.204 177.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -133.29 159.67 39.56 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 125.524 1.53 . . . . 0.0 107.798 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.417 HG23 ' HB2' ' A' ' 29' ' ' PHE . 22.5 m -131.06 130.93 64.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 120.987 0.422 . . . . 0.0 110.577 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.455 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 50.4 tt0 -98.7 138.58 35.66 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 175.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.469 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 32.0 p -87.7 108.27 19.03 Favored 'General case' 0 C--O 1.25 1.121 0 C-N-CA 118.404 -1.318 . . . . 0.0 110.155 177.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -82.99 23.73 0.82 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.385 -177.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.32 -9.8 61.45 Favored Glycine 0 N--CA 1.417 -2.595 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.3 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 139.9 -14.35 3.1 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 119.12 -1.514 . . . . 0.0 115.567 177.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.469 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 19.1 m -87.41 -28.12 22.33 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 119.14 1.47 . . . . 0.0 108.709 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 59.5 21.59 10.08 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.961 -177.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' ' 20' ' ' GLN . 42.9 mt-10 -88.99 163.96 15.31 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 120.951 0.405 . . . . 0.0 111.653 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 44.9 m95 -108.14 128.69 54.91 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.239 -175.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.417 ' HB2' HG23 ' A' ' 19' ' ' VAL . 11.1 m-85 -121.89 158.54 28.77 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.913 -178.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.927 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 49.0 m80 -97.56 140.19 32.34 Favored 'General case' 0 CA--C 1.488 -1.413 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 174.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.532 ' NE2' ' HB2' ' A' ' 17' ' ' ASP . 50.8 mt-30 -56.95 -45.62 82.71 Favored 'General case' 0 C--O 1.191 -2.023 0 O-C-N 123.771 0.67 . . . . 0.0 112.75 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.442 HG22 HE22 ' A' ' 9' ' ' GLN . 9.8 p -71.07 -40.17 75.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 O-C-N 121.575 -0.703 . . . . 0.0 112.086 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.927 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 9.4 p -70.85 -33.95 71.16 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.837 -174.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.566 HG13 HG23 ' A' ' 36' ' ' VAL . 1.7 p -104.13 10.23 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 CA-C-O 121.291 0.567 . . . . 0.0 110.497 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.08 60.52 8.49 Favored Glycine 0 CA--C 1.551 2.339 0 N-CA-C 116.501 1.36 . . . . 0.0 116.501 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.566 HG23 HG13 ' A' ' 34' ' ' VAL . 74.6 t -115.87 148.3 18.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 175.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.1 p -100.13 149.83 36.36 Favored Pre-proline 0 N--CA 1.421 -1.912 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.477 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 72.9 Cg_exo -53.94 -30.23 57.68 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 122.961 2.441 . . . . 0.0 112.507 -178.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -69.3 -31.88 70.66 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.062 -178.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 35.2 ttp -74.84 -42.3 58.23 Favored 'General case' 0 C--O 1.208 -1.112 0 CA-C-O 121.269 0.557 . . . . 0.0 110.185 -177.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.42 -41.24 79.99 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -176.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -86.21 -14.02 45.19 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -113.37 -34.18 5.69 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -174.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -130.02 144.21 51.21 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 118.654 0.661 . . . . 0.0 111.105 -174.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -70.45 115.61 9.83 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.293 -178.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -69.74 120.2 15.13 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -176.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.8 mm -102.41 139.87 22.3 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.904 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 173.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.2 p -102.19 178.57 4.56 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.875 0.761 . . . . 0.0 109.88 -176.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.7 tt -55.98 -39.45 57.7 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.476 0 C-N-CA 123.769 0.828 . . . . 0.0 112.247 177.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -74.55 -38.47 62.72 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 121.159 0.504 . . . . 0.0 110.848 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 63.7 m -69.33 -27.18 65.14 Favored 'General case' 0 C--O 1.213 -0.819 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.89 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.109 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.67 -177.362 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.407 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 36.0 t . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 120.761 0.315 . . . . 0.0 110.324 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.8 t -123.81 130.69 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -178.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.42 ' SG ' ' N ' ' A' ' 4' ' ' ALA . 0.5 OUTLIER -90.45 -175.21 4.39 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.502 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.42 ' N ' ' SG ' ' A' ' 3' ' ' CYS . . . -95.67 123.17 39.1 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -176.11 151.31 1.04 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 172.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -47.13 -42.91 20.17 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.259 0.624 . . . . 0.0 110.928 173.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -141.58 107.57 5.18 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.801 176.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.589 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 47.0 t -101.19 116.85 33.77 Favored 'General case' 0 N--CA 1.42 -1.938 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.976 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -74.38 -11.38 60.23 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.156 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.521 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 31.5 mtm180 49.11 53.51 14.67 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 125.511 1.524 . . . . 0.0 114.388 -174.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 8.5 Cg_exo -78.05 139.7 17.36 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 121.826 1.684 . . . . 0.0 111.265 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.4 t -132.86 115.81 15.73 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -149.68 156.83 42.54 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.39 -15.38 63.53 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.194 0.598 . . . . 0.0 111.667 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -116.75 18.98 14.71 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -170.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.8 p -114.76 106.18 20.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.945 0.878 . . . . 0.0 112.465 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -72.75 148.37 44.69 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.355 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -113.18 158.97 19.77 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.511 1.125 . . . . 0.0 110.182 -174.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.2 m -125.98 132.16 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-O 120.678 0.275 . . . . 0.0 110.77 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -99.23 138.88 35.69 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.489 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 28.8 p -83.88 108.77 17.08 Favored 'General case' 0 C--O 1.255 1.345 0 C-N-CA 118.708 -1.197 . . . . 0.0 111.667 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -76.39 18.87 0.28 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.315 1.046 . . . . 0.0 112.17 -176.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.575 ' HA3' ' SG ' ' A' ' 51' ' ' CYS . . . -92.93 -18.67 39.36 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.117 -179.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 141.41 -6.83 2.5 Favored Glycine 0 CA--C 1.545 1.93 0 C-N-CA 119.185 -1.483 . . . . 0.0 115.978 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.489 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 16.9 m -88.89 -25.1 22.31 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 119.133 1.467 . . . . 0.0 109.315 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 59.92 18.48 7.53 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.299 1.04 . . . . 0.0 113.051 -176.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -85.91 159.36 19.68 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.212 0.529 . . . . 0.0 111.181 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -106.39 126.24 52.0 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.06 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.402 ' CD1' ' HE2' ' A' ' 46' ' ' TYR . 3.0 m-85 -118.64 159.31 23.83 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.706 -177.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.923 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 41.6 m80 -96.28 135.86 37.54 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.46 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 50.8 mt-30 -55.02 -40.05 69.76 Favored 'General case' 0 C--O 1.188 -2.148 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 177.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.415 ' CG1' ' HG2' ' A' ' 11' ' ' PRO . 11.7 p -76.43 -38.86 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.454 0 C-N-CA 119.692 -0.803 . . . . 0.0 112.092 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.923 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 7.7 p -75.08 -29.5 60.68 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -174.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.564 HG21 ' OH ' ' A' ' 46' ' ' TYR . 2.1 p -104.7 1.95 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 CA-C-O 121.678 0.751 . . . . 0.0 110.117 178.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.7 75.03 0.35 Allowed Glycine 0 CA--C 1.55 2.233 0 N-CA-C 115.813 1.085 . . . . 0.0 115.813 -176.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.563 HG23 HG13 ' A' ' 34' ' ' VAL . 64.3 t -127.97 147.94 32.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 175.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 52.2 p -99.54 150.97 37.27 Favored Pre-proline 0 N--CA 1.421 -1.886 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.46 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 18.2 Cg_endo -56.09 -23.75 45.86 Favored 'Trans proline' 0 N--CA 1.485 0.988 0 C-N-CA 122.925 2.417 . . . . 0.0 112.32 -177.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -74.2 -32.97 63.25 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.186 -178.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 35.4 ttp -73.91 -41.32 62.29 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -176.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.26 -43.06 87.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.214 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -83.58 -21.35 32.66 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -177.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -110.38 -27.68 8.93 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 -174.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -132.7 166.08 23.02 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.461 1.028 . . . . 0.0 111.927 -174.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -81.91 115.64 21.19 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.564 ' OH ' HG21 ' A' ' 34' ' ' VAL . 49.7 t80 -68.72 113.37 6.13 Favored 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.4 mm -101.28 140.5 19.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.48 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 8.3 p -107.9 178.53 4.49 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.171 -177.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.2 tt -55.36 -41.83 63.98 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 C-N-CA 124.131 0.972 . . . . 0.0 112.245 177.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -77.64 -25.31 49.58 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 121.25 0.548 . . . . 0.0 110.393 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.575 ' SG ' ' HA3' ' A' ' 23' ' ' GLY . 55.5 m -78.03 -26.93 48.68 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.191 177.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.779 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.023 -176.638 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.5 p . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.516 0.674 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.0 t -124.0 134.67 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.16 -173.56 3.29 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.43 119.73 33.6 Favored 'General case' 0 C--O 1.207 -1.162 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -177.64 142.26 0.31 Allowed 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 173.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -47.87 -45.1 29.94 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 124.046 0.841 . . . . 0.0 110.895 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -130.67 94.91 3.73 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.69 176.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.5 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 51.8 t -93.63 123.21 36.8 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 118.995 -1.082 . . . . 0.0 111.181 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -81.45 -11.68 59.15 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.831 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.569 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 62.4 mtm180 52.9 43.57 1.61 Allowed Pre-proline 0 CA--C 1.566 1.584 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -176.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.569 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 10.4 Cg_exo -76.86 143.63 23.57 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 121.619 1.546 . . . . 0.0 110.608 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 53.2 t -137.7 113.32 9.56 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.407 ' O ' HG12 ' A' ' 16' ' ' VAL . 97.7 mttt -142.69 151.38 41.3 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 177.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.24 -4.85 15.52 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 178.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -121.25 8.92 10.33 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -176.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 13' ' ' LYS . 7.2 p -102.86 107.18 21.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-O 121.756 0.789 . . . . 0.0 112.044 -178.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -74.07 146.8 43.38 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.592 176.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -111.95 159.16 18.67 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 124.638 1.175 . . . . 0.0 109.676 -174.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 23.1 m -123.86 132.65 71.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 O-C-N 121.949 -0.469 . . . . 0.0 110.763 -177.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -101.15 138.82 37.67 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.1 p -90.66 107.81 19.41 Favored 'General case' 0 C--O 1.255 1.35 0 C-N-CA 119.161 -1.016 . . . . 0.0 110.741 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -86.79 23.83 1.62 Allowed 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.926 -176.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.72 -14.09 60.14 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.11 -9.11 1.74 Allowed Glycine 0 CA--C 1.542 1.755 0 C-N-CA 119.032 -1.556 . . . . 0.0 116.234 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.479 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 13.9 m -92.58 -28.71 16.57 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 119.641 1.72 . . . . 0.0 110.209 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 61.91 17.69 9.15 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.831 1.253 . . . . 0.0 111.69 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -87.8 161.48 17.53 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.134 0.493 . . . . 0.0 111.598 -178.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -107.33 127.9 53.97 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.004 -176.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.411 ' HE1' ' SG ' ' A' ' 21' ' ' CYS . 3.5 m-85 -119.48 155.32 32.31 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -178.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.911 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 42.5 m80 -91.18 139.85 30.36 Favored 'General case' 0 CA--C 1.476 -1.867 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 174.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.493 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 48.4 mt-30 -54.45 -51.32 65.35 Favored 'General case' 0 C--O 1.192 -1.947 0 O-C-N 123.666 0.604 . . . . 0.0 111.806 177.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.8 p -68.2 -39.51 81.32 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 CA-C-O 121.125 0.488 . . . . 0.0 112.136 -178.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.911 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 3.4 p -72.76 -25.05 61.05 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.336 -174.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.486 HG13 HG23 ' A' ' 36' ' ' VAL . 0.9 OUTLIER -110.81 11.72 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.821 177.259 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.54 39.98 95.85 Favored Glycine 0 CA--C 1.546 2.021 0 N-CA-C 117.34 1.696 . . . . 0.0 117.34 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.486 HG23 HG13 ' A' ' 34' ' ' VAL . 69.4 t -93.92 147.95 5.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 118.153 0.976 . . . . 0.0 109.378 175.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.9 p -99.37 147.35 33.2 Favored Pre-proline 0 N--CA 1.414 -2.249 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 175.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.493 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 74.9 Cg_exo -51.41 -32.27 41.83 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.312 2.675 . . . . 0.0 114.062 -175.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.57 -26.02 60.63 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 35.9 ttp -73.38 -38.17 65.74 Favored 'General case' 0 C--O 1.213 -0.822 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.42 -43.98 79.9 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.659 -177.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -90.46 -12.28 37.82 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -113.59 -27.0 8.02 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -128.77 151.19 49.84 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.06 0.457 . . . . 0.0 110.324 -175.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -79.15 115.71 18.98 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.659 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.423 ' OH ' HG21 ' A' ' 34' ' ' VAL . 90.5 t80 -67.01 114.86 6.13 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-O 122.812 1.292 . . . . 0.0 114.428 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.0 mm -103.64 141.65 18.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 172.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.457 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 9.3 p -106.83 179.21 4.33 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.361 -176.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.5 tt -56.04 -43.28 74.94 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 C-N-CA 123.684 0.794 . . . . 0.0 112.269 177.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -76.04 -28.23 57.61 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.095 0.474 . . . . 0.0 110.943 -178.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.457 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 58.0 m -76.59 -25.56 54.07 Favored 'General case' 0 C--O 1.213 -0.83 0 CA-C-O 121.524 0.678 . . . . 0.0 110.901 176.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.293 -1.877 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.753 -176.809 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 121.644 0.735 . . . . 0.0 110.372 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.5 t -129.43 137.71 56.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.633 ' SG ' ' HA ' ' A' ' 29' ' ' PHE . 0.5 OUTLIER -100.77 -172.43 2.18 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 119.108 -1.037 . . . . 0.0 109.767 -176.204 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.99 121.94 31.85 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -173.78 145.3 1.14 Allowed 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 172.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -47.99 -42.0 26.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 123.771 0.669 . . . . 0.0 109.439 173.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -136.06 97.93 3.74 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.337 174.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.595 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 53.4 t -94.19 156.92 16.31 Favored 'General case' 0 N--CA 1.422 -1.843 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.24 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.646 ' C ' ' HD3' ' A' ' 11' ' ' PRO . 76.6 mt-30 -119.2 173.27 7.03 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.772 -177.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.422 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 19.2 mmm180 -116.69 62.88 2.77 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 123.416 0.686 . . . . 0.0 111.085 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.646 ' HD3' ' C ' ' A' ' 9' ' ' GLN . 5.0 Cg_exo -88.6 145.43 5.76 Favored 'Trans proline' 0 C--N 1.359 1.099 0 C-N-CA 123.389 2.726 . . . . 0.0 112.077 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 42.6 t -130.16 107.44 9.31 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.801 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -152.97 156.57 39.12 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 124.862 1.265 . . . . 0.0 108.581 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -87.77 -51.1 6.05 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 172.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -72.32 79.55 1.01 Allowed 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.992 175.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.6 p -165.61 102.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 122.125 0.964 . . . . 0.0 110.604 176.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -67.88 137.89 55.61 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 114.191 -1.368 . . . . 0.0 112.283 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 21.4 m95 -106.53 160.3 15.53 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.015 1.326 . . . . 0.0 108.945 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.5 m -127.83 132.72 68.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.115 0.483 . . . . 0.0 110.851 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.412 HE21 ' HA ' ' A' ' 26' ' ' ASP . 53.9 tt0 -100.45 138.99 36.76 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 30.6 p -87.69 102.67 14.87 Favored 'General case' 0 C--O 1.256 1.416 0 C-N-CA 118.997 -1.081 . . . . 0.0 110.595 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.52 24.44 0.57 Allowed 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.122 -175.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.64 -18.27 41.91 Favored Glycine 0 N--CA 1.437 -1.253 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 147.61 -10.65 1.27 Allowed Glycine 0 C--N 1.351 1.41 0 N-CA-C 116.951 1.54 . . . . 0.0 116.951 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.455 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 15.9 m -88.9 -26.8 21.4 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 119.754 1.777 . . . . 0.0 109.724 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.412 ' HA ' HE21 ' A' ' 20' ' ' GLN . 13.6 m-20 61.1 20.53 11.0 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.859 0.863 . . . . 0.0 112.417 -176.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -91.77 158.08 16.55 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.744 -178.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -107.77 132.78 53.02 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.896 -177.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.633 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . 3.5 m-85 -120.72 159.72 24.79 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.152 -177.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.874 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 42.4 m80 -93.35 134.49 35.52 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -56.87 -33.04 66.46 Favored 'General case' 0 C--O 1.197 -1.7 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 176.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.6 p -77.2 -41.6 30.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-O 121.336 0.589 . . . . 0.0 111.968 177.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.874 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 4.2 p -75.52 -29.17 59.37 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.992 -173.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.49 HG13 HG23 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -106.66 2.79 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.764 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.485 179.66 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.31 72.49 0.62 Allowed Glycine 0 CA--C 1.555 2.586 0 N-CA-C 116.316 1.286 . . . . 0.0 116.316 -176.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.49 HG23 HG13 ' A' ' 34' ' ' VAL . 59.3 t -121.2 148.77 24.34 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 C-N-CA 124.547 1.139 . . . . 0.0 108.176 175.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.6 p -99.99 150.83 37.22 Favored Pre-proline 0 N--CA 1.42 -1.946 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -49.95 -42.71 44.3 Favored 'Trans proline' 0 C--N 1.358 1.066 0 C-N-CA 123.051 2.501 . . . . 0.0 112.115 -177.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -60.07 -35.04 74.29 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 42.2 ttp -69.25 -43.33 74.19 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.617 -176.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.13 -48.24 80.84 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 123.792 0.683 . . . . 0.0 112.072 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -77.91 -13.78 59.77 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -176.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -122.19 -43.03 2.34 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 117.021 2.23 . . . . 0.0 117.021 -172.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -126.89 171.31 11.38 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -168.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -68.35 115.14 7.44 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.48 0.712 . . . . 0.0 112.184 -173.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.481 ' OH ' HG21 ' A' ' 34' ' ' VAL . 79.3 t80 -82.81 105.66 14.01 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 122.239 1.019 . . . . 0.0 111.757 172.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.0 mm -98.92 145.14 10.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 175.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.441 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 13.5 p -105.32 178.28 4.61 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 119.306 -0.958 . . . . 0.0 108.872 -178.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.0 tt -55.83 -41.31 65.94 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 124.071 0.948 . . . . 0.0 111.928 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -75.62 -39.89 57.15 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.912 0.485 . . . . 0.0 111.433 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.441 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 52.1 m -63.21 -29.81 71.08 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.023 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.696 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.587 -175.399 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.9 m . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 121.174 0.511 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.7 t -132.08 139.93 49.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -87.68 -173.68 4.43 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -178.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.59 119.98 34.1 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 174.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -173.25 140.91 0.89 Allowed 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 171.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -48.99 -43.61 40.38 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.931 0.769 . . . . 0.0 109.474 176.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -127.96 104.88 8.04 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.797 177.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.563 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 42.1 t -105.9 125.23 50.75 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 117.738 -1.585 . . . . 0.0 112.614 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -81.23 -6.06 58.45 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.161 -1.381 . . . . 0.0 110.571 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.587 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 73.3 mtp180 53.11 39.9 0.69 Allowed Pre-proline 0 CA--C 1.57 1.712 0 C-N-CA 124.465 1.106 . . . . 0.0 113.787 -176.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.587 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 7.2 Cg_exo -74.67 134.0 17.85 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 121.687 1.591 . . . . 0.0 112.076 -175.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 51.2 t -127.69 125.1 39.44 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -149.04 164.23 35.23 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -77.35 -14.63 59.69 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.498 0.666 . . . . 0.0 109.253 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -131.45 91.44 3.01 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.929 -177.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.2 p -171.56 103.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 122.164 0.983 . . . . 0.0 111.143 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.678 ' HB2' ' NE2' ' A' ' 31' ' ' GLN . 4.1 m-20 -68.85 140.56 55.22 Favored 'General case' 0 C--N 1.275 -2.665 0 CA-C-N 114.433 -1.258 . . . . 0.0 111.722 177.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -107.55 159.82 16.14 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 124.198 0.999 . . . . 0.0 108.825 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.4 m -127.26 134.08 66.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 120.905 0.383 . . . . 0.0 110.397 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -101.0 139.07 37.2 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 30.1 p -91.63 99.68 12.54 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 118.875 -1.13 . . . . 0.0 109.951 176.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -85.07 22.45 1.42 Allowed 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.698 -175.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.21 -2.75 62.02 Favored Glycine 0 N--CA 1.426 -2.022 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.562 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.15 -23.74 1.12 Allowed Glycine 0 CA--C 1.541 1.675 0 C-N-CA 118.878 -1.629 . . . . 0.0 116.203 178.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.458 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 5.6 m -95.09 -31.84 13.38 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 119.089 1.444 . . . . 0.0 110.015 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 61.59 19.39 10.36 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 124.019 0.825 . . . . 0.0 111.908 -176.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -85.73 158.95 19.9 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.716 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -104.67 127.63 52.49 Favored 'General case' 0 C--O 1.242 0.669 0 O-C-N 123.619 0.574 . . . . 0.0 112.342 -176.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.411 ' HE1' ' SG ' ' A' ' 21' ' ' CYS . 8.9 m-85 -118.12 156.38 28.77 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.889 -1.051 . . . . 0.0 108.786 -177.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.937 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 47.2 m80 -93.56 139.11 31.13 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 174.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.678 ' NE2' ' HB2' ' A' ' 17' ' ' ASP . 50.6 mt-30 -56.12 -46.24 79.23 Favored 'General case' 0 C--O 1.188 -2.137 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.0 p -72.66 -37.85 57.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.738 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.937 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 5.4 p -72.24 -31.75 66.09 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.832 -175.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.463 HG13 HG23 ' A' ' 36' ' ' VAL . 1.4 p -104.47 5.69 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.659 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.36 72.12 0.73 Allowed Glycine 0 CA--C 1.548 2.142 0 N-CA-C 115.408 0.923 . . . . 0.0 115.408 -176.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.463 HG23 HG13 ' A' ' 34' ' ' VAL . 74.5 t -127.61 147.3 32.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 173.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.4 p -100.25 150.56 37.02 Favored Pre-proline 0 N--CA 1.422 -1.832 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 176.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.418 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 11.0 Cg_endo -53.58 -25.2 32.0 Favored 'Trans proline' 0 N--CA 1.488 1.148 0 C-N-CA 123.513 2.809 . . . . 0.0 112.735 -177.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -73.53 -34.27 65.14 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.364 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 39.8 ttp -74.43 -38.16 63.12 Favored 'General case' 0 C--O 1.21 -0.986 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.206 -176.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.88 -44.11 77.84 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -176.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -85.82 -46.14 10.92 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 176.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -75.1 -35.48 61.76 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 -173.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -128.08 164.07 23.22 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -171.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -82.93 115.67 21.89 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.877 0.871 . . . . 0.0 111.512 -174.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.445 ' OH ' HG21 ' A' ' 34' ' ' VAL . 77.8 t80 -78.49 110.77 13.86 Favored 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.2 mm -102.29 146.22 10.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 172.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.481 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 7.9 p -111.0 179.83 3.94 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 119.226 -0.99 . . . . 0.0 109.737 -175.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.6 tt -55.02 -40.05 52.43 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.538 0 C-N-CA 124.448 1.099 . . . . 0.0 112.636 177.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -82.93 -29.13 29.38 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.481 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 56.7 m -73.98 -27.98 61.25 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-O 120.887 0.375 . . . . 0.0 111.198 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.423 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.578 -176.043 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 40.6 m . . . . . 0 N--CA 1.495 1.825 0 CA-C-O 121.951 0.881 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.2 t -123.53 139.84 48.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -178.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.4 p -87.72 -172.16 3.75 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -176.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.61 118.87 32.38 Favored 'General case' 0 C--O 1.206 -1.206 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 172.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -177.03 135.56 0.2 Allowed 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 171.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -51.36 -43.31 61.79 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.287 0.565 . . . . 0.0 110.483 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -121.91 103.11 8.61 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.886 175.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.579 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 42.2 t -107.49 122.16 46.08 Favored 'General case' 0 N--CA 1.417 -2.083 0 C-N-CA 118.024 -1.47 . . . . 0.0 111.993 177.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -79.49 -8.46 59.15 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.233 -1.349 . . . . 0.0 109.33 178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.487 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 38.1 ttp180 46.1 61.81 12.22 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 126.763 2.025 . . . . 0.0 111.997 -175.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.487 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 17.0 Cg_exo -76.23 132.98 14.32 Favored 'Trans proline' 0 C--O 1.252 1.184 0 C-N-CA 123.048 2.499 . . . . 0.0 111.752 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.4 t -123.82 102.66 7.92 Favored 'General case' 0 N--CA 1.44 -0.971 0 O-C-N 123.894 0.746 . . . . 0.0 110.479 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -141.03 159.6 41.87 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 175.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -81.74 -50.1 9.66 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.826 -0.75 . . . . 0.0 112.031 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -73.39 18.83 0.11 Allowed 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.5 p -102.74 111.21 31.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 119.287 0.949 . . . . 0.0 111.928 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -71.39 146.93 48.43 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.047 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -113.69 159.2 19.95 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.262 1.025 . . . . 0.0 109.822 -175.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.7 137.59 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-O 120.71 0.29 . . . . 0.0 110.546 -177.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -110.52 138.3 47.09 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.572 178.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.4 p -93.22 102.42 14.71 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.497 176.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -86.68 25.26 1.29 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.808 0.813 . . . . 0.0 109.881 -176.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.11 1.68 57.71 Favored Glycine 0 N--CA 1.431 -1.643 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.699 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 151.75 -35.28 0.86 Allowed Glycine 0 CA--C 1.534 1.256 0 C-N-CA 118.726 -1.702 . . . . 0.0 115.608 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.4 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 7.4 m -89.27 -32.75 17.23 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 118.548 1.174 . . . . 0.0 109.488 -176.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 59.95 21.39 10.43 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.748 1.219 . . . . 0.0 111.634 -177.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -88.15 163.7 16.06 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.731 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -105.29 127.52 52.99 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.115 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -117.12 155.15 29.8 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.684 -178.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.95 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 44.2 m80 -92.54 137.73 32.11 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 174.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -52.46 -51.74 57.76 Favored 'General case' 0 C--O 1.198 -1.62 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.3 p -68.63 -37.02 77.04 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 CA-C-N 118.533 0.606 . . . . 0.0 112.246 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.95 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 8.1 p -72.51 -27.29 62.17 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.23 -175.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.528 HG13 HG23 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -109.68 12.92 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.944 0 CA-C-O 121.753 0.787 . . . . 0.0 110.727 177.779 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.18 35.98 92.65 Favored Glycine 0 CA--C 1.553 2.433 0 N-CA-C 117.257 1.663 . . . . 0.0 117.257 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.528 HG23 HG13 ' A' ' 34' ' ' VAL . 86.5 t -93.97 147.48 5.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 117.775 0.788 . . . . 0.0 109.74 176.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.3 p -104.36 150.69 38.72 Favored Pre-proline 0 N--CA 1.415 -2.198 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 175.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -47.59 -39.63 29.74 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 123.475 2.783 . . . . 0.0 112.987 -177.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -58.15 -38.86 77.41 Favored 'General case' 0 C--O 1.214 -0.809 0 C-N-CA 124.475 1.11 . . . . 0.0 111.609 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.415 ' HB3' HG13 ' A' ' 36' ' ' VAL . 33.3 ttp -72.36 -39.54 67.99 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.813 -175.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.83 -49.05 77.96 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 123.741 0.651 . . . . 0.0 112.71 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -90.13 -24.01 21.2 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -177.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -98.53 -28.03 13.77 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.177 -1.009 . . . . 0.0 113.684 -172.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -139.05 -179.83 6.07 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -176.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -83.92 118.26 23.88 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 113.586 -1.643 . . . . 0.0 112.477 -174.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -88.18 110.37 20.64 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 122.272 1.035 . . . . 0.0 113.551 175.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.401 HG23 ' HB3' ' A' ' 51' ' ' CYS . 47.2 mm -107.89 141.15 23.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 172.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.9 p -97.9 176.56 5.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.276 -175.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.8 tt -54.15 -36.25 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.343 0 C-N-CA 124.255 1.022 . . . . 0.0 112.596 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -81.71 -35.67 29.51 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-O 120.881 0.372 . . . . 0.0 110.095 -178.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.401 ' HB3' HG23 ' A' ' 47' ' ' ILE . 64.6 m -74.39 -25.05 59.25 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-O 121.422 0.63 . . . . 0.0 111.482 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.1 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -178.812 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 37.4 t . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 120.934 0.397 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 99.6 t -99.12 127.72 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -178.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.49 ' SG ' ' HA ' ' A' ' 29' ' ' PHE . 0.5 OUTLIER -94.28 -174.83 3.48 Favored 'General case' 0 N--CA 1.433 -1.313 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.35 -176.08 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.07 120.06 31.72 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -175.25 147.19 0.88 Allowed 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 123.166 0.586 . . . . 0.0 109.454 171.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -48.04 -41.52 25.97 Favored 'General case' 0 CA--C 1.558 1.267 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.825 173.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -137.69 98.27 3.64 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.488 173.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.528 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 43.8 t -94.33 117.82 30.69 Favored 'General case' 0 N--CA 1.428 -1.562 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.284 -178.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -85.67 164.34 17.73 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.47 83.64 11.07 Favored Pre-proline 0 C--N 1.311 -1.073 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -70.4 157.43 59.16 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.759 2.973 . . . . 0.0 111.49 172.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.9 p -135.72 27.73 3.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.127 0.489 . . . . 0.0 111.28 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -94.54 146.48 24.08 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 120.475 -0.49 . . . . 0.0 112.022 -177.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -68.33 -53.93 20.87 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 174.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -76.05 91.49 3.1 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.366 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.8 p -170.43 98.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 122.409 1.099 . . . . 0.0 110.961 173.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -66.52 142.71 57.43 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 114.252 -1.34 . . . . 0.0 113.589 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 15.7 m95 -109.12 160.3 16.18 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.763 1.225 . . . . 0.0 109.899 -177.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.3 m -130.35 143.61 40.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 121.291 0.567 . . . . 0.0 111.898 -178.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -112.62 138.73 48.99 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.547 ' HB3' ' O ' ' A' ' 25' ' ' CYS . 43.4 t -77.67 101.31 6.55 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.424 0.631 . . . . 0.0 111.401 -178.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -88.74 10.57 20.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 122.524 1.154 . . . . 0.0 108.435 -178.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.9 -2.14 78.75 Favored Glycine 0 N--CA 1.419 -2.436 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.338 177.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 144.74 -26.25 1.94 Allowed Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 119.919 -1.134 . . . . 0.0 114.929 176.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.547 ' O ' ' HB3' ' A' ' 21' ' ' CYS . 17.2 p -114.87 90.09 3.25 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 117.151 -1.82 . . . . 0.0 111.955 -177.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -39.73 13.96 0.0 OUTLIER 'General case' 0 N--CA 1.532 3.631 0 N-CA-C 117.806 2.521 . . . . 0.0 117.806 173.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 25' ' ' CYS . 40.4 mt-10 -81.73 160.91 23.52 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-N 118.769 0.713 . . . . 0.0 109.725 176.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -105.73 130.21 53.78 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.49 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . 17.6 m-85 -118.95 151.62 37.84 Favored 'General case' 0 CA--C 1.562 1.407 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.646 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.884 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 35.2 m80 -88.5 141.87 28.18 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 173.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.466 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 49.8 mt-30 -56.94 -52.11 66.5 Favored 'General case' 0 C--O 1.192 -1.932 0 C-N-CA 120.3 -0.56 . . . . 0.0 112.015 176.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.5 p -67.12 -40.52 85.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.884 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 2.1 p -71.1 -27.31 63.51 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.215 -174.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.476 ' CG1' HG23 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -109.96 9.15 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.123 0 CA-C-O 121.255 0.55 . . . . 0.0 111.448 178.781 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.38 40.54 96.47 Favored Glycine 0 CA--C 1.557 2.675 0 N-CA-C 117.392 1.717 . . . . 0.0 117.392 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.476 HG23 ' CG1' ' A' ' 34' ' ' VAL . 78.5 t -92.13 149.18 4.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.9 p -100.7 150.42 36.98 Favored Pre-proline 0 N--CA 1.426 -1.666 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 176.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.71 -34.58 54.49 Favored 'Trans proline' 0 N--CA 1.483 0.855 0 C-N-CA 123.031 2.488 . . . . 0.0 112.733 -176.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -72.98 -27.86 62.05 Favored 'General case' 0 N--CA 1.414 -2.235 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.287 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.427 ' HE1' HG22 ' A' ' 36' ' ' VAL . 49.9 ttp -73.12 -37.3 66.73 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -177.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.02 -32.11 70.58 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.823 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -95.7 -21.31 18.26 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -113.32 -33.81 5.83 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 115.729 1.752 . . . . 0.0 115.729 -171.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -123.33 163.52 20.59 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 118.809 -1.156 . . . . 0.0 113.045 -173.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -82.63 115.13 21.45 Favored 'General case' 0 C--O 1.253 1.266 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.153 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.491 ' HD2' ' HA ' ' A' ' 21' ' ' CYS . 63.5 t80 -71.59 108.97 5.23 Favored 'General case' 0 C--O 1.249 1.079 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.6 mm -98.61 146.21 8.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 170.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 18.2 p -107.04 178.68 4.49 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 119.509 -0.877 . . . . 0.0 110.6 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.3 tt -50.5 -34.79 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.368 0 C-N-CA 125.399 1.48 . . . . 0.0 113.126 177.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -89.79 -37.92 14.16 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 80.1 m -78.04 -23.5 48.12 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.889 0.376 . . . . 0.0 111.155 -177.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.685 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.357 179.553 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.41 ' N ' HH21 ' A' ' 10' ' ' ARG . 51.0 m . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 120.923 0.392 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.8 t -129.46 137.35 57.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.446 ' SG ' ' HA ' ' A' ' 29' ' ' PHE . 0.5 OUTLIER -100.08 -172.38 2.21 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 119.544 -0.862 . . . . 0.0 108.731 -178.506 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.54 119.45 29.0 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -177.88 143.8 0.33 Allowed 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 172.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -47.58 -40.91 20.38 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 123.63 0.582 . . . . 0.0 110.956 175.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -136.8 102.03 4.77 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.118 174.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.588 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 50.3 t -96.48 117.49 31.01 Favored 'General case' 0 N--CA 1.412 -2.345 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.846 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -76.16 -5.35 46.3 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.379 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.564 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 80.7 mtp180 54.92 38.25 0.46 Allowed Pre-proline 0 CA--C 1.573 1.856 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 14.0 Cg_exo -69.99 139.16 38.74 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 121.213 1.275 . . . . 0.0 112.24 -176.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 53.3 t -139.67 118.72 12.62 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.223 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -145.06 174.08 11.35 Favored 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -70.29 -66.16 0.63 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.239 0.542 . . . . 0.0 110.794 175.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -87.35 94.0 9.56 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -178.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.3 p -165.07 103.85 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.981 0.896 . . . . 0.0 111.305 176.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -69.16 146.3 52.57 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 114.233 -1.349 . . . . 0.0 113.238 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -115.71 160.4 20.12 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 125.779 1.631 . . . . 0.0 109.201 -177.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.3 m -126.64 136.93 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 120.772 0.32 . . . . 0.0 110.772 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -104.55 138.05 41.48 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 174.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.402 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 28.8 p -87.81 106.58 18.17 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 118.728 -1.189 . . . . 0.0 108.973 176.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -83.82 17.24 2.4 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.685 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.63 -1.27 66.12 Favored Glycine 0 N--CA 1.435 -1.397 0 C-N-CA 121.049 -0.596 . . . . 0.0 113.159 -176.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.23 -31.17 1.07 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 118.581 -1.771 . . . . 0.0 115.793 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.4 m -86.74 -28.66 22.91 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 118.934 1.367 . . . . 0.0 110.167 -175.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 60.02 22.28 11.42 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.763 1.225 . . . . 0.0 112.11 -176.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -93.87 165.79 12.5 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -108.93 130.87 55.45 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.446 ' HA ' ' SG ' ' A' ' 3' ' ' CYS . 6.3 m-85 -122.83 153.62 39.33 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.493 -177.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.905 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 49.5 m80 -91.18 137.61 32.23 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 173.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.594 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 50.6 mt-30 -55.38 -45.67 76.55 Favored 'General case' 0 C--O 1.189 -2.104 0 O-C-N 123.892 0.745 . . . . 0.0 112.623 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.4 p -72.01 -40.42 67.52 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.39 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.751 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.905 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 2.8 p -72.8 -32.36 65.5 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.476 -173.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.55 HG13 HG23 ' A' ' 36' ' ' VAL . 2.5 p -103.61 6.9 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-O 121.256 0.55 . . . . 0.0 110.136 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.87 73.85 0.43 Allowed Glycine 0 CA--C 1.543 1.825 0 N-CA-C 115.452 0.941 . . . . 0.0 115.452 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.55 HG23 HG13 ' A' ' 34' ' ' VAL . 56.5 t -127.15 145.15 35.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 174.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.7 p -92.22 147.57 34.88 Favored Pre-proline 0 N--CA 1.425 -1.69 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 175.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.594 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 10.7 Cg_endo -51.22 -39.39 62.0 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.424 2.749 . . . . 0.0 113.457 -174.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -74.03 -25.38 59.84 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -178.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.484 ' CE ' HG13 ' A' ' 36' ' ' VAL . 37.5 ttp -68.48 -36.73 79.36 Favored 'General case' 0 C--O 1.211 -0.951 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.77 -39.76 81.97 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.286 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -88.4 -21.97 24.0 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 -177.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -115.64 -31.71 5.76 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -172.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.437 ' HB2' ' HG3' ' A' ' 40' ' ' MET . 37.5 mt-10 -117.96 157.11 27.35 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.975 -171.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -83.36 116.25 22.38 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.139 -176.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -82.82 103.81 12.58 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.2 mm -94.32 137.87 21.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 113.581 -1.645 . . . . 0.0 106.692 172.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.8 p -99.0 178.34 4.97 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 119.406 -0.917 . . . . 0.0 109.3 -174.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.8 tt -55.76 -41.45 65.83 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.287 0 C-N-CA 123.969 0.908 . . . . 0.0 112.383 178.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -76.61 -33.14 58.42 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 121.395 0.617 . . . . 0.0 110.88 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 61.4 m -72.75 -26.67 61.64 Favored 'General case' 0 C--O 1.211 -0.944 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.156 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.296 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -177.243 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.444 ' N ' HH21 ' A' ' 10' ' ' ARG . 22.5 m . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.737 0.303 . . . . 0.0 110.604 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.8 t -125.75 140.68 47.76 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -178.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -92.17 -172.24 3.07 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.61 118.78 28.51 Favored 'General case' 0 C--O 1.213 -0.859 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -176.65 145.7 0.55 Allowed 'General case' 0 CA--C 1.492 -1.251 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 171.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -48.09 -43.58 30.9 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 123.732 0.645 . . . . 0.0 110.324 175.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -137.39 105.75 5.77 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.228 175.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.608 ' HA ' ' HB2' ' A' ' 33' ' ' CYS . 53.4 t -97.71 117.12 31.29 Favored 'General case' 0 N--CA 1.402 -2.83 0 C-N-CA 119.734 -0.787 . . . . 0.0 111.512 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -69.48 -8.6 48.35 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.936 177.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.568 ' N ' ' HD3' ' A' ' 11' ' ' PRO . 46.3 ttt180 52.64 43.21 1.46 Allowed Pre-proline 0 CA--C 1.604 3.057 0 C-N-CA 124.727 1.211 . . . . 0.0 113.768 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.568 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 2.8 Cg_exo -78.84 145.54 20.08 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.072 1.848 . . . . 0.0 112.622 -178.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 50.9 t -133.47 115.96 15.41 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.122 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -146.84 154.02 40.85 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 174.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -69.15 -12.55 61.77 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.225 0.536 . . . . 0.0 110.509 176.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -125.36 51.27 1.71 Allowed 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.21 -173.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.5 p -141.51 99.57 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 121.809 0.814 . . . . 0.0 110.718 175.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -68.72 145.0 54.22 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 114.817 -1.083 . . . . 0.0 112.07 176.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -106.93 159.73 16.05 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 124.577 1.151 . . . . 0.0 109.34 -176.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.0 m -125.76 141.37 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.602 -178.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.447 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 61.4 tt0 -111.29 137.85 48.5 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.474 ' SG ' ' HB2' ' A' ' 25' ' ' CYS . 31.6 p -94.81 104.48 16.38 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.882 178.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -88.22 23.97 2.0 Allowed 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.264 0.554 . . . . 0.0 110.322 -177.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.4 -4.98 73.01 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 148.6 -17.48 1.27 Allowed Glycine 0 CA--C 1.539 1.586 0 C-N-CA 119.68 -1.247 . . . . 0.0 115.64 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.474 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 9.6 m -97.8 -33.37 11.29 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.505 1.152 . . . . 0.0 110.495 -178.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 62.24 19.03 10.67 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 123.767 0.827 . . . . 0.0 111.877 -176.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 20' ' ' GLN . 47.8 mt-10 -85.05 168.14 15.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.831 -176.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -114.49 125.9 54.33 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-O 121.283 0.563 . . . . 0.0 111.915 -176.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -119.32 159.03 24.91 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.505 -176.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.939 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 38.1 m80 -94.37 136.17 34.97 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 173.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.437 ' OE1' ' HA ' ' A' ' 38' ' ' PRO . 50.3 mt-30 -55.34 -41.06 71.97 Favored 'General case' 0 C--O 1.191 -2.017 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 177.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.8 p -74.77 -41.74 47.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.914 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.939 ' SG ' ' HB2' ' A' ' 30' ' ' HIS . 9.2 p -72.0 -29.27 64.05 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.574 -174.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.53 HG13 HG23 ' A' ' 36' ' ' VAL . 1.4 p -105.0 5.48 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.958 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.87 73.64 0.46 Allowed Glycine 0 CA--C 1.553 2.443 0 N-CA-C 115.452 0.941 . . . . 0.0 115.452 -176.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.53 HG23 HG13 ' A' ' 34' ' ' VAL . 54.9 t -125.58 149.46 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 174.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.7 p -101.25 147.97 34.51 Favored Pre-proline 0 N--CA 1.418 -2.056 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 176.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.437 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 19.4 Cg_endo -55.84 -27.47 62.76 Favored 'Trans proline' 0 N--CA 1.487 1.132 0 C-N-CA 123.11 2.54 . . . . 0.0 112.283 -176.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -73.7 -28.36 61.69 Favored 'General case' 0 N--CA 1.421 -1.895 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.719 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 44.2 ttp -74.13 -39.67 63.16 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.07 -43.91 82.58 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -176.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -88.12 -13.62 40.86 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -111.39 -39.24 4.74 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -175.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -126.07 166.32 17.21 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -170.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -74.98 118.58 18.1 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.907 0.883 . . . . 0.0 112.473 -178.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -83.11 103.8 12.81 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 122.383 1.087 . . . . 0.0 111.979 175.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.6 mm -100.21 143.57 13.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 173.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.416 ' H ' ' HB2' ' A' ' 51' ' ' CYS . 12.4 p -103.93 176.97 4.98 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -176.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.2 tt -54.0 -38.23 36.75 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.343 0 C-N-CA 123.979 0.912 . . . . 0.0 112.89 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -87.04 -26.5 23.7 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.982 -0.448 . . . . 0.0 111.683 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.416 ' HB2' ' H ' ' A' ' 48' ' ' CYS . 52.1 m -72.41 -25.63 61.55 Favored 'General case' 0 C--O 1.213 -0.828 0 CA-C-O 121.101 0.476 . . . . 0.0 110.796 176.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -1.001 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -177.766 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_